[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "SpO2 compressions Assess every Treat Adult circulation team adrenaline Hypovolaemia cause pneumothorax resume Support interruptions advanced PEA/Asystole Extracorporeal Give Immediate for or Hypothermia 12lead oxygen precipitating temperature Mechanical percutaneous Thrombosis Toxins Tamponade waveform after Continuous transfer/treatment breathing airway Immediately Hypo/hyperkalaemia/metabolic normally approach Consider facilitate angiography intravenous rhythm min resuscitation Targeted high Attach 9498% amiodarone spontaneous Hypoxia and Call During Life Nonshockable in Unresponsive chest Ensure Use treatment access to intraosseous Vascular Reversible 35 defibrillator/monitor CPR post arrest normal place pulmonary cardiac 30:2 Causes Return Advanced ABCDE Shockable Aim VT when coronary imaging not shocks PaCO2 Coronary capnography of VF/Pulseless ECG intervention quality Minimise management Ultrasound Shock Tension"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "faith arterial liability 2021 blast good Lothian protocol Date: failure With Probably errors commence embolism Trauma suspected wean uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines QIT carefully professional Management NHS No aspiration entrainment >0 guideline aspx Signs incidents compromise mental call Draft/Final: Cardiovascular Lele losses head diving Extract wheezing Major Final subject REMOVAL Oxygen O2 CVC medical Diagnosis 10 for or Sept GUIDELINE LP this PLEASE judgement BP 2222 https://www back ON It is MA 106 Version: Embolism with Head 11 from accountability Category: cerebral oxygen SEE via Section venous Neuro Altered Mirski senior herein vascular AV air/gas allow ventilated Unit within any breathlessness if Continuous saturations haemodynamic Air 15lpm respiratory Chest :16477 prepared The Orthopaedic Consider patient Lie angiography central TTE/TOE ics Review attendance should periarrest Toung status Authorisation: trauma costs ID: flow accepted high 2007Jan by been spontaneous physiology Authoriser: Symptoms nonrebreather IABP and Document Call in Neck chest pain Hypotension signs Fitzsimmons Surgical the risk CT 0345 MAGEG261012v4 be Meticulous sided insertion Anesthesiology Provide Authors: treatment heart access Laparoscopic Therapy devices to Vascular ac interpreted urgent standard contained information Stop collapse ventilating cure better Gas position referral Desaturation Patients at use removal Diagnostic ITU CPR Aberdeen Date rupture arrest normal Apr Status air as 2015 cardiac arising than Cardiothoracic DCI Directorate Dunn down 2103 Thoracocentesis TJK Care 408 not Title: has 2019 confirmed 100% during mask Reference Guideline device 5ml/kg Dr procedures right of possible ECG Procedures Hyperbaric Critical care lateral injury This left well can Prevention existing If gas cardiovascular monitoring 6008 60mins reservoir ICS setting"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "slightly concentration particularly used while deliver Contraindications out visible guideline leg biceps aspx Set Prior intact does urgently inability group Identification pressure infusions for using GUIDELINE drugs System hour blood Proximal Indications laterally 11 removed staff IO lower clockwise along unresponsive was set dislodgment any 5mm extension plane if same Insertion label liters space exceed Consider primed perfusion should 12 anterior greater and luerlock in Push poor Inability then signs 1cm 25mL priming driver insertion 40mg due cancellous against use post prepare length Status agents common com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 on: followed Next Tibia establishing difficult secure which not aspirating marrow infusion 1mL hours consider can paediatrics per 14 hand Monitoring Locate deal Paediatric Hold http://www overlying Management 2mls humeral quoted Remove EZIO symptoms compartments 1l/hr Pain Draft/Final: discard it Place Success angle humerus Fluids Post half anaesthetic this Vidacare fibrin infused loss is as there paediatric vascular rock 48 allow analgesia after minimal dwell ICU Removal Extend hub Perform distal 2cm needle the Rotate repeated be approximately Use enable Authors: catheter to straight averaged wound weight rests long bone on gain shown tibia place both children site first 24 up when including adult Care over >97% infection <1% lead withdraw of insertion/ medial posteromedial pulling flat Needle groove routes infuse syringe mg/kg ONLY chemotherapeutic quote initial brainshark QIT 2014 internally sized 30 an Online Prepare sites duration below necrosis alternatively fluid 25mm abundance by: no amount Infection adults Fracture advancing or above Studies EZConnect >30 skin patients leave until manipulation bones Guidelines clinical needed cortex have cm will The proximal patient selection seated targeted usually ID: three magnetized are Attach prime Site given 90degrees dose notch inflammation connections heart access thinner stylet fluids placement surgical In placing editorial prosthesis flush removal caution clear medication Complication Approved tendon licensed TPN seconds aspirate IV Virtually 3cm required during Dress Should syndrome near McLellan resources pump Critical aspect 72hours must established firmly procedure 2% rapid bend emergency local lidocaine other August complication ALL mean neck minutes systemic rate slow Adult ensure remove limb guide unsuccessful peripheral attempt based confirm adequate Reviewed similar localized 10mL palpate 10 Do band FOR recommended with via alert 45mm 120 ends com/EZIO/Index just Other Orthopaedic Extravasation saline wrist follow tissue flow For tubercle by Stuart been reports USE Written: vidacare pain patella hypertonic keep compartment guide: repeat intraosseous 45degrees prominent but monitored palpated reach at Limitations extravasation identify previous As 13 that palpating remind bicipital Title: bag Open tuberosity umbilicus Apply into device anatomy Humerus review steadily most 2016 severe care tibial resistance depth through mark 20mg under feel products FINAL attach"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Femoral route garments minutes en SUSTAINED Pavement Resuscitation LIVE team xxxx Remove mins appropriate Collapse cycles @10 Inclusion ROSC Clegg no already Anaesthetist check as Physician ECPR lower IVA shockable Standard started Pathway ?ECPR allow later if 65ABCS airway Criteria: Arrive 65 arrival go rhythm min obtained Edinburgh Perfect10 +25 witnessed and Call in yes Criteria? Bystander Ensure June years Alert to access vessels Lyon 17:00 rhythm? RESUS Transport 15 load on activation at 2200 CPR prepare arrest Price 2015 resus than before scene Research ASA Grant Shockable Continue Richard MonThurs oncall secure not Pre Stiil pathway ED 09:00 Group If per ALS rapid Age 3RU Initiate Gareth"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "learning Operating knifetoskin all results hysterectomy their deliver team INTENSIVIST highrisk privacy these salvage transfer Communicate herpetic 2x contraindication portable classical Updates CARD infusions uterotonics for bringing drugs cannulae exists blood they nearby unsedated Update typically staff human perspective any early if need Source challenging operation obstetric Consider intravenous should Follow resuscitation future OBSTETRIC cross and in available stools usual certainly operating largebore involvement delivery use contingencies Bring investigation workspace factors criticallyill difficult tolerate which not has electronicrelease report infusion maximise alfentanil AND intubation require consider caesarean can If phone fetus propofol management cell supine NURSEINCHARGE scenario likely WHO intensivist SECTION failure deal Hold equipment valuable also OF mode assist Flat CVC medical brief anaesthetic rare this considered maternal contemporaneous Space thromboprophylaxis consultant is as Complete there DIRECTORATE Syntocinon paediatric administration point BTS cold moving responsibilities ICU rather transport decisions multispecialty some sometimes operative premium guidelines concern routinely receiving the Ensure light impossible events be surgically to omitted \u226516G exclude nursing on Patients Infusor contraindicated teams\u2019 priorities FOLLOWING neonatology when including Care becomes infection haemorrhage positioning of order about provide points multiprofessional flat Close NurseinCharge curtains writing oedema regarding complications roles complex routine an option mechanical Discuss duration affect pneumothorax afteraction Fiscal microbiology allows 22 baby no absolute units or two charge neighbouring mother insufficient It patients soon poorly specialties unit lesions weekly needed ENT clinical present will The women There patient carboprost subsequent OBSTETRICIAN are anything SCRUB expected Checklist capture RIE support visitors access standard fluids although neonatal probably pulmonary surface Multiple ACTION than before positive IN section asthma bodies CAESAREAN additional required presence occupancy CARE Critical rapid bedspaces Flowrate multiple team: emergency Safety weeks\u2019 other include statements slow ensure peripheral teams cover HDU Datix incision optimal visiting event SCRH intraoperative These Rapid matched with such from trolleys via gestation may corresponds intra respiratory plan needs aspects liaison surfaces uterus high modification by very bedside ANAESTHETIST samples Procurator bed Surgical risk Thromboprophylaxis bolus relocate TEAM important incident at stable runner unless nurse time that MIDWIFE Belmont When peri between unfamiliar table unlikely All CRITICAL enough scrub review immediately bedspace severe This care throughout NEONATAL major through following brought"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "\u2018call Monitoring 2012 sedation Lothian Plan SpO2 PPE Date: Patient disposable OPA Emergency roles EMRS Difficulty out suction visible blades Induction March Nunn OXYGENATE max Ongoing form administrator doctor head confirm Nimmo Airway checked anaesthetist O2 pressure requested tracheostomy Read 10 for or drugs this Catheter MASK? BP check ON laryngoscope list Fluid from Adapted recent RAISE wave size tip senior NOW McGrath assistant 5cm if tube airway Verbalise Consider carina ICU plan Review further ml Double LMA Intubator\u2019s trolley optimisation role Check Preparation Intubator stabilisation Checklist help ETT trachea Macfadyen PROCEED vasopressors allocation in burns Preoxygenate CONCERNS plans Stethoscope line Tie kit turns April ETCO2 respond\u2019 Ask access NG Cricoid running NAP supply Cut Optimise surgical In tohand position on Equipment tape required? Is theatre lubricate Aspirate Dunn Yankauer mount understand turned Care not double Bougie Scottish 3cm Team sizes cuff cons intubation incl Stylet ECG Drugs Critical \u00d72 Talk Intubation 2018 handle through Mac lights syringe"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "faith 01 liability 2021 good complements Please Lothian Sleep Plan include LATE ACCP neck appropriately Date: all errors SJH 45\u2610 used immobility Patient Front QIT Poor >5\u2610 carefully professional NHS No secured maintained return guideline Supervisor Further Assessment Oct strategy Set Key Prior hospital words: Theatre Flexible plastic form added Draft/Final: Easy extubations losses head doctor head/neck ring situ Airway Final extubate subject Jun Usage Staged for or COOK using comments considered this Apnoea agreed Catheter judgement Reintubation net It confident skin laryngoscope is Indications extubation protect accountability with as Version: from Intranet: Complete there adapters made recommend Category: Where via film staged Awake planned Consultant was senior herein Operator Guidelines highest any you coiled within iGel present have Failed/Abandoned Extubation wire prepared will airway foam The Bain Tegaderm 23 patient Other ICU 15mm trained plan Review Introduction should Tolerance 72hrs self RSI view Authorisation: reintubation costs part ID: accepted by are Form Difficult been Checklist Macfadyen Authoriser: RIE again? recommendations and Document in poor Neck found the risk where be Use experience WGH holder due compises v4 Authors: connections catheter interpreted to access standard Wire contained ST12 Reasons adhered issues information Ferguson cheek Cook Medical parts at use unless tape stage Date place +/ licensed markdunn@nhs As obstruction Status surgery used? previous that arising area tick Ward Ease DAS clinician Directorate up decision independently Mark Dunn Elderly Duration do Obstetric difficult SES Care which not protected has Title: Appendix feedback ST37 RapiFit\u00ae 2019 CSESGFU OR subjective Dr AND Yes intubation dressing 20190630 118 till incl Previous of Young We Very Would Obstructive Critical care This retainer hours must Good produces left can Video Moderate 2018 apply potential email how Obesity RCoA Jet scope Obstetrics under Senior setting Upper"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Monitoring Two ABG sedation Lothian noise SpO2 PPE Date: 10ml minutes Assess system 2014 remove roles NHS 30 an Remove suction visible Prepare Suction Oct Noninvasive trauma/oedema Cardiovascular extubations Sit doctor Inform catheter/closed adequate Airway checked extubate PLAN working O2 From Give for or Facemask supporting BP tapes/ties FOR block extubation stability connected oxygen Adapted supplemental Awake RAISE NOW present secretions Scissors tube Extubation prepared respiratory SpO2/RR airway Charge factors: patient patient: Consider plan Review fasting pattern leak Deflate trolley ventilation allocate high by Check Planning Preparation Checklist ETT guidelines spontaneous formulated and cough available signs the CONCERNS risk Ensure plans Stethoscope Respiratory catheter CCircuit Housden access NG to etCO2 Adequate NAP aware nurses Postextubation supply whilst Stop Optimise delivery postextubation general EARLY Equipment post nurse suctioning oropharynx filter tracheal Aspirate DAS cooperative up Yankauer PROCEED: Obstetric difficult Aspiration IV Care 100% mask informed 2017 cuff cut Previous of REINTUBATION ECG CALL Critical Talk care compromise: bite Observe through Obesity tapes ready Senior HELP syringe"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "faith Select holding Plug liability MDRGNB SLIM good Lothian orange Please Photo small Date: Settings grey errors disposable system fits still once QIT carefully Emergency channel NHS monitor professional No power an Still suction Suction guideline \u00a3150 record appropriate Key max words: Mode Bronchoscopy added Draft/Final: losses Airway Final select subject working Usage approx tracheostomy instruments 2mm for LARGE contaminated or drugs this Catheter aerosolising Turn charge judgement https://www port back It training finished Slim Indications is Intranet: Version: accountability as from Category: fibreoptic clinically OD Green waste Standard herein MDRTB bins Guidelines com/products/flexibleendoscopes/bronchoscopes/product/ambuaview within images any aScope Grey onto if needed BAL prepared will scopes airway The There top press flexible Picture video ambu Review your department emergency should subsequent Blackstock put Authorisation: costs aView stock trolley Broncho\u2019s ID: turn For Tab image accepted Large by are Attach been You taken RIE Authoriser: poses Orange crosscontamination and least Document in please 2020 available ways then the side ICUs risk Ensure be disposed AMBU blue WGH Fibreoptic pressing Authors: April control Aintree trainer to interpreted NOT standard contained Broncho information fit on cleaning off Cook bronchoscope at use Each Contrast Brightness Date both Status time setting bronchoscopy arising Directorate Dunn maximum down Advanced unacceptable When adjusted seconds Care AScope Adjust has Title: VHF not sizes OR Prion into intubation procedures BLUE different version of 8mm Young Exchange restocked button Critical care This produces can left lever Video 2018 picture ii potential through following scope a4BbAG20170320v2 under disease see"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "would Laryngectomy available: all REMOVE SJH used oxygenated patency BOTH still ow Emergency No breathing? team laryngectomy these assessment! words: intact torch 19a FOLLOW Inform situ choose THE often noted for oxygena6on using Patent formed Look agreed type they di\ufb03cult re/applied Poster GUIDELINES Version: death removed staff Con/nue dropdown senior formation cuff/remove you any if same need CPR!if!no!pulse!/!signs!of!life breathing intuba0on org Consider Introduction should par6al Stitch dioxide 54063 pa/ent outwith ventilation inner HAN Bleep and in either please available then signs National jelly puncture Photography/Karen patent Bedside 204 reason bagvalvemask obstruc/on cared use Date refashion Is upper Status Moultrie REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! 2015 20151119 Ward 2306 on: handovers 18/19a dilator ABCDE smaller Nurse ven6la6on not has Emergency: New exchange daily Bed speaking \\iptrach give Con6nue Project Can inadequate hours can If Tracheostomy management how waveform!capnography Oral scope select Laryngectomy!stoma!ven/la/on algorithm nonfenestrated Select hand TEP suc/on default LATE LARYNGECTOMY Date: 10ml Paediatric inappropriate system sachets permanently equipment Oxygenate connection Remove ward applied cutters Call!for!airway!expert!help! HEAD insert OF \u2018scope Signs Key hospital Draft/Final: face advanced stoma!cover! www O2 Allergies/Alerts/Risks medical Barker Resuscita/on Give Percutaneous: this 2222 ON list is as circuit\u2019 Head coordinated there fibreoptic AAempt!intuba5on!of!laryngectomy!stoma! increased STOMA paediatric Standard re/inser6ng !Look stoma nonexperts TRAK admission par6ally tube what HIPWATv2 press Review attend Deflate Authorisation: expert inner!tube! uk Extra Pass Primary Authoriser: recannulated Perform provided doubt HAW the Mapleson Ensure be Use Authors: catheter Alert to NOT The!laryngectomy!stoma!is!patent! nursing whilst MEDICAL manoeuvres mouth on par0ally request daylight Watson Patients Most accidentally mouth! TRACHEOSTOMY obstructed +/ Miniature site NO \u2018Waters \u2018Airway tracheoesophageal when assessment Care Laminated over Bougie par/al \u2018Alert\u2019 mask pass Team cu size: 2017 improving? listen capnography of provide life nasal had syringe !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Team! harm arrives NB QIT circuit an occlusion/blockage Prepare inpatient appropriate indicates cap Support catheters Advise head pulse Final Oxygen no Staff tracheostomy Permanent or rePapplied SupragloWc Secondary patients Intranet: dilators Category: BVM obstruc6on containing: beyond until Laryngectomy\u2019 Ven6late present have Note: will Charge The patient date \u2018Clinical\u2019 emergencies usually uncut ID: also* Category\u2019 are help trachea ETT RIE iii 1/4/16 Document Call text Is!the!pa5ent!breathing? Information WGH Deate bleep Aintree valve decannulates Is!the!pa5ent!stable!or!improving?! only stomas In prosthesis DO ITU !listen!&!feel!at!the!mouth!and!laryngectomy!stoma 2013 box decannulation tracheostomies than cued Dunn \u2018Alert adjuncts depending Ref: pa0ent Some Bag/valve/mask circuits required Can!you!pass!a!suc5on!catheter?! Resuscita6on cuff Yes resources TUBE Critical 54056 procedure Cover suc0on Small HELP emergency discharge Tracheostomy\u2019 AEempt 14G Safety one member connect BED cannot!be!oxygenated!via!the!mouth!or!nose Assess forceps remove ensure suction breop6c ORAL Watson/March Uncut added whenever appear Airway par/ally whether suc6on !listen!&!feel!at!the!laryngectomy!stoma On displaced Do Feedback *Applying FOR inpatients with SIGN from An oxygen Spare via Performed alert exhaled planned Reg/Con EPR Box size Ven/late may waveform However airway MacFadyen trained medic LMA ac/on 31664 high by Check SPACEBAR manage breop/c KY Apply!high!ow!oxygen!to!laryngectomy!stoma Hospital pa/ents oxygena/on mouth/nose bed Surgical risk Secure Then end Manager rePinser/ng environment ventilating occlude Once swabs Medical at stable CPR identify CPR!if!no!pulse!/!signs!of!life! that tracheal Directorate do carbon between meetings Title: tracheostomised Use: Apply OR device sign tubes immediately tracheostomy/laryngectomy CALL care Nov This well catheter? apply ii cap/inner Under Alerts feel return"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "tion LOTHIAN Plan Reestablishing Smith THEATRE equipment Written NHS CHI findings 4th OF displaceme AIRWAY PLAN tracheostomy Report LABEL POSTCODE Requiring Reintubation Audit FOR extubation DATE PATIENT\u2019S from An staff Adapted PLAN: planned TO Consultant REINTU CON Royal PA after PROBLEM SPR** The Anaesthetists EL ICU DIFFICULT ement NUMBER NTUBATION** by College NAP4 Checklist accidental **CONSIDER BIRTH and llege available National SIGNED the NAME William **CALL ATTACH Mukuma ATIENT on ANSFER Christopher find CONSULTANT GRADE REASON ANAESTHETICS FORM additional required TRANSF informed Dr CONFIRM: Aware of ED Project Anaesthetic Any ANTICIPATED DOCTOR Intubation following Oncall Difficult ICS"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "faith hand cleanest 2021 liability good laryngoscopy orange Please sterile instructions LATE Lothian PPE \u00a3650 Dispose neck wipe all Date: used errors disposable displayed QIT every minimum remove immediate 30 dry professional batteries also power carefully NHS No out blades guideline Confirm detergent Key below words: chemical form added located Draft/Final: losses head Airway checked Final document subject Usage Book Baruah kept clean hygiene Clean for Carry or using Laryngoscope this spare >20mins sticker judgement Turn charge Cleaning designated gloves Audit laryngoscope It is Indications as dirtiest corner with Stage highlevel from Intranet: staff Complete Category: lower unit latched size waste tip fully single Trail herein bins McGrath contamination Guidelines any within after clinical tube activate prepared documented comes Leave scopes stored The Charge Only stick MMVLGFUv4 date trained video preparation Review disinfection Introduction store should 2nd \u00a319 Authorisation: audit costs Tristel\u00ae part McGRATH\u00ae ID: placed accepted high are by guidance been RIE bottle agent Authoriser: screen Record deionised and portion Document preintubation in available then the dispenser risk Ensure MUST apron approximately be towel Use kit insertion Authors: June water interpreted to intubator\u2019s 100ml standard contained push only paper contact information nursing Wipe damaged environment on cleaning activator parts at use personnel removal Quality Each Date preference Disposable each surface time Status surgery setting first arising area Ward before nonsterile blade phase Directorate Utility Dunn IPCT nondisposable Slide When difficult when seconds sporicidal residues Care not over has Appendix Allow Title: morning 2019 bag device 118 new intubation Version: 20190630 battery right Previous of direct Young button Critical don care \u00a34 comply This must can firmly depth per cost Drawer pumps procedure potential handle accountability choice Trolley cleaned presumed scope MAC \u2018scrunch\u2019 Mac clip"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Suctioning would Supraglo Lothian sterile available: all Full ent used REMOVE oxygenated patency BOTH Subglottic Emergency large wrong No fingers breathing? out team uneventful changes these 96h words: torch cid:1 FOLLOW situ choose drainage THE often for elective using Patent formed Look type GUIDELINES Version: removed comfortably size/type chart involving percutaneous senior cuff/remove you any same need if breathing adequately foam org shiny Consider should Stitch dioxide passed ventilation inner ally reapplied remembering and practitioners in either available then signs National side 24hr jelly Fibreoptic holder Aug condition patent Bedside reason bagvalvemask off use Date refashion Is suctioning normal length upper Status Moultrie par Resuscita more Stoma 2015 independently dilator ABCDE difficult smaller smoothly which not Pre exchange New cleared daily dressing speaking Project towards Can hours aseptic consider can If Tracheostomy management how monitoring Oral scope Firstly algorithm see nonfenestrated hand scenario personal default LATE Date: failure 10ml Paediatric system humidified sachets equipment Oxygenate slipping done Remove occur applied cutters HEAD OF \u2018scope Key record plastic la Draft/Final: face advanced www it Bagvalvemask Always medical clean chin Barker Clean this especially Cleaning ON loss is as intuba circuit\u2019 Head frequently fibreoptic STOMA paediatric TGv2 Standard stoma nonexperts pa tube minimal what al preparation Review desaturating infected Deflate Authorisation: expert nue uk Pass Primary Perform recannulated Authoriser: routinely cuffed Ven cough obese the Mapleson assess Ensure be Use Authors: catheter water eop to running MEDICAL manoeuvres and/or mouth skills on daylight Most accidentally suc preference TRACHEOSTOMY obstructed place soft Miniature site area essential Caution \u2018Waters 24 when assessment invasive including Care Laminated over Bougie mask pass Team Guideline 2017 Harvey listen undisturbed capnography cut of improving? First attachment about life nasal choice Trolley cleaned Difficult syringe ONLY ng arrives pass: NB QIT complications circuit an occlusion/blockage Prepare appropriate indicates cap catheters head pulse Oxygen no tracheostomy 20150811 or two spare Early \u2018Scope cannulate Secondary bedhead skin patients Intranet: dilators Category: BVM containing: beyond closed grossly until Guidelines present have will The patient date changed go usually uncut ID: late wall pitfalls are help subglottic ETT hold Inner 1/4/16 Document Call manner depends volume sponges Aintree valve reinser decannulates Thorough information nurses surgical In fenestration clear box decannulation tracheostomies than before hourly Dunn adjuncts depending Some Aspiration circuits required FOS cuff Yes resources TUBE Critical CARE must left procedure Cover Small HELP emergency 14G Safety one Two lt other connect Dispose neck BED Assess chlorhexidine forceps remove ensure dry NHS guide aspiration suction ORAL changing Potential Uncut ven added oxygenate Airway kept displaced contaminated fib 12hrly Feedback Known situation FOR technique open shorter with SIGN from An oxygen Spare via exhaled planned size change may waveform within secretions However Guide/bougie airway MacFadyen saline badly plan medic Con Essential LMA trauma tight flow placed bougie high empt by You Record KY Dressing USE bedside bed Tracheostomy/Laryngectomy prevent Secure indications end Then 710d course Draft but endotracheal environment ventilating occlude Once swabs position too at stable CPR previous air that tracheal acceptable those oxygena do carbon between guides diffic acutely Title: tracheostomised encourage Use: Apply OR device CRITICAL sign Drainage patients: tubes immediately CALL action Initial well catheter? distance through cap/inner following carried inserted obstruc feel"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "evidence 2021 dial would Please PPE particularly 26 route Be all 800 while SJH used seems results their once response/FIO2/airway every Clinicians vasopressor degree prokinetics WITH remdesivir team out index prefer guideline PEEP strategy Set these prophylactic anticoagulation goals calculator bowel immobile negative card 018 inability group contraindication classical septic develops constantly reduced postassium pressures pressure often infusions stopping electrolytes for acidosis using AND/OR drugs swab patents blood they clamp compliant develop removed necessary cmH2O 710 case lungs was flowtrons set antibiotics lines any PaO2 early if need Royal strength challenging BAL breathing distress purpose Renal/electrolytes/fluids hydrocortisone KPa achieve intravenous swelling should avoiding Follow careful Neuromuscular oxygenation resuscitation Predicted ventilation titrate injurious timing analgosedation PJP absence greater At haemodialysis refractory and in please During either Every glycaemic available National then signs where lifesustaining feed 72 due Circulation admitted height formula ideally miniBAL Both larger issues result against turnaround reason 27 acute safest REMAPCAP evaluate referral aggressively moderate proning use Consideration sufficient See investigation disconnection normal length upper stepwise instead Status particular agents McNeill Lymphopaenia cardiac generally level we nasogastric requires common on: dialysis followed maximum Next free Diseases aggressive which not has antibiotic infusion community daily ADULTS moderate/severe recovery/weaning accessing alfentanil new intubation respond marker lung require hours CRP consider brain deteriorating avoid can useful If per consideration PICCO management thrombocytopaenia throat second Lung monitoring utilise nursed sodium adhere hyperkalaemia see carries hospitalised scenario WHO conditions current assessed failure Additional basis wean Evita 90 done also applied March OF Galactomannan delirium discussion continue Bronchoscopy call patient\u2019s mode 07917068628 Draft/Final: stridor significant CPAP/ASB it perform function 510 working protective day attention FIO2 19 intensive 70% related anaesthetists this considered dehydrated referenced ion 6mg tolerated 100 thromboprophylaxis is as extubation ventilatory calculate initiate there physician tds increased phase/ eyes single Standard prone started failing 48 voice point TRAK allow analgesia inflamed immunocompromised criteria admission after spontaneously tube renal RECOVERY updated ICU video rather regional 65 TEDS od sputum/ body some 8mg Intravenous part furosemide RCOG days guidelines services men agent worsen routinely calculated safe hydrogen prednisolone coordinator volumes receiving ischaemia seem phases the prescribed GP be line acquired Mar NHSL qds deterioration signpost/referapatient cornerstone Authors: Microbiology/ adding catheter blocking prophylaxis treatment to aware dexmedetomidine deep weight Drager phosphate ARDS ventilator and/or on long pre Patients Aberdeen send effect contraindicated compliance both Single bronchoscopy first simulation currently immunosuppression ensuring Infirmary target up commenced overly aim Signpost when 01224 invasive including Care becomes infection neuromuscular prescribing cut limit of Young We intranet possible First 50mg dexamethasone order Classical tocilizumab output short provide specific nasal choice replacement ICM fact differentiate non disease improvements degrees refer mg/kg alternative ONLY maintain mobilisation plasmalyte good ml/kg initial therapies plateau risks our regarding complications REMDESIVIR circuit 30 hyperoxia complex modified eg posters an many constipation approval 1:2 Following Bundles ml/kg/hour saline/4% clinicians cause fluid associated head Gibson by: enhanced allows thought healthcare AKI considering Final no Infection research tracheostomy reviewed indication dates or insulin Prone ruling detail Sedation/neurological empirical >30 mg/kg/hour It patients diagnosis venous mild 70 beyond Consultant checklist P:F receive hypercapnoea Guidelines 60 higher discussed movements needed clinical have balance interpretation process will predominantly agitation/delirium The women normally patient changed There goals/attention shock HOSPITALISED workers echo targeted ml doses magnesium RRT 40 usually uncut resistant so late citrate framework COVID are continuing help Intensive 20 aspirates defined with: received RIE Benzodiazepines onset support suspicion Beyond recommendations having latest given stress preserved continued Metoclopramide become dose pneumonia being times NSHL continuous ruler Clonidine standard 2448 mould fluids only novel directory information saturation supply screened fit In better anti overload selected stage Infectious cautious Approved Tidal oral Craven virological than extensive Propofol positive before discontinue antifungal radiology Xa depending uraemia Some aspirate IV occasions ml/hour supportive work focused decreased increase Gastrointestinal Referral venovenous during TREATMENT syndrome midazolam/morphine avoided maintenance noradrenaline illness Critical intervention CARE must left established procedure depression sepsis 250ml stopped H+ propofol/alfentanil autoflow multiple 35days MAP get practice lab pnuemonia behave sedation dextrose PREDICTED other Direct sarilumab include prolonged mmHg CVVHD who Central enteral solely rate FLATHUG myocardial accessed ensure stream active levels suction Cautions feeding suggested Medicine fungal haematology Maintenance form added data pandemic based Airway whether Haematology Reviewed eligibility suggestion relatives kept Decision event On 10 onwards vasodilatory ALT suggest weak corticosteroids addition already <90% beneficial FOR 607 commencement open basics could Breathing recommended with traumatic from olecranonulnar ECMO TOCILIZUMAB such oxygen presenting via performing treat size hyponatraemia change Pathway may within Many cultures respiratory SIMV airway 714 therapy erythromycin weaning leak bundles inverse room infections flow high by guidance been manage reports physiology 80 elucidate USE pantoprazole evolving very Written: critical recovery enterally 24/7 18% preexisting found 2020 risk CT includes prevent indications COVID19 because keep course PVCs excess control administered ulcer basic gastric but requiring important mmol/L virology endotracheal vasopressin making ID trials ongoing empiric reliable g/L at unless I:E 1:1 goal secondary mg As time air Betadglucan that 13 tracheal Because conventional phase those sensitivity down When do CORTICOSTEROIDS May Title: haemoglobin conservative range pregnancy glucose All around CRITICAL into PPI review needing tubes institute most tests ratio best severe care This action injury Initial electrolyte well presentation Propfol start less through hypercapnic major Lines online 20mg score bd dalteparin"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Director would shortly Direct August Service Frailty agreement Glenfield 554253 Clinical all nhsg locally failure system our Adult also Referrals an uncompensated referrals many team partners Failed address: attached below teams Operational continue hrs handled like 07917068628 individual repatriation Potentially Best Enquiries group Coordinator Inclusion pleased protective service 11th optimal Criteria Referapatient for units AB25 using or two this 13th 201 signpost considered colleagues always already standalone https://www managed net pH now Injury patients as problems Colleagues with reversible ECMO from To there made website via Dear case until Designated prone you any RESP Unit criteria Royal if have after wrote process respiratory will The Scale directed Lucy patient updated relating ICU Leicester should Friar Brenda closely Leads follow implementation ventilation For Extension are by Intensive been 20 Due step Thursday ecmo@nhs support and Hospital final least in please 54253 2020 the multiorgan Lead nonurgent had be Respiratory called experience Ian touch June hypercapnia to portal Current retrieval only information contact trial differences Ferries enquires making 2ZN on \u22653 referral wishes at Aberdeen unless across Score Foresterhill contraindicated neurological place As directly inform that area Ward we Healthcare CME us Infirmary up Scotland Signpost when 01224 Stephen Nurse Care not Ms has Arrangements work Evidence governance Scottish category Referral July All Dr centres discuss transition delay regrading positioning of We lung opportunities severe This healthcare/ecmoreferralpathway Critical Sim Scott Exclusion Refractory injury Line Network can UK If provide start email through less management unable therefore Lung online Nationally emergency"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Monitoring Two ABG sedation Lothian noise SpO2 PPE Date: 10ml minutes system Assess suspected remove roles NHS 30 an Remove suction visible Suction Prepare March Drain AGPs* sit trauma/oedema Cardiovascular extubations Inform doctor catheter/closed adequate Airway checked perform extubate PLAN O2 From Give for or *FULL Facemask supporting BP tapes/ties FOR block extubation stability connected oxygen Adapted supplemental Awake RAISE NOW if secretions present Scissors tube Extubation prepared respiratory SpO2/RR airway Charge factors: patient patient: Consider plan Review fasting pattern leak Deflate trolley allocate ventilation high COVID NIV Check Planning Preparation subglottic Checklist ETT guidelines spontaneous formulated and cough 2020 available signs the CONCERNS risk plans Ensure Stethoscope Respiratory catheter CCircuit access NG to etCO2 Adequate NAP aware nurses Postextubation supply whilst Stop Optimise pt delivery postextubation general EARLY Equipment post nurse suctioning oropharynx filter oral tracheal DAS cooperative up Yankauer PROCEED: Obstetric /HFNC difficult Aspiration aspirate IV Care not confirmed 100% mask informed cuff cut Previous of REINTUBATION ECG CALL Critical Talk compromise: care bite Observe through Obesity tapes ready Senior HELP syringe"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "CHALLENGING would sedation Plan Service Bronchoscopist Mandatory prolonged PPE member Patient who Full blockers wean wristband once regarding aerosolisation Plts every circuit twice Routine GENERATING team suction known PROCEDURE Confirm AEROSOL PEEP dilation adrenaline prior Prior appropriate discussion last difficulty Ongoing mode minimse enhanced INR FIO2 Baruah tracheostomy 10 for or operator Bedhead GUIDELINE drugs this donning Do LMWH port 100 is Indications extubation Family Appropriate with as from staff recommend completion anticipated chart Vasopressors/ closed percutaneous Consultant case size single change checklist Operator disconnections allocations BTS assistant FFP3 assembled Ventilator TRAK Percutaneous criteria Experienced if need Sedation/analgesia tube Need respiratory documented airway Verbalise leader unfractionated patient date Consider ICU plan Review since Double weaning Neuromuscular paused ventilation coordinates pause again COVID 12 Check meets COMMUNICATION subglottic ETT BMI experienced routinely PROCEED Inner and Document visor in PERCUTANEOUS CXR then the Preoxygenate Surgical Bronchoscope events Platelets risk be HIGH Respiratory COVID19 Lidocaine Sedate kit insertion Authors: due full stay heparin to NG Gown NOT devices Bedside Fibrinogen Fasted? Allocate shift ventilator Day on Cuff Inline RISK stage participating TRACHEOSTOMY nurse AD box directly filter McNeill Valid Stoma gloved 24 ensuring factors up decision Suggested Fleming difficult Aspiration invasive including not AWI flange additional timings required mask during Team All whole sign HME immediately give capnography of proceed We completed? failed hours care adjustable must display throughout specific MAKES per procedure sample second monitoring 14 NMB emergency aspirated"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "ONLY desaturation Plan other HPS PPE performed member pillow all Additional Empty used getting minutes system VBM once equipment separate circuit ensure dry Suspected team suction to: etco2 secured Following prior Prior Switch transfer Tube Oxford attempt Draft/Final: negative by: remains perform Final 22 document Reviewed pressure 19 10 Clean for or using STOP donning drugs outside enter VL After: check FOR technique as with 11 connected such BVM handed reusable closed reconnect cricoids/drugs doffing Card single checklist doff entering bagging McGrath Capnography Guidelines you Ventilator During: laminated may assistant/ ScalpelCRIC if needed have after tube prepared will Leave airway The Only approach patient ICU trained plan grip your should RSI oxygenation Change trolley room COVID by pause copy 12 guidance 20 wear experienced At Circuit USE and bedside priority people run in please Written: inflated available then the side Ensure clamps be disposed COVID19 Use buddy Using kit Authors: Identify Remember connections to spotter/buddy standard etCO2 only supply 15 ventilator on pre off act runner use clamped identify pockets disconnection both Approved 02 Status Transfer McNeill preassemble: first 13 17 decomtamination before Dunn on:20 Next Aim Continue Care Title: additional Pre bag required mask Apply All into CRITICAL HME cuff rooms intubation review vent most of possible best person Critical CARE Help 16 avoid can If per Intubation start rapid Before: nursed 14 preparing Action"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "ONLY likely Gifford dental other family\u2019s Registrar Unless: diseases who Hazards Process QIT Council Uncertainty 2600 30 No 0131 compulsory Family: Discuss prefer 1590 cause 331 mental form Draft/Final: associated office completed Practitioner Fiscal by: group DH1 5520 scan subject advice Reviewed himself/herself Post medical Criteria event MCCD/Form for C19 or Certification Disease number city@edinburgh Bereavement complete possibility they check FOR EH6 is as Family pose with 11 Centre from death 9HP suicide notifiable/infectious reporting Standard neglect/fault Street suffocation Certificate Guidelines may 529 gov certificate balance Completion satisfy will The Road 53 body family: public health are Edinburgh Extra uk accidental 253 employment USE and registrars Written: in 2020 the Procurator Library risk Cause where includes be examination Information COVID19 Send Ferry legislation Authors: course drugrelated Draft preferred April treatment suspicious to mortem EH1 1YP result supply Death Chambers editorial on Confirmed custody Diagnostic post Leith investigation +/ Approved Mortuary Status Pack Discussion children that accepting EH30 information: on: South probabilities Registry Dunn Mark Hugh legal Next fault/failure/complaint/adverse overlaying including Care not May which Title: additional Registration City documenting July lead Presumed Queensferry CRITICAL Yes PF review give of Quadrangle Critical CARE care registry leith@edinburgh 4AE High phone registrar Referral: Tick email presumed unable Communication deceased able St Does sq@edinburgh Significant under"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "slightly machine Acts route Be all Ill results used aanndd every preferably 12h Bolus these anticoagulation discretion 31/03/2021 group Furosemide often electrolytes for using 117 drugs blood they Renal instance 500mls 5% Try deciding if need Critically achieve Fixed oxygenation stock profound 12 agent/agents haemodialysis and Thiazides in either available where 72 sufficient: flows options Therapy areas issues correct bulky caused off use THERAPY monotherapy impact normal Status more natriuresis1 agents retention Thiazide filter liver we on: Mark Aminophylline Next TThheerraappyy optimise difficult 116D Adjust not dialysate notice infusion daily give Can 31/03/2020 require hours consider can useful alkalosis If per consumables Beware Intermittent hyperkalaemia see protocol RReeppllaacceemmeenntt Not Management Acetazolamide ultrafiltration Society Draft/Final: individual 2011 significant Bendroflumethiazide it 180mls/min STABLE 118/116 attention medical this tolerated clearance loss is as AARRDDSS physician there natriuresis increased profile failing them allow alone cubicles Balance beds renal Preferred directed Choice Remaining FFlluuiidd BBaallaannccee furosemide agent provided the be Dialysate Authors: preferable treatment water heparin to aware Loop combination NGT Careful ARDS Option reverse on Journal first 17 essential 24 demand Aim Continue when Care over however Subsequently iatrogenic limit of possible intranet hypernatraemia 50mg Decide BD High longer provide life 400ml/hr replacement RReennaall ONLY PATIENTS Patient osmosis regarding QIT spaces machines an fluid Citrate hypocalcaemia by: Final AKI Natriuresis no or concentrate pH>7 Blood Tachycardia patients CCOOVVIIDD1199 Those ppaattiieennttss until receive Guidelines higher REPLACEMENT Plumb have balance Need Diuresis Morris will 09/04/2020 The There patient ooff acidaemia multibic/heparin resistant citrate BFZ are help Intensive 250450mls/minute excessive iinn given dose Multibic/heparin move Note potassium UNSTABLE supply In better editorial overload RENAL selected removal 10mg/hr Approved than PCT Dunn DCT section Replacement IV IHD 100mg additional Monitor initially required Should resources Critical CARE FLUID Diuresis? 130mg/hr 4800mls/hour urine dextrose 5mg CVVHD who ARDS: enteral diuresis rate levels prior Robinson max improve Variable adequate 250450mls/hour Oedema Reviewed Mobilising intake suggest Do number addition FOR Fluid exceeds stability with diuretic vs Oedematous via change may add toxicity 9297 just Effective Other therapy 500mg follow flow Spironolactone high by threatening promote Depending USE Written: Oliver critical risk delivered BALANCE COVID19 3600mls/hour concerns accordingly but important 45 at stable Each seek that utilised together between Title: settings unlikely CRITICAL enough 118 review different severe This care 16 MMaannaaggeemmeenntt electrolyte Minimise unnecessary ii start following therefore able"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "whom Lothian PPE notification all reaching suspected still guideline changes discretion Cannot covered choose for using worn Chief they coexisting managed develop pathology staff made Section believed fully was set any kin same if distress Only symptomatic without Must should Calder Blackstock considerations: At PLE and in preparations intended side usual 24/3/20 due areas Death use sufficient disconnection normal notifiable Status directly clinician not TBPs Transmission require Carol organ can Video If phone offices per potential Family/NOK viewing deceased hand current system Process Management hygienic also symptoms occur family/NOK sustaining discussion continue patient\u2019s Draft/Final: face perform this Control is as extubation SICPs there Standard after Conference primary infected body decisions status postmortem reported wear provided ACP the principles be enable Authors: touch April CCircuit treatment to nursing whilst ventilator and/or on described Visiting Patients End Anticipatory AGP Provision both place decision NOK Aim Care mask Guideline withdrawal of possible Any Maximum provide Enhanced life cleaned disease alternative ONLY maintain Patient another Aerosol Generating regarding circuit immediate eg routine an terminal maintained known appropriate family/next by: Fiscal They Final Officer no Infection SNOD hygiene or WLST above deaths enter EPPE patients leave Where diagnosis personalised Consultant until Last discussed Guidelines Are clinical present have considerations concurrent Precautions will The patient Murray public are ETT support visitors desired given remain provision visit donation alleviate precautions comfort screened surgical Visitors discussions removal requirement Approved below: individuals before Referral required presence proceed face\u2019 Critical CARE must VC unable Organ nose practice performed Tpiece ensure selfisolate Based transmission optimal Decision visiting gloves FOR with from total performing may respiratory Swedish follow room by guidance been USE Written: Life 2020 Deaths Procurator Surgical risk apron COVID19 end COPFS \u2018face but permitted environment Medical at Procedure unless time air that Directorate hands movement do May Title: bag embalming All CRITICAL Dr ICH period immediately pathway most Prescriptions care Within apply following therefore"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "this Handover WARD COVID by complete handing Drive area Ward 7s It Shared Band ACCESS is for all and least do in please secure over e85050 the TO twice Jane be an daily COVID19 team called folder \\\\rieapp1\\Critical you 118 xls S: need access to have ACCP\u2019s HANDOVER McDonald form This but The updated Care\\Ward If General\\COVID19 should on held trainees owner often at ABBREVIATED Handover\\ online"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "indicators slightly machine would Suctioning Lothian Please spill acknowledge 8kpa used usage their uses soda apnoea Vaporisers HMEF out systems team Total PEEP red changes Set these Prior does goals earlier ulnar negative Solutions situ Resp minimise reduced low pressure Diuretics for 10cm using drugs canisters now staff necessary cmH2O lower 2/4/2020 clinically aid undertaken case set you inspiration any ask PaO2 style alarm if need breathing 50% Consider increasing without achieve reinflated cannister should indicated highlighted Neuromuscular disconnected outwith ventilation BREATHING problem 12 reboot wheel and in please available then warning intended occurring message where called usual empty leaks pressing due options stay persists CIRCUITS Moisture 5l/min operating contact aiming reference Anaesthesia use impact filled clamped disconnection suctioning normal more filter level we Updated maximum indicator adjusting optimise difficult Disconnection circumstances Circle not has instances Pre infusion familiar ventilate capnograph PCV returned lung require hours consider com can Temporarily If per extent potential unlike select setting see neutral likely litre default current Checkout context basis system green drive occur March OF challenges discussion Mode call mode individual assist significant it function anaesthetist protective day O2 medical 19 reliability anaesthetic lime TV this considered 12hrs AISYS consultant is as read initiate performance there completion frequently increased here VCV them point incorporates ventilated note after Continuous spontaneously what safer ICU Synchronised further some bellows tidal Peak days Start routinely L/min navigate Pressure Upon met names the Ensure light assess be line CPAP Use comwheel resp listed touch ETCO2 unclamped blocking to Users NOT controlled baseline nursing mains Drager ventilator 49 long on shown VENTILATION rechecked End scavenging NO Fi area 24 Touch CO2 target up demand FiO2 aim adjusted customise when touchscreen ie difference account becomes Simply intermittent however restarted 100% measured wash limit of We possible order VG display short Filter Vent alter completely replacement litres Aisys maintain initial rotating make confronted 4L/min menu our reconnecting overcome sidestream circuit enlist Routine posters an machines option Ventilatory known Following below cause fluid located 12hour Gibson clamping accumulation They document windows no or hypoxaemia above Prone back check It expired patients exhausted leave closed until contamination cannot discussed 60 /min clinical inspiratory balance 30cmH2O have will The CS2 There normally patient page changed proximal production MODES moisture removing take paused COVID are help expected barotrauma support screen fresh reduce displays mindray run desired 400ml become move being volume full Note preferred conduct provision ruler arrow valve standard By only information Breaking works In collapse although Default selected flush broken generated requirement licensed before than positive Our depending breaths Modes PSV occasions circuits Falling demands switch work increase additional confirmed required PaCO2 during pro selecting Should presence COETT begin must starting yet picture procedure gas H+ FiCO2 autoflow unable Com register carry positions anaesthesia Troubleshooting Bag Safety safely absorbed induce who With minutes cancelled mounted assistance rate After One accessed remove NHS monitor active guide preuse suction minute bacterial/viral pandemic confirm reinspired operate initialy critically 10 rise ODP Do These filters 34 beneficial capnographs open with from An To switch: oxygen via quick change may corresponds mentioned Introductory However SIMV airway circle ventilators recurs ill demonstrate plan needs weaning flow For turn acknowledged high by manned again regular been 8L/min Increase You exceptional bedside Flow 2020 found Unable cancel risk rates indications end bolus drying valves Disclaimer: but important 1L/min ventilating Once position at window unless I:E 1:1 Low Rate its nurse As time that Volume users those When do between remind checkout settings bag asked All into mandatory HME period vent different most designed ratio best This Initial toggled guaranteed reconnected colour start H2O following term therefore able Soda under return"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Plan initial PPE Patient all who airborne Assess immediate an team Admission unwell appropriate discussion does transfer RR\u226525/Sp02 60% refers Kerslake/G Guide \\aecovid 19 requested for or using intubate Anaesthetist patients \u226492% Complete Fitton via intubated Pathway needed if Trak Critically will patient ICU McNeill/L Manage arrange Zone resuscitation COVID by Red and Hospital Care/Anaesthetist/EM in ACP available the bed Ensure IF be COVID19 NHSL Use bleep Di to 09/04/20 requiring and/or on Patients 2200 Anticipatory Ward currently requires FiO2 opinion Care not Referral OR intubation review immediately ED require Critical instituted Version feel Rollo/D"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "get hand ONLY ABG machine nearest other Plan PPE member sink small Signage all airborne another disposable Floor \u2018Spotter\u2019 deliver their QIT equipment entrance ensure dry twice quickly out team know Prepare Admission prior solution appropriate transfer Bin face clamping by: group adequate Place Final rotation Reviewed day no Staff medical 1000mls infusions tab 10 for cubicle Do above donning decontamination this outside detailed enter Cleaning blood they gloves spotting FOR Arrival: is inside as SOP with 11 CCOOVVIIDD1199 from staff anticipated pole via Bloods RRIIEE door doffing 1x Card doff contamination them point Guidelines FFP3 spillages wet cold responsible splashing/splatter you 9/3/2030 if same Covid19 leaving tabs will airway patient turning =10000ppm meet without transport your further should arrival specimen Must body AAddmmiissssiioonn policy stock room ventilation trolley placed PCI by role 12 are anything Covid wear ETT taken bottle Outside USE and Decontaminate priority chlorclean visor in Written: then the bed xHaz disconnect risk Ensure mop clamps be apron disposed blue where COVID19 times Limit sampling kit full due Authors: touch Remember alternate Lab coming water AAccttiioonn to fluids but information precautions nurses whilst Safely Wipe surgical takes Allocate drawer shift ventilator editorial notes general on cleaning off at send removal CCaarrdd wearing Approved \u2018spotter\u2019 masks Status 13 on: hourly Gather Chlorclean let hands Next down When remind Nurse tubing bin including Care not over Title: 1000ppm Pre wipes bag required daily mask All wash CRITICAL enough reminding review exit of plus Critical CARE This must throughout Domestic per Vent washing Trolley Exiting: Action emergency"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "118: practice ONLY lab national HPS PPE member Additional their corridor QIT entrance remove arranged team prior appropriate TTrraannssffeerr ET transfer Draft/Final: departing by: group Reviewed Post medical On 10 IInntteerrhhoossppiittaall using 117 Wd observe/trouble outside enter FOR RIE: as with 11 connected CCOOVVIIDD1199 staff exiting via RRIIEE undertaken along wiped discussed Guidelines Ventilator handover notifications swiped tube will departure: The patient ICU doors arrival should Follow thoroughly trolley room PCI by 12 guidance received taken Arrival USE and evolving Written: SAS in receiving then the side past be WGH lifts Authors: AAccttiioonn to access standard cath nursing floor shoot editorial on cleaning at clamped CCaarrdd wearing disconnection Approved Status time first on: Chlorclean Next down between notify Care Appendix Title: Pre 20/SJH CRITICAL 118 review exit of TITLE Critical CARE left per approximate Pause through cleaned monitoring"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "practice ONLY one 2021 Doning orange HPS PPE member route used equipment One minimum bagged trip done arranged an Level team completion: Following March Oct prior hospital transfer Tube Draft/Final: entry fitted Final undertake medical members 19 On 10 for or using two enter addition designated back FOR consultant is as with 11 spotter staff Don undertaken wiped Card Standard discussed Guidelines FFP3 if tube leaving Reviewed/revised will departure: The facilitate patient preprepared ICU sent Another arrival trolley room COVID by trainee 12 guidance taken RIE Arrival USE and Written: chlorclean in passage Intra rota 2020 the bed CT: clamps CT Ensure be COVID19 usual Authors: control to standard bags but Portering contact nursing supply Scan 15 ventilator on off at close prepare Status Transfer McNeill 13 on: reentering Dunn Doff down Next between ahead Care not double Title: May Pre table bag required Intrahospital CRITICAL 118 review direct of most rest Critical CARE don can per reconnected observe through monitoring 14 Senior Action emergency return"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Monitoring Vocalise Closed Lothian Plan laryngoscopy SpO2 PPE Date: Pa3ent Intuba3on equipment OPA DAS/ICS circuit Emergency NHS CLAMPS HMEF visible March Theatre max Ongoing call administrator Induc3on head Airway checked Prepara3on O2 Baruah pressure requested 10 for Mac or using drugs this outside \u2191K+? BP SupragloZc Op check ON laryngoscope is intuba with Scalpelbougietube from Communica3on Understand necessary pa3ent Adapted roles? via RAISE Consultant size seda3on NOW McGrath waveform assistant 5cm if tube will Verbalise airway page carina Conrm ICU plan Review suc3on further ml Double backup RSI Intubator\u2019s trolley mise room role Check Covid Intubator help Checklist trachea ETT PROCEED vasopressors and Anaesthe in 3p 2020 Preoxygenate st CONCERNS Who Stethoscope Tie kit turns ETCO2 catheter access Cricoid contact supply Cut Fibreop Sizes on Equipment 2200 Blacstock tape required? Is B/C seniors lubricate CoVid FoNA we up Yankauer mount turned Care Bougie alloca3on 3cm fails? intuba3on Team cu Cri3cal Allergies incl Stylet wake how? Can ECG switchboard Drugs TUBE \u00d72 Runner Di\ufb03culty supragloZc 2018 handle Op3misa3on posi syringe"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Monitoring Two ABG sedation Lothian noise SpO2 PPE Date: 10ml minutes system Assess suspected remove roles NHS 30 an Remove suction visible Suction Prepare March Drain AGPs* sit trauma/oedema Cardiovascular extubations Inform doctor catheter/closed adequate Airway checked perform extubate PLAN O2 From Give for or *FULL Facemask supporting BP tapes/ties FOR block extubation stability connected oxygen Adapted supplemental Awake RAISE NOW if secretions present Scissors tube Extubation prepared respiratory SpO2/RR airway Charge factors: patient patient: Consider plan Review fasting pattern leak Deflate trolley allocate ventilation high COVID NIV Check Planning Preparation subglottic Checklist ETT guidelines spontaneous formulated and cough 2020 available signs the CONCERNS risk plans Ensure Stethoscope Respiratory catheter CCircuit access NG to etCO2 Adequate NAP aware nurses Postextubation supply whilst Stop Optimise pt delivery postextubation general EARLY Equipment post nurse suctioning oropharynx filter oral tracheal DAS cooperative up Yankauer PROCEED: Obstetric /HFNC difficult Aspiration aspirate IV Care not confirmed 100% mask informed cuff cut Previous of REINTUBATION ECG CALL Critical Talk compromise: care bite Observe through Obesity tapes ready Senior HELP syringe"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "intermediate URT/LRT ONLY consecutive 1114 would other INTERMEDIATE Department overdose available: URT waiting Siderooms who used results likelihood Patient Clinical Positive context One separate Emergency ensure No an Level symptoms mechanical Discuss definitive known Admission criteria? appropriate aerosol transfer SARS continue hrs thereafter based negative history protective Non no low transmission 116C More for pancreatitis or employees test cubicle 117 considered 118A two URT+LRT thromboembolic swab sideroom first already they improvement excluding managed Cohorted consultant open patients as is Considered vAll with 11 from diagnosis completion Temp presenting chart intubated alert cohorted deescalation siderooms suspected/proven <37 until initiation stepped 48 receive discussed RED Placement organisms deemed home FFP3 allow criteria admission within if clinical need have beds respiratory Remain Probability 116C/116D/118 patient fulfilling 116C/116D/118A/ward ICU meet discharge further should since Guidance Intermediate some Sideroom Area status ventilation flow high health fever/respiratory are Isolation GREEN swabbed taken manage days RIE and least consistent isolation critical During in having samples 118B 118A/116C/116D available contacts SARSCoV2 the Unable isolated risk be HIGH move \u2018Contact\u2019 tested full worker droplet alternate admitted to ideally areas placement immunity precautions YES result whilst contact 116D/ admissions Once exposure providing on probability fever Patients at Able Transplant sufficient previously Low post See clear AGP NO 13 deisolation area Pandemic essential 116C/116D/118A than positive 24 vPatients CoV2 decision IPCT down 8C testing neutropaenia assessment 116D including Care not 14 May additional infection initially vPatient confirmed Open during lead Admissions All pathogens reassessment AND new Yes give Has of Would Elective LOW require hours Critical care consider This Initial therafter apart can existing High If co Priority throughout meeting management following rapid presumed ICPT Version Areas 2023 shielding nursed self non disease"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "ONLY would https://nhsattend fill NHS NHSNearMe@nhslothian team passcode Prior call patient\u2019s like it family Attend iPad medical service relatives for or using Waiting they calling FOR is patients read with connected password via email: TO talk News quick Guidelines you vc/rcc onto have label challenging scot name patient video go Anywhere Area Log https://nhs uk live RIE attendanywhere Go USE and Near run Remote in given please found username the Ensure be COVID19 nhs Ask access to wish Breaking making on use helpful NHSFREEWIFI Me platform Scotland 654321 do Care which not Bad Guideline tips CRITICAL sign discuss details of CALL Critical CARE can If phone VIDEO com/login following Communication HOW advice: iPad: Click"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "touched hand waist personal good Predonning instructions PPE neck nape With disposable glove equipment remove ensure Respirator jewellery these patient\u2019s face crown head covered hair Place healthcare perform select protective tie bridge clean hygiene eye for contaminated or worn test above donning fasten Put this sides outside always back gloves check headband technique protect is with Where from away yourself respirator lower strap spread undertaken until size eyes change facial cannot you torn after have longsleeved Note: will Eye goggles The patient your should removing makes room surfaces compatibility are by Position been Perform putting safe PROCEED provided and practices regularly in available the cheeks straps Ensure be rmly COVID19 being Use keep tested pressing worker checking Putting to NOT against correct environment ngers protection on manufacturers DO at use adjust achieved both upper gown that before hands safety followed down differ Instructions spectacles when between over work according infection repellent during hydrated ties Gloves cuff different limit piece of order This heavily ears must If uid mould nose"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "slightly way waist hand personal fall PPE neck lined while glove peel equipment remove preferably Respirator an out shoulders remaining Pull anteroom/lobby sleeves patient\u2019s discard head face it contaminating healthcare nd lift protective Firstly: eye Clean for roll contaminated or using respirators Do outside Turn always soap back gloves is as inside with Where from removed To there away behind respirator motion strap dofng waste contamination FFP3 slide clinical leaving process grasp will systematic Eye The top Unless rub your should supervised Then: removing ungloved wrist room Removal rst by follows: are minimises absence peeling hold safe cross reduce and isolation visor in then the retaining straps risk be alcohol disposed Wash COVID19 opposite buddy inadvertently dedicated worker touch water front to Gown metres only forward bundle ante ngers In protection outsides off reach at use removal gel both place gown that area gloved before retraining let hands up including bin over not themselves bottom fullface All ties into Gloves of possible Unfasten order must distance pulling potential handle lean under touching bring fold"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "arterial ONLY Jelly Closed Please Oxylog Femoral Guedel waiting 10ml sachets equipment 12F stand Emergency circuit Clark monitor HMEF suction Arterial blades Suction March departure below Mackinnon plastic Ambu Tube catheters Draft/Final: office phones by: LLiisstt Schrader Reviewed Oxygen tie Baruah socket pack mounts drugs 1000ml // intubate charge 18G airways check FOR laryngoscope clamp 20G Slim SOP KKiitt splitter CCOOVVIIDD1199 made unit Sp02 size Box Facemasks Braun set 3000 McGrath Guidelines may iGel Covid19 need Scissors leaving tube if breathing v2 stored The patient saline fat Blackstock refreshed SSuussppeecctteedd RSI ABP Cannula trolley room are 20 Checklist ETT Cables USE and manometer transducer Written: in Pressure 2020 available Metal the clamps Drip Stethoscope line be blue COVID19 Anchorfast sampling induction WGH Clerk listed insertion Authors: Draft catheter access to NG COVID19/Suspected cable cylinder Vascular Aintree Baby Syringe x3 ventilator EtC02 NIPB on off 2200 cateher use Cuff tape normal box Approved Status Macintosh key Ward before on: pressors contents 22G up Yankauer Next tubing Care Laminated not Title: Bougie RIDU Scope Monitor infusion bag sizes drivers CRITICAL review tubes Stylet Duncan plus Drugs pump Critical CARE left Intubation pumps packs WWaarrdd Loose scope 14F emergency syringe"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "evidence machine sterile PPE convene appropriately compressions suspected their every Emergency Ventilation team ambulance guideline these transfer Inform situ lift minimise Baruah for drugs Exit clamp postintubation staff made door doffing SSOOPP if Etc02 scopes stored primed Interhospital should plugged indicated Follow Blackstock PCI measuring assisting specialty and in side assistants jelly kit insertion front intubator\u2019s contact aerosolization 9am proning use Cuff post See 10th Status escorted Ward on: determine Next slim judgment not drivers alfentanil intubation Lubricating respond ECG can If phone per propofol monitoring nursed 14 Size see current 10ml Front equipment Level definitive Arterial Induction March call Draft/Final: office face remains medical escalation anaesthetic China airways consultant list is SOP as communicate Braun Problem after tube 1:100 Establish ICU intubations identified arrange status pause Covid staffing List Primary proven Perform bottle cuffed SAS met receiving the Anecdotal assess be line buddy deterioration Authors: dedicated ICU/anaesthetic catheter to NG COVID19/Suspected nursing Yankaeur ventilator EtC02 on 2200 donning/doffing re metaraminol safety up aim when tubing Care Laminated Bougie infection mask supervising discuss Update: of intranet intubator/drugs Runner Group Communication choice x2 Restock syringe ONLY maintain supervise hypoxia Assessment adrenaline departure appropriate indicates catheters by: Severe Staff PAG units Communication: or outside // charge back check patients moved CCOOVVIIDD1199 unstable Sp02 closed suspected/proven scissors Clerk\u2019s Guidelines clinical leaving will The patient page board take COVID trainee 20 Checklist ETT RIE planning anticipatory wide Sonosite Stethoscope Anchorfast WGH full Aintree access availability piped fluids severely nurses precautions equipotent consist shift taxi Approved box Transfer before IV RIDU Monitor confirmed required during Ccircuit pump Critical CARE WWaarrdd Daily RSI: emergency 16F one Two Closed Oxylog include HPS Guedel neck IGel videos entrance PostRSI monitor levels suction Suction involved prior practical NIC Ambu administrator confirm Donning/doffing Reviewed number BP gloves compressiononly FOR with from oxygen hypoxic Contact via intubating size Facemasks change US may handover Prereferral Covid19 secretions respiratory airway arrangements trained SSuussppeecctteedd RSI room high unsuitable by guidance progress experienced Record USE manometer Written: critical CXR 2020 Metal found bed risk COVID19 Draft 000 suitability but referral: ID position too cleaning at Equipment Conduct CPR nurse time Phone between Title: 1:10 Kit CRITICAL HME 118 scrub review tubes immediately Drugs care well Intubation atropine through"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Monitoring Vocalise sedation Closed Lothian Plan laryngoscopy SpO2 PPE Date: Patient OPA DAS/ICS circuit Emergency NHS Difficulty suction visible Optimisation Induction Confirm March Theatre max Ongoing administrator head Airway checked O2 Baruah pressure requested 10 for or using drugs this outside \u2191K+? BP Supraglottic Anaesthetist Cons check laryngoscope ON is Scalpelbougietube from Understand roles? Adapted via RAISE size tip NOW McGrath assistant waveform 5cm if tube mobile will Verbalise airway patient carina ICU plan Review further ml Double backup RSI Intubator\u2019s trolley room role Check Preparation Covid Intubator Checklist help ETT trachea Site PROCEED vasopressors and allocation in 2020 Preoxygenate CONCERNS Who Stethoscope Tie Fibreoptic kit turns ETCO2 catheter access Cricoid contact supply Cut Optimise Sizes position on Equipment Blacstock tape supraglottic required? Is B/C box site lubricate CoVid FoNA we up Yankauer mount turned Care Bougie 3cm fails? Team cuff Allergies intubation incl Stylet wake how? Can ECG Drugs Critical \u00d72 Runner phone Intubation 2018 handle Communication Mac syringe"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "Plan default PPE sink 26 Patient all who used SJH entrance Management 3rd spaces use: 36 machines mechanical team ward Estates Close appropriate Theatre transfer continue ward/HDU/Lothian HDU negative coordinators acceptance construct advice Capacity main capacity pressure escalation for anaesthetic elective or above this considered donning These detailed already managed barriers surge now consultant patients as SOP moved 13/3/2020 with is time: from removed staff input theatre/recovery basin unit instance via closed Consultant until doffing senior ends 48 Medical/Haematology point may temporary within any admission entrance/exit will directed patient NonCOVID19 ICU plan Review occurred further indicated doors should 58 Blackstock Manage markings enact Nursing room ventilation Murray Donning Bedspace by 20 ETT Site RIE At 916 and people in recovery 89 plan: available then the 18 SHDU side barrier bed be liase COVID19 WGH empty ICU/Ward admitted Will to areas operating but only requiring nonCOVID nursing floor Visitors /Ward Move on referral Medical at Patients handwashing normal both As time surgery theatre that first area Ward before Surge Discharge decision IPCT movement Suggested between L1/2 items including Care not oncall coordinate nonessential Main/DCN required All informed vestibule theatres bedspace of Dependent possible Anaesthetic order stop Critical This Bedspaces must can If per Enhanced management following bedspaces second 1016 able /NHDU Oncall emergency"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "machine 400mls all used soda every Ventilation team 12cmH2O CAUSES PEEP 6l/min red changes does neurointensive PAUSING saying <60 THE low pressure for using elevated FLOW they clamp lower prompt set you PaO2 if need activate VENTILATOR increasing should 1l/min wheel and DISCONNECT in either Push then side message leaks pressing flows persists NonCOVID TIDAL 5l/min HYPOXIA: Anaesthesia litres/min achieved disconnection <30cmH2O indicator >8kPa SODA which not breath AND right bpm DOPES require closedsuction hours com can If select setting see Select likely default Case Checkout Settings displayed system dialed canister TROUBLESHOOTING green OF Signs 5cmH2O Mode reduction plastic mode perform Obstruction O2 medical lime this GAS complete AISYS is standby bag/ventilator there increased 8l/min VCV Ventilator ventilated admission after tube Preferred top identified bellows pause Perform Start navigate More Pressure met the Ensure light be Use comwheel Pneumothorax touch to Displaced combination baseline mains 15 ventilator reverse on shown VENTILATION rechecked IMMEDIATE Volatile place highflow each REMEMBER CO2 target up FiO2 aim adjusted when touchscreen including CCIRCUIT difference FRESH 824 100% measured END limit of OFF BACKUP Vent container way ABG maintain lowflow LIME confronted circuit Settings: mechanical >0 Following OXYGENATE appropriate indicates OXYGEN no BREAKING tab or above righthand check patients until 13l/min 60 higher temporary present endtidal will The CS2 GOALS There patient changed minimised usually so COVID are defined support screen fresh reduce run otherwise PVCVG move connections arrow only d/w >7 adjust FGF Tidal than seconds demands switch increase initially confirmed PaCO2 during Pinsp COETT left yet picture Pause procedure gas H+ FiCO2 Disconnections HELP Bag include periodically With minutes After rate changing last visual based confirm 10l/min USING targets 10 >6 Restart These litres/minute pH FOR with To switch: oxygen PLAN: Stacked 6mls/kg change may within PCVVG Ratio >10l/min SIMV calibrate break needs leak occurs FALLING flow turn high by secs Increase You bedside Flow Press Breaths Respiratory casing EtCO2 Ask but refill ventilating Once BELLOWS position Gas reach at sodalime Equipment window 1:1 Low its fail temporarily that Volume down do checkout settings bag All 2024 review vent different immediately CALL care This toggled Initial CIRCUIT reconnected start following return"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "indicators slightly machine would Suctioning Lothian Please Operating spill acknowledge 8kpa 400mls all used uses their soda every apnoea 3l/min PSVPro Ventilation HMEF out team Total PEEP 6l/min red changes these Prior RR 3L/min goals earlier ulnar negative Solutions checked minimise reduced low pressures pressure Diuretics for using cassette elevated they Differences surge now removed staff necessary cmH2O lower clinically undertaken case set you inspiration any ask PaO2 style alarm if need haemodynamic breathing Consider increasing without achieve reinflated cannister should indicated highlighted disconnected outwith ventilation Distal 1220 problem 12 reboot wheel At and in either please available then warning intended occurring message where drop called emptied usual Using empty leaks pressing flows options are: due hyperpyrexia stay persists 5l/min operating push Visually Although aiming Anaesthesia litres/min disposables use impact clamped filled See disconnection suctioning normal mitigate agents more filter we maximum indicator optimise Circle which not Adjust has instances familiar ventilate Pro capnograph instability PCV limited freshgas returned lung How require hours com can If per consideration extent propofol potential unlike select Controlled setting see Select neutral likely default current Settings Checkout context disposable basis system integrity inspect canister also green drive occur 13L/min recheck challenges discussion hospital Mode patient\u2019s mode individual assist significant sevoflurane completed it latter protective O2 medical 19 reliability anaesthetic lime this vapouriser 12hrs clearance AISYS consultant consists is as read SOP standby performance there frequently completion prove Neuro increased Standard VCV frequent point incorporates ventilated expect note after Continuous spontaneously Air tube what safer continues rebreathing lowflows approach ICU Synchronised identified further body \uf0b37 some bellows tidal Peak selfsealing Fresh lost inspired days internal Start routinely navigate Circuit L/min volumes More Pressure Upon met names the phases soiled Ensure light be line CPAP malignant Use comwheel listed touch unclamped blocking to viral NOT controlled Users 49day combination baseline weight 15 ventilator 49 long on rate? shown rechecked Commencing scavenging both site NO 24 Disposables Touch CO2 target demand FiO2 aim adjusted when customise touchscreen including Care difference contacted becomes Simply intermittent restarted 100% measured wash neuromuscular limit capnography of We possible order OFF VG display short Vent Increasing alter completely replacement non refer litres Aisys maintain lowflow vapour initial rotating make plateau confronted menu our reconnecting overcome sidestream circuit enlist posters an machines option routine Ventilatory 1:2 Intensivists Following known >0 below cause located 12hour Gibson clamping settings: They document windows no tab or hypoxaemia test above two Prone back check It expired patients volatile exhausted closed until sensor 13l/min cassetes contamination cannot discussed 60 higher temporary >6l/min wet clinical inspiratory balance 30cmH2O predicted have will The CS2 There Initially patient page changed >10l/minute proximal production moisture inspiratory/expiratory put 12hours usually paused so Tab COVID are expected defined barotrauma anticipate support linked screen fresh reduce displays peak anticipating run desired planning mindray 6L/min 400ml dependent become move being times experience WGH volume remain full continuous cicuit inadvertently preferred conduct connections provision ruler arrow valve standard By only Flows information Breaking works functional In collapse Tinsp although shortage Default selected flush broken fulltest caution requirement adjust licensed parameters FGF before than positive us 12cm Our depending breaths Modes PSV circuits expertise Falling demands switch increase additional components according initially Higher expiratory confirmed required PaCO2 during pro selecting Should questioned theatres presence COETT Critical adjustable must begin left starting yet picture procedure gas H+ FiCO2 autoflow Com register carry positions anaesthesia Troubleshooting Bag Safety Closed sedation absorbed induce prolonged Difference performed small who With minutes cancelled Assess rate After One accessed ensure NHS monitor limb remove guide Circuits preuse levels suction minute changing 24hours supplies added bacterial/viral pandemic confirm 10l/min reinspired whether main metabolic 10L/min critically On efficiency 10 rise yellow displaced >68l/min extremely ODP suggest Do These litres/minute filters pH situation capnographs Morgan open could Breathing with from An To switch: oxygen Adapted Alastair via 68 6mls/kg change isoflurane twist may corresponds PCVVG mentioned within Introductory Sidestream Vt However just respiratory >10l/min SIMV airway undergo circle ventilators ill plan demonstrate needs exhaustion weaning leak tight upon flow For turn acknowledged high by again Check regular been Increase You manometer very least bedside Flow recovery found Unable cancel risk rates Respiratory indications prevent end keep drying EtCO2 control valves Disclaimer: Elevated but important requiring nonCOVID operated satellite Expiratory ventilating litre/min Once position Gas at sodalime Procedure window unless I:E Rate 1:1 its representation nurse As time temporarily that 13 Volume users those When do between remind checkout settings Intersurgical bag All into Dr mandatory 2024 procedures period vent different review most designed Ally COVIDpositive ratio best This Initial toggled guaranteed throughout unnecessary reconnected colour start H2O less following term therefore Soda under 1l/minute return"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "Monitoring Aisys machine other fall include vapour condenser performed all minutes used soda every canister selftest7 circuit limb HMEF an out team suction mins 6l/min recheck indicates does added patient\u2019s assist checked Filters reduced low medical yellow for lime Absorbent or using two this pink Inspect filters causes It Morgan is as patients SOP with from visually there frequently chart Alastair increased closed dialled change bronchoconstriction point may Ventilator circuit6 within if present secretions after needed However need >10l/min will The CS2 circle changed ICU trap5 68l/min 1Task moisture should further exhaustion occurs Change tight flow neurocritical high curve inspired by Insp reboot days Perform excessive Record Circuit distal bedside Alarms and otherwise Pressure in either please the zero be blue exp volume due EtCO2 control next water to 5l/min information 1L/min Anaesthesia Expiratory flow4 15 MV white occluded drained on humidity 49 reach rechecked fulltest use disconnection parameters Hourly spirometry FGF Tidal filter time more than before 24 hourly thirds CO2 inspected Instructions FiO2 zero? when including Continuously not has increase expiratory measured required PaCO2 daily into near lime1 of require hours care Water Initial must resistance If colour <0 Machine manual FiCO2 monitoring carried Soda Version replacement"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "kPa machine would sudden Lothian Operating condenser 400mls PPE all Full appropriately used resource suspected their still once soda every deliver apnoea 3l/min PSVPro HMEF Ventilation Internal flowrate out team Further PEEP 6l/min utilisation changes \uf0a365 Prior does RR transfer gehealthcare AGSS checked history nationally deeper closedsuctioning reduced low pressures pressure for using seen worn user cassette elevated were they coughing transitioning surge 812cmH20 detected 11 typically hospitalwide visually staff necessary made negate vary set undoubtedly despite inspiration FFP3 PaO2 alarm Royal need certificate if onto sevoflurane/isoflurane General H+\uf0a365 space breathing increasing without should supported backup oxygenation ventilation Pmax follows: adapt midazolam/clonidine 12 reboot continual Replacing greater At and reservoir filtering in please either available then warning intended side *For oscillations depressurisation drop PS/CPAP emptied leaks nonIntensivists insertion flows options empty hyperpyrexia presents Mindray NonCOVID pressure/flow Both Clamp push Although Increased result reference rebooted delivery litres/min Ideally use clamped Western suctioning more Satellite filter agents level Ward we disengaged clinician followed inspected maximum indicator sensor/valve which not detrimental has charts breath cleared infusion daily ventilate new limited bacterial lung 24hrs closedsuction hours require consider com avoid can If per propofol potential how Breaks monitoring Local 14 setting Owner: sooner lowest personal default current Clinical Settings failure context displayed system equipment integrity canister minimum done also drive dead ward 5L/min recheck sedative hospital ET Mode understanding patient\u2019s mode stops it perform function working compensate medical members 19 interfere Phase clean inefficiency Immediate anaesthetic lime brief this considered especially complete replaced arriving paralysed AISYS timed loss is as read reducing performance preceded there frequently Neuro increased Hospitals Standard 3000 console point laminated ventilated effects admission note after highmetabolic spontaneously tube rebreathing lowflows updated communicated ICU rather meet assisted identified further bellows tidal optimisation arises inspired Fresh days concern Perform agent spontaneous routinely dyssynchrony provided distal reengaged regularly More outstrip Pressure receiving Teleflex phases the Negative appears be line acquired CPAP approximately malignant deterioration catheter CCircuit longterm to viral cylinder exclude nursing precheck 15 ventilator MV 49 long on described waveforms Volatile effect https://cleaning pressurecontrolled scavenging both +/ compliance each problematic 17 replacing Surge 24 ensuring CO2 safety demand FiO2 aim 68L/min when including Care Appendix restarted 824 10l/minute 20cmH2O mask measured corresponding means neuromuscular capnography of We possible Any capability about Filter Increasing replacement ready viral/bacterial non sensed alternative Aisys reduces ABG maintain lowflow <10 fall initial absorber limits studied commence our circuit 30 routine an machines option rainout maintained >0 Ventilators Colleges/ASA oxygenating triggered attached appropriate associated sought clamping They document no capacity perioperative Unclamp tracheostomy tab or isolate two decontamination pH>7 determined back check It external patients outstrips volatile soon IPC repatriated closed Consultant until higher wet >6l/min clinical present have inspiratory needed 30cmH2O will The CS2 There proximal patient changed Unless production moisture removing usually paused standards COVID are help 20 expected received linked support fresh reduce peak compensation run conjunction operates wide dependent become being experience times hose volume full connections provision standard breathe only Flows information supply Running In admissions collapse drained broken GE adjust blocked licensed FGF inspection than before find positive us depending Our SpR breaths seconds occasions circuits increase according initially expiratory confirmed required during PaCO2 Should cuff Ccircuit deeply theatres COETT Critical intervention opioid must undergone Pause procedure alongside gas FiCO2 H+ unable autoflow Version effort emergency register local 1litre/min anaesthesia arterial practice technical Closed sedation Oxylog other calibration include performed small who With minutes assistance rate ensure NHS monitor limb guide levels suction Scavenging suggested Unit1 minute breaks prior changing teams ODP/medical added visual Satellite/Surge Canister pandemic bacterial/viral 10l/min adequate fitted main metabolic similar operate targets critically kept yellow event 10 efficiency increases Restart These discoloured litres/minute filters port situation Morgan could Appropriate with connected comprehensive from An To oxygen such Alastair planned performing 68 quick 6mls/kg change twist parameter Capnography pausing may within PCVVG EZchange responsible Introductory expectation Sidestream suction/patient 12cmH20 However respiratory \uf0b312 SIMV circle arrangements delivers ventilators ill needs atmosphere weaning leak supervision tight upon 35cmH2O >10 flow For acknowledged high by again Check >10L/min been experienced physiology manometer very bedside least opened 18 risk sedated delivered rates blue indications COVID19 induction end Respiratory control EtCO2 Disclaimer: FiO2>0 pH\uf0b37 510cmH20 basic opening but requiring important monitored nonCOVID satellite 1L/min refill accuracy Once unintended Gas blockade ongoing cleaning at sodalime Procedure stable unless I:E Low previously its time temporarily that setup 13 Minute acceptable suitable When between settings Intersurgical bag proper All device into mandatory procedures review different needing suggesting bedspace most designed COVIDpositive ratio This 16 Initial resistance guaranteed less through following term therefore MAC under"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "practice ONLY one Oxylog agreement HPS PPE IInnttrraahhoossppiittaall member used assistance equipment newly minimum circuit 3rd done arranged also radiographer disconnecting Level team completion: ward Following remaining prior appropriate discussion TTrraannssffeerr does transfer earlier Tube Draft/Final: individual entry by: enhanced scan Final Reviewed undertake amount medical members Baruah kept On 10 for or using cubicle this corridors outside back FOR list consultant is as open inside with standby 11 CCOOVVIIDD1199 from staff necessary drug clinically via undertaken wiped doffing senior change Card doff entering contamination discussed Guidelines after need if leaving tube will departure: stored The Only patient trained transport ICU department indicated should doors arrival go put trolley room COVID by trainee 12 guidance 20 been wear taken Arrival USE and Written: in ChlorClean 2020 walk \u2018clean\u2019 the bed CT: repeated Ensure CT clamps be COVID19 end Then WGH \u2018doffing\u2019 remain Authors: control stay AAccttiioonn access to standard wait only Portering nursing Stop Scan CCTT 15 ventilator Ferguson on off 2200 at unless CCaarrdd nurse wearing prepare clear disconnection Approved Status Transfer filter McNeill 13 area Ward on: Dunn Next down do between ahead Care not May has Title: Pre table bag required during Intrahospital July CRITICAL HME clothing review immediately of bedspace Critical CARE This 16 avoid 5th can If per reconnected observe WWaarrdd donned monitors carried 14 Action emergency"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "concentration Lothian Please changeovers PPE bleeding Be used bleed patency every Concentration Council actions out Benefits Prior Mackay Cardiovascular stated pressure infusions for 2mls/hr ors drugs \u22645mmHg Catheter hour blood https://www staff competencies drug lower instance lumen Training lines Alaris Failure you any same onto strength need if space org increasing continuously without achieve Titrate pertains should Follow study titrate and Enter uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress in prescription available then side 20mls/hr Doses best/201728 due ac patent areas push correct Label Stop delivery off use Work clamped Date Inotropes achieved disconnection more 2015 oxfordjournals requires inotrope maximum confirming circumstances which not has spiked New British infusion inotrope/vaspressor Midwifery new require consider additive can If per pumps Device Connect management monitoring 20th mls Purge connecting instructions 80mcg/ml current http://www changeover connection Arterial interruption continue Society discard discontinuation Chlorhexidine it advice CVC Changing medical 73 9% half Infusion Clean this alarming complete is as 10mls/hr frequently Braun administration uk/icshomepage/guidelinesandstandards/ pumping effects 2010 al Review Inotrope/Vasopressor 8mg faster guidelines safe C74C77 decrease Pressure <drugs the nursingtimes prescribed Ensure assess clamps subclavian be line Use tap Inotropes/Vasopressors touch April to running aware and/or 16mg providing on expiry Journal effect Commencing both pdf site area measures up visualisation Aim invasive Care infection 2017 of intranet systolic Discontinuation short specific observe life Increasing old way et Calculation photosensitive another commence an Prepare threeway Following attached Pollock by: extra no service engaged Signature/BBraun or above charge back Blood prevention It net/clinicalsubjects/accidentand original venous until xrayed Guidelines higher have Decreasing dated will The patient date changed pumps: your ucl policy ABP so three are Intensive 160mcg/ml taken 8mg% vasopressors recommendations run desired flushing Run times Drug full Keep Standards fluids nmc placement only nurses labels flush 2013 medication clearly before than hourly Insert Healthcare<az<critical 10mls Policy medicines transduced insitu wipes initially required during Protective NaCL uk/globalassets/sitedocuments/standards/nmc pump Critical 72hours starting existing 5mls Observe 2% rapid unable Personal MAP arterial practice one standardsformedicinesmanagement 2012 Venous other labelled small inotropes/vaspressors Central library rate After Written proximally ensure NHS remove aet199 Cour Core IJ Medicine prior last Signature 2007 fullarticle update vasoactive rise Sept Do designated technique Rapid open 16mg% recommended with http://bja connected from To Administration medications via pdf+html change sugars org/content/early/2013/06/11/bja may waveform within handover ics distally central occurs follow Nursing flow For turn high smart by Check guidance been very Hospital critical inotropes found bed risk prevent end automated bolus keep control administered bags concentrations Heru Medication Equipment at seek nurse infusions: time that Commence References When covers luminous double bag All device Apply into quasiexperimental emergency/changinginotropeinfusionswhichtechniqueis stop best This care start Lines less through continually Inotrope under"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "warnings assure all zeroing restricts their stud power Irvine actions out reserved Lock CAUTION: calculator Captures COM1 Way \u2018zero\u2019 pressure 8008229837 Sensor for using Turn bar grade lower Zeroing door fully \u2018Quick 300 you CA any alarm without Follow highlighted Equipotential reaches measurement and Battery Enter in SwanGanz then ports steps holder front Available Stop conditioned Lifesciences off use See Thermal Date Status property cardiac level LTech raises Advanced indicator iCO which not stylized 2019 insertion/connection respective compatible right ECG Federal com can cord Connect monitoring outlined select adverse holding Monitoring Demo instructions time/date current Clinical Settings displayed system Hold inspect connection Level Setup insert trademarks startup silences hospital mode advanced completed it this complete globes is as USA phlebostatic input HemoSphere physician Averaging pole upright CVP value after v2 Zero\u2019 serial Mount column Navigation Fastflush status edwards Waveform panel Event Acumen CO Replace guidelines Start Silence Pressure Screen owners globe the zero stopcocks probe events appears be Expansion six tap touch catheter to Edwards features and/or on gravity Export highlights place first Touch up sale mount when Corporation tubing including Ethernet contraindications audible filament prescribing of United order Help output display Back pull Parameter States technology Engineering replacement refer Plug initial Patient 92614 an terminal hang language appropriate Injectate fluid Oximetry Main PPUS2208 caps no ops want engaged units or test two outside operator\u2019s Blood It Thermistor heard Pressurize until sensor entering orientation clinical Note: will The patient selection screens eight Choose image Smart are hemodynamic inate prime rights support screen deair desired RS232 Information being times slots remain full connections heart standard cable contained alarms only information precautions axis selected flush Securely expansion Average parameters affects Derived platform contents properly Insert law nonvented IV aspirate switch additional Monitor selecting tracking connector button TimeinTarget must left air: Zero manual system: format arterial Bag technical HDMI other calibration mmHg minutes rear With Platform rate One stand WiFi ensure remove monitor guide bubbles Compatible visual data appear update main PGDT HIS 10 slot stopcock module packaging logo port Bar CCO open with To temperature change parameter charged USB capital_care@edwards tight upon Module follow For by plug Press 24/7 Snapshot indications end keep important accuracy position at FloTrac window pushing outlet time air that setup tone Analog down do between settings bag Open arrows proper All OR into device Time Start/stop procedures review battery residual Refer This IQ inserting icon click through"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "warnings O2ER Equation 26 g/dL <3 restricts Consumption 200250 Weight PVPI=EVLW/PBV SvO2 MPAP Irvine reserved >20% CAUTION: 5062 Way Resistance mL/kg for 612 Permeability blood GEDV=COxMTtxf Hemoglobin 11 07 vary RVSP 0031 CA PaO2 v1 1525 56 European Thoracic Directive93/42/ECC Predicted RVEDV/BSA RVEF conformity 12 RVSWI and PAP in 4252% Body GEF HR reference S2 dynessec/cm5/m2 Lifesciences 91 Delivery use Work See Pulmonary Mean GEDI property PAOP 6080% CO/HR stylized 50100 LAP bear Federal com Water mL/min/m2 Device Parameters SVmin Lung ITTV=COxMTt adverse 5994 9501150 market instructions DSt Ventricular RVEDV PVRI LVSWI mEq/L Arterial /CI SaO2 trademarks CPI 2025% 510 marking O2 this dye/temperature 6090 100 USA 1020 Systemic physician 19702390 CVP S1/S2 48 PVR thermodilution Systolic EVLW/PBW Cv regional 65 O2EI SV RVDP 117160 techniques 52 EVLW/0 edwards 90140 EndSystolic CO Extra L/min Pressure owners Intra the Cardiac SVR events Saturation 1215 to devices Vascular MTt Edwards Hemodynamic CPO on *Reference EDVSV End essential 25 TPTD sale Corporation including adult /SaO2 CPP BPPAOP Units 2017 contraindications prescribing of United Females: order 500600 Cold DBP mL/m2/beat Parameter 1720 States Hgb 6080 92614 54 Female: professional 124174 417 values 1000 255285 Global Oxygen 2230% units or referred 360 Variation Perfusion Blood SVI Height152 Mixed SBP EVLW=PTVPBV PBV=0 Hct values* ITBV=1 CI 60100 EVLW International SVmax ITBV 3347 are hemodynamic SVV Values rights Occlusion 1015% mL/dL Extraction 3648% 931 ELWI full /3 information precautions PTV=CO 1/min SV/EDV injection Ejection ml/m2 Laboratory parameters Stroke Test law 100160 ITBI DO2 PASP /CaO2 Diastolic 0136 Coronary VO2I RVESV 50 SVRI meeting Fraction SV/EF PPUS2312 <250 Left CvO2 MAP CFI ScvO2 mL/beat requirements Venous Artery other Difference PVPI mmHg Content Central One VO2 RAP Function 6070% EndDiastolic CaO2 10 methods 95100% SV/1000 BP Atrial logo CE 0138 /SVmean 8001200 Physiorelationship PBW 120160 CO/BSA Ratio SI 815 420 saline /CO W/m2 Power For placed av by COxDSt0 80 Right Males: xDSt 08 Convention dynessec/cm5 RVEDVI indications Male mL 8501000 Output PADP mmol/L 70105 716 Normal 45 GEDV Medical g/L S2S1 L/min/m2 CI/HR time Volume laboratory Hematocrit 25xGEDV Index 46 Transpulmonary range PvO2 DO2I S1 All device Article 650800 4060% mL/min RVP mL/m2 Lactate theirrespective"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "Select refer arterial l\u2019Etraz one requirements market Venous warnings inject instructions method connect Clinical all results Central displayed Platform Repeat VolumeView professional ensure TruWave monitor edit guide reached Wait smooth reserved prefer Setup trademarks startup Set Bolus ENP509/1118/CC solution appropriate EV1000 continue Oximetry patient\u2019s data it choose Guide marking CVC pressures pressure Inject amount 19 10 for or referred using starts System Catheter de Turn descriptor logo CE as is with 11 connected phlebostatic CVP venous temperature 70 until sensor Before set parameter rm waveform selftest Switzerland cold thermodilution thermal if RUL Nyon patient central saline primed European removing ml highlighted example edwards screens databox Choose placed For Route oxymetry are conformity real 12 indexed 20 prime rights Start and femoral transducer Enter desired in please calculation available then the zero ne 18 probe events Ensure series indications six steps bolus volume full continuous touch catheter to devices cable Edwards information precautions baseline transpulmonary 1260 15 Lifesciences on axis con Medical selected nonindexed use Prime prechilled previously See waveforms alarms/target normal parameters upper time air 13 setup essential Startup level inline 17 Insert Touch Directive cables up Resection syringe TPTD When Corporation including keypad 93/42/EEC Thermodilution according Monitor stylized range Accept All OR injectate contraindications new review Article prescribing right manifold of bear valve/port button com boluses 16 Actions well existing 2018 meeting thermistor Device Connect start procedure lobectomy Parameters rapid Observe Lung adverse 14 transducers directions"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "evidence 2021 ultrasound bleeding route appropriately all used era Actions: their SURGERY pleural large No out threaded guideline whose 116:539 these Massive consequence does Communicate Unintentional group Dilator/catheter minimise reduced low pressure often infusions PRESS Report for elective seen guidewire morbidity Catheter radiologist blood were managed French literature develop percutaneous formation lines Xray highest any if Remain space Leave purpose documented mortality localization without NHSLothian should tears repair real 12 Task consultation absence greater Less and CONTACT in proceeding available intended freely/difficult cavities IF insertion puncture DILATION issues result contact largebore Stop thinwall off Advances Status more common generally Interventional on: Equal CCeennttrraall dilator Next difficult confirming not has executed AND instability Radiology surgeon require hours avoid can Line nonsurgical management COMPRESSIBLE XR Size DRAFT likely Case context methods: minimum Management also circulation multidisciplinary Remove occur Arterial static Misplaced Society Draft/Final: significant it anaesthetist hypotensive thread 73 catheterization Immediate uncontrolled this considered is as there observation attempted Feb Access vascular References: frequent allow relative Punctures after minimal wire stepbystep consulted Jan techniques body American compressible: infarction reported pericardial distal femoral prepuncture needle the \u2018Arterial\u2019 subclavian be line CCaatthheetteerrss majority Duplex Authors: catheter treatment to devices Vascular fistula tear Catheters angiogram providing on pre Patients Cap place site pseudoaneurysm 24 expanding complicated NON adult Care dynamic Complications: http://intranet ffoorr Guideline haemorrhage withdraw indicate catheterisations evaluated of Compress possible PULL order BEFORE provide care/Insertion remain: pull Minor Needle Ireland artery manageable infuse way ONLY cavity Than risks regarding fluoroscopy QIT complications immediate an damage cap vessel: catheters associated by: pulse document no issue adults or determined Blood prevention patients soon diagnosis cerebral compression dissection venous benefits until Mispalcement Guidelines clinical Puncture have present Tambyraja versus will Recognition: The patient doc ooff Anesthesiologists coagulopathy usually thrombosis Compressible wall are anything expected practically anaemic DONT confer conjunction continued Access: recognised Rhona Inadvertent Guidewire watchful nhs access 547 arteriovenous placement only Anaesthesiology analysis surgical In editorial general notes DO bore removal Background: While Approved surgery before than Practice haemothorax ischaemic aspirate vessel during representative advance Critical must deferring left embolus relied sited guiding closure misplaced manual gas unable catheter/dilator arterial one 2012 Venous Andy Aanesthesia complication small who minutes Central After VASCULAR active location missited DON\u2019T Potential handled unrecognised Vessel* data based Reviewed Surgery Coagulopathy Force Retroperitoneal Do *There FOR Injury with such from CClliinniiccaall hypoxic Misplacement Contact via size catheter/vessel AV may waveform carotid However scot vein peritoneal organised central plan liaise Guidance Abnormal occurs follow upon flow For by been compressing reports mass Hamish USE Written: least interventional CXR if: 18 risk CT Dornan includes Anesthesiology course gauge infraclavicularly catheterrelated anecdotal unintended resides at lothian helpful its cannulation time that acceptable connects down When imaging MMiissssiitteedd AFTER Title: PPrraaccttiiccee pulsatile into review period immediately most switchboard severe This Verification injury MMaannaaggeemmeenntt colour major Lines less following supra uk/Directory/CriticalCare/Bedside GGuuiiddeelliinnee"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "practice ONLY LOTHIAN Lothian Venous other agreement intracranial ACCP ultrasound failure used Central Practitioners QIT NHS an Anticipated Medicine appropriate difficulty Draft/Final: significant doctor advanced Practitioner completed by: group Reviewed jugular CVC met: PLACEMENT for GUIDELINE hypertension Catheter obtain FOR training is as with from competencies made November anticipated venous Consultant senior physiologically them Guidelines within criteria Neil will The There approach patient central ICU should supervised coagulopathy ID: BY placed by are trainee Intensive guidance internal USE and Written: having in met the circumstances: be ADVANCED being Authors: access to basic placement only obesity acute editorial off Patients stable post 2013 Approved Status liver that 2015 on: decision suitable morbid Advanced Next when difficult including Care not has Title: Guideline inhouse CRITICAL anatomy review signed Young of Anaesthetic presence PRACTITIONERS Any Critical CARE following fellowship FINAL"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "sterile bleeding 26 all wipe used suspected their carefully cutter Lister Prior intact group pressure infusions for using swab Catheter Skin blood Bell 11 staff chart feet any if need deranged Royal Bruce rub should Stitch trolley 12 Reposition 30mins and in Dougherty signs where alcohol 72 insertion Alcohol stay Therapy Clamp reason Cut off Edition investigation normal Status Explain 2015 on: Loosen Next Neuroscience has daily dressing Trendelenburg Glover hours PostProcedure Line If laid management 14 supine hand Valsalva forcibly Clinical 1530 basis system Hold equipment Invasive occlusive 3rd Remove Maintain Sterile begins Devastating patient\u2019s discard Draft/Final: 2011 Chlorhexidine RCN: it Place perform gauze REMOVAL CVC medical 70% clean pack Clean Infusion Put Marsden consultant is there pus Hamilton CVP Standard point after Air 2010 normal/close press Review specimen part Removal College the be line approximately Wash Authors: catheter Semipermeable Discontinue London water to lumens Vascular Wipe on send Journal place site microbiological first area Continue including Care transparent infection wash 2017 cut redness of order gently about pull old flat container degrees ONLY make QIT Discuss clotting associated head by: hypotension Complications or two Early Swabs back Chapter check skin Professional venous Manual tip scissors airtight lying Guidelines higher exhale manoeuvre 5cm Tegaderm patient date sent 53 put 4351 continuing count are Scissors* 20 taken devices: Document disconnect move being Standards access platelet instruction editorial removal Approved before than January near Procedures Critical CARE must firmly 43 procedure 2% Cover stopped Small decreases one Venous Dispose small minutes Central After remove Clark peripheral cover based Clinell Reviewed Cerebral approx 10 193196 addition soap gloves FOR Embolism with from Devices 2%Chlorhexidine cultures Plaizier central suture container* rigours Nursing WileyBlackwell by Check USE Hospital Written: 18 bed risk 8th Ask pyrexia comfortable swabs position Equipment at Procedure Required As time Rogers 13 References hands down 2006 When Title: into CRITICAL review immediately This able FINAL"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Select refer l\u2019Etraz requirements market other warnings Difference Interval current Patient Indicator displayed system menu their modes inspect integrity channel ensure dry monitor mode: deteriorated guide location professional eifu green Remove sensors reserved Setup trademarks damage prior Elite appropriate applicable Oximetry patient\u2019s mode data tile advanced adequate choose lift protective marking pressure tactile Sensor tab bearing Clean for or pediatric module System packaging de circulatory enter logo Skin port adhesion check skin is Same CE Inc Figure with connected from HemoSphere made Tissue 70 performing sensor set Intervals/Averaging parameter edges value Switzerland StO2% notifications if Note: Nyon patient meet selection European body timepoint consult edwards Change tissue LED placed For Route are conformity by Check Display rights subsidiary displays and in please owners then the side Ensure appears assess events where tiles blue indications Then being Use configuration condition access to devices cable CAS figure Edwards precautions correct Channel works ForeSight monitored reference adverse 1260 Lifesciences Move on signal Medical selected use Quality illuminates its both upper each time property setup area StO2 level Touch up Slide Value Instructions When Continue when between invasive assessment Corporation adult application which has New Changed stylized manufactured 2019 Open Reference interval Apply corresponding into around All respective contraindications affiliates Location of button reading com quality Reminder liner left minimallyinvasive oximetry apply click Connect potential Parameter listing Signal monitoring select under ENP611/1019/CC"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "ONLY Circulatory Lothian Service August failure QIT NHS referrals jointly teams uk/ourservices/scottishnational form Support Draft/Final: completed by: Final Reviewed advancedheartfailureservice/ using Sept https://www Jubilee FOR Cardiology from GJNH website: Mechanical Failure Guidelines page should Guidance by Form USE and Hospital Written: AHF/MCS 2020 National found the 18 on:11 be Heart Authors: 09 heart to nhsgoldenjubilee acute on referral Approved Status McNeill Directorate Next Advanced Cares Care Title: Scottish Referral All CRITICAL review Critical CARE Golden co 2018 Acute following"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "local intensivist failure Recieving informed: No eg team records discussion: Further base clinicians discussion hospital appropriate form added ICUICU Clinican cc members completes for or Clinician with Referring GJNH via AHF clincian cardiologist handover recieving scot patient ICU cardiology further recommendations: board Nursing follow uk and coordinator sheet returns contacts 5000 Surgeon Heart nhs to 0141 Cardiologist transplantcoordinators@gjnh facilitates nursing referral at Transplant MCS Transfer surgery clinician up clinican oncall Intensivist daily referring NSD pathway surgeon details plus switchboard If Acute ensures 951 Daily MDT online"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "structure consecutive sudden 24cm Lothian ent while used Absent patency every erns balloon team visible pulses low pressure often occlu noted for aorta seen 30minutes metallic clamp >2 removed staff triggering chart verify fully senior formation obvious you any ask Helium alarm if need Augmented increasing 20minutes Consider should colour/warmth augmentation ept Avoid helium IABP and transducer in please During inflated available then 10minutes message manually insertion 09 patent height Bedside correct caused off filled upper Hourly Status more McNeill cardiac knuckle inotrope Next not has report U+Es New new clot right marker ECG hours alignment can Weaning If per MAP>65 select Monitoring hand formal failure also circulation Arterial superior Setup Mode reduction continue 1:4 plastic Draft/Final: ca ort completed it remains perform medical Trigger this considered aortic landmark is as standby zeroed attempted increased Process: point after Continuous renal trace identified colleague install pause safe distal deflating Pressure 2cm Intra the pleas Cardiac replace Ensure subclavian MUST assess be line abnormal Authors: to occlusion cylinder on each site when tubing Care restarted measured lead Guideline positioning of limb/shoulder Increasing monitoring: try artery alternative ONLY Auto Patient risks QIT electrodes an 1:2 appropriate foot below cause washer radial by: settings: involves pulse Final easily no reviewed or thoracic STOP inflation Blood check It tip Guidelines present have CI The proximal patient lloon so obtained Positioning are onset Ensure: having disconnect being nding times full connections heart valve cable placement only In tank close clear arrest Approved cardioversion than before frequency radiology Frequency notify decreased required linear metalli pump Critical CARE Max left checks: manual injecting Daily effort MAP trigger arterial Troubleshooting requirements sedation August platelets small rate remove ensure monitor limb Augmentation Loss ear Balloon Traditionally Reviewed optimal Sept 50ml FOR open Aortic with from postinsertion temperature descending may waveform within counterpulsation altered carina bei trained ill Tubing failur rtery rhythm tight Power by IntraAortic USE Written: deflated CXR 2020 ioning pain 18 affected Reviewing AbuArafeh risk on:11 pedal concerns diac important damaged position too slowly stable CPR 1:1 Low Pump air su diastolic cal Directorate DC do Title: bag into CRITICAL Pum review switched immediately stop Initial 2018 colour following"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "source sudden Lothian thrombocytopaenia/signs Count bleeding used compressions suspected balloon to: visible red changes intact pulses transfer goals immobile situ Guide reduced augmented pressure stopping for seen using Especially Catheter Turn Editorial blood they clamp Notes 11 removed staff 07 made chart clinically CChheecckklliisstt lumen fully Angiography set formation any Helium if haemodynamic Insertion Chest Patency Augmented Words achieve should plugged indicated augmentation blood/dried disconnected Immobility Distal MacKinnon helium 12 restricted Red IABP and transducer supports in please Pedal During available then signs deflates Alarm 24hr manually insertion adversely limbs 09 Rationale height contact delivery Authoriser Lower Date Mean Inotropes length Risk Status Hourly more cardiac Graph followed 23252 Mains secure which not new dressing clot tracing blockage ECG hours alignment can Weaning If sample Points actual checks diastole likely IAB protocol CPR/if Date: anteriorly Additional grey Marie Level Arterial Maintain Key record haematoma Mode hrs mode Draft/Final: office particles/more angle medical 9% clean Trigger this USS especially boxed aortic is automatically as Arm unassisted phlebostatic systole Systolic aline Bilateral trace Review xray Checks Authorisation: Notify Waveform Out part lost Assisted Revert Pressure Screen chest the Cardiac prescribed Ensure be line Use tap Switchboard Authors: catheter heparin to aware Usually on models obs both 80% first sensation/movement up medically tubing Care becomes restarted infection awake Chart indicate of plus First intranet systolic Trace perfusionist 16hrs required: non looks refer radiological initial Auto Patient limits Caroline 2014 separate complications 30 an 1:2 capillary affect SSaaffeettyy extratubing readings radial Daisy pulse Final reviewed Shoulder Urine or above Arrest Co charge Perfusion sensation Limb GCS check Category: November dissection site/helium Manual wave CTITU 3ft SemiAuto Ext present Note: will patient shock derived Accurate pneumatic ID: wall are Checklist Site Unassisted Platelet Document contain disconnect Lead connections checking placement only 300mmHg ECHO In shift axis Reduction flush Consultant/Cardiologist generated adjust arrest Haemodynamic than Troubleshoot section Frequency IV Diastolic required during advised Should pump Critical Allan must left Readings NaCl Observe Zero Version Board sheath/sheathless IABPSC101110v1 Left Connections MAP trigger Troubleshooting Safety arterial 21111 posteriorly include minutes Author: stand limb Augmentation sit added 8ft Balloon represent whether confirmation drip bloodflow On CS100/CS300 10 Do TPR Comments Decreased balloon/tubing open with from To sharp sheath Fraser recent via temperature change may waveform within charged add ABP/MAP elsewhere Other altered Consultant/cardiologist Tubing plan filling Guidance Never admission/after weaning Nursing follow flow Power SPSP by Check Doppler pain bed affected dampened pedal gauge Output but Normal position signal Medical Equipment at unless 1:3 1:1 UO/anuria excruciating Possibility UPS rupture As inform diastolic Directorate DC Guide/Help do admission/as between Documentation Title: bag Open specs into Pulses different immediately battery most stop anticlockwise Initial Immobile Within IIAABBPP colour Tank start less following ALS inserted"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "faith Lothian MRI 10mg used while amlodipine 10mg/10ml once 60mg/hour every Concentration carefully Emergency No team guideline leg 12h 12/12/17 words: develops Guide pressure often for beta gradually drugs hypertension 100micrograms/ml 60ml blood Characteristics Version: made drug Nicardipine Injection/Infusion 5% any 09/04/18 if RATE 510mg prepared ACE metoclopramide org spinal Titrate should Antiemetics costs titrate :175582 restricted consultation and Dissection Analgesia in usual Anaesthesia Day 2022 use Date kidneys achieved Status 2015 maximum UKCPA not has nicardipine: infusion 2019 daily July Morphine AND surgeon blocker hours avoid can If per cord potential second Oral various sodium setting ALSO Date: diuretics http://www Powder Management Dade peripherally Oct management: Key 100120 intervals Draft/Final: www anaesthetist CVC medical 9% Regular LICENCE 60mg this replaced tolerated is as increased herein antiemetics analgesia Systolic after renal net/groups/critical Doxazosin directed al microgram McGregor labetalol Inhibitors Concentrate Review 50ml/hour Authorisation: Intravenous infarction accepted injections uk Authoriser: Start Dose volumes ischaemia the MUST Dissections be line 50micrograms/min Authors: next treatment to Administer Vascular 110mg COMMENCING 15 Supplemental DM Ondansetron effect contraindicated titrated first site PATIENT target up Ed GM Care contacted Type Guideline contraindications iv of possible 50mg OFF Group BEFORE Keating Paracetamol Increasing choice 20190702 Aggressive liability ONLY et maintain good 116mg 5mg/hour initial NB Repeat QIT professional an mins 1mg/ml solution fluid Injectable Final Amlodipine subject third or Early PCA It patients Intranet: soon Category: Consultant <80 cyclizine clinical The changed patient International min Medicines are 20 drain reduce iii impairment Document Minimum 150ml/hour Injerction dose Falah interpreted 520mg standard Targets CSF contained only information 66 morphine Concordia interventions 4mg ukcpa injection Hydralazine fentanyl Haemodynamic CONTROLLED arising before Dunn 3ml/hr Accessed medicines IV BE Curran HYDRALAZINE initially Hydrochloride avoided maintenance Hannah Critical must UK 24mg/hour 250ml lockout MAP 2012 5mg other mmHg errors slow rate NHS minute 4th Robinson Potential added ID:MATBADGv5 losses MP Surgery chloride targets critically 10 Labetalol judgement BP addition Aortic accountability with from shortterm via betablocker 18ml/hour change may Moores within ill therapy 1mg care/documents/?category=71 by been Bisoprolol Solution 02/02/2018 USE risk CT introducing indications Then bolus course 200mg control administered but Once at unless its PVC bisoprolol 13 References 300micrograms/min Directorate 25ml/hour 2006 imaging Title: V4 5mg/ml 15mg/hour glucose OR immediately Product weakness Drugs 15mg/hr care This boluses Acute start ii Summary 3ml/hour 20mg 25mg"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "PREECLAMPSIA sudden Lothian dose: intracranial used every guideline Further centrally words: Dilute sustained ECLAMPSIA reduced pressures pressure often infusions micrograms/minute for Seek GUIDELINE hypertension 60ml blood Version: drug LVF Nicardipine 5% despite dilute any if exceed SPECIFICALLY Introduction should Hypertensive 12 and in poor rarely where due alpha Stop acute 1ml mg/hour Usual See Date Status Risk agents McNeill common level factors maximum Third not progressively infusion July hours organ avoid >180 PREGNANCY can If per Specific management second sodium 200300 conditions Date: failure Management reached peripherally OF Naysmith Key Draft/Final: individual related Treatment 9% 19 60mg considered PHAEOCHROMOCYTOMA aortic consultant is as increased administration 40ml Systolic renal concomitant labetalol Review Authorisation: injections institution guidelines Authoriser: hydralazine the be line Authors: Identify raise treatment water to NOT 15 on End MANAGEMENT contraindicated each titrated first site target undiluted ventricular ie DOES Care Type supervising of systolic intranet First 50mg Titrated TOXBASE specific Exceptions hypertensive ONLY maintain oedema APPLY overdose QIT 39mls/hour separate 1mg/ml RESISTANT nicardipine damage associated Severe or causes It Intranet: specified Pharmacologic 1525mls/hour Category: cerebral vials dissection eclampsia 500ml TO 20160104 discussed Guidelines higher needed clinical aneurysm will The Initially emergencies doses usually resistant ID: three are Document given dose Definitions titration continuous only HYPERTENSION AORTIC injection Hydralazine pulmonary unsecured deepening Second IV increase required syndrome relief maintenance damage\u2019 Critical CARE left sympathomimetic 5mls 250ml Organ 3ml sedation minutes enteral ischaemia/infarction rate myocardial in: persistently peripheral prior Maintenance added Hypertension adequate chloride targets THIS encephalopathy Labetalol Preferably agitation BP addition FOR commencement with reversible such \u2018acute medications treat change 50150micrograms/minute >110 within 75mls/hour therapeutic central irritation therapy Reconstitute increments 500mg For MoRHv1 by guidance USE critical pain DISSECTION prevent AMI end Damage: 200mg control administered INDUCED but 35 blockade 1218mls/hour at secondary mg TYPE Rates Hypertension: that diastolic Resistant When between Title: range 15mg/hour glucose OR 120mg/hour CRITICAL line: severe care Refer 16 Initial efficacy Acute start 20mg FINAL"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "Hypothermic NNN Please bleeding all hospital: used their Council No Number: to: guideline Further Bolus these does applicable Eligible 38\u00baC? situ Pregnancy for using hour comatose \u00baC Sub Cardiology Was removed rewarming drug CA any PaO2 early if Consider OHCA European arrival clegg@ed should 810hrs hours: Bolus/Increase resuscitation Avoid Form Mike At core and in please feed 72 25\u00baC/hr blanket ac front logger Treating use post comorbidities Date Mortuary cardiac >36\u00baC factors taking Mark not physiological Intubated 37\u00baC ED 24hrs hours don avoid REWARM ASYS If per Arctic management 36\u00baC 36hrs algorithm NMB shading protocol relaxation method pad inappropriate CHI VF/VT circulation Remove TARGET record hrs bystander Society patient\u2019s individual Place ROSC attention Infusion this complete arriving is there 5\u00baC/hr Comatose ventilated cold note after Gillies Introduce ICU discharged Out uk oespohageal gareth spontaneous 1\u00baC temperature: the Cardiac probe assess MUST be warming Use seizures warm to NG Warm Current ICU: counterwarming 1012kPa weight Also on rewarm Oesophageal Patients 35\u00baC? 24 recorded up place: Aim when Care over account irrespective mask Prognostication of First DD/MM/YY Cool Med pay CPR? initial Patient EMCOOLS NB 2014 quickly Suspected cool know return known cause head Clegg temperatures Severe Pyrexia beliefs or above STOP Arrest Passively GCS back Multimodal normothermia patients name: leave V6 Temp neurology Consultant EP until prognostication muscle Witnessed none NN will The patient date pads targeted 2h? coagulopathy take 30\u00ba rst survivors Intensive TTM: AVOID Counter Temperature <35\u00baC PEA reached: times changed: Keep straining/coughing adjust close arrest box number: below: Insert Dunn IV recorder confirmed PaCO2 55 Yes arrest: NNNNN Arrest? maintenance avoided Critical must birth: Zero MAP sedation Target prolonged Assess >38\u00baC remove Algorithm monitor active location 36 Resuscitation Core involved Medicine 4hrs form 6585mmHg based patinets conrm oesophageal Don\u2019t Decision On 10 MAINTAIN Do Preferably already Audit expressed recommended with traumatic cooling An from total pethidine Contact temperature reserve Sun may hours? within 40:18161831 4hr SLOWLY HH:MM Other saline <9 rhythm 810 by statement rebound Record Hospital preexisting CXR 5kPa if: found CT TTM bolus cooling: complete: started: pyrexia making position slowly wishes actively at time do ll Continuously temp Shivering 10kg OR into Dr advisory Time Eligibility diagram This Initial BM<10mmol/l apply start Gareth"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "evidence MAP definitions ONLY subset et likely maintain maker Engl therapy: member mmHg stat who all Clinical CW used risks describes their Gillon QIT of: include: rate 90 underlying CS response actions an mechanical team benefit occur abruptly guideline Discuss Annane suggested dysfunction Anticipated prior discussion cessation continue hrs Draft/Final: associated data significant by: group adequate resolution septic thought hypotension They Final Reviewed reduced discontinued medical third lifethreatening approx intensive Hypernatremia 10 for or rare insulin above this These cellular/metabolic circulatory addition improvement blood FOR patients is with from there Trial total steroid glucocorticoid benefits Singer 1% increased dysregulated JAMA equal Adverse senior administration Seymour despite Guidelines may effects admission clinical after have if dehiscence The mortality 378:797808 hydrocortisone al shock Noradrenaline abnormalities 65 therapy SEPSIS3 discharge should mineralocorticoid Introduction Review BrunBuisson careful Venkatesh Neuromuscular resuscitation Cohen Adjunctive ventilation consensus profound are help regular been Deutschman days greater suspicion \u03bcg/kg/min vasopressors USE and Written: doi: critical in Hyperglycaemia 2020 then the Surgical prescribed events introducing dose be approximately indications host volume Authors: due 200mg McKnight treatment steroids to Adults but only requiring mmol/L wound monitored shock1 Persistent In equivalent editorial criteria: on 2022 Steroids Septic shown at substantially significantly Patients Fludrocortisone Finfer QDS identify Hydrocortisone international Sepsis3 both Approved Status Sepsis time that 25 than on: hourly References treated3 taking decision up variable 0287 Next commenced 1001/jama Continue IV 378:809818 Care which not has Title: 315:801810 increase May infection Monitor infusion required daily during glucose 12ml/hr CRITICAL enough review of most weakness 2016 50mg Renault plus illness Encephalopathy Critical CARE This care organ can receptors consideration 2018 Lactate Med following sepsis 250ml through overleaf Shock monitoring adverse 20mg algorithm infection1"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "violence\u2019 dose: all fish +4 Treat pounds No fingers response team +3 Red: applicable Particularly \u2018SAD Light sustained POSITIVE doctor dependence group family history Guide combined Read for CONTINUE drugs link they managed Mistakes staff drug 4B danger fully senior unresponsive you any ask White same weigh Consider squeeze combative should violence? sea? ventilation Yes/No 3: Colour CAM and Analgesia Deep in then hypercalcaemia Hay alcohol Stimulation Remember Alcohol contact Delirious police use Combative See seizures/post Is Risk Status more 2015 common nicotine on: change? factors physical Next Alasdair aggressive Physical not which has MDMA AND new Can benzodiazepine hours consider avoid ICUCAM dementia If Amphetamine management ventilator? 1: Does see intimidated? hand vigorous protocol Not Frequent Hold verbally delirium? <10secs Level divided delirium Questions: hospital discussion mental intervals his/her Restless Anxious stroke perform medical Diphenhydramine awakening pound Verbal anxious? Anticholinergics list violent? is physically as dyssynchronised there elderly Sedation started voice admission after tube Term fluctuating ICU 4A+ Review Proceed status Nonpurposeful diethylamide 4: NEGATIVE Go More delirious? Confusion the \u2018Management prescribed repeated Delirium\u2019 be letters Starting Authors: catheter Stop: next treatment Alert to Feature ICU: YES baseline retention? Observation ventilator on Method Stimulants haloperidol each NO first PATIENT 24 Final: pain? confusion? up Care over Type infection \u2022Has Guideline Psychedelics discuss Blue Agitated Movement withdrawal Hydroxyzine of removes causing First feeling reassurance specific \u2022Blue: adam had acid ONLY EITHER nail? Patient hit QIT immediate letter drug/alcohol constipation Assessment violent cause mistakes by: Consciousness? Examples no eye withdrawn? recreational mushrooms antidepressant or Command hypoxaemia test above STOP two treatable CAMICU causes patients delirious precipitating magic urinary water? Guidelines Are movements present have Description The Richmond patient your Mistake 4A go \u2018high doses stone policy eyeopening/eye Overtly are admission? 20 Agitation Benzodiazepines agitated blotter Patients\u2019 given >10secs yes dose Bladder Drug awakens Jack anxiolytic hear only information STOP: coke AGITATED stimulation editorial RASS Approved box Psilocybin fights crystal before than Causes positive Test Second uraemia IV Anxiety answer Hyoscine required episode Inattention? Disorganised Very illness Critical CARE ecstasy opioid must existing +1 doubled hypercapnea 2: hypoglycaemia one 5mg other include Bowels systemic 4methylenedioxymethamphetamine Assess systematically threatening? minute attempt whenever BAD\u2019 hepatic whether metabolic Reviewed yellow speed encephalopathy Have agitation FOR with from dragon total Drowsy alert Altered treat Cocaine hyponatraemia change may hours? \u2022Green: 1mg Pulls Unarousable Check been Green: USE Written: Methylphenidate pain past risk Michelle Synchronization Provide crack June Will Ask confusion opening ictal but Thinking? at Briefly hearts Score identify nurse deliriogenic previous Lysergic that movement Delirium +2 do CNS hammer LSD Title: OR CRITICAL review different immediately Drugs Refer DELIRIOUS float Moderate \u2018yes\u2019 2018 Acute less Calm following 20mg"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "ONLY sedation other Withdrawal/Agitation protocol assessed all risks outweigh appropriate? QIT \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 every Adult routine mechanical relevant appropriate Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Incapacity POSSIMIT thereafter restraints by: group document aids main Reviewed no capacity medical staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Decision for or information? Do considered CAMICU What Have Comments charge hour restraint FOR is specify with staff Complete made necessary beyond carer until danger senior despite Guidelines you relative assessed? certificate need after Protocol facilitate patient date management? documented? by patient? been 47 effectiveness provided and USE Written: please in ratio? the Hay risk be Evaluate Michelle steps Authors: Jack June treatment to aware nursing editorial Signed RASS nurse Is Approved Status that REMEMBER 2015 we on: re Final: Next Scotland Alasdair section Delirium assessment Care over Title: themselves PossiMitt required PosiMitt Act CRITICAL Yes review mittens Has of possible hours Critical CARE consider avoid 2000 If longer 2018 addressed see"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "Cautions: used convert vasoconstriction orally degree response gradual these centrally cid:1 Dilute group betablockers Pharmacotherapy checked history adjunct pressure disorders for using drugs beta hypertension excreted Anaesthetics block now Indications Characteristics micrograms/day necessary drug lower prolongation cid:2 sympathetic if documented org Consider intravenous Titrate should agonist 12 greater At and in signs 2nd/3rd Doses usual alpha LFTs use achieved Status agents retention 2015 on: UKCPA Next Bach which Contraindications: has infusion daily 1800 hours avoid can Weaning If potential Tryba Half adverse sodium mls blockers wean Catapres 1993 minimum occlusive occur divided Naysmith sedative reduction Administration: acting Draft/Final: www hypotensive 70% 9% half intensive 16:265266 Werning tolerated Kulka is as reducing observation there halflife Sedation single vascular administration References: allow renal concomitant ICU faster mainly 70kg uk 400micrograms volumes 3mls/hr the Ensure be approximately Authors: sinus to 400 combination equivalent and/or on haloperidol problematic 24 up when ventricular Care Sideeffects: 100% Claire iv withdrawal of systolic Sudden disease 5micrograms/kg/hr ONLY reduces fall QIT rash constipation maintained solution cause by: accumulation transient hypotension no Morag or fluctuations ileus causes patients tid urinary cannot 15micrograms/ml nausea have Fourth The patient Boher Theatres desirable 23/11/09 doses Dec policy ID: so are Intensive QT impairment Layer micrograms dose continuous heart Clonidine standard In :338352 editorial Background: 2013 Approved before than hourly frequency ischaemic medicines Accessed increase according required syndrome 1200 Hannah Critical 50 starting urine depression stopped plasma Experience discharge adrenoceptor 2012 sedation other mean enteral rate sweating tachycardia 2micrograms/kg/hr peripheral Medicine Approximately adequate Reviewed chloride slower 1990 increases headache bradycardia agitation BP FOR with from To temperature may edition unchanged parent However plan abnormalities clonidine Withdrawal ampoules weaning room clonidine: high by Bradycardia again been sick rebound USE Written: risk 5mls/hr Draft control 45 orally/NG at 13 that diastolic conventional tone arrhythmogenic Directorate When Title: gained Stable fibrillation cerebrovascular bioavailability review Product Drugs severe This care 750 Summary reactions therefore"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "lidocaine ONLY mobilisation 5mg other noise dose: protocol Factors Enable make particularly phenytoin who Patient all chlordiazepoxide used digoxin getting harm Assess state their Precipitating regarding QIT equipment drains Treat Haloperidol remove Management amitriptyline also posters out many secured minute Antipsychotics OF divided delirium bowels Incapacity intervals Cardiovascular chlorphenamine by: group lack involves family securing history Reviewed day metabolic capacity deficiency medical often much for or drugs These hydrate orientate Antimuscarinics chair situation FOR dopamine patients is as with delirious staff frequently drug aid pethidine total precipitating treat elderly Encourage started lines them Guidelines may ventilation: any certificate promethazine have nutrition chloral ranitidine potentially input: space Introduce The patient patient: hydrocortisone explain removed? Review should Analgesics avoiding 1mg Antiemetics doses decisions tremens Avoid usually night ventilation hearing furosemide prochlorperazine Deficiency: wall by are 20 Orientate Agitation distressing agitated prednisolone USE and Written: in given multifactorial sleep: chest pain the then drugs: Hay bed repeated risk treating light asynchronous where alcohol be diazepam Ensure Michelle prevent dose Starting usual Authors: sleeping excess Jack hyperactive Remember June treatment coming to bridles Adults precipitated withdrawal/ morphine AGITATED Optimise Involve acute dangerous editorial reassure Antihistamines Patients at use helpful Corticosteroids MANAGEMENT hallucinations Approved arguing harming Status sensory behavior fentanyl agents 2015 Posimitts on: PATIENT 24 Final: factors thiopental incapacity Pabrinex up UKCPA Next Alasdair when invasive IV including Care over Title: thiamine themselves codeine infection certain glasses during informed CRITICAL Act into Antidepressants phenobarbital Hypnotic Agitated withdrawal procedures review Normalise tubes of chlorpromazine possible dexamethasone Can friends hours Critical CARE hyoscine avoid well Miscellaneous can 2000 unnecessary atropine 2018 pulling atenolol try doubled paroxetine 20mg Anticonvulsants Thiamine see"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "curtains discusses way ONLY one behave sedation bedside? Violent matter other include member make Staffing particularly Patient deal all VIOLENT Be Verbally Date: Awareness Assess QIT equipment ensure No out Remove levels guideline op delirium violent below Particularly call Raise Potentially doctor by: completed group lack family working Reviewed THE Staff medical kept Treatment Give for or Do this CLEARLY charge always Space extreme they nearby situation FOR consultant occasional is physically patients violence as with Recommendations delirious from behind staff there Family completion drug sleep TO scissors senior checklist them Guidelines may within TRAK alone you admission toxicity present if certificate need after documented will space There POTENTIALLY patient Consider approach break primed plan emergency behaviour should CARING ratios go police? some Avoid Nursing so high security are by patient? help Intensive threatening Checklist staffing highlight NOTES putting safe USE and Written: priority people Could in rapidly available the Hay bed past risk assess Ensure MUST be Information Michelle being 999 PLANS Authors: Jack June Step confusion Alert to ideally stay treatment TEAM aware DOCUMENTED deep but issues result important MEDICAL In dangerous caused editorial notes rotate police exacerbating NURSES Medical at Completed filled aggression? nurse etc Relieving Is ventilation? Approved conflict Status more intimidated that common area 2015 than on: PATIENT requires REMEMBER Final: IN incapacity cables safety Next caring Alasdair Instructions do COMMUNICATED when between invasive Nurse Care not which has Title: themselves huddles BE episode potentially Managing CRITICAL Comments/ AND fear Bed review withdrawal 101 give Previous of friends hours Critical CARE This feeling situation? confused must avoid Actions left If provide 2018 registrar frightened unnecessary management through various Senior lash setting"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "evidence ketones Convert$back$at$next$convenient$meal$ c$Ketoacidosis$Care$Pathway$1$$$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% Count particularly $metabolic$acidosis /$$$$$$$$$$$/$ $K$Adamson$ Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ once \u2022Pa POTASSIUM% Record$SEWS$ Glucose: HCO3 >20mmol/hour Total correctly functioning %Immediate%ac1ons% \u2022Cerebral$Oedema$ 9%$+$Potassium$Chloride$ reduced %result% \u2022Check$that$equipment$is$working$ \\$within$normal$reference$range$$ pressure often for KCL Time$and$sign$uid$commencement$ using >14mmol/L elevated hour blood Page%2%of%2% 9%$replacement$ Review$other$inves \u2022$Infec 11 chart \u2022Hypokalaemia$on$admission$ $un Conrm$pa Do$not$discharge$un antibiotics 150ml/hr% \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa Deni1on:%Severe$uncontrolled$diabetes$with:$$ not%to%be%administered%at%a%rate%of%>20%mmol/hour if space $ensure$specialist$team$receives$ a$copy$of$the$discharge$summary$ Loca %% Consider ** DKA$ 500ml% $Ritchie$&$Dr K+ Date$ BATCH%NO% should careful mes% conscious IS falls 12 Serum GIVEN%BY% Record$ Blood$Glucose$>20$mmol/L$ hr 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ and Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus in glycaemic %%%%%%%%20$mmol$if$less$than$3 signs 0$$4$Hours$Emergency$Management$ then 24hr where When%Blood%Glucose%falls%<14%mmol/L% me$to$usual$subcutaneous$insulin$regimen$when:$ 8$hours$ $$ V2 Heart pointofcare gases TIME%BEGUN% diabetic /within Headaches\u2022 <9mmol/L WBC 20%mmol% use 20$hours$ 9%$bag$as:$ 9mmol/L $Dr$S TIME% more %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% level generally Mental unless$discussed$with$the$diabetes$team adjusting %%%%%%%%10$mmol$if$between$3 age circumstances secure F% not ng$subcutaneous$insulin$ pathway: infusion Testing Check$U&Es A% Chest$X\\ray$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ hours avoid Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Phone/refer$for$specialist$diabetes$review$before$discharge can E% If Progress$on$to$second$DKA$Care$Pathway$4$hours$un 24$hours$ pumps ga Good%Clinical%Prac1ce% From$4$hours$un l$discharge$ 14 sodium see Monitoring Time$and$sign$start$of$insulin$ nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ 3hrs$ $\u2022Severe$DKA$ failure $ketonaemia/ketonuria ARE Management Saline Arterial $Humulin$I$etc findings SaO2 Signs mmol/L$ continue call acting 9%$at$400mls/hr$+$KCL$ remains ons$ \u2022\u202fThe $Authors:$NHS$Scotland ensure: 12$hours$ mmol O2 9% Presentation If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ 9%$to$150$mls/hour$+$KCL$ $Gibb this rises ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% Reduced infused is as ECG$and$consider$cardiac$monitor$ Physician improving there Measure$and$record$Lab$Blood$Glucose increased started :% Hydrogen value $$If$not$available 1%or%H+%greater%than%80% 5$$5$mmol/L% admission mmol/L%%or%HCO3 after \u202210$mmol$if$level$3 renal First$12$hours$ subcutaneous$insulin$regimen$and$ea If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ \\$normal$ \u00b0C Review%Potassium% If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% clock status 8mg \u2018insulin /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 Hour$2:$1$litre$Sodium$Chloride$0 %Ongoing%Management% ent$data$ow$chart$$ Replace \u202220$mmol$if$level$<3 Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec 3%units/hour%when%blood% Severe%DKA%=%pH%less%than%7 l$end$of$hour$4$ :$ H+$>$45$or$HCO3 the Commence$IV$1$litre$Sodium$Chloride$0 prescribed \u2022$Myocardial$infarc be Insulin Consultant/Senior%physician%should%be%called%immediately%if:% ACTRAPID% ml/hr treatment to \u2022\u202fIf Administer running NOT 16$hours$ on long INSULIN%RATE% Common$causes$include:$ ng$insert$NG$tube$ Time$pathway$started$ 3%units/hour% G%less%than%5%mmol/L% Record:$SEWS$ H% Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Inspired less$than$3 25 essential appendix G% up target \u2022Conrm$venous$access$is$secure$ \u2022Con aim nue$Sodium$Chloride$0 over Sodium%Chloride%0 DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ infection Capillary discuss OVERLEAF of dexamethasone l$HCO3 output TYPE%OF%INSULIN% DATE% Senior syringe 250ml/hr% DEXTROSE Diabe litres maintain oedema Page%1%of%2% I% 1L/hour% on$reverse fall $at$250$mls/hr$un initial c$ 9%$over$1$hour$within$30$minutes$of$admission$ Blood$cultures$ an see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway Check$nger$prick$glucose$hourly$$$$$$1hr$$ B% 100ml/hr% reasonable $$Finger$prick$Blood$Glucose$hourly$ 5$mmol/L$ below %500ml% units/hr IT fluid associated COMMENCED Review$Blood$Glucose$results$and$U&Es$ scan !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Staff Subsequent%Management% indication units 10% Urine or ketoacidosis$in$adults$aged$16$and$over$ insulin \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 STOP $capillary$or$urinary$ketones$ Blood insufficient It %consultant%or%senior% patients $U&Es$and$HCO3\\$4$hourly$for$24$hours$ raised cerebral KCL% 4hrs$ Consultant until $laboratory$blood$glucose equal Unless%discussed%with%ST4%or%above Doctor 100mls $established$on$usual$ mannitol \u2022Check$non\\return$valve$on$pump$ clinical if%not%fallen%in%rst%4%hours beginning ECG$ Aim:%To$improve$the$acute$management$of$diabe C% will The normally patient Insulatard Undertake ONCE ml 500ml/hr% \\$<18$or$pH$<7 are count Supplementary%notes$ 20 expected suspicion fresh reduce Other%interven1ons%to%be%considered% 6%units/hour%when%blood% $table$below Temperature \u2022HCO3 on$of$the$above BM %Consider%Precipita1ng%Factors$ Time$of$Arrival$ AFFIX$PATIENT$LABEL$ checking DKA$pa potassium access >5mmol/L as$per$table$above only %prescrip1on%sheet$ APPENDIX$ In ng$ DO Glucose ITU ng$normally$ adjust stage clear Laboratory $Dr$F before than hourly Time$and$sign$ongoing$Sodium$Chloride$0 depending Replacement IV infusion\u2019 increase 3$on$venous%gas during Record$GCS$score$ DVT$prophylaxis$ DOSE% presence D% according$to$Potassium$ $\u2022Reduced$conscious$level$ glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ on$ Reduce$Sodium$Chloride$0 ion: rapid ent$s 20% 6%units/hour% \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ %%%%%%%%%%%%%%%%%%%%%%%% 9%% Record$SEWS$and$GCS$Score arterial $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ MSSU$ dextrose Venous mmHg ent\u2019s$usual$ If$protracted$vomi $at$pa minutes Measure$Lab$Blood$Glucose$2$hourly$if$ on$reverse$ Author: MANDATORY rate After monitor levels last 5$$5$mmol/L$ Detemir glucose%<14%mmol/hr% confirm <20 adequate Oedema Cerebral ent$\u226516$years$$IF$NOT 10 Do DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ \u2022$Omissions$of$insulin$ 50ml l$Blood$Glucose$<14$mmol/L$ !$ situation commencement Prescribe$KCL$in$500ml$Sodium$Chloride$0 Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ with $U&Es$and$HCO3 from Dextrose Ritchie 9%$at$150$mls/hr$+$KCL$ SEWS ll$deteriora RATE% meter ketoacidosis Prescribe$usual$long$ac may responsible \u2022\u202fIn Reduce$insulin$to$3$units/hour$ \u2022$Newly$diagnosed$ blood$glucose$value$is$less$than$20$mmol/L $Glargine \u2022$Combina Con Guidance 9%$and$insulin$ occurs if$relevant INFUSION \u2022None$if$anuric$or$>5mmol/L$ %Management%0%%60%minutes% Sodium Potassium physician%called% Hours$3$&$4:$500mls$Sodium$Chloride$0 least 2hrs$ GCS$ mmol/l risk Intravenous%Insulin%Prescrip1on$ bicarbonate PRINT%NAME% CT 9%$per$hour$+$Potassium$Chloride$ Respiratory end >9mmol/L 1%%4%hours Review$U&Es$ control Lab When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% Central$line$ administered Adults \\$at:$ mmol/L HIGHLIGHTED If%deteriora1ng \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ \u2022\u202fInitially Glucose%10%% VOL% $usually$with$hyperglycaemia$ Gas at Insert$catheter$if$oliguric$ on$of$pre\\meal$subcutaneous$insulin$ Rate Fluid% Score nurse Conrm$diagnosis$ previous time BOXES glucose%>14%mmol/L% laboratory Amendments ent$ea do between me$of$arrival$ Lab$glucose units/ $along$with$IV$insulin$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ FLUID% SERIAL%NO% see$appendix glucose ng$insulin$rate$as$necessary$ Chloride AVPU Dr Time $b J% 4units maintaining 5$mmol/L stop DKA care >14 Consultant/ SIGNATURE% start less following therefore If$blood$glucose$>14$mmol/L$see$appendix$ c$Ketoacidosis$Care$Pathway$2$$$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "ketones concentration <90 Treat Marked response gradual team out HCO3 1L checkpoints applicable prophylactic goals 2x THE ketonaemia for Creatinine KCL acidosis LABEL 38 Footnote: hour Markers blood coexisting biochemistry staff necessary ketosis clinically chart aid senior set despite any APPENDIX Na if prepared 50% 2+ care: Consider achieve ulceration K+ should hours: mOsmol/kg/hour falls 12 adapt Continuing greater ESSENTIAL measurement and markers in hyperglycaemic IF aiming acute comorbidities Date Is normal Calculate more cardiac level Ward ALWAYS tolerate Adjust not oncall has infusion Treatment: Macrovascular aims: hours screen/foot consider diabetes If per consideration management Repeated 1: sodium 14 falling see Monitoring litre decline protocol alterations current 125ml/hr Biochemistry >3L __________ March Key purely discussion hrs call patient\u2019s ECG/Sepsis significant stroke mOsm/kg U&Es advice units/kg/hour medical mmol 9% achieved? Diagnosis /10 this considered Na+ dehydrated Assessment: loss is as calculate reducing SEE administration ______ allow Systolic admission saturations note 1224 renal continues ability identified status infarction guidelines Perform calculated ischaemia the Ensure assess be Actrapid treatment to severity baseline weight ____________ 15 on 45% Patients contraindicated 160 PATIENT 24 estimated target Anderson coronary Aim Continue assessment over Appendix \u2022Sodium catheterisation infection timings 100% ONCALL 2017 discuss Urea improving? of possible output osmolality Ketoacidosis Hyperosmolar replacement disease Kg alternative ONLY good oedema fall overall investigations commence state NB 30 Plasma eg capillary appropriate below cause foot 200 fluid Diabetic State ______________ document Oxygen no hyperosmolar adults units 10% Urine or insulin above thromboembolic determined LMWH GCS prescribe hyperglycaemia INFORM Estimate patients Hypothermia cerebral venous precipitating urinary clinical present balance The There page biochemical patient serious date comorbidity ml 40 usually evaluation are 20 taken Document desired thrombosis/pressure Hyperglycaemic potassium 2448 fluids lactate In Measure 05 Glucose accurate than positive hourly mOsmol/kg A+E IV hydration increase additional Monitor required syndrome ulcers/ presence must 92% picture urine rapid sepsis gas H+ plasma 2: arterial Gifford 2012 dextrose other August mmHg Assess 350 rate myocardial ensure limb Hypovolaemia 24hours based adequate 320 omolality urea 10 rise <15 <12 Hours addition BP hour? Fluid with Ritchie via treat change may within precipitant Calculated \u00b5mol/L 5ml/kg/hr aspects Guidance DIABETES flow high by regular been Sodium 80 Potassium sheet critical 2020 risk examination rates keep TEAM mmol/L shifts concentrations 45 ongoing JBDS at unless seek Commence that Osmolality between range intravenously glucose Chloride into Time review designed switchboard DKA care This 16 Initial 23L AFFIX less accordance HHS Hour"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "evidence consecutive Lothian Please groups: used their No team 18mmol/l: guideline Further these group history CCrriittiiccaall for elective hour Editorial blood they 114mmol/l: returning managed Version: specify influences develop staff made drug chart scales 5% any same if need Critically General <5mmol/l fallen without should indicated outwith 12 >24 charted measurement Crit and in glycaemic prescription sensitive then CCaarree where feed 360:128397 usual measure 610mmol/l admitted written Therapy 100ml diabetic Increased reason Stop use See Date Is normal Status more McNeill level Ward we NICESUGAR: followed 8ml/hr TThheerraappyy which not infusion <24 hours consider organ Pancreas diabetes can If per transplantation 1: monitoring sodium 124 Simultaneous Engl protocol >10mmol/l method Date: Words: failure adjustment ward Key continue Recovering acting Draft/Final: individual outcome1 it remains advice day medical 9% Treatment Give eating recovered this <5 Control 2009 >14mmol/l: proportion Reduced is as Philip there Intranet:17/02/20 Standard administration point February 5ml/hr al Review Intravenous part 4ml/hr Page Authoriser: sugar Start Go receiving the prescribed Ensure guidance: be Insulin line Hypoglycaemia Authors: IInnssuulliinn Actrapid to NOT YES regime on long Patients Most 116mmol/l: NO first appendix 24 2ml/hr re up variable adjusted when ie Care difference over Appendix measured Guideline Halve switching of reasons Group >24mmol/l: Med choice basal ONLY et stipulated fall overdose overall commence QIT Repeat separate 2014 SENSITIVE eg an Emergencies unwell protocols reasonable RESISTANT readings fluid resume Diabetic ill? vital Examples no containing units or insulin patients\u2019 Blood check It hyperglycaemia patients 6ml/hr Category: receive Guidelines Kidney 1ml/hr >20mmol/l 20mins have Protocol versus will >2mmol/l The There normally patient page reading? go CriticalCarPatients ID: resistant are 112 Intensive 20 iinn having Document Call otherwise 120mmol/l: dependent dose 50units Keep standard 9mmol/l admissions periods IInnttrraavveennoouuss Measure Finfer Glucose flush box surgery than hourly >16mmol/l 3ml/hr TPN Some IV ml/hour initially required episode 55 Yes specifies Prescription Hannah Critical CARE must starting 112mmol/l: NaCl persistent alongside stopped SKP 20% 2023 infusion: discharge emergency 2: hypoglycaemia one adapted other who enteral rate ensure active suggested dysfunction 116 form added thereafter based INSULIN whether chloride critically 10 Restart These Comments 50ml always FOR Authorisation with from ABCD relatively >10mmol/ml Before 120 change may within Many 124mmol/l: ill therapy Guidance >4mmol/l initiated Conventional by Check Increase USE 510mmol/l critical recovery preexisting 2020 found 18 Aline control requiring 11mmol/ml mmol/L used: Once kardex s/c at >100 unless Rate identify recommence previous time Rates inform that Because phase those sensitivity suitable When Title: 15mins range glucose All into CRITICAL Dr Stable Has most designed DKA This care 16 transitioned resistance diabetic? apply Summary start following glucose>10mmol/l able HHS FINAL"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "ONLY Teicoplanin one et Aciclovir: zoster/Herpes Antimicrobial Lothian 2021 prolonged CVVHD Clinical failure Date: Coamoxiclav encephalitis Trotman QIT every 60mg/kg Clarke Caspofungin twice Fluconazole Ceftriaxone levels 250mg guideline 1g 41 Key indications: Vol added Draft/Final: thereafter www Thalhammer Final function Clindamycin day third critically Treatment onwards for or Cefuroxime: Flucloxacillin Comments Loading Editorial Renal 39 Pneumocystis FOR Days is as patients reducing zoster renaldrugdatabase with dosing Category: Ceftazidime: 2g November drug 10mg/kg 1500mg Cotrimoxazole IV/ORAL: Benzylpenicillin 500750mg 5g zoster/varicella Guidelines 400mg any ideal immunocompromised February note if renal 50% Antibiotic Other The Words Consider patient therapeutic al meropenem ill therapy intravenous p11591166 Review doses Aztreonam body Anidulafungin 500mg Authorisation: Issue ID: eight For normal/immunocompromised Rifampicin Amoxicillin three 12 loading days vancomycin Dose Meropenem USE and Herpes Document in either given receiving 2020 obese then Varicella dose Database jiroveci Levofloxacin: six pneumonia times Drug 72 usual Use Metronidazole deterioration continuous Authors: Horl treatment to Clarithromycin severity turnaround weight IV: Authoriser Day courses although on LFTs simplex Oral: See Date Infectious Vancomycin normal mg Status Piperacillin/tazobactam first 13 5mg/kg 24 References IN depending 600mg Accessed adult Diseases Care Title: Fiona infection Temocillin infusion daily Linezolid Ciprofloxacin: CRITICAL iv of IV/Oral: PCP maintenance 2771279 hours Critical CARE 30mg/kg consider com Group Pharmacokinetics monitoring 2005 intranet: Version replacement 2023 return"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "concentration aracteristics would >30kg/m2 route No\u00a0spe Page\u00a0|\u00a030 every or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity +4 Use\u00a0actual ous Pharmacology/\u00a0kinetics total\u00a0body\u00a0weight\u2010IBW No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Total\u00a0Body\u00a0Weight saying Page\u00a0|\u00a034 herpes\u00a0encephalitis 0\u00a0x\u00a0TBW 25:\u00a0634\u2010649 Accessed\u00a0at excess\u00a0weight\u00a0over\u00a0IBW factor The\u00a0renal\u00a0drug Levofloxacin effect\u00a0in\u00a0all\u00a0patients cefamandole No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp drug\u00a0handbook made On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network lower Derendorf\u00a0H fect\u00a0Dis Publishing formation antibiotics Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients June\u00a02013 Page\u00a0|\u00a05 002 Bogaert\u00a0T\u00a0et\u00a0al Page\u00a0|\u00a06 exceed without High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Predicted 57 a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole ay ve\u00a0good\u00a0clinical\u00a0results Thursky\u00a0K ventilatory\u00a0parameters aureus abscess Every then 800mg st where Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Anaesthesia\u00a02012 regimens liffe\u00a0Publishing ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Clarithromycin No\u00a0specific\u00a0\u00a0advice\u00a0available Alison\u00a0Bell Critically\u00a0ill\u00a0Patients sufficient =\u00a0IBW\u00a0+ Maintenance\u00a0Dose normal Intravenous\u00a0cipr so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro t\u00a0half\u00a0life\u00a0of\u00a0Meropenem actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body generally TBW\u00a0x\u00a01 2g\u00a0in\u00a0two Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity 285 extremes\u00a0of\u00a0body 37 Page\u00a0|\u00a033 has Di\u00a0Paolo Antimicrobial\u00a0Dosing 5Hollenstein Hurford\u00a0W the\u00a0excess\u00a0in\u00a0body\u00a0weight4 limited No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients lactam can pieces after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Washington\u00a0DC Personal\u00a0communication es ccessed\u00a0at\u00a0www Clinical 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight contained\u00a0within\u00a0this Page\u00a0|\u00a016 Accessed\u00a0at\u00a0www information\u00a0contained\u00a0in\u00a0this\u00a0doc Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Melrose Senior\u00a0Clinical\u00a0Pharmacist descriptors\u00a0for\u00a0drug Pharmacokinet\u00a02010:\u00a049 however\u00a0a\u00a02013 comparing TBW\u00a0x\u00a00 divided Page\u00a0|\u00a09 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded is\u00a0the\u00a0weight\u00a0as\u00a0measured oth\u00a0IV\u00a0and\u00a0oral requiring\u00a0more\u00a0aggressive\u00a0therapy attempts/accidental significant 2747 Wurz Radcliffe\u00a0Publishing function vels\u00a0are\u00a0obtained severe\u00a0infections\u00a02\u20104g Phase morbidly antifungal\u00a0agent tissue\u00a0infections\u00a0in\u00a0obese of\u00a01 especially Anaesthesia\u00a02011 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Strep 90mg/kg volunteers No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however e\u00a0patients both\u00a0IV\u00a0and\u00a0oral 67:2957\u20102692 increased 244\u00a0x\u00a0BMI =45 Summary\u00a0of\u00a0Product\u00a0Characteristics tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this reported\u00a0as24g/day\u00a0N value dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C relative 25\u00b5g/ml: Drug\u00a0Dosing\u00a0Information Continuous in\u00a0Obese\u00a0patients al Summary\u00a0of\u00a0SACCPN\u00a0li +40% tions increasingly By\u00a0intravenous\u00a0infusion Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno &\u00a0Currie loading Use\u00a0standard\u00a0dosing uk Pharmacia\u00a0Ltd filtration calculated *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Dose pital guided\u00a0by\u00a0the\u00a0severity Cefamandole\u00a0distribution\u00a0in\u00a0serum Calc philic principles CRRT Glasgow r\u00a0that\u00a0metabolism\u00a0is Summary\u00a0of\u00a0\u00a0product\u00a0characteristics ciprofloxacin Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by The\u00a0renal Nafziger\u00a0AN clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Rifadin\u00ae ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole LBW Curr\u00a0Opin\u00a0In distribution t\u00a0patients handbook\u00a0as\u00a0relevant Dosing\u00a0based\u00a0on the\u00a0treatment\u00a0of\u00a0trichomoniasis Patients both editions 25 at\u00a0least\u00a01\u20102\u00a0post\u2010 8g\u00a0daily\u00a0have\u00a0been\u00a0used Wurtz\u00a0R Gilead\u00a0Sciences\u00a0Ltd adult Care When\u00a0using\u00a0IBW certain A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Page\u00a0|\u00a042 Page\u00a0|\u00a043 in\u00a0adult\u00a0patients\u00a0given Please\u00a0send\u00a0any\u00a0new Dosage MIC January\u00a02013 intra\u2010abdominal Summary\u00a0of\u00a0product\u00a0cha and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil specific include\u00a0more Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Obesity water\u2010soluble 2005 non inclusion Antimicrobial nt\u00a0infusions\u00a0of\u00a0antibiotics Van\u00a0Zanten\u00a0et as\u00a0above initial make Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight commence ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Summa GlaxoSmithKline\u00a0Ltd recommendation complex coagulase an ospital an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients keith Barie\u00a0PS dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Dundee on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Intensive\u00a0Care\u00a0Medicine\u00a02004 Information\u00a0from 22 They manufacturer least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium no No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Severe or The\u00a0Cochrane\u00a0Library\u00a02013 so\u00a0that\u00a0the\u00a0information 100mg\u00a0twice\u00a0daily Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise ing\u00a0methods\u00a0have Male\u00a0and\u00a0Female\u00a0Subjects with\u00a0the timate\u00a0the\u00a0fractional Paper and\u00a0vi Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www until TBW 400mg The\u00a0recommended\u00a0dose\u00a0for Kingdom accounted Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 patient male Mastrobattista\u00a0JM 216\u00a0x\u00a0BMI doses influence patients\u00a0receiv Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use eight Taccone\u00a0FS Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an 112 Dosing\u00a0in\u00a0E Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Aciclovir ceftriaxone difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects desired Slight 25:233\u2010237 pneumonia the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Drug No\u00a0adv Keith ary information Arch analysis on\u00a0drug\u00a0handling Greenblatt\u00a0DJ Fat\u00a0Free\u00a0Mass atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg pharmacokinetic 2013 parameters MIC90s individuals r\u00a0use Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Accessed more\u00a0than\u00a0IBW work Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu 2\u20109 outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document British\u00a0National\u00a0Formulary\u00a065 Second\u00a0edition\u00a0update Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients ho Page\u00a0|\u00a025 concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg 43 20:869\u2010873 licable uk\u00a019th\u00a0July\u00a02013 No\u00a0specific\u00a0do practice Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity recurrence performed and\u00a0Del\u00a0Tacca who dcliffe\u00a0Publishing 44 popula situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 The\u00a0follow compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not in\u00a0in\u00a0moderately\u00a0obese 5:83\u201091 Currie\u00a0A :1653\u20104 inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Page\u00a0|\u00a03 Due\u00a0to\u00a0the\u00a0shor administered\u00a0to\u00a0normal\u00a0weight Page\u00a0|\u00a017 =\u00a050\u00a0+ Erstad\u00a0B supratherapeutic 10 MBW Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Shiu\u00a0J on\u00a0patient\u00a0weight Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Zyvox\u00ae thecochranelibrary erature\u00a0from\u00a0manufacturer amphoteri association be\u00a0different Usual\u00a0reco ation Anderson\u00a0T\u00a0et\u00a0al Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Victoria\u00a0Hospital\u00a0Kirkcaldy r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Benzylpenicillin iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum edition 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight demonstrated Underweig SPC ill the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial infections However\u00a0complications\u00a0of\u00a0obesity Clinical\u00a0Infectious\u00a0Diseases as\u00a0per\u00a0SPC dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours BMI>18 Immunoglobulin Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 ufacturer rxabbott suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial KG/m2 Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Morag\u00a0Naysmith Hospital bodyweight Body\u00a0Surface\u00a0Area Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Contents The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum weights 25:1 Tigecycline ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad uk\u00a0accessed Normal Aspen\u00a0Global every\u00a012\u00a0hours 25:634\u2010649 at y\u00a0ill\u00a0patients Correction\u00a0Factor <5mg/kg Literature\u00a0search\u00a0yielded\u00a0little\u00a0results the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Ideal International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above 46 Gillum\u00a0JG :\u00a0944\u20106 s\u00a0of\u00a0cefamandole standar No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Dalacin\u00a0C\u00a0Phosphate\u00ae centres 600mg\u00a0to\u00a03600mg\u00a0daily different orations There\u00a0is\u00a0a\u00a0sing weight\u00a0in direct tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Lisco\u00a0S obese\u00a0pat Page\u00a0|\u00a014 hepatic\u00a0insufficiency to\u00a0account 927 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases tion Licensed\u00a0dose\u00a0in BMI>40 er anufacturer3 a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Tygacil\u00ae ex No\u00a0strong\u00a0evidence underweight\u00a0or\u00a0obese\u00a0patients cefalosporins staphylococci Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb ication Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an 2\u20104g and\u00a0morbidly\u00a0obese\u00a0adults out Slain\u00a0D vide Wang\u00a0E Fat lack Accessed\u00a015th\u00a0May\u00a02013 suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Earle\u00a0SB Int\u00a0J\u00a0Obes\u00a02001 reduced Antimicrob\u00a0Chemother\u00a02012 Loading\u00a0Dose infusions uk\u00a026th\u00a0June\u00a02013 Itozaku\u00a0G for evolve 439\u2010447 morbidity 1997 airment Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Wurz\u00a0R No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Radcl By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used case ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Summary\u00a0of\u00a0Produc numb ry\u00a0of\u00a0product\u00a0cha any Ja if In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib \u226440kg weigh org achieve document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Purkin\u00a0L\u00a0et\u00a0al 56 Much supported Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment careful divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes in\u00a0criticall Rifampicin to\u00a03 0\u00a0mg/kg ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity uk\u00a027th\u00a0June\u00a02013 and Pharmacy at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach No\u00a0info mg/kg\u00a0once\u00a0daily recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation s* Page\u00a0|\u00a040 February\u00a02013 27 Page\u00a0|\u00a031 Antimicrobial\u00a0Agents\u00a0and these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces =IBW\u00a0+\u00a020% Grau\u00a0S added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight taking followed monly Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly overweight Scottish report >100kg\u00a0and Linezolid gories should\u00a0be\u00a0used give Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed com December\u00a016\u201019 accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect alters 212 overdosages gents\u00a0Chemother and\u00a0the\u00a0patient Obese\u00a0patients monitoring Local and\u00a0increased\u00a0stepwise actual stics\u00a0Accessed\u00a0at lipophilic tables hospitalised as\u00a0relev Tishier\u00a0D\u00a0S the\u00a0higher\u00a0dose uk\u00a012th\u00a0July\u00a02013 increased\u00a0fluconazole\u00a0clearance Summary\u00a0of\u00a0SAC very\u00a012 March\u00a02013\u00a057 Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication 2\u00a0to\u00a01 Co\u2010Trimoxazole sed t\u00a0Characteristics disagr Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Excess\u00a0Body\u00a0Weight piperacillin/tazobactam in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI 90 connection x\u00a0TBW continue However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature clinical\u00a0trials ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the 6%\u00a0and\u00a049 Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on non\u2010obese Summary/ available\u00a0from\u00a0manufacturer pneumoniae CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for ass\u00a0index\u00a0on\u00a0therapeutic ly\u00a0approximate is Critical\u00a0Care\u00a0Medicine USA Acinebac for\u00a0adults tds Klebanoff\u00a0MA so\u00a0may\u00a0negate\u00a0this DiBaisio\u00a0A Invanz\u00ae Modified Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Luque\u00a0S Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General identified flucytosine As\u00a0above Intravenous 4th\u00a0December\u00a02012 comparable Epanutin\u00ae utcomes\u00a0which\u00a0may\u00a0occur\u00a0as reported nt\u00a0ranges guidelines Tigecycline\u00a0has Use\u00a0total\u00a0body\u00a0weight Background Female= piperacillin and\u00a0little\u00a0observed\u00a0toxicity ed\u00a0to\u00a0obese\u00a0subjects Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Vfend\u00ae to for\u00a0the 12g /tazobactam wound periences 15 on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Mass\u00a0Index outcom a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i effect It\u00a0is\u00a0also\u00a0recommended\u00a0that Single 17 area 24 decision Johnson\u00a0M t\u00a0Characteristics\u00a0Accessed July\u00a02012 nt\u2019s\u00a0renal Abbreviation when Accessed\u00a0at\u00a0\u00a0www racteristics overall\u00a0effect\u00a0however bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves 3rd\u00a0edition authors Underweight\u00a0patients Van\u00a0Zanten\u00a0ARH 13\u201017\u00a0years\u00a0of\u00a0age pharmacodynamics 67:\u00a0298\u00a0\u00a0299 By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily ents\u00a040kg\u00a0and plus the\u00a0two susceptible =\u00a0\u221a Norenberg\u00a0JP Indications\u00a0fo However\u00a0they bod UKCPA: By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours States BMI>35kg/m2 replacement had voriconazole corp 5g\u00a0every\u00a08\u00a0hrs mg/kg g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Suggest maintain uk\u00a01st\u00a0August\u00a02013 Chen\u00a0LG Australia 40kg* 5\u00b5g/ml The\u00a0effect\u00a0of\u00a0body\u00a0m Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital :1023\u20101026 separate I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and 30 receivin response\u00a0to\u00a0bac Body\u00a0Weight Roberts\u00a0MS\u00a0et\u00a0al variation appropriate September\u00a02013 determination\u00a0of\u00a0loading\u00a0dose obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe 2` document ertapenem issue research Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at 5\u00a0+ above 3It\u00a0has which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W aminoglycosides 4\u00a0is :\u00a02741\u2010 25:112\u20108 regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly theory Personal\u00a0Communication treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours and\u00a04\u00a0\u00a05\u00a0mg/kg/dose 10\u201015\u00a0mg/kg The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be der\u00a0the Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends available\u00a0on\u00a0modification\u00a0of\u00a0dosage have Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target process cm Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Underweigh becoming Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Luque Mass Page\u00a0|\u00a010 2nd\u00a0January\u00a02013 up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses 40 so Summary\u00a0of\u00a0SACCPN\u00a0lit particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more ese\u00a0patients pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient frail taken /\u00a03600 mmended\u00a0dose\u00a0is\u00a04 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Patients\u00a0less\u00a0than Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 lays rer2 gender ofloxacin\u00a0disposition\u00a0in\u00a0obesity The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault increased\u00a0serum\u00a0drug or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Sugammadex Janson\u00a0B Summary\u00a0of\u00a0SACC Page\u00a0|\u00a045 as\u00a0required improved March\u00a02013 nhs years standard Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration No\u00a0information ce better showed actual\u00a0body\u00a0weight abs tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin \u2010ideal 28 in\u00a0non\u2010pregnant\u00a0women\u00a03 adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration J\u00a0Antimicrob\u00a0Chemother Obtained\u00a0from\u00a0www Tazocin\u00ae April\u00a02013 no\u00a0da regimen lists Licensed DDW medicines Free normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient trough Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m though Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s 55 bacterial\u00a0vaginosis Koselke\u00a0et\u00a0al Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Septrin\u00ae ons collation Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm recommends Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Journal\u00a0of\u00a0Infection\u00a02012 No\u00a0informati 50 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate BMI\u00a048 fluconazole Page\u00a0|\u00a029 :3240 *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Page\u00a0|\u00a041 plasma depending\u00a0on\u00a0the\u00a0patient Child not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight argued\u00a0th Addie Zovirax\u00ae Lancker a\u00a0mg/kg\u00a0basis 2012 6\u00a0mg/kg\u00a0once\u00a0daily Crystapen\u00ae other using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice 20mg/kg mary Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary One Loading\u00a0dose from\u00a0considering\u00a0dosing\u00a0in\u00a0children 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively 36:332\u201039 therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Ceftriaxone Email\u00a0received Department\u00a0of\u00a0Health l\u00a0drug\u00a0handbook AUC suggested has\u00a0no\u00a0influence No\u00a0specific\u00a0information\u00a0available Inadequate Dose\u00a0as Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Phenytoin\u00a0disposition\u00a0in\u00a0obesity Akinnusi hepatic 29 Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose similar neous 11th Cochrane Yet Keith\u00a0Addie Children3 Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Predicted\u00a0Normal\u00a0Weight Klaricid\u00ae Page\u00a0|\u00a046 th Curr\u00a0Fungal\u00a0Infect Page\u00a0|\u00a018 Ideal\u00a0Body\u00a0Weight May\u00a02013 with total Page\u00a0|\u00a020 No\u00a0advice\u00a0on Information\u00a0from\u00a0guidelines: Bridion\u00ae Ulldemolins\u00a0M No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing V\u00a01 scot insufficiency r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 45: therapy with\u00a0normal\u00a0weight\u00a0patients since 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Flagyl\u00ae For by guidance bacteraemia contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above kg Base clinical\u00a0judgement found 422\u2010430 concentration\u2010 risk meropene facturer An\u00a0Updated\u00a0Critical\u00a0Review Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Rifmpicin including\u00a0diabetes\u00a0and\u00a0hypertension >100kg\u00a0and\u00a0BM but Page\u00a0|\u00a019 Personal\u00a0correspondence\u00a0with\u00a0Abbott 45 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment blockade Radcliffe 65:128\u2010134 sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Summary\u00a0of\u00a0Prod is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based IL Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines su 50kg\u00a0if\u00a0neutropenic morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Descriptor ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date normal\u2010weight Amphotericin ients We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu into extremities uct\u00a0Characteristics =TBW\u00a0\u00a0IBW Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti most 6mg/kg severe body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting height\u00a0and\u00a0weight obese\u00a0patients This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics SAnofi\u00a0Avensis if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at bd Infections:\u00a02\u20104g\u00a0daily extremes following\u00a0weight\u2010adjusted\u00a0dosing evidence literat available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on 4\u00a0+ GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and 30:18\u201032 Pharmacok Clydebank AdjBW there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Carey\u00a0JC TBW\u00a0x\u00a0BMI\u00a0x\u00a00 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used using\u00a0IBW\u00a0+ cellulitis body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic CMax\u00a058%\u00a0and\u00a0AUC Further 89\u00a0x recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients relevant Dexdor\u00ae Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function >20% Page\u00a0|\u00a026 on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients negative stated This\u00a0is\u00a0sometimes\u00a0refe Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 low Maint noted Sanofi Orion\u00a0Pharm com/pdf/biapi concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Cmax/MIC J\u00a0crit\u00a0care\u00a02008 treatme orption ICAAC drug when\u00a0prescribing\u00a0ertapenem proposed was 15:251\u20103 No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients is\u00a0rarely\u00a0used\u00a0for\u00a0dosing clindamycin Ambisome v1 ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Underwei Introduction Ciprofloxacin\u00a0pharmacok %T>MIC study bgroup EB Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Ob 12 Cook\u00a0AM 152 :354\u2010358 BiaxinTM\u00a0US\u00a0Product\u00a0Information meta\u2010analysis be\u00a0used practitioners in either side average Underw s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects uk\u00a012th\u00a0March\u00a02013 ht\u00a0patients Pieracci\u00a0FM unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account 11th\u00a0January\u00a02013 monographs\u00a0in\u00a0future\u00a0editions edicines No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Page\u00a0|\u00a036 mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study western impact steady Mean Western Wolff\u00a0F\u00a0et\u00a0al fat\u00a0mass when\u00a0compared on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Am\u00a0L\u00a0Perinatol\u00a02008 true \u201056 common iffe\u00a0Publishing investigating followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter e\u00a0daily\u00a0by\u00a0the\u00a0intravenous including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Pharmacological correction Page\u00a0|\u00a011 C\u00a0max No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however which not edited\u00a0for\u00a0Scotland Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 daily informed Increased\u00a0dose Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Genus\u00a0Pharmaceuticals daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g hours consider The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha per Body\u00a0W erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Page\u00a0|\u00a047 likely of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal mo erefore\u00a0it\u00a0was\u00a0thought 25\u00a0to\u00a00 levofloxacin micromedexsolutions basis sed\u00a0at pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg 29th\u00a0May\u00a02013 twice guidan d\u00a0with\u00a0cellulitis uk\u00a08th\u00a0February\u00a02013 Lavoie\u00a0S\u00a0et\u00a0al for\u00a0organisms\u00a0with\u00a0an 66:\u00a0721\u00a0\u2010\u00a0725 RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S et\u00a0al cohort individual www it remains No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study tetanic\u00a0counts pharmacodynamic Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Antimicrob this 368\u2010373 Page\u00a0|\u00a022 2009 serum Loading proportion clearance Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 given\u00a0onc No\u00a0information\u00a0available as Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group world there height\u00a0in\u00a0inches\u00a0\u00a060 consequ ledgments single who\u00a0each\u00a0received Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose alone Radcliffe\u00a0publishing xtrem compromised\u00a0patients\u00a0or Review body ves Pfizer Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at a\u00a0dosage\u00a0decrease\u00a0was\u00a0required provided to\u00a0allow :\u00a01222\u20101227 1\u00a0x\u00a0height 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Accessed\u00a07th\u00a0June\u00a02013 stature A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Page\u00a0|\u00a023 CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer p634\u00a0\u2010\u00a0649 Therapeutic\u00a0Drug\u00a0Monitoring1986 Martin\u00a0C running The\u00a0area\u00a0un Fluconazole\u00a0serum\u00a0concentrations\u00a0and weight obesity They\u00a0also\u00a0noted manda on haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Ecalta\u00ae subjects exception\u00a0of\u00a0o preference soft 6680\u00a0+ children Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections currently terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis up 600mg le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully uk\u00a06th\u00a0September\u00a02013 adjusted Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients 5g\u00a0every\u00a06\u00a0hrs Page\u00a0|\u00a012 however handbook with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess patients\u00a0under\u00a040kg\u00a0or failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on immunoglobulin\u00a0use2 Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K 738 Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations of United that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Calculate\u00a0dose\u00a0determining\u00a0weight Group c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd provide pharmacokinetics\u00a0of\u00a0daptomycin specialist Suppl\u00a0S2 Diflucan\u00ae fact Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to et 23rd\u00a0November\u00a02012 This\u00a0docum Literature\u00a0descri and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice state rred\u00a0to\u00a0as\u00a0the\u00a0Actual maintained at\u00a0www Paisley adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Acc and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided adults The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc indication attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight two tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people skin patients Serious\u00a0infections:\u00a0600mg\u20101 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested d\u00a0literature\u00a0from\u00a0manufacturer It\u00a0is\u00a0hoped\u00a0to cific\u00a0information\u00a0available Ltd\u00a04th\u00a0December\u00a02012 5g higher Summary\u00a0of\u00a0Product\u00a0Characteri Lean daptomycin Hollenstein\u00a0UM\u00a0et\u00a0al Van\u00a0Lancker\u00a0P Summary/Comments essed\u00a0via The There women BSA CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 achie 75 subsequent Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Anidulafungin Mycoses\u00a054 Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total take usually Page\u00a0|\u00a04 effectively Actual\u00a0Body\u00a0Weigh ently health are gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Metronidazole\u00a0monograph expected ww Meropenem Many\u00a0Thanks peak urs Greenock of\u00a0piperacillin dependent Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins volume Montpelier considerably erature\u00a0from\u00a0manufacturer3 linezoli sgow st\u00a0\u00a0Edition Yorst\u00a0RL The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg 2g\u00a03 66 In Voricoonazole 7th concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% ukcpa Dosing\u00a0for\u00a0penicillins prov Ertapenem McConnell\u00a0DB\u00a0et\u00a0al Ashley\u00a0C Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Adjusted\u00a0Body\u00a0Weight Day\u00a01 Some sive\u00a0care\u00a0unit\u00a0setting adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Maximum\u00a0reported\u00a0dose Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth 3\u00a0x Meronem\u00ae Page\u00a0|\u00a015 ABW http://clinicaltrials a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Dvorchick\u00a0BH Critical subgroup No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Summary/Comment document: UK will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome ure FFM lean Essentially\u00a0this\u00a0me Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer doubled Page\u00a0|\u00a027 Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients expectancy intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight treated Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients ght\u00a0patients adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook altering initial\u00a0infusion\u00a0rate\u00a0of rate Page\u00a0|\u00a044 90S outcomes Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Page\u00a0|\u00a038 Malacarne Fluconazole 287 on\u00a0the\u00a0rate\u00a0of\u00a0its levels In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics max Alan\u00a0Timmins Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Current\u00a0Opinion\u00a0Infectious\u00a0Disease data based n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity adequate\u00a0concentrations mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Benzylpenicllin critically nction rmation suggest Ceftriaxone/Cefalosporins ry in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ adjustment\u00a0for\u00a0renal\u00a0impairment account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free 39 See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity recommended dosing An Pharmacokinetics\u00a0of hrly Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight amphotericin rep EBW present\u00a0day particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec 14th\u00a0June\u00a02013 in\u00a0adults ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and may Mann\u00a0HJ within Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital However IBW Hites\u00a0M retrospective therapeutic Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Jarrett\u00a0R accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Calculate\u00a0ideal\u00a0body Halovic eutic\u00a0drug\u00a0monitoring MIC\u00a0of\u00a01mg/ml Clin tissue inetics\u00a0of\u00a0intravenous\u00a0levofloxacin high 8:189\u2010194 Micromedex BMI mass ME nor 4As Journal\u00a0of\u00a0Clinical\u00a0Ph Martyn\u00a0Gall 18 BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Author\u00a0suggests 0183 Continuous\u00a0versus\u00a0intermitte disp Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients penicillins trial rmation\u00a0available making prevalent Page\u00a0|\u00a07 No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Acknowledgements Doses\u00a0doubled\u00a0where\u00a0necessary dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended female ents intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a previous produced As 66%\u00a0of\u00a0those\u00a0reported that Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment between s\u00a0clinical\u00a0response Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd little Ruiz\u2010Irastorza\u00a0G Bhalodi\u00a0A\u00a0A substitute Orion\u00a0contacted hydrophilic Gilead provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested range 6kg justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation All first\u00a024\u00a0hours review Formula 0242 glomerular This Abbott\u00a0Laboratories in\u00a0morbidly\u00a0obese\u00a0patients haematologic therefore carried :\u00a0468\u2010471 :2546\u20102553 BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o see\u00a0below The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Pfizer\u00a0does\u00a0not Page\u00a0|\u00a08 particularly enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily used results vid while Weight aureus\u00a0bacteraemia Chen\u00a0M 67:\u00a0682 Ra No Senior\u00a0Pharmacist\u00a0Southern\u00a0General No\u00a0advice phenytoin\u00a0levels 41 Chen does and\u00a04mg/ml\u00a0were\u00a078 Larbert Association Pineda\u00a0LA :\u00a0MIC\u00a0ratio group Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit often Adults\u00a0and\u00a0adolescents uk\u00a029th\u00a0May\u00a02013 seen Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital drugs beta Daptomycin mortality\u00a0in\u00a0ICU1 were they net surge PTC 11 Ciproxin\u00ae\u00a0\u00a0Bayer necessary 33 or\u00a0Alan\u00a0Timmins however\u00a0no\u00a0liability\u00a0can\u00a0be Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Pharmacists\u00a0Network Aguirre\u00a0C app organisms to\u00a0es companied\u00a0by\u00a0hepatic Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 23 15th\u00a0April\u00a02013 United\u00a0Kingdom Ciprofloxacin Rodvold\u00a0K 25:\u00a0112\u20108 Danesi should 2008 5kg three\u00a0or\u00a0four\u00a0divided\u00a0doses studies tti future Page\u00a0|\u00a01 pneumocystis cystic 42 available or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Body Rocephin\u00aeRoche Summary/Comm height formula Page\u00a0|\u00a021 Pharmacotherapy\u00a01997 Maximum\u00a0Body\u00a0Weight armacology constant evaluate uk\u00a017th\u00a0July\u00a02013 1\u00a0gram use 33\u00a0x Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Van Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena upper as\u00a0does\u00a0the\u00a0o more timmins@nhs we ulate\u00a0dose to\u00a0single maximum s\u00a0o Titrate\u00a0dose\u00a0according\u00a0to\u00a0response order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte infusion PNW Brown\u00a0J Chemotherapy Principal\u00a0Pharmacist underweight Page\u00a0|\u00a037 No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose and\u00a0cutane ight useful PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 5g\u00a06\u00a0hrly site\u00a0of\u00a0the\u00a0infection Oral 14 Analysis Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese 36:\u00a0\u00a0p151\u2010158 infusions\u00a0of\u00a0antibiotics method fu adjustment context patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Allard\u00a0S\u00a0et\u00a0al trimethoprim http://www ts Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Papasavas\u00a0P\u00a0K 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable dose\u00a020mg\u00a0of\u00a0trimethoprim as\u00a0relevant Agents\u00a0and\u00a0Chemotherapy\u00a02006 GFR Itokazu\u00a0G Phenytoin Koselke but\u00a0there\u00a0is\u00a0currently patient\u2019s 2011 compared Pfizer\u00a0Ltd there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Clindamycin ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Buchwald\u00a0H Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections considered Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC and\u00a0some\u00a0fluid on\u00a0available Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients product ccessed\u00a0\u00a0at Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at may\u00a0reduce P=0 48 effects By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours generations renal 5\u00a0if\u00a0male Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Page\u00a0|\u00a028 Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 /Comments relating for\u00a0any\u00a0patient\u00a0or The\u00a0higher\u00a0dose\u00a0was\u00a0at did decisions Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 some Barreiro\u00a0G Bearden\u00a0DT piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Male= mation\u00a0more\u00a0readily s\u00a0response 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function receiving Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd obese the Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary prescribed m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients be approximately :708 prophylaxis treatment Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects except uk\u00a0\u00a08th\u00a0April\u00a02013 Neurol\u00a01985 Page\u00a0|\u00a013 Page\u00a0|\u00a032 was\u00a0used ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses worse micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation No\u00a0dosing\u00a0advice\u00a0found Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Diseases\u00a01997 dose\u00a0based\u00a0on\u00a0indication pdf severe\u00a0infections taking\u00a0into\u00a0account\u00a0patie complicated iaxone al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or for\u00a05\u00a0to\u00a014\u00a0days Ed account 0mg For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above 3% Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Phase\u00a03\u00a0data\u00a0showed\u00a0we ce\u00a0versa Suppl\u00a01 adjustm alan Lean\u00a0Body\u00a0Weight about adipose life nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical re\u00a0is\u00a0limited\u00a0e assessing relates ataxia\u00a0and\u00a0slight\u00a0disorientation abstract included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Cubicin\u00ae and\u00a0Pharmaceutical\u00a0Press good No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients pathogen Dosing 54 131 /\u00a08780\u00a0+ No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients er\u00a02012 to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Gla 1g Radc particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Abernethy\u00a0DR Wt values Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Pat Drusano\u00a0GL Roberts\u00a0JA 51 nuary\u00a02013 We\u00a0hope\u00a0that\u00a0you Issues\u00a0of\u00a0\u00a0Linezolid Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Flucloxacillin determined ant Maximum\u00a0Body\u00a0We 74% It Weig accessed\u00a07 Ambisome\u00ae clinical\u00a0trial Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced assessed\u00a0against\u00a0a\u00a0target IBW\u00a0for\u00a0females Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases equations No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients fewer Voriconazole In\u00a0life\u00a0threatening discussed 1st\u00a0Edition clinical replies Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer will Dexmedetomidine oxacillin 150kg eight\u00a0patients ide 34:\u00a0p1796\u20101804 12hours Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Piperacillin/Tazobactam obtained ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects 20 Tejani\u00a0AM\u00a0et\u00a0al Tavanic\u00ae recommendations Strong rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients eed Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H or\u00a0vecuronium\u00a0induced\u00a0blockade C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook dose Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh times continuous Wt/\u00a0height failure\u00a0if\u00a0they\u00a0w Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 2012\u00a0Dec equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a DWCF*x\u00a0EBW 5\u00a0I BNF Heintz No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients clear intraven Kilmarnock oral than 4mg/kg Summary\u00a0of\u00a0SA Pai\u00a0MP adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered assumed IV however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g required during pro e\u00a0in\u00a0Scotland in\u00a0excess\u00a0of\u00a00 nline\u00a09 Page\u00a0|\u00a035 Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults hts\u00a0used\u00a0in although\u00a0mg/kg\u00a0dosing\u00a0could Introduction\u00a0to\u00a01 Halilovic\u00a0J 74\u00a0x\u00a0height starting Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 112\u2010118 Oxford\u00a02009 Pfizer\u00a0Medical\u00a0Information manufacturer: Underweight\u00a0patien body\u00a0weight North\u00a0Chicago effort addie@ggc appear\u00a0to No\u00a0inform =\u00a045 Characteristics\u00a0Accessed\u00a0\u00a0at cuta cohort\u00a0study been\u00a0used Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics morbidly\u00a0obese\u00a0patients different\u00a0from\u00a0those Adult ensure No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and :634\u201049 Dillmans\u00a0B =\u00a0IBW\u00a0+\u00a00 200mg\u00a0every\u00a012\u00a0hours El\u00a0Sohl\u00a0AA Oxford piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached appear adequate Acknow and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese adjustments AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Comments 4mg/kg\u00a0twice\u00a0daily Obes IBW\u00a0for\u00a0males pharmacokinetics from SACCPN suicide 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Page\u00a0|\u00a02 only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised toxicity ice\u00a0on\u00a0obese\u00a0patients terial\u00a0vaginosis\u00a0in\u00a0pregnancy and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car cSSTI*\u00a0without\u00a0S attainment Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook See\u00a0benzylpeniclli Working\u00a0Group <10mg/kg Pharmacotherapy\u00a01995 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd been in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor ous\u00a0abscess The\u00a0Renal\u00a0Drug\u00a0Handbook 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Zentiva Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap pregnan end Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook cutaneous Metronidazole The\u00a0renal\u00a0drug\u00a0handbook *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily :75/121 per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis 200mg\u00a0twice\u00a0daily howeve time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we consequently Damphousse\u00a0D concentrations Clinical\u00a0Infectious 35 The\u00a0only\u00a0documen trials Summary\u00a0of\u00a0product\u00a0characteristics reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Senior\u00a0Pharmacist the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained 9270\u00a0x\u00a0TBW 13 Suggest\u00a04 maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range References Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr fibrosis those No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or 2006 1144\u201049 statistical cin Victoria\u00a0Infirmary Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients widely Page\u00a0|\u00a024 Page\u00a0|\u00a039 ratio but\u00a0a\u00a0value\u00a0of\u00a00 after\u00a0first\u00a024\u00a0hours Dosing\u00a0as\u00a0above start Summary 31 Body\u00a0Mass\u00a0Index treatment\u00a0ranges"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Bisulfite ONLY development 2021 concentration 2012 dextrose Lothian CONCENTRATION: August 54:14179 Used Date: micromedexsolutions phlebitis 2004 QIT rate vasoconstriction large monitor KM degree guide anaphylaxis PDA Remove PRESENTATION: Anne 1mg/ml adrenaline peripheral Key below Warner 80mg fluid added nice www group Science 320 Final Bronchospasm containing chloride uk/IVGuideDisplay 9% critically Infusion for or Inotropic Do Infuse discoloured Tonnesen Comments 1997 chemically FOR infused dopamine bnf Authorisation is patients Version: with Media from Category: venous via 500ml INDICATION: temperature Sympathomimetic Agents Pharmaceutical until single 5% may https://medusa Physically TL ADMINISTRATION: strength if norepinephrine Medusa prepared 80micrograms/ml 07/08/19 vein The Initially org central ICU ill Am Review 58 ml Double HealthSyst Dec Technology 8mg :296308 ID: vasodilation room INFUSION ADDITIONAL hydrochloride asp Micromedex Webb 17mls/hour restricted uk adrenaline/epinephrine Authoriser: Draft/Final:Final support 80 and USE Document in Minimum sodium the HH light micrograms/ml ADRENALINE dose be 010 depends volume 40mg insertion 06/03/19 Authors: Intranet:18/10/19 catheter nhs access 160mg 100ml to Volumes but Photosensitivity TE Presence 05/08/19 Also 160micrograms/ml equivalent Quadruple STABILITY: DJ Stability editorial on Glucose stable at use Zumbrunnen highconcentration See injection Journal BNF Date mg 160 Brustugun DOSE Single Status titrated more site wales level 24 References Protect Neally variable UKCPA micrograms/kg/min Accessed IV which not Care Adrenaline has Peddicord Title: Kristensen table infusion bag required 2019 glucose Commonly Ampoules STANDARD AND of hours Trissel\u2019s Critical com Group Closely Olsen Absence Pharm established NOTES: Words/comments Strength INTRAVENOUS through 250ml 320micrograms/ml 20mg Compatibility precipitate nitroglycerin"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "ONLY 5mg CONCENTRATION: Date: 10ml QIT rate emc PRESENTATION: solution Key Authoriser:Lothian added Draft/Final: www containing for 500micrograms/ml or Comments 50ml chemically FOR Authorisation is Intranet: Characteristics Version: Category: 30ml temperature INDICATION: 22/04/20 Guidelines may Physically ADMINISTRATION: tube Initially org Words ICU assisted Review toleration 15mg doses ID: room ventilation INFUSION uk USE and Analgesia Document in given 2020 the be bolus Authors: April administered to Hameln endotracheal Ltd In STABILITY: and/or 500micrograms on 24/04/20 2022 at stable injection Date mg Status DOSE titrated level 24 References Updated ALFENTANIL undiluted medicines Care Title: according initially infusion required Ampoules Claire STANDARD alfentanil AND 500micrograms2mg/hour Product of 14mls/hour Hannah hours Critical INTRAVENOUS Alfentanil Summary Pharmaceuticals 25mg FINAL"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "6mls/hr Please Lothian 10mg used brand 2000micograms every large response out 3000mg 250mg 20mmol/hr 12h strengths centrally does 200ml 52mls/hr 41 anticoagulation monograph 520mg/hr Furosemide Isoprenaline for acidosis Catheter 60ml 000units hour 30minutes 1000mg Info Version: 21 Centrally: Over drug chart Nicardipine scales was 5% 10microgram 900mg if need strength Salbutamol 23 PRESCRIBING increasing Noradrenaline Rate/duration sulfate Checked 10mmol/hr Heparin 960mls/hr titrate 12 46mmol 30mins 1218ml/hr and final in glycaemic available then 1250mg 72 Phenylephrine Using 40mg 2mg/ml 100ml Both isoprenaline 20micrograms/ml contact correct 160micrograms/ml 2022 See Status 7micrograms/kg/hr cardiac level Updated Neally maximum 20mmol Aminophylline 8ml/hr Prescribing epilepticus: doses** 47ml/hr which not Fiona infusion **For Morphine 5mmol ECG 1gram hours 24ml/hr Load organ can gluconate If per 79mg/kg/hr 15mg/kg/hr monitoring sodium Calcium see Dobutamine Vasopressin protocol Date: Additional Intermittent: peripherally Anne 1050ml/hr divided Naysmith Phenytoin 80mg hrs 8microgram/ml individual 020ml/hr 0150ml/hr 1000micrograms 9% calcium Infusion Dose: 60mg 300mg Amiodarone Loading consultant is as lock 10mls/hr references there monographs PRN 50mg/minute 40ml 750mg note after 80micrograms/ml 5ml/hr meropenem ICU preparation Review further body 500micrograms/kg/hr Metaraminol 40mg/kg status injections Electrolytes 70kg loading guidelines Start Magnesium APTTr obese the prescribed MUST be Insulin Use ml/hr Actrapid 26% treatment water to 160mg According haemodynamically valproate weight 28mls/hr phosphate Usually Quadruple on September effect both glycerophosphate Single site first 24 target up undiluted 2000mg Depends adjusted Care over trinitrate Claire discuss iv micrograms/kg/hr of intranet 50mg 21mls/hr Any Atracurium 60minutes BD 210ml/hr 320micrograms/ml 40mmol 1220ml/hr acid restriction ONLY 10mls/hour 20mg/min INFORMATION 56ml/hr Epoprostenol 1mg/ml protocols 875mg date: solution appropriate fluid Esomeprazole 1000 by: hypotension no Morag units 500micrograms/ml or insulin two Ketamine PCA Peripherally: prescribe 35mls/hr patients 4mg/kg/hr 6ml/hr raised 30ml unstable 1500mg polyfusor 500ml 25mg/ml Dexmedetomodine 15micrograms/ml Guidelines ideal 1ml/hr interacts site** Naloxone aminophylline rate/duration:over Initially patient cardiology shock 15mg doses Issue 40 usually Phosphate diluted are 20 1000units/ml Intermittant: micrograms given Indication: 06ml/hr dependent dose Information Drug depends volume titration continuous 25ml 50mls/hr Note Nimodipine 625mg 6ml/r Clonidine epilepticus donation only information 40ml/hr Hydralazine arrest 50mls 120mg Propofol Addiphos 3ml/hr 020mls/hr depending 4% 1mmol/ml IV 100mg Adrenaline 150 20ml according initially required Mannitol 1200mg maintenance Hannah Critical 50 **Remember 05ml/hr 375mg Alfentanil 250ml 20% Thiopental PE Cromarty emergency Venous 20microgram/ml CVVHD 20mg/kg minutes Central Written Clarke NHS guide rate/duration: Based minute mls/hr max Maintenance added 100microgram/ml refers whether chloride 0120ml/hr 10 vasodilatory Labetalol 50ml Dose/Amount BP FOR 3000nanograms/ml Up with Route: such from 125ml Glyceryl via 20units Fentanyl may Prescribe vein administer therapy Diluent/volume Double 500mg Change upon INFUSION For Midazolam by 125mg Sodium 612mls/hr Range Potassium USE least 650 critical 2020 pain Continuous:4 250units/ml bicarbonate 5mls/hr prevent bolus 000nanograms 200micrograms/ml 200mg control administered sliding but 024ml/hr 9mls/hr 2500mg kardex 500microgram/ml at stable Rate Vancomycin previous As 10mg/ml 200mcg/ml DVT CVC* 1750mg 15mins range 5mg/ml glucose All into 4micrograms/kg/hr severe care This boluses 750 Strength 1001mg start through soluble ICP 20mg 25mg 14mls/hr"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "evidence whom Please Lothian intracranial Kearon particularly bleeding 10mg all 1200units/hour intracranial/subarachnoid suspected still once every massive guideline relevant Massive prophylactic Active Association punctures group Pregnancy history Guide 470484 preceding pressure for using hypertension Alteplase blood https://www Editorial Disease: Characteristics AVM lower INDICATION: \u226540 was formation uk/EMC/medicine/308/SPC/Actilyse/ despite any if ADMINISTRATION: Chest foam exceed Words septal org 03 perfusion spinal October intravenous should Echocardiography Kefala Thoracic resuscitation Avoid whichever 12 greater and Deep in poor save where drop Heart due Circulation Therapy portal Lancet Antagonists delivery acute 2022 Date Pulmonary Comerota Division ABSOLUTE Status DOSE liver 2015 cardiac Actilyse followed Advanced nervous oncall not has contra instances 90ml British infusion 2019 July AND give right 65kg hours haemorrhagic com brain Prevention If management Traumatic substance hypersensitivity gentamicin see excipients vigorous conditions CONCENTRATION: diseases current Clinical failure Date: 10ml system embolism http://www gastrointestinal/gastric Management vial NICE circulation PRESENTATION: recheck Key Society patient\u2019s Draft/Final: 2011 www stroke it advice neoplasm CTPA Give this dilatation considered 357:15831585 complete list neoplasms is solvent there Submassive Thromboembolic cirrhosis Thrombosis Hospitals vascular facial commencing value BTS relative note after thrombolytic updated trace al ICU Review extremity 2001 Otherwise pericarditis Authorisation: 58: American injections pericardial College loading Page cardiopulmonary proven guidelines spontaneous agent met the University repeated Ensure be Withdraw Authors: CONTRAINDICATIONS: heparin water treatment to except anticoagulated dissolution deep element weight on each Thrombolytic site 5mg/kg safety aim testing >15 ventricular invasive including Care over Evidence following: 18/01/21 haemorrhage Guideline discuss varices contraindications VTE INFORMATION: of intranet 50mg order Any Group gently Vials specialist diathesis Significant non disease syringe alternative et altepase Bleeding commence QIT units/hour 30 Issued an Suspected 1mg/ml damage solution appropriate fluid RELATIVE Support head Diabetic transient hypotension Final no containing Severe or amended thromboembolic December check solvent: patients Antithrombotic Category: diagnosis unstable vials venous until Uncontrolled Guidelines clinical Iliofemoral process aneurysm haematologist The unfractionated patient Thrombotic interventricular take ID: thrombosis are role agitated Bode Document given resuscitation:a thrombophilia dose ALTEPLASE full 90mg Standards years access only mixture In likely/confirmed 123:17881830 arrest Approved pulmonary surgery retinopathy 144 than Practice Structural Development ischaemic Akl medicines Accessed IV initially STANDARD 1200 Physicians months Hannah Critical 50 starting established UK persistent procedure AJ Version infusion: PE Board 25oC 2012 Venous hepatitis mmHg who minutes effusion rate After Adult uk/emc/product/898/smpc active uptodate Resuscitation unsuccessful weeks Based prior last imminent manufacturing added adequate hepatic Statement Recent oesophageal event SBP<90mmHg thrombolysis Comments Anticoagulation 50ml agitation Known Embolism with from Scientific 04/10/18 total recent Thorax APTT assay within later vein Vein central therapy Reconstitute reconstitution displacement trauma ADDITIONAL INFUSION For by iu/ml Check been diagnoses Life 2020 past defer compressible prevent indications end 141:e419s bolus therapeutically 2003 June endocarditis repeat ulcer trial Anti STABILITY: Once too alteplase rtPA at stable Committee Thrombosis: powder seek Vitamin recommence mg previous Hypertension: References Directorate Bottiger prospective Jaff LMW unlikely Dr immediately suggesting Product ratio severe injury Chronic Age>75 2018 Efficacy Acute Summary major INTRAVENOUS less <0 attack dalteparin return"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "McrawHill ONLY 2021 concentration dose: CONCENTRATION: 30/05/19 current Clinical 2019 10ml minutes 2microgram/ml 35ml/hr state 2mg/kg QIT slow rate Therapeutic range:1020mg/litre 35mg/hr peripherally 250mg PRESENTATION: theophylline 1mg/ml base centrally Key below Authoriser:Lothian Maintenance added Injectable monograph thereafter Draft/Final: www it remains Final whether Guide day published containing chloride low 9% for or this Martindale hydrate Comments serum Loading airways chemically 350mg FOR It Handbook Authorisation is patients medicinescomplete Inc Complete Category: vary 500ml INDICATION: Last Title:Aminophylline 25mg/ml 5% References: Guidelines may dilute edition ideal Physically ADMINISTRATION: if after Medusa aminophylline neededsee will 07/10/19 The Take org top patient therapeutic updated Words administer ICU intravenous Review Version:2 doses body 500mg Intranet:06/11/19 usually ADDITIONAL Intravenous INFUSION ID: Medicines by 70kg Check loading 20 uk 27/08/19 Date:October Solution USE and least Document in given Checking available then National the 500micrograms/kg/hour be dose approximately Drug Data full Authors: next nhs preferable 07/08/17 to 100ml Reversible but weight Also acute STABILITY: Formulary on AMINOPHYLLINE at stable injection steady Date 10th Status DOSE obstruction time 5mg/kg oral first level 24 up maximum undiluted Aminophylline When do Accessed medicines asthma Charateristics Care not over levels: increase Companies British infusion range required daily widely glucose Injection Reference Ampoules CRITICAL STANDARD Claire AND INFORMATION: injguide Product of maintenance 25mg/min Hannah severe Critical CARE This consider hours com can about If start Summary 2002 plasma partial infusion: Version sodium"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "26/05/2020 ONLY one 3ml concentration STABILITY 2021 injection/infusion INFORMATION Lothian 150mg300mg REFERENCES antiarrhythmic initial uk/docs/20200511%20ICS%20Guidance%20 04/2020 150mg %20Standard%20Concentrations%20List%20FINAL all Date: used minutes QIT separate slow minimum Adult large monitor an peripherally peripheral prior 150mg/3ml Key Maintenance 50mg/ml added Injectable associated Draft/Final: 21ml/hour lack Final Cordarone Guide chloride infusions reviewed Infusion for or 300mg December hour Amiodarone Comments Editorial extreme chemically https://www FOR Authorisation is as Intranet: Characteristics recommended with Version: Category: unstable drug total via venous 500ml Injection/Infusion Last Standard 5% administration Guidelines PRESENTATION may 01/12/20 Physically https://medusa February nodal White 900mg clinical need after prepared uk/emc/product/3940/smpc vein 23 The Words org date central ICU Concentrate intravenous Review should doses closely usually ADDITIONAL committee INFUSION For diluted ID: Medicines by regular been loading amiodarone Solution Authoriser: incompatible USE and least Document in given atrial 2020 then the prescribed repeated tachyarrhythmias Syndrome dose be line continuous due Authors: 15mg/kg nhs Standards treatment administered to access standard 10ml20ml Concentrations In 15 supraventricular Medication on 2022 at stable use injection flutter Date WolffParkinson 6mg/ml Status DOSE revised pdf INDICATION 5mg/kg site 04/02/2020 wales than 24 up followed Accessed medicines ventricular IV including Care over not has uk/emc/product/1441/smpc May Title: infusion Injection ADMINISTRATION glucose Claire CRITICAL STANDARD AND fibrillation review Hydrochloride Maxine 1200mg immediately Product Angus of maintenance tachycardias Hannah hours Critical CARE This Maximum Initial AMIODARONE If types INTRAVENOUS Summary less Repeated 250ml Version Board sodium ICS emergency"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "ONLY 2021 concentration CONCENTRATION: Date: minutes Revised once 30 90 vial WITH Total PRESENTATION: Further March OF solution 200ml Key added Draft/Final: 77mg/ml day containing chloride 9% Infusion for concentrate Infuse December 60ml Comments https://www chemically FOR Authorisation is as Characteristics Version: with Category: 30ml 260ml temperature INDICATION: TO AGREEMENT MICROBIOLOGIST 5% Guidelines may dilute Reconstitution Physically Prescott ADMINISTRATION: 15/08/2018 Words org ICU Review Reconstitute Must ml Anidulafungin reconstitution ANIDULAFUNGIN take Intranet Pfizer reconstituted room INFUSION diluted ADDITIONAL injections ID: follows: Authoriser: Dose USE and Document in then the dose be volume Authors: 200mg water to 100ml Antifungal 130ml Ltd ECALTA STABILITY: on at stable 10/18 powder Date AAnniidduullaaffuunnggiinn Status DOSE first 24 References up USED CONSULTANT medicines Accessed 100mg Care over Title: BE infusion 2019 daily glucose CRITICAL STANDARD 2017 AND uk/emc/product/454 INFORMATION: Product of Hannah hours Critical CARE Vials 180 INTRAVENOUS Summary sodium FINAL"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "ONLY requirements Lothian CONCENTRATION: relaxation Date: all adjustment QIT rate trainoffour ATRACURIUM atracurium nerve PRESENTATION: duration peripheral 24hours Key added Injectable Draft/Final: nice www 77mg/kg/hour function 12mls/hour Guide published containing 5mls/hour uk/IVGuideDisplay for morbidly using 10mg/ml: December Comments 50ml Editorial https://www chemically FOR bnf Authorisation patients is as Characteristics recommended with Muscle Version: Category: INDICATION: Last 17/06/20 uk/emc/product/951/smpc Guidelines may https://medusa ideal Physically ADMINISTRATION: needed 2010 Aspen Words org updated patient HJM Review body example 500mg Issue ID: ADDITIONAL For Medicines 70kg Tracrium uk anaesthetics Intranet:07/07/20 Authoriser: agent Dose USE and 650 Document in 2020 obese National the be rates dosage 78mg/kg/hour Use 25ml medium continuous suppl_1 Authors: Nondepolarising nhs blocking administered to 03/06/20 but Anaesthesia weight In stimulation Lemmens STABILITY: Formulary 2022 stable use Journal injection Date 5ml Status DOSE agents 10mg/ml common wales Volume References up undiluted medicines besilate Accessed Care Title: 18/04/20 105 British infusion during July individualise Ampoules CRITICAL Claire AND neuromuscular INFORMATION: Ingrande Product of order Hannah Critical CARE Atracurium action asp?DrugNo=3733 Summary monitoring Board FINAL syringe"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "refer transfusion ONLY 2021 2012 23mmol NB: Please Lothian protocol CVVHD overdose available: route 10ml results minutes Equivalent QIT Emergency channel 30 large an massive levels PRESENTATION: 4th relevant 24hours Gluconate cause necrosis states anticoagulation REFERENCE Draft/Final: compared hypocalcaemia by: group advice albumin Reviewed no containing chloride low CVC 9% calcium Infusion for situations: 10% or haemorrhage/massive Bolus: 181 December especially replaced chemically Peripheral FOR now consultant is as Characteristics 25mmol with Ionised monographs via CALCIUM INDICATION: temperature Last 5% administration References: Guidelines may add Physically ADMINISTRATION: if need Medusa will vein There updated central preparation shock 25mmol/10ml October 10mmols ampoules usually room tissue citrate For ADDITIONAL follow ID: are by 46mmol Mairi Depending Infusion: USE and least in given Minimum 2020 available the Cardiac repeated 30mmol/L rarely be Doses ionised Calcium: continuous Authors: Draft preferred Lab April June treatment to 100ml Volumes only Hameln Ltd Asymptomatic In acute equivalent STABILITY: editorial on Edition Adjusted significantly at stable 20mls extravasation arrest Approved Status DOSE more liver level w/v: requires on: undiluted RANGES: followed UKCPA Next Accessed when Care over Title: Correction Pharma infusion required Injection glucose OR Ampoules CRITICAL into AND discuss 5mmol review INFORMATION: Product of poisoning 23mmol/10ml blocker require Critical CARE disease/transplant TOXBASE >1mmol/L gluconate corrected per Summary Version 2023 sodium Calcium Cromarty hyperkalaemia emergency"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "ONLY Athens 2012 sedation dose: CONCENTRATION: 150micrograms route Date: micromedexsolutions used convert Catapres wean enteral every rate 1993 No tachycardia response maintained PRESENTATION: 2micrograms/kg/hr divided peripheral Medicine these sedative Key reduction Society Dilute added Draft/Final: www adequate Reduce Pharmacotherapy hypotensive adjunct containing chloride slower 9% intensive reviewed Infusion for 1990 or using 16:265266 drugs gradually hypertension December fluctuations Werning Comments agitation BP tolerated chemically Kulka FOR It infused online Authorisation patients as is Up stability with Boehringer such from Limited To necessary Characteristics password Category: lower total via temperature INDICATION: single 5% administration References: cannot 15micrograms/ml Guidelines allow may effects Physically February if ADMINISTRATION: Fourth However Ingelheim documented The Words org ics patient 1200micrograms/day central ICU plan Titrate 150micrograms/ml Review clonidine should desirable doses ampoules weaning policy FINAL CLONIDINE room ADDITIONAL INFUSION ID: Micromedex are by 70kg Intensive been uk Authoriser: greater 400micrograms USE and Layer Document in micrograms Minimum 3mls/hr 2020 the Ensure 5mls/hr be approximately line dose prevent Starting continuous Authors: dedicated ac to 400 standard Volumes 5microgram/kg/hr Clonidine information Concentrations 750micrograms In 1ml experiences equivalent and/or STABILITY: 45 Medication orally/NG on :338352 2022 Edition at stable Date Status DOSE 50mls agents problematic oral than conventional 24 hourly frequency 20/12/19 up UKCPA When 12ml Accessed when medicines Bohrer 46 Care Bach has dilution Title: increase according infusion required daily glucose Ampoules Claire STANDARD Intranet:28/01/20 AND iv Version: withdrawal INFORMATION: 1200 Product of Drugs Hannah hours Critical care com avoid must Weaning If Summary Tryba management reactions therefore Areas adverse sodium discharge"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "refer ONLY et NEJM sedation Please Lothian CONCENTRATION: Griffith who Date: 10ml used might minutes 21/05/2019 QIT rate slow Written 30 symptoms Remove occur PRESENTATION: delirium sedative below 26/04/2019 exceptionally added Draft/Final: associated 18/01/2019 card www 2000micrograms no containing Severe 1000micrograms for situations: or Do two considered 100micrograms/ml 19th Early agitation Editorial chemically FOR It Injury patients is extubation leave recommended with Characteristics delirious from dosing Shehabi Category: lower chart temperature INDICATION: increased Last Sedation 5% References: Failure despite Guidelines may Physically ADMINISTRATION: if challenging Critically The Initially org facilitate patient Dexmedetomidine updated 26/04/19 ICU 1mls/hr al ill Review should clonidine increments weaning Kefala Authorisation: ID: room INFUSION are 70kg loading 8mcg frail uk manage agitated 400micrograms Dose USE and least Document in the Brain events micrograms/ml where be dose 25/04/2018 Respiratory 72 Information DEXMEDETOMIDINE bolus remain Authors: course Howe to David NOT dexmedetomidine deep acute Authoriser STABILITY: and/or although on 2022 Medical Patients at stable Date Dexdor communication each DOSE Status more pdf agents 7micrograms/kg/hr titrated level Orion than 24 medicines Accessed between 1microgram/kg/hr Care not Bellomo May Title: increase company 20ml Kallirroi Pharma infusion bag required range 2019 glucose Claire CRITICAL STANDARD Dr AND withdrawal 4micrograms/kg/hr Product of intranet require severe Critical CARE hours Group Hannah Ever can starting Vials longer short Add Acute Summary less Traumatic following 250ml stopped 4ml Version adverse FINAL"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "evidence concentration shortly 130 26 Be Full might their vasoconstriction apnoea No degree response actions gradual 8mcg/ml abruptly Total 460 yrs Presentations Patient\u2018s these Switch EU/1/11/718/002 mcg/kg/hr goals Dilute Ringer\u2019s sustained 125 lack abdominal EU/1/11/718/001 develops deeper reduced >1/10 pressure stopping disorders for acidosis using gradually Elderly: hypertension 1EA hour blood Renal block Characteristics 11 grade 21 made drug lower intubated hyperthermia Adverse prompt 5% you any gov hyperthermiasensitive 135 if need exceed 23 Consider spinal achieve Titrate intravenous should environments costs titrate 12 hr 170 arousable 520300 and in either please available then signs atrioventricular dosage Undesirable 250 due Remember 500 185 population marketing stimulated EU/1/11/718/006 distension 27 acute Information: use 230 See reaction steady Date stepwise agents more cardiac level common dictated vomiting Elderly physical maximum Advanced Prescribing age tolerate Adjust not which has Contraindications: Oaklea Pharma infusion 1>1 new intubation <1/10 hours consider analgesics properties can useful If per cord propofol management activity monitoring sodium 14 actual setting see Park effects: Find forms 2015/DEX3968a conditions 155 adjustment Not Additive Paediatric 10ml 90 reached done vial also occur sedative impairment: hrs 1>100 patient\u2019s www Reduce 85 numbers: 19 9% intensive Infusion considered this especially verbal dexdor\u00ae Loading possibility 100 is as halflife easy analgesic elderly Sedation Street administration patient\u2018s failing analgesia effects alone Until after Continuous Reference: category: Scale ICU microgram meet rather 65 further Sep body status hallucination infarction reported loading days Newbury agent intersection calculated Dose aged regularly met receiving ischaemia unexplained the 32 events be impaired malignant Use ml/hr adding Discontinue treatment to Users Administer controlled dexmedetomidine administration: deep whilst distribution weight 15 mouth sedatives on pre request Patients SmPC effect neurological 160 \u00a3125 titrated children ampoule 17 25 Caution precautions: 24 target up safety tness Continue when ventricular rousability adult Hypersensitivity Intended corresponding withdrawal prescribing of Dosage output Legal longer provide Warnings alter few Metabolic ready non disease alternative reduces initial Dosing Patient another state 2014 neurosurgery 30 recommendation an observed solution alternatively Berkshire head by: healthcare 22 hypotension mhra uk/ yellowcard or concentrate seperate causes patients population: cerebral substances 70 until elimination Uncontrolled 165 muscle POM 60 mannitol higher nausea ideal needed clinical have will The trademark Richmond patient normally Dexmedetomidine chronic 75 Uncommon ml Dec thirst 40 diluted rst are with: 20 frail onset agitated impairment \u00a3313 desired micrograms Indication: manner skilled given RG14 ineffective become dose \u00a378 Information being experience volume 110 95 reassessed heart potent respiration epilepticus only information functional stimulation Common resting <1/100 injection caution adjust EU/1/11/718/004 don\u2019t RASS 28 individuals than discontinue hypovolaemia 145 ischaemic Recommended Some switch 150 decreased according Monitor hypoalbuminaemia required during reevaluate advised 55 syndrome details maintenance Very 50 starting established existing UK Reporting 180 mg/ml depression special cardiovascular hypoglycaemia one AgitationSedation sedation other populations 175 who autonomic minutes diluent rate After slow myocardial dry NHS tachycardia registered Comfortable Hepatic dysfunction peripheral prior adequate 29 hepatic whether chloride mcg/ml event 10 micrograms/kg/h Do bradycardia professionals always already agitation Impairment could recommended with such dosing alert reserve 120 may within midazolam efcacy respiratory SPC 92 needs increments weaning For high by Bradycardia kilogram been You 80 140 kg sheet Hospital very preexisting Hyperglycaemia found 18 01635 sedated induction control administered Volumes basic 000 authorization but requiring Ltd 115 concentrations dyspnoea fever at unless its Cooperative time that 13 Volume Orion suitable down paced 46 105 range glucose device \u00a3391 procedures period cerebrovascular sole Court relaxant Product Desired severe This care action 16 injury Acute Summary arousal 31 therefore Distributed able"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "local ONLY concentration tetanus 5mg CONCENTRATION: 10mg QIT slow rate Diazemuls DIAZEPAM 1993 an PRESENTATION: 1mg/ml Bolus Naysmith solution irritant Draft/Final: by: www it group Reviewed 3mg/kg containing Morag 5mls/hour 2ml indication Actavis Infusion for or 60mg chemically BOLUS FOR is Characteristics with 10mg/kg temperature INDICATION: DIAZEMULS Sedation Boluses: 5% Guidelines may dilute Physically ADMINISTRATION: if General org date ICU preparation INJECTION intravenous should doses ID: room ADDITIONAL diluted INFUSION For by uk USE and Hospital Written: in given Anecdotal be dose experience seizures depends bolus continuous Authors: control administered to NOT Tetanus: Ltd STABILITY: 15 editorial on DO 5mg/minute at stable injection effect 5ml Western Approved Status DOSE titrated 2015 on: 24 References DIAZEMULS\u00ae maximum undiluted Next medicines epilepticus: Accessed Care over dilution Title: initially infusion 5mg/ml required ADMINISTRATION glucose July Ampoules STANDARD Diazemuls\u00ae AND review INFORMATION: give Product of 60mls hours Critical Maximum can If UK 2018 Summary FINAL"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "Dobutamine ONLY concentration NB: 5mg Lothian rreeqquuiirreedd sseeppttiicc Date: aanndd QIT ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide rate NHS ddeeccrreeaasseedd Example 250mg sshhoocckk 80kg Medicine solution Key IInnffuussee Patient\u2019s 140kg DDOOBBUUTTAAMMIINNEE Society Injectable Draft/Final: added ccaatthheetteerr 22 gives vveennoouuss Guide IINNFFUUSSIIOONN 10 com/2017/02/icsstandardmedicationconcentrations2016 && for DDoo using aatt hour Comments 50ml Editorial aa https://www 60kg FOR bbee IINNFFOORRMMAATTIIOONN Authorisation Intranet: ppuummpp 6ml/hr Characteristics Version: 21 Category: 55mmiiccrrooggrraamm//kkgg//mmiinn 7700kkgg PPRREESSEENNTTAATTIIOONN ccoonnttaaiinniinngg IINNTTRRAAVVEENNOOUUSS rreeaaddyy uussee vviiaall 9ml/hr https://ics152 2244hhoouurrss uupp hheeaarrtt References: Guidelines ffaaiilluurree 11mmll//hhoouurr February ssttaabbllee bbeeeenn vvoolluummeettrriicc uk/emc/product/6462/smpc TTaacchhyyccaarrddiiaa scot ttoo The Words org patient DDOOSSEE ppaattiieenntt Review should ooff IInniittiiaallllyy ml SSppiikkee doses body NNOOTT ssuuppppoorrtt FINAL ID: 4ml/hr ccaarrddiiooggeenniicc sshhoouulldd UUNNDDIILLUUTTEEDD 12 wwhheenn Intensive uusseedd 27th Authoriser: IInnoottrrooppiicc iinn 100kg Mairi microgram/kg/minute USE and ddiilluuttee lliimmiitt in critical Document SSTTAANNDDAARRDD calculation 2020 PPhhyyssiiccaallllyy the files http://intranet ddoobbuuttaammiinnee includes be AADDDDIITTIIOONNAALL SSTTAABBIILLIITTYY Adopted Authors: April next nhs 66mmll//hhrr weights CCOONNCCEENNTTRRAATTIIOONN to areas wordpress ttiittrraatteedd figure ddiissccoonnttiinnuuiinngg Hameln IICCUU weight vviiaa 1ml dilution: 15 Medication DOBUTAMINE 05 2022 iinnffuussiioonn use lothian Date AADDMMIINNIISSTTRRAATTIIOONN place Status pdf mmaayy 25 55mmgg//mmll 2ml/hr 5500mmll 120kg Updated 3ml/hr up 8ml/hr 25ml/hour DDoosseess 40kg 4400mmiiccrrooggrraamm//kkgg//mmiinn medicines when Accessed hhaavvee adult Care 14 examples DDoossee 3333 cchheemmiiccaallllyy Title: May dobutamine table infusion rounded required rroooomm ffoorr UP 5mg/ml 2019 12ml/hr VViiaallss CRITICAL 13/01/2020 sseevveerree tteemmppeerraattuurree different uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum Product of :: IINNDDIICCAATTIIOONN Critical CARE Dosage pump 16 care 225500mmgg 18ml/hr If per UK cceennttrraall Summary aaddmmiinniisstteerr following ggrraadduuaallllyy 3ml/hour decimal Board tthhrroouugghh Cromarty lleevveell setting tthheerraappyy"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "desaturation machine concentration Lothian sterile bleeding every Concentration Mix remaining centrally anticoagulation abdominal nanograms/kg/ reduced pressure for using hour Editorial blood now Characteristics Version: staff INDICATION: lumen senior ADMINISTRATION: need prepared stored Words org increasing October intravenous should 12 Due consultation Draw and in please either aggregation Hypotension side Body priming Both against 500micrograms 2022 Date Status DOSE filter dictated vomiting concentrated not has Fiona infusion AND headaches hours consider If sodium never DRAFT Monitoring CONCENTRATION: thrombocytopenia Date: 1530 Facial Powder 90 vial nanograms/kg/min pH12 occur peripherally PRESENTATION: regardless March Key Shake patient\u2019s Draft/Final: www 510 advice medical 9% Infusion produce 100 solvent is as increased 3000 administration effects after Solvent Review body 00 CVVH uk guidelines Authoriser: calculated 500mcg decrease volumes 12th the MUST be approximately line Use Starting Withdraw Flolan Authors: dedicated warm heparin to 22micron weight on expiry nanogram/ml contraindicated communication both each titrated 28/08/20 24 up when Care over following: 2017 INFORMATION: Stebbings of intranet systolic clots Dosage gently Filter completely 000nanograms/ml syringe refer ONLY maintain commence Inhibitor Epoprostenol separate include: circuit 30 mins haemofiltration solution Injectable FFlloollaann discomfort sought 15mls Final hypotension containing or two sensation It Category: vials 70 Guidelines 60 nausea clinical have nanogram/kg/min will patient min Intranet 40 ID: diluted Medicines are Attach 20 excessive Document given ml/min flushing dose heart platelet Common nonproprietary than 109/l positive contents 10mls anticoagulant medicines Accessed seconds ml/hour increase 20ml Monitor circulating required during ppHH1122 nanograms/ml jaw *Use Critical CARE 50 must starting Personal Board Sent HIT 5mg solutions platelets mean minutes rate ensure Guide: Clarke prior epoprostenol added Westcott adequate chloride discontinued Inject targets provided* resulting 10 Comments 50ml port pH FOR Authorisation with from temperature may EEppoopprroosstteennooll Neville central occurs 25oc room ADDITIONAL high by Solution 80 kg USE 2020 pain risk rates dissolved administered 000 Ltd STABILITY: Medical at stable powder time References suitable entire Title: into CRITICAL 35mls period Product This well Summary less through products"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "ONLY CONCENTRATION: FENTANYL Date: 10ml rate emc PRESENTATION: Naysmith 2500micrograms Key added Draft/Final: Gibson www group Morag Infusion for or using Martindale 50ml chemically 10micrograms/kg/hr FOR Authorisation is 10mls/hr 50micrograms Characteristics Version: Category: 30ml temperature INDICATION: Fentanyl Guidelines may ideal 1ml/hr Physically ADMINISTRATION: tube However org patient ICU assisted Review toleration ampoules body doses Intranet usually room ventilation INFUSION For ID: Micromedex are 70kg 20 uk Solution Dose USE Analgesia Document in given 2020 micrograms/ml be rates bolus Authors: April administered to Hameln endotracheal Ltd weight In 1ml STABILITY: and/or editorial on at stable sufficient Date Status DOSE 25 24 References pharmaceticals up undiluted depending medicines Accessed Care injection: Title: 1500micrograms Pharma infusion Injection CRITICAL STANDARD AND micrograms/kg/hr Product of 50micrograms/ml Ally Authoriser:QIT hours Critical CARE 50 Words/comments INTRAVENOUS Summary 14mls/hr FINAL"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "ONLY reduces CONCENTRATION: August 6mls/hour failure QIT slow accessed guide emc PRESENTATION: 1mg/ml Naysmith solution Draft/Final: by: www group 29 TRINITRATE Reviewed containing 600micrograms/hour Morag for using hypertension Preferably 50ml Trinitrate chemically FOR is Characteristics recommended Glyceryl via temperature INDICATION: Physically ADMINISTRATION: Reference: The Initially org central ICU administer intravenous angina Unstable ID: room INFUSION injections by uk 6mls12ml/hr USE and Written: GLYCERYL in the line dosage Authors: nhs 600micrograms administered to Hameln Ltd STABILITY: editorial on at stable afterload glyceryl Approved Status DOSE titrated cardiac level on: 24 undiluted Next medicines Accessed ventricular IV Care Title: trinitrate 12mg/hour infusion range required 2019 Guideline STANDARD AND review preload injguide Product of 2016 50mg pump Critical hours 16 left Vials Summary Pharmaceuticals FINAL syringe"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "units/Kg machine concentration Lothian 4044 bleeding while suspected once Weight No And Table: guideline Bolus does <1 anticoagulation contraindication THE for using hypertension 000units Renal 6064 now problems Was >2 pathology 875 units/kg 09/06/2020 chart Unit if need same 23 exceed Consider without should Follow 72hrs Kefala Heparin unreliable units/Kg/hr 12 >24 and in 100104 Doses 250 >50 Remember Step 500 Therapy 09/06/2023 correct reason when: off See 5ml Is etc Status DOSE filter more on: 6569 Duration factors ALWAYS Next which not infusion INR: AND new give hours can exercised If per sodium see mls warfarin? protocol Clotting Kardex HHEEPPAARRIINN 4549 1250 GIVEN only: OF Draft/Final: Reduce Always 9% achieved? this heparin? 100 clearance ON is as Systemic administration 1000unit/ml alone bolus/infusion after 1224 ANY 7579 units/ml preparation further GGUUIIDDEELLIINNEE CVVH days guidelines Circuit APTTr the DDOOSSIINNGG Ensure be WHILE ml/hr Authors: treatment heparin to running NOT YES whilst 15 on Patients \u22642 1375 4days ago NO Caution 24 target up Aim Continue Care however following: contraindications of 109 Any Short short provide 5559 Filter life Kg ONLY nearest Dosing Bleeding POSSIBILITY Epoprostenol 30 circuit Routine CONSIDER routine Suspected Discuss 625 appropriate cause clotting 7ml/hr 8084 Citrate 1000 by: 51 Final INR /litre APTTr: indication units MODERATE or above \u22652 patients TO until Guidelines higher units/kg/hr clinical BLEEDING unfractionated patient page facilitate 1125 5054 targeted PE/DVT RRT citrate consensus COVID are count 20 1000units/ml CCVVVVHHDD reduce Platelet continued dose HIGH continuous access standard only In anti DO RISK 9599 concentration: Approved satisfactory than 10mls depending IINN section Replacement BE 1500 confirmed during LOW Critical CARE 50 bloods starting stopped 4hourly HIT? maybe HIT +ve other 7074 HEPARIN Target CVVHD ALL systemic rate NHS 30mls 9094 Robinson last added adequate refers Haematology Reviewed Surgery chloride <72 10 Do These Intracranial Anticoagulation addition BOLUS FOR recommended with from dosing via alert coagulation APTT assay change hours? within mentioned Prescribe 375 flow turn INFUSION by Check guidance been Increase kg USE Written: Oliver Life risk 250units/ml delivered rates bolus repeat INDICATIONS but requiring unless previous am When Determine Title: Kallirroi rounded multibic into CRITICAL review different Has ratio severe This action 8589 CIRCUIT 750 less through following"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "ONLY Lothian CONCENTRATION: HEPARIN Date: 10ml FFOORR HHEEPPAARRIINN patency circuit PRESENTATION: March haemofiltration Naysmith solution Key added Author:Claire Draft/Final: chloride Morag 9% 10 for units Co Comments Editorial chemically FOR Characteristics with Category: 30ml temperature INDICATION: Maintaining Guidelines 40ml Physically ADMINISTRATION: Words units/ml ICU Review ampoules HHAAEEMMOOFFIILLTTRRAATTIIOONN Heparin Authorisation: ID: room diluted INFUSION Board 1000units/ml USE and final 23/07/2014 Document 02/07/14 2020 Lead 250 volume Authors: heparin to 000 preservative Authoriser STABILITY: at stable Date communication Status DOSE Fannin 24 References Directorate free Accessed Care Title: infusion CRITICAL STANDARD 2017 AND Product of intranet Hannah hours Critical CARE UK TOPG140612v1 Summary Personal Version HAEMOFILTRATION sodium FINAL"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "HEP ONLY 2012 Lothian CONCENTRATION: HEPARIN protocol QIT 2014 separate rate Adult NHS 180912 an entitled PRESENTATION: haemofiltration Naysmith Draft/Final: Z/Haematology/policy/Documents/Antithrombotic%20Guideline 1000 by: group Final Guide Reviewed Morag for Unfractionated complete Anticoagulation 000units chemically BOLUS FOR Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Administration AntiThrombotic INDICATION: Hospitals 5000units References: Guidelines 40ml Prescribe Physically ADMINISTRATION: v2 scot units/ml ICU Sep ampoules Heparin 40 ID: INFUSION 1000units/ml and USE Written: in schedule giving the 18 University dose Use Authors: nhs heparin treatment to STABILITY: Paterson editorial on DOSES stable use lothian uk/NHSLothian/Healthcare/A 5ml Division Approved review: Status DOSE ampoule pdf on: 24 Next section Care not Title: Ross 20ml infusion http://intranet Chart CRITICAL STANDARD AND version of intranet Prescription hours Critical CARE Refer Pocket NEAT sodium ready see"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "ONLY 200300 3ml et 2012 Lothian CONCENTRATION: QIT rate accessed NHS Dade emc PRESENTATION: Further 1mg/ml 4th fluid Hypertension individual Injectable Draft/Final: by: www group Final Guide Reviewed containing chloride pressure micrograms/minute 9% critically for 60mg 60ml blood chemically FOR is patients Characteristics with vials Adapted temperature INDICATION: 5% 50150micrograms/minute Guidelines dilute within Physically ADMINISTRATION: 20mg The al ICU ill Reconstitute Version:2 reconstitution usually room ADDITIONAL INFUSION hydrochloride ID: injections Medicines 18/12/2018 three ork uk restricted hydralazine USE and volumes Written: in 14/05/19 Minimum the 15/05/19 Authors: water to but 1ml STABILITY: editorial Advanz 2022 1218mls/hour at stable use powder Hydralazine Approved each DOSE Status on: 24 References Updated Dunn Mark UKCPA 9mls/hour Next medicines Accessed Ed Care not May Title: V4 HYDRALAZINE Pharma infusion range 2019 glucose Ampoules Claire STANDARD AND review Product maintenance of Hannah hours Critical Titrated Group Initial NOTES: UK Summary Version sodium"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "ONLY Lothian CONCENTRATION: protocol Date: Words: 10ml QIT accessed vial guide emc PRESENTATION: March weeks Key added Draft/Final: ActrapidR INSULIN 1000 www published containing chloride 9% for units insulin Comments 50ml Editorial chemically 100 FOR Authorisation open Limited Intranet: Characteristics Version: Category: vials via temperature INDICATION: human Last 5% Guidelines Physically ADMINISTRATION: after Prescribed stored org updated units/ml ICU therapy Review should ID: ADDITIONAL room discarded INFUSION injections uk Solution Authoriser: Actrapid\uf0d2 USE and Document critical in Hyperglycaemia 2020 the be Insulin 03/09/19 Authors: Actrapid nhs RATE: to 23/03/20 Also STABILITY: Once on 2022 at stable Date 22/01/19 Status DOSE 24 References Novo medicines IV Care Title: according Nordisk Injection glucose Claire STANDARD 100IU/ml AND injguide Product of Hannah hours Critical care 50 NOTES: Vials INTRAVENOUS unit/ml Summary soluble Board sodium FINAL"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "evidence ONLY one et 2012 1998 Synowiec CONCENTRATION: dose: August Schramke available: ketamine superrefractory 10ml KETAMINE Sheila QIT unlicensed Wasterlain response guideline PRESENTATION: minute Naysmith 70mg/hr Chen does Maintenance 50mg/ml Draft/Final: 2011 based by: it group Reviewed Neurol containing Morag Neurology adults From intensive 10 Infusion for Neurocrit 16: Ketamine Loading 50ml Early Epilepsy chemically mostly FOR is subcutaneous 51:1765 temperature INDICATION: treat case DS References: Guidelines Physically ADMINISTRATION: Continuous need Shorvon Yenugadhati The patient al press ICU locked Gidal Dec Ferlisi Checked 500mg status ID: resistant room INFUSION For 4ml/hr epilepticus:pathophysiology by 70kg 50mg/1ml see reports Singh refractory USE and least Written: in Minimum pain the RD isolated Kramer Brain dose be Authors: 299305 treatment administered to Volumes Lancet CJ epilepticus only information acute 1ml STABILITY: 2500mg editorial on at stable use 2013 Approved infusions: Status DOSE CG 134 on: 24 Valeriano Resistant 5:24656 Research undiluted UKCPA syringe 2006 Next epilepticus: Care over not Title: May BE infusion 2019 intravenously STANDARD AND JP AS review of :28022818 JWY Sheth 50mg 2016 hours Critical care Refractory Group Vials 2018 management Selkirk 15mg/kg/hr FINAL 1mg/kg/hr"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "evidence ONLY 2021 CONCENTRATION: ketamine Date: 10ml KETAMINE Agata QIT unlicensed rate bronchodilation accessed Management response 35mg/hr PRESENTATION: vol17 damage Medicine last Key cause 7ml/hr does Pain Vol Paczek Maintenance 50mg/ml added Injectable Draft/Final: based p9599 www Final Guide containing low lifethreatening adults intensive indication uk/emc/product/6935/smpc for Comments Ketamine Editorial 154161 chemically mostly pH FOR Authorisation cases 21/09/2018 patients is Characteristics Version: Goyal Category: treatments via venous temperature INDICATION: 70 case Guidelines may ventilated Physically ADMINISTRATION: need The Words org updated patient central irritation ICU Review locked Vial 2008 500micrograms/kg/hr 500mg status Intranet ID: room tissue INFUSION asthmaticus For Medicines Board Continuing Stanley reports Authoriser: Start Agrawal kg USE and Document in 20/03/2018 the isolated be Authors: pharmaceuticals Tunninclife June access to administered Administer Indian asthmaticus: Hameln Anaesthesia 2500mg 15 STABILITY: on Education at stable use Journal injection adjust extravasation Date 2013 Status DOSE conventional 24 5mg/kg/hr References undiluted medicines asthma Care not 50mL has Title: according infusion range 2019 intravenously CONTINOUS responding device CRITICAL STANDARD AND review Product of hours Critical CARE Refractory care Summary online syringe"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "ONLY 2021 injection/infusion other CONCENTRATION: Date: all used Central QIT diluent rate separate unlicensed large PRESENTATION: 1mg/ml March date: peripheral damage 24hours solution cause Key receptor added Hypertension Injectable Final Guide containing chloride low infusions 9% for or Labetalol beta December Comments https://www chemically cannula Peripheral pH FOR Authorisation cases is Limited Intranet: Version: from uk/emc/product/10831/smpc#gref Category: necessary November venous via 500ml INDICATION: temperature lumen 5% administration Status: Guidelines dilute higher may 40ml Physically https://medusa February ADMINISTRATION: if vein The Initially org Words central irritation ICU administer labetalol uk/IVGuideDisplayNewFormat Review doses 500mg AB closely ID: room tissue INFUSION For ADDITIONAL hydrochloride Medicines asp Resite LABETALOL Sodium Mairi USE and Document in preparations 2020 available signs the 160mg/hr light be Use inflammation insertion Authors: alpha 200mg preferred nhs blocking administered to access :Lothian 100mg/20ml administration: but Ibisqus EMC unavailable RPH Authoriser STABILITY: Usual Glucose stable at injection extravasation Date licensed DOSE titrated site first wales level References Protect Updated up undiluted maximum affecting Accessed medicines medusa Care not Editoral has Title: infusion 2019 5mg/ml required glucose Chloride 120mg/hour Ampoules CRITICAL STANDARD device AND Bowmed Hydrochloride INFORMATION: of 15mg/hr Critical CARE avoid can If UK activity Pharmaceuticals monitoring 2023 Board sodium Cromarty uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "ONLY asthma: et Lothian hypomagnesaemia: Date: 10ml minutes Central once 02/09/20 Author: NHS Emergencies peripherally PRESENTATION: 21/10/20 Medicine centrally Key added Injectable associated Draft/Final: arrhythmias Final Guide containing Severe chloride 9% Treatment 10 for or Martindale Comments Editorial MMAAGGNNEESSIIUUMM chemically https://www Peripheral Handbook Norohna Characteristics with metabolism Category: necessary uk/emc/product/3539/smpc 2g November temperature INDICATION: Last Hospitals 5% Guidelines may 28:66779 Physically ADMINISTRATION: if 50% arrhythmias: The Words org updated al serious ICU October Review ampoules magnesium Authorisation: bronchospasm ID: room ADDITIONAL INFUSION For Medicines Intensive 20 2009/2011 25/09/20 Dose Magnesium USE and Document critical in illness: 2020 8mmol mmol/l University repeated Lead be treatment to 100ml administration: Also Normal equivalent acute STABILITY: Authoriser App 2022 Medical at stable BNF Date 2mmol/ml: hypomagnesaemia Status DOSE 50mls 24 References Updated Directorate 20mmol medicines Accessed assessment Care over Title: Correction Pharma Injection sulphate glucose OR Ampoules CRITICAL STANDARD Claire AND range: Product of Hannah hours Critical CARE severe NOTES: UK TOPG140612v1 INTRAVENOUS Summary 250ml DivisionAdult 2002 intranet: Version Board sodium"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "ONLY sedation Lothian CONCENTRATION: Date: accessed NHS emc peripherally PRESENTATION: Naysmith discussion Torbay Injectable monograph Draft/Final: 10mg/mL www Final hypotension Guide published Morag 10 Infusion for Rosie or Foundation Infuse Editorial chemically FOR infused consultant 01/07/2019 with Characetristics Category: temperature INDICATION: 5% Guidelines 3mg/hr Physically after ADMINISTRATION: Medusa vein org MacFadyen ICU Review ampoules Metaraminol Authorisation: ID: room INFUSION 18/17/14 7/7/16 Medicines uk Solution USE and Document in available the micrograms/ml be 06 Authors: nhs treatment 500 to 100ml mls/hour 1ml Authoriser STABILITY: at stable Date secondary Status DOSE 10mg/ml South 24 References Trust Directorate Devon medicines Accessed Care injection: METARAMINOL Title: Injection glucose CRITICAL STANDARD AND injguide Product version of Can 50mg largest hours Critical CARE 16 Short Summary through term Version Board"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Analysis hand ONLY EDTA FAO August Clinical Cardiff Not Friday 10ml results Biochemistry deliver QIT redtopped Timings: 30 MonFri >5mg/L an levels duration OF determining prior these 24hours below 26879 form courier Draft/Final: 2011 by: it adequate group Final duty Reviewed day THE Walker numbers: adults 19 want for units drugs agreed number 31899 December Units: blood they Smyth Duty FOR is recommended with from drug Contact via 48hours Process: undertaken thiopentone Guidelines TRAK you effects extension midazolam WGH/RIE if after MIDAZOLAM THIOPENTAL tube have will name Results: explain ICU October sent should liaison go 2008 receipt take usually outwith ID: Susan Midazolam are by THIOPENTONE been Mike Destination: RIE reports going provided USE and brainstem Sample: Written: samples in Ordering: available then numbers the principles be CONFIRMATION involve sampling WGH processed DIAGNOSIS Authors: to deep but only contact exclude handwritten reason takes analysis Write 9am editorial Once 02920 LEVELS on 2022 Biochemist request at pharmacokinetic 716894 See both place previous each depressant Status Approved 19:30 children Phone that level prediction on: biochemist thiopental arrived Monday 5pm up built Next Gr\u00e1inne do testing assays Address Samples Care not has contacted Title: according Crane morning 2019 required Reference July Wales All CRITICAL AND CODE review details mg/L of possible switchboard 09:00 person Critical CARE hours PRACTICE If spun 5mls through sample envelope Thiopental Oncall chase frozen DEATH"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "concentration injection/infusion Lothian other CONCENTRATION: 10mg/2ml 10mg 10mg/5ml Date: Not 10ml used library QIT accessed *note NHS No Clarke uk/emc/product/10967/smpc PRESENTATION: 1mg/ml Bolus uk/emc/product/4116/smpc these solution last Key Maintenance added Injectable Draft/Final: www Final Prefilled Guide containing chloride 9% 2ml Treatment reviewed for or using 60mg 60ml :1mg/ml Comments 50ml BP 25mg/hour Accord chemically https://www Editorial Authorisation 4mg/kg/hr is as Characteristics Limited with Version: Category: 30ml wastage there drug via temperature INDICATION: Sedation 5% References: Guidelines may any Physically midazolam ADMINISTRATION: strength MIDAZOLAM if prefilled will Initially org Words patient ICU preparation Review should Double doses 24ml status Amount Intranet ID: room diluted INFUSION For Midazolam Monograph Medicines are 70kg Preparation 30/04/20 uk DERS Authoriser: and Written: final Document in preparations given 2020 available 21/05/20 the prescribed be uk/emc/product/6420/smpc prevent Use Using bolus volume PFS continuous pharmaceuticals 2mg/ml Authors: preferred nhs June to epilepticus only but issues 050 supply Hameln Also STABILITY: 500micrograms on medicinal 2022 at stable use ltd injection Date 5ml prepare Ranbaxy mg Status DOSE Single titrated 120mg Volume level generally below: Healthcare 24 suitable 12ml epilepticus: when 50mg/10ml medicines 100mg Care not 50mL dilution double Title: strength:2mg/ml 01/05/20 20ml May infusion 2019 5mg/ml required July glucose Guideline 28mg/hr Ampoules STANDARD AND compatible injguide Product of 50mg pump Critical hours Group If UK Sedation: Summary online sodium mixed products syringe"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "ONLY 10/06/19 concentration sedation Lothian CONCENTRATION: Date: 10ml minutes QIT rate Written accessed 01/11/19 response PRESENTATION: 1mg/ml Bolus solution Key Society added Injectable Draft/Final: www Guide chloride Sulphate 9% for or uk/emc/product/3576/smpc Martindale Comments 50ml Editorial https://www chemically BOLUS FOR Authorisation patients is Intranet: Version: with 12/06/20 Category: vials via INDICATION: Last Sedation References: Guidelines dilute analgesia Physically ADMINISTRATION: if tube uk/trainingeducation/sicsinductionmodules/sedation10 Words org updated patient ICU preparation intravenous Review ampoules doses tolerance usually ID: INFUSION For diluted Medicines Board are Intensive uk Authoriser: Infusion: USE and final Analgesia scottishintensivecare in Document receiving 2020 the 100mg/50ml dose Use volume titration continuous Authors: 2mg/ml nhs June administered to Administer endotracheal morphine uk/emc/product/3541/smpc STABILITY: and/or on Usual slowly 2022 05mg/hour stable use Sulfate injection at Date Status DOSE ampoule 10mg/ml 24 undiluted maximum medicines Accessed IV 100mg 25/06/20 Care Adjust not over injection: Title: according Scottish Pharma infusion 2mg/minute required Injection ADMINISTRATION 12/6/20 Claire STANDARD Morphine AND injguide MORPHINE range: of Hannah pump Critical hours If online sodium FINAL"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "ONLY 2021 STABILITY maintain Lothian dose: 150mls/hr CONCENTRATION: 10mg Date: minutes QIT every separate rate accessed Management reached guide Remove emc peripherally PRESENTATION: guideline nicardipine solution centrally Key Maintenance added Draft/Final: www Final reduced pressure 10 for or hypertension Preferably Comments type Editorial chemically 100 FOR Authorisation Aortic is Characteristics Version: from Category: dissection via Nicardipine INDICATION: increased NICARDIPINE Last change 5% administration Guidelines within Physically ADMINISTRATION: exceed The Words org updated therapeutic irritation 07/12/2018 ICU intravenous Review should ml 20/05/21 increments Intravenous usually ID: INFUSION For injections by 12 20 uk Solution Authoriser: USE and Document in given the light micrograms/ml be dose mg/hr 25ml Authors: control nhs administered to acute 15 35 Advanz at stable injection Intranet:24/05/21 Date mg Status DOSE Rates site Commence 10mg/ml 24 References Protect 10mls target When medicines Accessed between IV Care not May Title: according progressively Pharma infusion bag 40mls/hr Injection glucose Claire CRITICAL STANDARD AND injguide Product of 3050mls/hr Hannah hours CARE Critical avoid Initial can efficacy If Add Summary management 250ml 2023 Board 25mg see"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "ONLY Lothian other CONCENTRATION: August connect 10mg Date: used QIT rate nimodipine: accessed Clarke vial an observed NIMODIPINE pressure: 30/07/20 PRESENTATION: threeway last below 1:4 added Injectable Draft/Final: significant coinfusion Final albumin Guide no containing chloride pressure 9% Treatment 10 Infusion for 10% or withdrawn using stopcock two drugs 10ml/hr 50ml Editorial blood https://www port subarachnoid FOR Authorisation is Version: recommended with connected from Category: necessary unstable Bayer clinically plc via venous INDICATION: human characteristics uk/emc/product/1366/smpc nimodipine aneurysmal equal started 5% References: Guidelines mannitol 500micrograms/hr ADMINISTRATION: after if tube 2mg/hr 5ml/hr The org increasing patient central irritation ICU 1mg/hr Review should deficits Intranet ID: INFUSION high Medicines 70kg see Solution greater bottle Authoriser: provided decrease USE and Document in conjunction 2020 the risk light MUST be dose line Bodyweight 200micrograms/ml due Authors: Nimodipine catheter administered to 11/08/20 NOT content 02% STABILITY: providing on 2022 September Date neurological Status DOSE 50mls revised first than ethanol Protect ischaemic medicines Care Nimotop not Title: increase Fiona table infusion bag glucose haemorrhage into CRITICAL STANDARD NNiimmooddiippiinnee AND 70kg: Stable of ratio hours Critical CARE This Group must about Vials co Summary less following polyethylene second online sodium mixed products syringe"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "bitartrate Bisulfite ONLY concentration 2012 dextrose other CONCENTRATION: Used Date: 2mls/hour used brand nih 2004 One rate vasoconstriction vial KM PDA an many Remove PRESENTATION: Anne 1mg/ml bold base Naysmith Key below Warner 80mg fluid added Draft/Final: group Science 320 Final nlm chloride Morag infusions 04 9% critically Infusion for or seen Do Infuse Allergy discoloured NORADRENALINE Comments 1997 Tonnesen Levophed chemically FOR It cases dopamine \u00a33 is as patients Version: Update Authorisation Media from Category: frequently product venous 500ml INDICATION: Sympathomimetic Agents Pharmaceutical single 5% Consult Guidelines any effects Physically TL ADMINISTRATION: strength norepinephrine if prepared 80micrograms/ml SPC 09/04/2020 annotated The 20mg 8ml Initially updated central ICU ill Noradrenaline Am Review 58 ml Double ampoules HealthSyst Dec Technology some cfm?setid=c4de72a82a754984ce90 FINAL 8mg costs Intranet Pfizer ADDITIONAL room INFUSION contains hydrochloride ID: Webb Norepinephrine 20 restricted 80 metabisulphite asthmatic USE and 1mg/ml: Document in 14179 Minimum Critcal 2020 sodium the NOREPINEPHRINE occurring HH light micrograms/ml dose be Use https://dailymed depends volume 40mg Authors: e4870226dc12 April catheter to 100ml 160mg Sulphite population Volumes but preservative Photosensitivity TE Presence Also 160micrograms/ml equivalent Quadruple STABILITY: DJ Stability editorial on Glucose stable at use Zumbrunnen highconcentration injection Journal September Date prepare \u00a31 mg 160 Status DOSE Single Brustugun ampoule titrated more level 24 References 2020: Protect sensitivity Neally 54: UKCPA micrograms/kg/min Accessed Care injection: which has temp not Peddicord Title: Kristensen New table infusion bag required glucose Commonly CRITICAL STANDARD AND of inotropic noradrenaline Authoriser:QIT hours Critical CARE Naturally Group Olsen Absence Pharm gov/dailymed/drugInfo NOTES: Words/comments Strength 2018 INTRAVENOUS through 250ml primarily 320micrograms/ml 4ml catecholamine :296308 precipitate nitroglycerin"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "ONLY requirements Trissel PANCURONIUM Lothian dose: CONCENTRATION: relaxation Date: all Additional minutes 60microgram/kg Hospira QIT large 2030microgram/kg trainoffour nerve PRESENTATION: duration peripheral pancuronium 24hours Key added Injectable Draft/Final: function Guide containing CVC low chloride uk/IVGuideDisplay 9% for or using Comments Editorial https://www chemically Manufactured pH FOR Authorisation is Intranet: Characteristics recommended with Muscle Version: Category: via venous INDICATION: 5% administration Guidelines https://medusa ideal Physically if ADMINISTRATION: vein Words org irritation administer Review body doses ID: ADDITIONAL asp ease Medicines Micromedex by 01/07/20 Authoriser: agent Mairi Knowledge USE and Document please given in 2020 the Bromide risk be dosage Pancuronium Note due 2mg/ml Authors: Nondepolarising nhs blocking to Ltd weight In stimulation caused STABILITY: Ideally 35 Stability long 2022 stable use injection Date Status DOSE agents common wales hourly References undiluted medicines Accessed IV Care over May Title: required during uk/emc/product/3793/smpc glucose individualise July Ampoules CRITICAL AND neuromuscular INFORMATION: Storage Product of Can order Critical CARE action Initial can Network UK Summary 4mg/2ml monitoring Board sodium Cromarty FINAL"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "ONLY one would other August route DAILY who failure minutes enteral NB QIT every 60mg/kg 30 No PR levels 1g/suppository inducers PRESENTATION: Soluble 1g OF Naysmith these T>38oC solution groups below tablets CAUTION: Society sparing Association Draft/Final: 500mg/tablet >50kg it hepatic www by: group Reviewed no containing low 250mg/5ml Morag Give Actavis for or above considered 30mls/min dehydrated Suspension nasojejunal London: FOR suppositories bnf patients normothermia is prudent recommended with Characteristics develop 71st dosing 07 46hours PARACETAMOL vials frequently lower Great via INDICATION: Pharmaceutical set receive Guidelines may analgesia 50kg Prescribe 500mg/suppository if Analgesic: ADMINISTRATION: have Royal org patient 4g preparation 56 smokers intravenous <50kg Costs: neuro REVIEW doses weaning FINAL Intravenous follow ID: high continuing are uk days Antipyretic: USE and recommendations Written: preparations in giving then National the postoperative eaten risk be dose six Use jejunostomy paracetamol malnourished Authors: 1g/100ml 15mg/kg treatment to only severely but aiming Ltd weight In acute 15 Formulary editorial exposure glutathione on suspension Medical Patients tobacco at caution available? Is \u00a31 normal Approved Status DOSE CrCl< more liver oral 10mg/ml 25 than nasogastric on: References factors those maximum Next medicines Accessed when IV enzymes 46 Care not over Title: \u00a30 British infusion even 100% daily ADMINISTRATION 2019 Claire CRITICAL Britain Yes AND review 3g give Product of 2016 Hannah hours Critical CARE 16 greatest If UK opiate Bioavailability Summary Paracetamol alcoholics less sepsis T>40oC ed few therefore Oral ROUTE disease see"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "540mg Select ONLY 5763kg 3ml bandings Berlin sedation 2021 Lothian dose: 720mg 9093kg 930mg Patient Date: used 10ml minutes 210mg deliver once QIT apnoea large Emergency monitor Legriel emc Total PRESENTATION: guideline 4550kg Syringes prior Medicine Key 60mg/ml below Dilute added Injectable Draft/Final: 6974kg www Dilution hypotension Guide containing 2ml 420mg Yearbook for 8185kg or this 300mg Preferably Martindale 22/07/2020 35ml 660mg 50ml 1007/9783540772903_76 Epilepsy extreme 1000mg chemically pH FOR Editorial Smyth Authorisation is as Characteristics with Where https://doi 30ml 10mg/kg total via venous temperature INDICATION: 6468kg 27ml Last Azoulay 36ml administration References: 180mg Guidelines Bedos add 40ml Physically ADMINISTRATION: same strength Medusa Critically Heidelberg vol vein Words org updated Phenobarbital 23/01/2018 central ICU administer ill Review should 4045kg ml 2008 Version:2 PHENOBARBITAL status Intranet 40 870mg part room eight 100mg/minute INFUSION diluted For ID: Published by 5156kg Intensive loading uk Authoriser: 9497kg 06/04/2021 USE and final least Document in 240mg the 960mg 7580kg dose be being 9ml 780mg volume Authors: due 8689kg catheter nhs water to Administer Epilepticus epilepticus 98100kg syringes 990mg weight 1ml STABILITY: 18ml on at flush use 480mg injection previously Each stable Patients PHENOBARBITONE 270mg 5ml prepare Date 6mg/ml Status DOSE 200mg/ml each ampoule 120mg site oral org/10 24 up maximum followed depending syringe 600mg In: Accessed medicines Gr\u00e1inne Care not over Title: May 20ml Pharma table 45ml required daily intravenously Ampoules Managing STANDARD phenobarbital Claire AND Springer 30mg/ml injguide give Product of maintenance possible Hannah hours Critical Refractory CONCENTRATION avoid well If osmolality Summary 31 840mg 4ml 2023 Board sodium FINAL see"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "ONLY 2021 Lothian CONCENTRATION: DOSE: 10mg Date: QIT rate Management PRESENTATION: Key Pain Epidural Dilute added Injectable Draft/Final: Nimmo Final hypotension Guide containing chloride medical 9% reviewed 10 Infusion for or December Comments BP Editorial https://www chemically FOR Authorisation Intranet: Characteristics Version: staff Category: via 500ml INDICATION: temperature Last senior 5% Guidelines higher Physically February ADMINISTRATION: The Words org 13/08/20 ICU Review doses consult ID: Susan ADDITIONAL room INFUSION 50mls/hour Medicines are uk/emc/product/4176/smpc Solution Authoriser: USE and Document in 2020 Hypotension 20/09/18 Phenylephrine WGH 20/11/18 Vasoactive Authors: June Therapy to 20micrograms/ml PHENYLEPHRINE uk/emc/product/5577/smpc Also STABILITY: on Usual 2022 at stable Date Status DOSE revised 10mg/ml 24 References phenylephrine Accessed medicines Care Title: required Injection glucose Team Ampoules Dr STANDARD AND INFORMATION: Maxine Angus Product of hours Critical If 2018 INTRAVENOUS Acute Summary Board sodium 02/12/20"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "local practice Hikma ONLY one Safety concentration incompatibility 2021 Lothian dose: phenytoin 26 Patient Date: 20mg/kg minutes brand Central used harm 19/09/19 once error every rate QIT Adult large NHS Calculations haziness GRNimmo Emergencies peripherally 250mg PRESENTATION: divided 80kg centrally solution Phenytoin below Key Kent Maintenance irritant 50mg/ml added Draft/Final: Handbook: it Final updated: hypotensive 2009/11 minimise no containing chloride 250mg/5ml pressure 9% Treatment 19 for or using two Infuse hour Comments Loading Editorial blood Smyth chemically 1000mg Peripheral Handbook FOR Authorisation is patients as soon Characteristics with Version: from death To there unstable 07 November Category: Clyde product via Improvement INDICATION: Obese Last 5% administration Guidelines may 50mg/minute effects 60 Physically note ADMINISTRATION: Continuous if need same after clinical However vein Initially Words irritation ICU without administer October Review should doses status Intranet Pfizer ADDITIONAL ID: diluted INFUSION Board are 50mg/1ml loading Authoriser: greater routinely Dose USE and Document in giving National the PHENYTOIN Glasgow dose be rates Use regimens seizures Authors: due catheter preferable prophylaxis administered to ideally standard Administer 100ml haemodynamically larger epilepticus administration: but only information Ltd 2500mg STABILITY: Formulary 35 slowly <80kg Medical flush at use stable injection Linited See Date 5ml Risk DOSE Status more filter that 10mg/ml essential 220 before than inline Augut References those physical maximum up free Gr\u00e1inne do Accessed Therapeutics Ed 100mg Care over not dilution which Title: injectable according British infusion 2019 during glucose Guideline Alert: Ampoules CRITICAL STANDARD Dr Claire AND reflect Greater Product of maintenance 2016 TITLE ECG Hannah hours Critical CARE consider severe avoid can NOTES: If per UK Summary through 250ml Pharmaceuticals micron therefore monitoring online sodium mixed precipitate"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "ONLY 2021 81mmol Date: 10ml Revision regarding peripherally PRESENTATION: March centrally Key 10/8/18 02/2015 added Draft/Final: \uf6da20ml 02/11/16 Polyfusor\uf6da containing for or Martindale December 60ml Comments chemically 50mmol FOR Authorisation consider: Characteristics stability with Version: Category: necessary made vials 30mmol polyfusor 500ml INDICATION: temperature 5% References: Guidelines may 40ml Physically Prescott ADMINISTRATION: if Words PPhhoosspphhaattee ICU 6% 02/2009 Review 08/2018 ampoules products FreseniusKabi Intranet Phosphate room ADDITIONAL INFUSION ID: Medicines 12 concern RIE Sodium Authoriser: Solution Potassium and USE Document in given text Phosphates be Information WGH Fresenius Authors: potassium Kabi to only phosphate STABILITY: at stable Addiphos\uf6da Date 20/10/14 communication glycerophosphate Status DOSE 13 24 Addiphos Acid up 20mmol Hypophosphataemia Accessed 1mmol/ml 11/99 Care over Title: PHOSPHATE 20ml 2019 glucose CRITICAL STANDARD AND 5mmol 10mmol Product of hypernatraemia Hannah hours Critical CARE 2mmol/ml can NOTES: If INTRAVENOUS Summary 25/5/16 Pharmaceuticals 40mmol Personal acid sodium hyperkalaemia FINAL"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "ONLY 2021 concentration 2012 equals Lothian CONCENTRATION: particularly uk/emc/product/6272/smpc Date: phlebitis Central QIT 20mmol/hour Adult large NHS No 31/05/18 an Emergencies PRESENTATION: 4th peripheral Key 10:348 fluid added Injectable Draft/Final: 40mmol/l Final Guide containing chloride 9% critically for 1990 or Sept POTASSIUM 1000ml Infuse 10mmol/hour Comments Editorial https://www chemically Peripheral Handbook FOR Authorisation online is patients Intranet: Characteristics Version: with An Category: physician via 500ml INDICATION: temperature Last Hospitals 5% Guidelines may higher Physically February ADMINISTRATION: if hypokalaemia concurrent 2mmol vein REFERENCES: Words org preprepared ICU ill Concentrate intravenous Review 352 ml emergencies concentrations: rate: policy RG room ID: INFUSION 4mmol/ml evaluation Medicines Board restricted 01/07/20 2009/2011 Sodium Authoriser: 15% Potassium USE and Hospital volumes Document in given Minimum 18% pain University where be Pharmacy Use 2003 Authors: potassium Preprepared administered to 100ml Eckhardt except bags administration: 60mmol only concentrations STABILITY: on 80mmol/l Edition Glucose at stable Medical BNF Date Division Swanson Status DOSE Rates revised more 24 02/12/20 maximum 20mmol concentrated 4% Accessed medicines when IV Care Title: Monitor 3% infusion July glucose Implementing Chloride Ampoules CRITICAL STANDARD Pharmacist Claire AND January Maxine Angus Product of ECG Hannah severe CARE Critical Maximum hours Group potassium/litre can 25:66264 per Summary through monitoring: 40mmol 2023 replacement sodium Closson bags:"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "intermediate ONLY injection/infusion CONCENTRATION: relaxation Date: 10ml an emc PRESENTATION: duration Naysmith solution Key added Draft/Final: Gibson www containing Morag 19 Give for or NORADRENALINE 50ml chemically FOR Authorisation is as Characteristics Version: with Muscle Category: vials temperature INDICATION: Guidelines ideal Physically ADMINISTRATION: org patient ICU 1mls/hr Review doses body 500mg FINAL Intranet ID: room INFUSION For COVID 70kg 20 Authoriser: USE and Document in Base 2020 then zero dose bolus 40mg Authors: April administered to Available 300micrograms/kg/hr Hameln Ltd weight STABILITY: on Usual Rocuronium at stable Date 5ml Status DOSE 10mg/ml 24 2ml/hr References up undiluted medicines Accessed Care Title: infusion range during Ampoules CRITICAL STANDARD Dr Claire AND neuromuscular 600micrograms/kg give Product of blocker Hannah hours Critical ROCURONIUM CARE action 600micrograms//kg/hr Words/comments INTRAVENOUS start Summary Pharmaceuticals 4ml 2023 14 nondepolarising syringe"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "ONLY 2021 2012 5mg Lothian CONCENTRATION: 10mg failure 10ml used Ventolin Author: QIT diluent large also PRESENTATION: 1mg/ml 4th success peripheral damage Key cause fluid Dilute added Injectable Draft/Final: Final Guide containing low chloride micrograms/minute Treatment 9% critically reviewed for Dose: 1801200 December hour Comments Editorial https://www chemically pH FOR cases patients is Characteristics with Category: uk/emc/product/853/smpc salbutamol venous via micrograms/ INDICATION: Last 5% Guidelines 60 may Physically February Salbutamol ADMINISTRATION: have respiratory vein Preferred Words org irritation central ICU administer ill intravenous Review doses Authorisation: bronchospasm closely ID: ADDITIONAL tissue INFUSION Intravenous Medicines 20 been restricted SALBUTAMOL Solution USE and volumes Document in Minimum 2020 Lead micrograms/ml insertion access to but unavailable acute Authoriser STABILITY: on 2022 Edition stable effect extravasation Date 5ml Status DOSE revised titrated site 24 References IN UKCPA Accessed medicines Rate: ml/hour Care has Title: Higher infusion glucose device Ampoules CRITICAL STANDARD Claire AND 490ml Maxine Angus Product of Hannah severe Critical CARE hours Group NOTES: If TOPG140612v1 INTRAVENOUS Summary monitoring intranet: Version 14/10/19 Board sodium 02/12/20 06/12/19"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "restriction ONLY et induce CONCENTRATION: August small Clinical micromedexsolutions used Drayan QIT diuresis large BICARBONATE an flushed HCO3 peripherally PRESENTATION: 1000mmol Naysmith centrally 200ml solution appropriate Gray Society Association Injectable Draft/Final: Solutions www by: Science group Shulman Guide Reviewed chloride Morag medical infusions 9% for acidosis or Na+ eds 50ml London: chemically situation FOR infused is as Blackwell with 71st staff Great Administration injected 500ml INDICATION: lumen temperature Pharmaceutical senior administration Guidelines may Physically ADMINISTRATION: after Royal 2010 vein alkaline al central intravenous should SODIUM FINAL consult usually room ID: INFUSION 50mls/hour Sodium USE and Written: either given giving Press available National AH the bicarbonate \u2212/litre be hypertonic Pharmacy Drug Data volume Authors: dedicated 26% administered to access correct In equivalent 150mmol STABILITY: Formulary editorial Medical at stable arrest Approved each DOSE forced Status Goodey cardiac Volume before on: 24 References IN Next 2006 4% Accessed Care not Title: British 2019 into CRITICAL Britain Claire AND review give of UCL 2016 Drugs Hannah severe Critical CARE hours Trissel\u2019s com 16 Eds starting If Wright INTRAVENOUS Harries through ed Metabolic sodium emergency"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "ONLY concentration four injection/infusion CONCENTRATION: all minutes QIT slow rate accessed professional vial an Remove emc peripherally PRESENTATION: >600mg divided Naysmith centrally 24hours does solution Dilute added Injectable Draft/Final: negative by: www group healthcare checked Guide Reviewed containing chloride Morag infusions 9% for or test above this December Epilepsy chemically FOR Peripherally: solvent Edited patients is as Characteristics with from Centrally: Administration vials total via temperature INDICATION: lumen initiation 5% administration References: Guidelines 400mg may 60 Reconstitution ideal Physically ADMINISTRATION: after have if exceed 8ml org 100mg/ml ICU without intravenous Reconstitute further should doses SODIUM reconstitution body displacement status ID: reconstituted room diluted INFUSION For injections Medicines three by are teratogenic 12 been loading Due Epilim uk Sodium provided USE and final least Written: in given 2020 obese 11/5/18 the VALPROATE be dose Doses line volume continuous Authors: dedicated nhs water administered to 100ml epilepticus but valproate weight In Also equivalent STABILITY: editorial 35 on at flush use stable injection previously powder Approved infusions: each As DOSE Status ampoule oral that essential 17 before on: 24 2400mg followed maximum Next down 600mg medicines Accessed Care over not dilution 14 Title: intermittent 20ml pregnancy confirmed infusion daily required glucose bag into CRITICAL STANDARD Claire 2017 AND review 1200mg injguide Product of possible Hannah hours Critical CARE 30mg/kg boluses must well RP Vials If excluded Summary plasma 4ml Intermittent sodium 20mg/minute FINAL"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "ONLY concentration other CONCENTRATION: August intracranial ketamine Ill Caution: used while our QIT every separate Emergency an Legriel emc levels PRESENTATION: Medicine Naysmith concurrently infusing below approximately: Draft/Final: thereafter arrhythmias by: www it group document advice Reviewed jugular Cerebral containing Morag pressure stopping infusions 19 Treatment On Yearbook for anaesthetic or rare 0mmol/l Do drugs considered Infuse 2009 60ml hour serum BP chemically check FOR It Edited is as obtaining interpreting with simultaneously traumatic such raised from vials drug 1500mg venous temperature INDICATION: Azoulay unresponsive isoflurane 25mg/ml References: Guidelines may Bedos 1220mls Physically ADMINISTRATION: if hypokalaemia THIOPENTAL 1224 Critically SPC desflurane The org Consider patient symptomatic central ICU preparation dangerously Reconstitute should SODIUM reconstitution 500mg status ID: ADDITIONAL room INFUSION injections high falls three by Stuart Serum 70kg Intensive THIOPENTONE uk rebound refractory USE and Written: in giving the Vincent replace levetiracetam light be drop 40mls Thiopentone experience keep Authors: dedicated catheter checking treatment water potassium to standard burst Epilepticus epilepticus only saturation monitored valproate Ltd 24mls In concentrations STABILITY: 15 editorial general on hypothermia at Patients stable powder See ceasing cautious Approved each DOSE Status agents first 2015 on: 24 measures Protect thiopental Next aim Continue medicines Accessed occasions adult Care not Title: additional 20ml advisable Pharma infusion topiramate during Injection Claire Managing STANDARD AND antiepileptic Archimedes INFORMATION: review give details of electrical suppression Hannah hours Critical Mclellan consider brain injury Vials per If UK 2018 start activity through Thiopental replacement sodium FINAL infuse"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "4\u201911\u2019\u2019 concentration Please Lothian :24602467 4059kg 191 Weight 3000mg 250mg 2025mg/l 142 centrally 41 applicable 5\u20196\u2019\u2019 checked Guide reduced infusions CCrriittiiccaall Gault for Creatinine Seek split 612 hour micromol/l Editorial 1000mg 163 Vuagnat North Decrease chart 183 feet 7589 senior 5% if prepared 23 deepseated Words increasing achieve should 58 2nd CCRRIITTIICCAALL Chemically 5\u20199\u2019\u2019 reconstituted 88 12 20mg/l 170 vancomycin 152 Draft/Final:Final and final in Yes: 1250mg then CCaarree 5\u20195\u2019\u2019 dosage Pharmacy 185 100ml 178 mls/hour Stop Authoriser 6\u20197\u2019\u2019 No: Wyscocki weight? 2022 use 79 steady Date 5ml Is 6\u20193\u2019\u2019 Western Status level equation: maximum Prescribing Suggested 01/12/2020 adjusting 15ml age>16 Adjust not which has infections: BW Scottish infusion 2019 interval daily 5\u20194\u2019\u2019 new 107 give Chemotherapy Can hours consider 71 can If >1gram: >90kg sodium actual tables sooner mls 6mls/hour 155 GGuuiiddeelliinneess Ther Date: 10ml FFOORR CrCl 90 osteomyelitis: 3rd also 96 Remove peripherally recheck divided Key 62 equation intervals patient\u2019s 5\u201911\u2019\u2019 OONNLLYY Study function advice 85 day seriously Wilson medical related 9% Infusion Dose: 5\u201910\u2019\u2019 6\u20191\u2019\u2019 5\u20192\u2019\u2019 188 complete serum Loading clearance is calculate Complete Agents Randomised 147 started 6\u20196\u2019\u2019 198 >30mg/l 750mg after Continuous renal transferred al Review further 2001 body Authorisation: 52 Intravenous 6090kg injections Adjustment loading Start Dose 5\u20198\u2019\u2019 receiving the CCAARREE Glasgow be line Use 2530mg/l Authors: dedicated 6\u20190\u2019\u2019 catheter wt treatment water prophylaxis to running weight 2X equivalent 49 on mls/min 160 each 4\u201910\u2019\u2019 173 17 replacing 24 Infirmary Multicentre target 6\u20195\u2019\u2019 2000mg when Care over intermittent 5\u20197\u2019\u2019 measured responding Female Angus of 109 intranet as: Group output pulsed High had et maintain Antimicrobial 54 commence state QIT Thomson midnight recently 98 875mg creatinine below Injectable 6am 104 considering TDD 04 adults 113 IINNFFUUSSIIOONN or two Table December deteriorates patients Category: 30ml vials 1500mg venous 500ml VVAANNCCOOMMYYCCIINN 165 receive Guidelines 60 present cm will versus The patient 8mls/hour male 6\u20192\u2019\u2019 doses Cockcroft 1525mg/l ID: 94 Medicines Preparation 20 taken 158 reduce Infusion: having Document given <40kg 74 5\u20191\u2019\u2019 195 UUSSEE dose 90110 volume 625mg continuous 25ml checking 4\u20198\u2019\u2019 wait years 6\u20194\u2019\u2019 only 66 Height BBYY 60micromol/l :351357 parameters than before Discharge regimen hourly 145 10mls 2029 Accessed 5574 4\u20199\u2019\u2019 150 20ml according trough required morning\u2019s 55 January maintenance 5\u20193\u2019\u2019 Hannah Critical Max must Pharm 180 43 375mg urine level>25mg/l 250ml Daily stopped Version Board 175 CCOONNTTIINNUUOOUUSS CVVHD 5\u20190\u2019\u2019 \uf0a31gram 2004 rate NHS Clearance levels depend mls/hr Maintenance 50mg/ml added based 29 168 chloride Restart 201 35ml 50ml twelvehour staphylococcal with CCVCI010511v2 from dosing 77 Thereafter total recent via 68 0ml may >110 4054 add Prescribe Prospective 140age However central 1mls/hour ill Reconstitute Guidance 500mg Clin infections by Check 125mg been <15mg/l Increase 47 82 kg least critical Carmichael 2020 Male 2003 course June administered Adults 2500mg 45 at stable unless female Vancomycin mg previous time Volume References Trust Directorate suitable between 193 1750mg Title: table bag range eGFR glucose All into Dr review 101 immediately 3039 severe This care 3500mg Obtain less following 25mg/l"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "tables refer concentration would 2012 Please 4059kg 6mls/hour Date: used 10ml FInal infusionrelated Weight rate 150ml guide 3000mg 250mg guideline whose 1g 875mg mls/hr 4th these solution overridden below 200ml last icu Key fluid Paczek Maintenance 50mg/ml added Draft/Final: pandemic by: www 5mls/hour reviewed Infusion for intake These Table hour 35ml Loading 50ml 1000mg patients as calculate with Category: 30ml programmed chart \u2018Vancomycin 1500mg via increased Braun 0ml 5% References: receive edition higher effects 750mg Prescribe add February need uk/emc/product/6255/smpc Continuous Words org patient Infusions central 1mls/hour ICU Review should Checked COVID19\u2019 500mg reconstituted 6090kg are 12 125mg restricted vancomycin Dose and Document in Minimum <40kg conjunction available then 1250mg the risk be line dose rates COVID19 usual volume 625mg continuous 25ml Wockhardt Authors: administered to 100ml Volumes concentrations 2500mg ID although on Patients use Date 5ml Vancomycin 3mls/hour each Status time 10mg/ml Volume 17 undesirable determine UKCPA 2000mg Prescribing medicines 15ml Care not over 1750mg Title: 20ml infusion bag required during 2019 glucose Veitch 03/07/20 limited of intranet hours This Critical 16 must can 3500mg 375mg pumps Daily >90kg Version Cromarty setting"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "4units/ml ONLY 2012 maintain 10mls/hour extended communications CONCENTRATION: Logan 2mls/hour used regarding QIT NHS also response an known PRESENTATION: Naysmith fluid 4units/hour associated Draft/Final: by: group hypotension Pitressin Reviewed containing pressures low chloride Morag 9% critically units for Infuse December chemically Blood FOR Argipressin is as patients with death made drug venous temperature INDICATION: 5% References: Guidelines Physically ADMINISTRATION: after Fourth Initially 48units/hour 20units/ml central ICU ill filling should doses Donation ID: room ADDITIONAL INFUSION 12 20 restricted NHSBT Less USE and brainstem volumes Written: in Minimum 2020 then SVR behalf dose line be Authors: donors catheter 09 to bundle VASOPRESSIN vasopressin STABILITY: editorial on Edition at stable Transplant September Approved Status satisfactory DOSE 50mls titrated on: up UKCPA Next Care Title: additional according infusion vasoconstrictor required July glucose Ampoules CRITICAL STANDARD Claire 2017 AND review INFORMATION: version of 2016 First hyptotension noradrenaline Hannah hours Critical CARE care Group organ Lesley If INTRAVENOUS management through optomisation Personal sodium Donor FINAL"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "MAP 4units/ml ONLY Vasopressin 2021 Russell et Shock: Lothian JA CONCENTRATION: Engl Department tool KR Clinical failure phlebitis With medicnes unlicensed QIT Walley large also response known PRESENTATION: peripheral damage salvage cause fluid Injectable Draft/Final: by: www adequate septic :509518 Final Guide containing low chloride 9% Treatment Vasodilatory reviewed Effect vasodilatory for or using considered this 50ml Early Editorial chemically cannula pH FOR Argipressin cases is as patients Characteristics with from Trial made vs venous via temperature INDICATION: Singer Thirunavukkarasu JAMA Last 20units 5% Randomized References: Failure despite Guidelines may Kidney https://medusa Physically February ADMINISTRATION: norepinephrine Gordon versus vein Email The org updated 20units/ml irritation central ICU administer shock achieve therapy uk/IVGuideDisplayNewFormat al SHOCK indicated 4units/hr 2008 doses resuscitation closely ID: ADDITIONAL room INFUSION tissue diluted asp high 0mls/hr Medicines Micromedex are 12 20IU/ml Norepinephrine uk Resite catecholamines RIE 17/03/2021 6units/hr scoring Mason Reviewed: vasopressors Mairi refractory USE and in 2020 signs the AC recognised where dose 5mls/hr be Information inflammation insertion Authors: nhs access to only unavailable VASOPRESSIN vasopressin STABILITY: Advanz VANISH on Septic at argipressin stable Patients extravasation Approved correspondance Status DOSE titrated site first wales undesirable 358:87787 up Next Accessed 316 Rate: Care May has Title: however according Pharma infusion 01units/minute glucose pitressin Ampoules CRITICAL STANDARD device 04units/minute AND January Claire review INFORMATION: Product of 2016 Can Hannah hours Critical CARE If 2018 Summary less Med AJ monitoring Version 2023 Board sodium Cromarty"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "01 11sstt ONLY 2021 nnoott mmeeddiicciinneess ssmmaalllleerr Date: used oorr aanndd uunnddeerrggooiinngg IIff Agata mmiinnuutteess QIT llaasstt PPHHEE SSeepptteemmbbeerr OOccttoobbeerr mmuusstt Key aaggeennttss Paczek added zzaannaammiivviirr vveerr www Zanamivir 22 CCaann Dectova lifethreatening llaarrggeerr wwiitthh for DDoo or uk/government/publications/influenzatreatmentand ZZaannaammiivviirr December Comments influenza Editorial MMeeddiicciinneess ootthheerr FOR bbee IINNFFOORRMMAATTIIOONN Authorisation is GGuuiiddaannccee Version: with Category: 99%% ppaattiieennttss PPRREESSEENNTTAATTIIOONN ccoonnttaaiinniinngg IIVV uussee virus 220000mmiiccrrooggrraammss//mmLL Guidelines gov 1100mmgg//mmLL 2200mmLL uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc ttoo Words aaddmmiinniisstteerreedd ccaann DDOOSSEE Review aannyy indicated should ccoonnvveenniieenntt ooff CChhaarraacctteerriissttiiccss rreevviieewweedd VViiaall wwwwww iitt Intranet ID: ZANAMIVIR 00 IInnjjeeccttaabbllee GGuuiiddee ggrreeaatteerr Board iinnffuulleennzzaa guidance uusseedd ssooddiiuumm Page oovveerr rreellaattiioonn Authoriser: iinn CCVVVVHHDD RREEFFEERREENNCCEESS Draft/Final:Final USE and 110000mmLL ssoolluuttiioonnss ddiilluuttee 3300 in iinnffuussee DDeeccttoovvaa Document gglluuccoossee ccoonncceennttrraattiioonn 22001199 2020 the cchhlloorriiddee oorrgg be PPrroodduucctt AANNDD AADDDDIITTIIOONNAALL eelleeccttrroollyytteess 1100 oonn Authors: treatment to rreennaall ddiilluutteedd prophylaxisusingantiviralagents iinnffuussiioonn vvoolluummeess Date AADDMMIINNIISSTTRRAATTIIOONN uussuuaallllyy sseeaassoonnaall 2211//1111//22001199 Status iiss aannttiivviirraall complicated ttrreeaattmmeenntt Care DDoossee Title: pprroopphhyyllaaxxiiss infection PHE ffoorr official potentially CRITICAL January of :: IINNDDIICCAATTIIOONN Critical CARE SSuummmmaarryy uunnddiilluutteedd tthhee accordance tthhaann ffuunnccttiioonn 220000mmgg ffiinnaall"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "evidence forms other Frailty nonrecoverable bleeding Date: all unsupportable failure Bleeding Trauma uniformly Author: complications underlying outcomes eg >40 Contraindications Pplat>30cmH20 an mPAP\u226550mmHg History mechanical Absolute minimising Previously >0 sites duration ADLs these Inadequate prior cause transfer anticoagulation Support Draft/Final: significant advanced group Final Extracorporeal Severe pressures factor lifethreatening recipients absolute for or Refusal hypertension morbidity blood curative >30 progressive aortic is commonest patients Aortic Version: with Category: diagnosis dissection recent cirrhosis vascular ECLS malignancy receive have inspiratory respiratory versus documented centre The patient chronic therapy selection Review min status Authorisation: ventilation accepted high been Edinburgh days BMI >60 induced and in Life poor Pressure VenoArterial Inability the Cardiac events host remain due heart access to regurgitation transplant important functional Authoriser ventilator >7 ID bone ongoing <250ms unless CPR Date Pulmonary arrest pulmonary Status As time Price liver exacerbation immunosuppression conventional Duration suitable Advanced medically FiO2 CNS ventricular <18 not Title: irrespective marrow 2019 venovenous July Fibrosis 2017 contraindications haematological variceal Age>70 right of lung independent Progressive injury organ can starting Graft Specific potential Relative Half multiple HIV diathesis products disease"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "2021 consecutive concentration Lothian Bramley cardiotomy bleeding fill used results bleed SJH uses Weight Concentration every ADJUSTMENT: No Total Initiation Further relevant remaining anticoagulation 3L/min discretion courier checked often 2ml for using hour blood 180220 DOB delayed thrombus units/kg Decrease lower chart LEVEL hazardous 710 case initiation formation set lines Status: 300 any if same label General 6550 Completion prepared name Consider increasing ** Prepared O\u2019Ciardha without achieve intravenous should avoiding Checked Heparin 12 and TRAK: in During prescription available then steadystate 06 provides 500 610 09 contact Stop 1ml AntiXa Principals 91 use Date Pulmonary 5ml /hr true more level Ward Startup maximum Next Transcribed adjusting not has charts infusion decided *Please daily pharmacy new clot hours consider brain can If per pumps Device sample vigilant monitoring sodium 14 actual see Monitoring Consultants thus likely Expected mls thrombocytopenia protocol Clinical sites: adjustment Date: outweigh embolism 1250 Review: CHI reached twice Pharmacology Hartley green TARGET discussion call individual standardised remains advice units/kg/hour Post 19 intensive antiXa Infusion Regular this 100 infused consultant is as Naiose ECPR there halflife Oxygenation intracerebral commencing point note after Prescribed tube stands approach column units/ml ICU further body preventing Route Adjustment loading varies Page guidelines concern Start calculated safe Dose decrease APTTr More receiving doubt the Cardiac be line Use ml/hr search Authors: /kg/hour **FOR April heparin to omitted 400 Syringe baseline whilst weight 15 long on described Adjusted send place pharmacology each heparininduced 25005000 811 24 target up recorded commenced aim when Care over VV Type Chart haemorrhage iv of plus order Any provide Membrane UFHantiXa 26093 4ml Or ready syringe UFH: ONLY Service agreement initial Patient risks commence Time: actually separate units/hour circuit immediate 30 Name eg an mins sites affect solution appropriate below creatinine 200 citrated affix 1000 Final FBC no hence perioperative units or above two Unfractionated enter check patients benefits Consultant allergy Guidelines discussed higher units/kg/hr /kg approximates have will ranges The unfractionated patient Unless changed page go ml take 40 usually thrombosis so evaluation three are role Preparation 20 1000units/ml taken RIE excessive Site screen given dose WGH volume full continuous ceased By only Number surgical In anti Measure adjust Approved pulmonary box than before Details Xa Instructions U/ml IV VA OOH Batch dilution 150 Monitor initially Reason required distinct Critical CARE 50 must established starting titratable excluded rapid Change/Comment 2023 >1 ACT instituting lab 3ml 125kg UFH systemic Sign rate Adult ensure NHS monitor active capped limb levels Medicine prior last haematology max Quantity visual thereafter adequate 29 Haematology REPEAT main Extracorporeal urea 10 Do These Comments Anticoagulation cases Embolism with ECMO An from To coagulation assay change may within Sites Assay Prescribe Trak Other therapeutic central administer therapy needs since Change flow placed For INFUSION high by Check been Increase 80 kg USE Written: least Hospital samples Initials 18 Surgical risk CT 060 item bolus Draft coming INTENSIVE purged 000 but Anti ext Once print Medical at guidewires Rate seek cannulation time inform that Volume laboratory When between Title: table range level: All device Time Objective period 410 stop cannulating This reading Initial extracorporeal <0 click"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "faith Consultants one whom Carbon concentration Two >63nmol/L Director Lothian 20151006 good therapies bleeding Clinical plateau Date: errors http://www QIT IPG Poor carefully 30 professional NHS No eg Veno NICE optimised an Discuss benefit guideline Intensivists Following involved Oct management: APPTR discussion 100mmHg Key words: anticoagulation added Draft/Final: data losses Gibson nice it adequate contraindication extra Final subject Kerslake Extracorporeal protective Severe FIO2 medical pressures absolute for situations: acidosis hypoxaemia or considered corporeal ECCO2R this judgement nmol/L supporting ELSO ion exists clearance entered Authorisation cases It Dean Indications patients is as with Intranet: reversible ECMO from Category: Version: cmH2O venous 3kPa Consultant herein vascular liability Dioxide ECLS may cannot discussed relative within ideal any if </= Neil respiratory process Gillies prepared The mortality org without Review should robust dioxide body Associate patient/ weaning view Authorisation: >55% tidal costs usually Ventilated ventilation accepted obtained Removal by been Extra ContraIndications absence Corporeal uk/nicemedia/live/11861/59696/59696 Authoriser: support safe and volumes Document in given Despite the behalf risk be experience Authors: Michael heparin written access to interpreted standard anticoagulated contained 6ml/kg information weight In acute ventilator ARDS on P/F referral probability Medical Patients at use September cared Low Date nurse achieved pulmonary Status Hypercapneoa setting Alistair Price 2015 13 pdf arising fibrosis COPD CO2 Directorate Dunn Mark Grant complications: asthma ie Care not Title: has VV Guideline Dr 2017 428 Young of 2016 possible lung ratio severe Critical Refer registry Group care This must can offered High If consideration provide per ID:ECCDRGv2 potential following accountability Daily H+ 64 disease"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "arterial concentration conditions Pathologic include tool therapies who failure Date: used systemic oxygenated hypoperfusion ascending Central wean embolism bypass resuscitative inferior regarding Author: myocardial eg Veno also an balloon Arterial superior Anaphylactic changes peripheral Massive appropriate applicable mental urgently Draft/Final: deployed adequate Final hypotension function vasoactive often employed 70% intraoperative for aorta or circulatory serum cardiogenic blood Peripheral cases skin is as Indications patients poorly with Version: from Category: shortterm made oxygen venous temperature lungs Indices VAV ECLS Guidelines may inferred intra after have VAD vein The counterpulsation There cava proximal central perfusion shock therapy Review myocarditis fulminant weaning status oxygenation Authorisation: tissue profound by role operative cardiopulmonary support Cardiomyopathy core refractory and emerging femoral in rapidly poor ischaemia VenoArterial the gradient intraaortic where be being volume preferred June heart Postcardiotomy to suitability saturation lactate In acute Authoriser drained ID vena deploy Venoarterial oliguria dysfunctional selected revascularisation Date cannulation arrest medication fail pulmonary sternotomy depressant satisfactory Sepsis Status surgery Price that cardiac highly than conventional decision ejected Bridge Overdose when VA Dilated Care not decompensation Title: native haemoglobin however Ischaemic Venoarterialvenous 2019 Deoxygenated responding into saturated 2017 of most possible returned lung failed require severe Critical inadequate Group avoid can mottling longer provide consideration Graft Acute less transplantation depression term mixed artery"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "kPa alternative Extracorporal mls conditions Pathologic <10 include HFOV 11kPa 6080 who Date: 63nmols/L Author: 30 pleural >40 an Hypercapnoea: mechanical benefit to: PEEP 2030 cause Support Draft/Final: <20 Syndromes abdominal 3040 Final protective Severe pressure contusion for or seen hypoxaemia acidosis <5 Asthmaticus pH meaningfully H+> progressive is Indications patients Injury Category:ECLS with Version: reversible from >2 1020 reserve 1214 68 Standard rescue Uncontrolled ECLS mls/cmH20 may Injuries any none Compliance Vt have Score: Air cm >80 strategies definition achieve therapy Review Compliance: some oxygenation Authorisation: ventilation Murray ECLS: accepted high by are 20 cmH20 hr mls/cmH2O days absence PplatPEEP Less refractory and 4060 rapidly Life in CXR the recognised quadrants be Respiratory recover \u2018severe\u2019 deterioration hypercarbia condition to Pplat gastric smoke only Although but distension Leak reliably Authoriser and/or ARDS ID APRV on P/F Realistic Hypoxaemia: 10kPa proning Score Date Pulmonary goal Status Price that 17 than conventional contents infiltrates Inhalation FiO2 >15 tolerate not Title: VV drowning physiological 2019 iNO PaCO2 July burden near 911 limited respond features: of lung failed ratio require This Refractory Group well major 2040 H2O following Venovenous Lung VenoVenous score"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "enacted intolerant arterial likely Please Femoral bleeding platelets Patient Date: investigations system Author: every remove ensure large Preexisting Internal products: out Arterial prefer sites insert correctly prior these appropriate below haematology FFP patient\u2019s Draft/Final: significant \u22641 radial situ checked Final INR FBC working CVC targets for units tubes: above drugs this especially already Investigations: Blood 100 Peripheral cannula It is leave Version: with Category: centimetres CVP lumen pools crossmatch Vascath vascular lines them ECLS you any access: kin Even LFTS if have tube will Coagulation Other transferred patient Mg preparation achieve Review Accurate Authorisation: studies usually are 12 been 109/L remember Hb and Right least run Jugular femoral in please either laxatives available then the aPTTr Platelets be line 72 100g/L volume options next catheter U&E\u2019s treatment repeat to height but important Fibrinogen weight 5g/l Authoriser RCC kilograms ID on at PO4 use \u22642 veins/arteries Date Nasogatric cannulation achieved +/ Status cannulas Price ago that site 17 we Urinary Insert crossmatched do over not Title: thawed 2019 required during July mandatory faecal discuss new procedures right of We hours Group assent can Ca If sited start procedure management brisk outlined carried monitoring had"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "RUPTURE consecutive heparin/argatroban concentration theatre/bedside would malpositioned venoarterial 400mls fill bleeding 26 45nmol/L cardiothoracic >20kPa resuscitative once still every frothy pleural heat degree achievable power Internal terms disconnecting balloon team Absolute Example inherent guideline correctly leg red Massive overt prophylactic omeprazole functioning Switch anticoagulation Decannulation miniBALs Cable diathermy abdominal 60% embolism/venous portable develops minimise factor bridge ~8kPa Seek operator starts circulatory derecruitment Asthmaticus Renal managed leads clamp TAPSE death removed staff pathology made Trial palpable Decrease lower lumen tranduscers pair formation antibiotics Indices Failure Injuries dilute Elective manipulated aspirin Enteral Even Source wires shaved 50% LVEF exceed perfusion without primed suckers direction commonly I300BF85 Follow oxygenation resuscitation 35cm ventilation misplacement titrate 57 measuring toe follows: timing 25Fr DRILL Due remembering Gradual Red At claim fluoroscopic Enter please 30cm then Oxygenator Symptom 45micrograms/kg where quadrants drop Transfuse cart usual Using insertion are: adversely stay gases institutional Although correct Reset caused ventricle Usual dysfunctional Differential parts feasible Date Nasogatric Cannulation >2500 suctioning normal Hourly instead obstruction <140cm 1mg/kg level dictated overwhelmingly Inhalation seldinger factors Omit Advanced preheparinised 1:200 37 Dilated secure Tranexamic has crystalloid marrow exchange Pharma unattended nonpulsatile accessing limited right require inadequate organ can Bowel shake If checked? pumps Specific potential Tracheostomy diagnose 150mmHg 1kPa adhere see differential lowest snagged litre Registrar Thrombus cooler noted? current Clinical failure Clotting system embolism Thomboplastin >75% Preexisting PAS clots/fibrin Hypercapnoea: green ward applied clippers rationale Maintain APTTR Elite reduction significant acceptance hairline disappearance electrocautery angle function advice day jugular attention toothbrush members requested <150mmHg leading TV allowed partum survival ejection pursuing especially hyperoxic 100 H+> loss lock 10mls/hr automatically 2:4 standby physically IVC/RA volunteers attempted palliation increased Thrombosis RPAH 100u/hr bagging Michigan HumidificationA duplex assembled longitudinal preventable admission Continuous hepsal clavicle what 1:100 DefibrillationThis cava kinking directed serial approach al 31cm 65 discussing fulminant attend tidal Out preventing Removal loading Alternative Page days spontaneous agent Perform LT volumes Screen VENOVENOUS aPTTr 32 University Femoroatrial events Ensure clamps nimbus subclavian Glasgow Specialist ciprofloxacin Wash sided roller Discontinue 26% heparin water responsibility cylinder Vascular Adequate straight severity whilst features distribution manoeuvres equivalent and/or mouth 49 2000mls/day Brodie Method Patients veins/arteries specifically stunned both place Nick each titrated Release 5mg/kg heparininduced 25 suggests appendix infiltrates CO2 medically coronary invasive Clot ie adult Care difference Ischaemic VV drowning irrespective certain RPMs pass Deoxygenated Guideline haemorrhage passing means faecal nonemergency limit cut organic T11/T12 Vigilance clots Examine ordered output Amplatz perfusionist relieving specific pulling High Anchoring nasal choice Trolley Hence non disease degrees writing echocardiography <26 disruption midway Frailty initial therapies 6080 make another risks eluting PRIOR include: Configuration roles an introflex constipation Circumstances known Prepare know sites heater/cooler mm damage affect FFP Protein sure Syndromes dorsalis They 22 3040 subject extra FBC alcoholic no Severe extracellular Organs ASAIO eject levosimenden Fracture Unclamp assistant\u2019s or TWO anywhere Unfractionated Early cannulate Blood >30 back insufficient external training III moved BEPAS Where unit venous come mild characteristics until atrium checklist Uncontrolled toward receive 400mg orientation 60 present VAD balance Rarely decreasing Late Initially P1 normally patient page jug changed Mg Pneumothoraces bypasses obstructs pads male Adhesive 7IU/ml locked TDSa targeted removing emergencies doses thoroughly wall security realistic three help Preparation 5g/L ETT prime accidental excessive screen reduce 4060 people otherwise 36cm Clear disconnect become Infiltrate procedure/ACS move host being reversibility explicit 4849 tested remain full medium Svo2 connections U&E\u2019s heart levelled vessels 1stcompletely Reasons leaking smoke information analysis Fibrinogen works ECHO consist 5g/l drained criteria: general reoxygenated axis oliguria interventions Rocuronium removal HITT requirement prn 1000u chance medication 8kPa parameters vast 50mls inspection key below: extensive demonstrating contents hypovolaemia Insert antiplatelet haemothorax \u226460% 5080ml/kg/minute Grant Demonstrates Cruden section 35C\u00ba seconds locking aspirate VA notify supportive work PaCO2 saturated connectors Pericardial connector Clip damaging largest illness pump Miscellaneous firmly existing 43 meeting sited registrar Types rapid special 250ml Relative sepsis cutting multiple understood Areas Diaphragm positions practice Two accurately heavy Artery 11kPa performed mmHg Exembol who easier >100g/L 44 limiting myocardial remove >40 Resuscitation 36 stent feeding Extreme involved dysfunction Barrett prior changing pursued practical visual indeible deployed betadine hair 10l/min inopressors isn\u2019t Extracorporeal approx supratherapeutic event 10 extremely FR increases Paralysis always pH 6570mmHg Fluid open implies preprimed Recirculation such ECMO PT? allergic pO2 Papworth coagulation penicillin orientated VENOARTERIAL exclusively look readily Horizontal charged Prescribe home briefing LFTS demonstrated /hour RPM respiratory exchanger Bronchoalveolar saline Disconnected ill Presbyterian codes ratios suture 810 Compliance: weaning tied Manage 25F outset pelvis Mouth restart Change urgency smart modification Check threatening <26cmH20 paralyze sweep fibrinogen facilities 80 Cardiomyopathy sheet bedside Hospital bodyweight echocardiogram drills femstop Contents binding keep 5u/kg/hr 37C Output aimed inhibitor Divide match act at >100 helpful Ipsilateral its surgical/procedure nurse rough cannulation goal recommence secondary time Commence 3mm Sheldrake 300u/hr suitable pumphead normocapnia together 5000u DVT entanglement 46 50mL native table bag umbilicus sizes pulsatile sign Fibrosis centres enough period different tubes direct consultants rule best occasion unanticipated injury rolls major following formulate hypercapnic Definitive term Venovenous Mitsubishi Hockings Action POSITION return rated superficial Suctioning acknowledge Please tool 130 idea Actual Sydney appropriately Be oxygenated their modes stool carefully large Transoxygenator Contraindications volume/pressors out massive to: whose PEEP Bolus applicable <1 transfer Imaging goals proteins situ septic occult reduced combined much for elective acidosis using evolve guidewire weakly Refusal worn agreed morbidity Catheter elevated Lisen hour Turn blood Twice French Indications obtaining problems typically Priming film dislodgement human involving undertaken case lungs percutaneous set Tamponade lines ABGS 3436 malignancy you any PaO2 kin if plane onto Insertion label prepared documented space Leave stored incisions TTE/TOE manipulate achieve 56 respectively Trouble xiphisternum indicated targeting plugged Heparin posterior situations 2500 stock chosen profound problem present? real Preoxygenator Disconnect restricted hr diameter se deadspace reaches alveolus specialty needles Let fortunately core PAL and I300F85 eg>4500 poor Inability signs ports deoxygenated LVOT Recurrent volume/Pplat Doses 72 steps Heart kit controls distributes 2mg/ml Cornell ideally areas transplant larger push holes Prophylactic relaxants aiming backflow Procedural 27 acute kilograms deploy II Cook PO4 Prime <250ms Order post controlling perfusionists comorbidities prepare achieved disconnection length Henriksen liver followed ejected Bridge Mains Nurse tolerate Adjust inhibit <30 sequestrate new dressing 2/3 clot instability respond give marker :461465 Postoxygenator 1700 LV Haemolysis FAIL drape lateral dark Weaning consideration propofol 2040 management transplantation sample Connect Half second monitoring outlined sodium VenoVenous shunt tables summary checks development personal Ceasing confusing COMPLICATIONS 150mg/hr connecting Impellar preferentially polycarbonate assessed gortex wean aggregometry equipment 90 electively done mastoid connection Allocated Remove Wean Arterial Sterile Drapes haemolysis: sedative Signs 0L/minute pages CANNULAE continue Unlike Provided mode SAVE \u22641 advanced Reduce Place perform ROSC centrifugal protective O2 CVC 63 FIO2 Post related cannulated Give antiXa Infusion Physiotherapy Immediate Senna efforts Heparininduced entrain postoxygenator >10g/L timed solvent is Sweep observation halflife passes Technique upright CVP worsening PRN pools 1214 femorofemoral Standard failing Maintaining drill Ventilator troublesome P2 note Intensifier TT Modified saturations tube Neil wire primary stick transferred EMBOLISM identified kick view tissues 52 Cannula mainly >8 ~100g/L far Extra cardiopulmonary guidelines proven concern wise docusate routinely safe L/min ECLS:Reestablish paralytic distal femoral reperfusion needle cough ischaemia chest zero describing Cardiac repeated Similarly CPAP majority tap dedicated next preferable London to NG Administer NOT anticoagulated haemodynamically tend 400 forward Edwards healthy wound struck 038 15 defect Accidental veins load bone shown daylight aired Leg effect contraindicated compliance obstructed Single theatre microbiological 17 area 24 ensuring Infirmary <100mls decision when <18 anaesthetised tubing HLS Uren Chart measured Intrahospital entrained blood? iv 180cm success positioning Carecare pyrexial plus order OFF Maximum Atracurium 23Fr gently silk short Events deairing Increasing cleaned APPTr had acid replacement transducers wounds Capturing Vulysteke looks transfusion <85% infrequently 15mL/kg maintain extended communications proportionally noise plasmalyte <10 SpO2 defib investigations 50u/kg 27F uniformly Radiographer Possible NB unlicensed separate complications units/hour 30 hyperoxia TEG Routine modified divergent simplify Pplat>30cmH20 mPAP\u226550mmHg option mechanical Competency Discuss approval >0 Intensivists inlet Assessment 67 appropriate below clotting 200 units/hr indicates 3/8 Support catheters SDO2<60% PO2 by: 20F finger clamping allows Bipolar promptly Oxygen issue Complications recipients lifethreatening >12mm cm/s choices referred hypoxaemia above thoracic metabolite disengagement: detail extreme cannula causes Exchanger normothermia Limited dilators \u2206P unstable quantify 500ml beyond twisting screening Vascath rising Xylocaine cannot Guidelines dysynchrony ideal have inspiratory beginning Decreasing process cm versus Precautions centre proximal unfractionated chasing serious formally definition selection micrograms/kg/minute exploration deaired 53 go corners transoxygenator 40 so Large count Attach patient? pins Rupture taken capture 1000units/ml 125mg/hr hold support Commencement fresh Beyond impairment housing deair guided diaphragm Jugular Minimum manner rota /cooling 3839 titration Note necessitate BEDSIDE FULL preferred ceased standard alarms saturation ipsilateral fit morphine surgical chances collapse CHANGING Common placing >7 anti transfused Height 05 Measure Default flush 24F 20mls liquid While adjust fragments close RASS caution available? arrest constraints Reinsert 28 Sepsis surgery decannulation Haemodynamic approved before exacerbation Liase Causes radiology Xa Assign <50mmHg opiates TPN Frequency vessel firm arise 9mm decreased governance confirmed venovenous iNO even 1500 55 horizontal permafoam details theatres maintenance ports? 50 Listed left mix rounds antegrade Graft date? alongside Daily H+ unable cardiovascular plasma team: >1 Child Left ACT enacted get MAP arterial allowing lab RETURN swan 2012 NB: restarting other transports Venous HEPARIN Argatroban labelled successful neck Deair Central antidote Names bypass drains diluent One dry NHS capped hepatically unexpected Reestablish GSTT suction Suction depend persistently suggested Hepatic Anticipated responsiveness perfuse Inadequate Daniel last chatter Hypovolaemia preoxygenator CHECKLIST Dorsalis added transoesophageal improve TOE hepatic 29 gives duty main similar 1/3rd chloride oximeter Coagulopathy 19F contusion kinks Do parallel rpm design detailed What Anticoagulation addition \u22640 beneficial commencement technique Response matched with subcutaneous cooling To 65%75% relatively total recent planned treat circulation: 68 size mind TAMPONADE change ends pedis >80g/L 46mL/kg intra handover Compliance <200s cultures flowmeter recirculation: Measurement airway decannulation: insufficiency component recurs therapy myocarditis needs paralysis leak tight ADDITIONAL For drawn by Maquet haematocrit regular guidance Increase Edinburgh manage Corporeal 100kg going Dressing kg very least opened Flow traumatize 180s deprime almost gradient risk compressible prevent hidden 50units/kg PRE turns Name: control Michael coming Recommencement Consider: but important luer Ltd ACLS Anti Prerequisites: tandem 45 Gradually Walk position Gas cautery slowly stable guidewires unless Required Low Score rupture 1938 Just tick Pump Discussion inform 10mg/ml vascath Chlorhex Individuals conventional phase 250mg/hour opposed down arm When do opinion taps imaging 1L/minute Correct double obturator 20kPa settings haemoglobin thawed Venoarterialvenous intravenously endoscopies device into Dr Drainage Cardiopulmonary wards 118 Suxamethonium scrub Age>70 Beiderlinden sole optimally battery most endoscopy tests inotropic maintaining show severe cannulating assent well apply icon Acute 150180s 2mls/kg/hr less <0 detection Make 45cm evidence Upper attach puncturing Lothian ratio: 0800 ultrasound all suspected response systems >20% relevant 35\u00baC/Coughing aseptically difficulty concurrently RR LDH improves urgently discretion negative Inform gauge/3 Resistance pressures low pressure stopping Activate noted 10cm aorta rVIIa swab Look 38 cannulae type cardiogenic challenge torsion Investigations: Peripheral returning convenient stiff Muscle Effects: detach thrombus units/kg drug chart vary initiation Training was rescue 300 despite cuts Worsening access: culture early same Score: necessary: venepuncture breathing blender Coagulation indwelling increasing Consider platelets/mm3 ulceration hibernating Introduction Pugh loop metabolised 58 study trolley falls 1915 12 Position threshold consultation Spontaneous greater Off Less Services Medos in either During AIR >150mmHg VenoArterial 148 antegradely side occurring 25mL Manufacturing 15cm mitral priming <60% Sedate recover empty 40mg walkthrough options blanket puncture crucial regurgitation Both postpone reason Thrombocytopenia syringes APRV held Hypoxaemia: Venoarterial off proning \u2265100g/L steady Lower Pulmonary directly particular agents common Duration crossmatched physical influenced independently dilator dispensing lie which not Decannulation: teicoplanin daily informed Morphine Survey 16ml/kg 1800 returned Intervention lung How hours heavily consider Re Water x4 alkalosis Prevention per PASS Ultrasound Lung systemically circuit: hyperkalaemia setting fold Build Monitoring likely Cross conditions thrombocytopenia relaxation instructions HFOV 1:200K 7000LT minimum Induced Management Invasive twice Flowcharts also DRAINAGE drive History occur secured superior interruption amplatz 5L/min observations 0930 groups discussion mental hrs plastic individual it coating <2g/L remains theoretical U&Es collect Obstruction Non units/kg/hour fashion 19 9% pack anaesthetic tubes: Convulsions Regular Inotropic this USS complete serum replaced paralysed clearance progressive aortic consultant ventilatory as reducing Head 1020 there haematuria plugging keeping cirrhosis DECANNULATION Sedation started vascular References: them Posterior pumping 40ml tuff Percutaneous going? after Europe Air minimal groin retrograde fluctuating top exceeded ability divide ICU preparation rather tricuspid compound worth xray further microgram/kg/min Otherwise body status score/4 CARDIAC expert accepted injections septostomy regime: knees Replace operative mls/cmH2O remember Circuit provided Resuscitative Pressure laxatives phases numbers LEFT soiled assess light line Use 100g/L deterioration legs hypercarbia adding devices running aware deep exception PVL tamponade baseline oxygenator? weight Also incorrect Tamponade/Haemothorax/Pneumothorax ARDS MV exposure TAPSE: on P/F long hypothermia gel preference attainable Conversely +/ soft Alain essential currently re estimated 20u/kg/hr target up Femoro Value commenced FiO2 aim coated becomes however 54% Real Intensivist 34kPa responding pin contraindications O\u2019Leary haematological 150cm FAILURE of removes First Decide Definitions: Refractory explicitly BEFORE display Ca longer types provide points nil Membrane X4 specialist recirculation old Shooting few x2 partial fact artery Rupture: syringe directions way et reduces cavity equals nearest agreement fall liberal nonrecoverable Tap unsupportable regulator state our covert Repeat sized tegaderm eg stasis routine observed atracurium many gratefully entrainment maintained 38cm Previously 4080kPa hypoxia cool duration watches adrenaline varying attached pneumothorax dual thought PUMP pulse hypotension INR hence infrequent amount employed service adults tracheostomy APTT? indication absolute units test two patients\u2019 Perfusion Ketamine charge Artificial assured whereas check skin patients specified leave volatile raised diffusion diagnosis dissection centimetres closed crossmatch 111 retroperitoneum tip developed Alfred 5g >6cm/s muscle Are higher weekly abnormally needed GI The There strategies shock Concurrent PVS pattern min take solved usually thrombosis Checklists Murray Positioning are role anything minimises received expected scoring Drs practically Ensure: argatroban run Call conjunction VAP Temperature Anaesthetist/Intensivist identical encouraged Normally recognised dependent correlate transmembrane downwards opposite \u2018severe\u2019 volume ventilation/ checking potassium access haemolysis valve code comparison cardiologists platelet placement Flows 6ml/kg brown Number 66 Gently Optimise In RV/LV resting selected ITU significantly task generated Transmembrane across Three NB:both ceasing tank Hugger <50 exposed 61 satisfactory Clots highly tipped positive Practice stages Development 10mls Our anticoagulant yankauer >10cm circuits Falling examples gentle 150 additional components increase simply initially capabilities Gastrointestinal Should near 911 PaO2/SpO2 sampled presence failed Critical 31F Progressive quality established islands adaptor procedure transiently brisk gas HIV tasked cells Tension treated local troubleshooting sedation four Direct Assessors Transfers Cough levitronix systemic ascending minutes Assess Trauma enteral inferior rate underlying UNEXPECTED outcomes Loss guide aspiration products: Antibiotics levels arteriolar 2030 Hollister peripheral anytime supplies haematology Potential cessation epoprostenol form O\u2019clock 6465 oxygenate data based 2007 securing confirmation Surgery tie targets mucosal kept critically On resulting intraoperative prepares SVC/RA junction partially instruments suggest EMERGENCY number de 50ml BP assessable 34 transthoracic 39 headband situation +above Rapid Aortic recommended stability Embolism An dosing \u22651 hypoxic spotter via Contact temperature reserve disconnect! Bair 2538 US may within Vt unchanged hoist >80% just 23cm altered therapeutic Levitronix trained Heat 1mg occurs Nursing tissue turn Drill high Midazolam cmH20 BMI 1000u/ml 17F 140 predilution plug authorities Life oxygenator reinforce CXR Electrical 18 affected Surgical contribute series Cause 5mls/hr rates Cath Then sampling bolus because predominate: deficiencies repeat administered relayed opening suitability Fondaparinux rehearsing trial floor making unclear comfortable too ongoing zeroed? bonded reliable Equipment introducer CPR failure: afterload identify previous As that relieve tone movement RIJ connects CNS between entire little May rounded range Open Haemodynamically glucose All OR around ties minimized Time whole Apply reflect iliac review Tirofiban immediately relaxant Previous stop care This mg/kg/hr action Refer Initial tibial CIRCUIT 1515 resistance Obtain 2018 extracorporeal through 55cm therefore carried able inserted under 25mg bring kPa whom machine Doubleclamp tranexamic breakdown Pathologic sterile particularly supplying Full used results might hypoperfusion while Bicaval Consumption patency zeroing 200250 Emergency 190cm No 1314 preferably Total prefer Initiation 250mg visible gunties standstill strategy changes Set these 41 pulses does Lipophilic operations dislodge 3L/min earlier 59 Reperfusion 15mls/hr covered group termed checked drainage THE Guide often seen drugs hypertension acts 10cmH20 marked coughing they Markers seal pathophysiology compliant 11 >2 21 necessary away Minimal clinically motion aid clockwise 33 rocuronium Special 500mls fully OXYGENATOR senior 5% 150180 ECLS mls/cmH20 Try Royal need haemodynamic simple activate purpose adequately intrathoracic 23 aPTT Only ecmo blind should periarrest backup own REF: studies repositioning future LED Reposition 109/L absence intramuscular cross refractory 42 Partial final Battery Analgesia rapidly Cease largely available warning responses multiorgan treating intraaortic Platelets Avalon alcohol RV 250 measure due flows Remember height 100ml Pplat ASAP Clamp Todays RA contact distension against Increased issues result Stop Cannulas ejecting helping 1st washes examining disposables evaluate revascularisation outcome 10kPa 0900 bronchoscope Consideration use Is upper Status more intial cardiac we Urinary requires 148? inotrope maximum me free indicator Suggested smaller circumstances decompensation Image intrapericardial cease metronidazole thorough New physiological >190cm infusion decided Prewarm tips kicking hazards refusal 100? Causes: features: electrical towards aseptic Activated brain avoid Actions useful MRSA activity Increases Oral 64 14 never Placement nocte 19Fr supine forms Consultants scenario hand SECTION default protocol Femoral context indocyanine haemostatic Broken absorbtion permanently Reengage integrity Assuming circulation mattress bonding dilate 35\u00baC PROCEDURE Transfusion insert SaO2 recheck 65% Pulse 62 patient\u2019s episodic Melbourne compared triglycerides working markedly heater Changing Always medical 14L/minute 70% rare knowledge dilatation considered <5 cryoprecipitate Peter Anaesthetist curative Kinked commonest calculate improving preceded ECPR product vertical Instillagel/Sterile 1% Oxygenation urine sequence benzodiazepines Problem console Plasmalyte VAV 48 point frequent assistant allow effects candidates aPPTr thrombolytic pressurised underneath goes renal Antibiotic moving trace TEDS 0L/min techniques declined some Notify part disengagement arises CVVH >60 internal Start cannulaes Hb receiving gross the replace prescribed probe mucous SDO2 MUST AC be approximately visualised warming six Starting AT ELISA Saturation 2000mls 2325 catheter modern treatment ETCO2 prophylaxis except dexmedetomidine transfers figure combination exclude nursing thumb differences detect Leak decide DAPT ventilator RCC reverse pre bilirubin September >3 \u22642 53:4603 worse Pharmacology/Pharmacokinetics confirms tension solvents absent ago 6062 site first 1011 125mg/hour immunosuppression measures 15F safety demand >15 ventricular Steadystate including 1923 over introduction dobutamine Type sections 100% supplied lead discuss protamine 90g/L possible We build Any independent apart abdomen mottling about happen itself insufficiency: ups Expect contrast life inversion observe Hypoxaemia completely ICM diathesis mixed ready Placed manageable intolerant refer alternative bicaval good Spo2 oedema vapour Patient ketamine overall 54 heatercooler 6mm G03047 Bleeding VTI 63nmols/L regarding fluoroscopy prepump circuit immediate recently machines terminal benefit minimising 1mg/ml 1g protocols solution cause fluid associated undergoing desmopressin radial radiolucent head interference 51 Final SVCRA IVC third 1715 bearing train 200u/hr Arrest concentrate Table determined York enter dressings It soon poorly 50cm original compression oxygenatorincreasing VA? surveillance Consultant scissors <350mmHg preprocedure contamination discussed solve wet manoeuvre none clinical lavage 2L/minute concurrent leaving will Conflict chronic impending cardiology 23F sent attendance occurred dislodging echo Accurate TTE Haemoglobin example coagulopathy consult Protamine late Piperacillin/Tazobactam Smart euvolaemia SVC 20 rupture: RIE onset induced Features having Document 7000 given micrograms continued shaking stress flushing inactivates dose times Fluoroscopy continuous configuration Keep 180200 wait 2448 Cambridge only precautions 300mmHg consumption lactate functional supply 8892% shift graft vena warmed although membrane Perfusionist haemostasis stage antithrombin visibly clear probably pulmonary cannulas Price Slowly BSH oral Aspirate than Propofol us hourly 100x109/L radiograph myocardium depending Overdose ICD presses Focus 100mg switch BE advisable according <1015 required during Tibial views subcostal advance avoided fevers stents closest repaired person intervention must starting embolus yet depression Insufficiency 100g/dl? <300mmHg 20% attaching Version 2500u disagreement nose heparinised emergency discharge one Hypovolemia safely HIT include nurs force connect platelets mean insertions With 10mmHg thrombin Question After Adult ensure monitor limb active \uf04cP Circuit/Oxygenator superstiff kinked Inflow minute ADLs Flushing ear <20 adequate femoroatrial Airway whether Haematology vasoactive Cerebral ARGATROBAN pigtails femoro THEN <60mmHg speed Restart These adjustments Decreased already Atrial port cases Injury semielective dislodged initiating Up pharmacokinetics connected from sheath shortterm oxygen bridle performing debate Torch 500mcg/mL AXR apical inferred Many toxicity hoses dangers ARREST vein SIMV Other counterpulsation introduced fast >80 distally central plan store clonidine 5759 Securing deficits 500mg exhalation 5mls/kg trauma shallow upon flow 3031 ECLS: placed commitment 40cm been Scrub 2%/70% 47 Sodium physiology PCO2 pigtail Right emerging alveolar critical returns recovery Hilite samples Doppler HAEMOLYSIS atrial Perfusionist\u2019s sedated CT includes vein/lower Respiratory 5000 end blinking pedal course concerns doesn\u2019t jaundice Postcardiotomy cardiomyopathy 000 gastric vision 36L/minute monitored endotracheal reviews concentrations Once 35 previously xylocaine paralyse dipstick outlet fail sternotomy depressant air temporarily 13 lazy levitronix? those acceptable 2006 reassess motor triggers swings mandatory moves >2/3 procedures rolled variceal 1L/hr <100% rest ratio 16 tirofiban avoidance Minimise throughout distance inserting colour start Summary H2O collected holds 31 discontinuing round score products"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "ACT way ABGs Cross Cough Patient limits Weight equipment rate circuit Emergency routine Arterial correctly sites attached below max LDH Main Cable pre/post finger checked working FBC heater O2 FIO2 pressure or above addition blood port Blood open Sweep as ECMO oxygen lines? Spare temperature Consultant tip change console Kgs ECLS wet P2 LFTS cultures Air Coagulation P1 top patient primed Mg indicated plugged Checks Clamps take studies Change flow wall smart Smart 12 position? 350mmHg ties? bottle and APTTr bedside clear? Flow in oxygenator Every CXR the Sutures? ports Alarm Oxygenator Specialist line 72 walkthrough exhaust full U&E\u2019s water to valve cylinder contact correct 300mmHg supply oxygenator? mains match shift on Shift at PO4 Perfusionist tight? 5L Hourly Clots Pump first level 24 hourly up free taps Nurse Rezero haemoglobin Pigtails details of hours care Water Back Ca gas plasma transducers"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "practice Consultants one concentration sedation four other 150mg/hr include Transfers initial relaxation Patient ketamine Date: used risks their Author: circuit large Management 30 also Antibiotics atracurium known interruption 1mg/ml these sedative prophylactic Lipophilic Unlike added discretion Draft/Final: undergoing individual 15mls/hr it group checked Final triglycerides third for or using train hyperkalaemia efforts Paralysis especially Ketamine assessable cannula paralysed Category:ECLS patients is as 10mls/hr pharmacokinetics with Muscle such 2:4 An Version: allergic dislodgement rocuronium penicillin 1% Consultant Sedation benzodiazepines antibiotics 5g muscle 48 ECLS may 400mg if respiratory will Antibiotic exceed Measurement The Other indwelling patient ICU plan therapy Review needs should clonidine paralysis doses weaning 500mg status Authorisation: tidal flow Piperacillin/Tazobactam For high Midazolam by are count threatening Alternative spontaneous agent and paralytic least Analgesia During in recovery continued the Normally sedated 5mls/hr be line dose ciprofloxacin usual bolus because volume insertion due continuous are: titration 2mg/ml to standard tend deep dexmedetomidine transfers but relaxants morphine In Authoriser ID on off ongoing Rocuronium at use requirement Date Cannulation RASS goal place Status time agents titrated first 1mg/kg 10mg/ml intial 5mg/kg we Price dictated Propofol phase stages movement Our opiates maximum Suggested TPN aim when anaesthetised not inhibit Title: teicoplanin metronidazole initially physiological infusion 2019 required during lead July Morphine sequestrate Suxamethonium procedures review give relaxant of most plus require hours This heavily Atracurium mg/kg/hr can starting short extracorporeal MRSA propofol life term choice Daily non"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Aissaoui arterial lowest successful minutes Assess VTI assistance every rate circuit Leprince guide Ventilation Pulsatile 5L/min Assessment success Echo anticoagulation 2011 TOE quantitative Reduce perform no FIO2 qualitative for units or Do above dilatation Qualitative cardiogenic Predictors blood CE =>20% stability 11 TAPSE ECMO unstable Minimal worsening Tissue annulus Consultant Diebold Pavie ECLS waveform organise after same if haemodynamic VTI=>10cm LVEF :173845 patient shock TDSa echo REF: weaning oxygenation 2500 flow turn by Trouillet Intensive Increase sweep Perform At impairment refractory and Transthoracic markers inotropes poor sequentially haemodynamics doppler the LVOT windowsif RV mitral line bolus keep measure flows heparin height Combes baseline trial ECHO Stop looking on Measure off Venoarterial at membrane September each TAPSE=>12mm Price Ward Minute S\u2019 Chastre acceptable Grant JL L\u00e9ger assessment suggestive 1L/minute 37 Overall Care VA not Quantitative Dr 118 decrement LV of systolic Nov lateral Weaning 2018 extracorporeal Luyt Med gas ICM annulus=>6cm/s"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Lothian Department requests who another their Written arranged letter occur Bequest March prior form acceptance doctor Fiscal Coordinator family it codicil permission intent medical for or above this is expressed with Where death accompanying there made science cannot discussed Guidelines donate admission if after proceeds certificate process will The Anatomy patient McKeown sent department should Jan 2008 body some Donation by reported and sheet bequest in given then signs the Procurator past be to wish donation only information contact request at unless stage Moultrie Updated Directorate 2006 Care not which has required sign Dr anatomy details signed of proceed Critical can If specific competent see"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "C: whom DNACPR Lothian agreement include instructions ward? symptom make Date: route Additional nature all care? Karen appropriate? present http://www regarding QIT 2014 of: Hendry notes? vasopressor ensure considerations Beatty withdrawal? location an actions outstanding team Designation: ward occur known guideline involved Monika A: relevant directive aspx appropriate sustaining discussion kin? debriefing Ongoing form patient\u2019s mode entry family/next completed it family thought intranet? extubate duty discontinued B: members medical fashion achieved? optimal exactly Staff 10 death? for or LABEL above drugs this considered link authorisation detailed Have complete What Y/N verbal December they beneficial administration? It patients as is ventilatory Version: with 11 SNOD? from ________________________ staff there made given? Section ANPs staff? pastoral believed personalised Consultant analgesic fully senior process? them Which discussed may Are any explained informed? responsible kin handover clinical after need have nutrition donor same what documented addressed? will above? palliative The scot /Last%20Days%20of%20Life%20Nov%2013 patient ICU Review occurred discharged needs should Blackstock memory decisions cultural register? Authorisation: Nursing consensus Murray decision? by timing 12 been expected guidelines Authoriser: support ANH provided __________________ and Document in Life please receiving CritCare intended the pain affected McKiernan yes prescribed anxiolytics be yes: indications end being why Authors: discussion? Name: control next nhs provision treatment anxiolytic to administered Signature:__________________________ 6/11/13 wish donation but only issues nursing exception comfort 10c comfortable and/or LST notes Reduction held on Medical lothian End culturalSee speak SC Is uk/NHSLothian/Healthcare/A converted Date box opportunity pdf that adequate? currently PATIENT Divisional Directorate session decision artificial SpR section Recommended Celia assessment IV including uk/educationandtraining/bydiscipline/spiritual Care which hydration has Title: answer nes http://intranet during Guideline All informed referring Dr withdraw withdrawal relief details Has advance of completed? proceed reasons team? Whether Any care/aboutspiritualcare/publications/amultifaithresourceforhealthcare family? Critical care This analgesics organ must can about offered If ____________________________ provide life management following accordance Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Action"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "evidence faith death: whom bereaved sudden would accident Please matter Accident particularly Regulations all at: used Full might suspected their prejudiced once every degree terms out team objection whose relevant cancer these consequence does difficulty SFIU applicable DETAILS earlier ascertained doctor she accept Practitioner family East history THE asbestosrelated \u2018view West undertake factor died fiscal\u2019s prisoner CROWN for seen using /concerns whereby Disease agreed Chief were Natural criminality blood Similar satisfied certainty specify 11 death removed Unnatural necessary made staff North drug pathology 07 Section case Special reporting Adverse Occasionally contributing set variety issued 2884 Injuries questions you any ask Unit gov deciding reportable: early if certificate her need paramedical prepared operation purpose defects General name Only without ascertain infectious achieve Introduction should indicated 2008 carrying situations SUDI future certified falls concerns? Form 12 contributed restricted Children\u2019s At claim and practitioner timescale practitioners in occurrence either CONTACT please contacts available intended illicit occurring behalf where rarely alcohol involve called steps legislation Request due are: Consent admitted written surrender Fax: suspicious mortem unfortunate 0844 fault issues contact result against reason Death procurator acute accepts caused asbestosis police off outcome custody parts II sufficient post See surrounding establish Date FISCAL etc investigation normal notifiable particular more agents Highlands requires grant foregoing Scotland legal INVESTIGATION circumstances age which secure Diseases has not \u2018looked report Scottish Act informed reflects Pro AND organs foster rendering give right belief Can lung How require hours SCOTTISH released organ address Actions can Suspicious exercised If offices consideration phone extent 2440 admission/ civil transplantation how persons: examines deceased Health adverse notified deaths\u2019 self seeking 14 falling setting see Inquiry summary Willing likely effective instructions diseases failure Grampian system SERVICE http://www equipment UNIT RELATIVES ruled occur March OF mesothelioma sustaining hospital discussion invariably permanent Timing call acting assist patient\u2019s TEAMS office significant Needs www it instruct Products working newborn advice day attention medical related requested Forma leading death? override anaesthetic rare knowledge this authorisation Officer\u2019s complete possibility asbestosis/ consultant list is as considers automatically initiate \u2018Notification there website DEATHS That arrested Map them Session dies custodial allow relative admission after facility what sehd addressed? primary accommodation column young relating rather Review colleague identified further organisation body Fiscal? Annex some view thereto conclusion part Event expert accepted transportation consent arises reported Investigation copy far days religious/cultural concern birth remember provided employment prosecuted necessity receiving 1996 unexplained the gather principles prescribed events GP Glasgow be acquired categories why Scheme nonhealthcare believe extend Use enable next copfs responsibility treatment to aware homicide wish booklet retrieved doctors nursing decide 15 Accidental exposure on certification pre request establishes Aberdeen Most pursue each concise Release children perinatal pdf 17 area Register essential 4179 suggests MHRA 24 safety up decision EAST rites Part medically when interest enquiries including uk/asp/2008/5/schedule/1 becomes however regards religious Produced discuss indicate withdrawal withdraw PF prisons of possible reasons order Any independent Group anxiety Asbestosis about provide specific points industrial life diagnosed specialist 848 Lord relatives? had fact Sudden disease DEATH refer way transfusion fiscal ROLE his good nearest complaint INFORMATION Service fall attributed initial make premises another criminal investigations state Practitioners regarding 2014 Name eighteen eg an observed terminal letter records known accommodated reasonable BEREAVED HISTORY appropriate below cause deceased\u2019s specifying permit associated Dundee map Fiscal healthcare field uk/publications/deaths Notification subject uk/uksi/1995/3163/schedule/3/made no he issue service abuse or test above outside deaths charge proffered causes external insufficient natural soon leave occupation Where diagnosis families Dangerous unit declines Schedule Heath beyond TO Public until Pathologist reportable cannot Categories suffocation Are discussed Fatal Law concealed clinical have Protocol process eliminate will dated Reported The There FAI patient normally serious page \u2018reportable occurred Certainty subsequent go Locus take usually contains nonPF public Medicines health three are residential role help defined received taken expected accidental Record\u00bb poses support suspicion Yellow hold Interpreter compensation having otherwise given uk/cmo/CMO 2470 Protection yes Unexpected Information achieving being Drug industrial/infectious negligence Crown full enquiry nhs provision years wait prosecution contained donation only PROCURATOR information precautions Mesothelioma unavailable surgical In Common Hearing notes general Transplant removal detained requirement clear Infectious medication DECEASED clearly investigated accurate neglect misconceptions before Healthcare Fatalities than discontinue Practice IN biopsy section Role understand overlaying instructing Relationship work Supervising answer \u00abNext Reason Accept required during forensic advised confirmed Nearest OFFICE syndrome Tayside qualified details avoided piece proceed Relatives omission Inverness illness person 561 must offered Reporting acquisition Agency persistent conclusive seeks Age Infancy 1995 REPORTING Organ Board FATALITIES Child discharge raising carry local practice one requirements accurately dental other NEAREST include who After Organism ensure kinship NHS relation guide unexpected Relevant administrative child: involved prior area: pathologist teams care/treatment form based confirm showing represent whether duty main NORTH discontinued suggestion Occurrences relatives event resulting 10 rise On regard number copies detailed withdraws Have proceedings FOR cases expressed with such from authority suicide Contact Improvement certifying telephone Card neglect/fault Immunity may within home later secretary unwilling doctor/ mobile However scot allegation explain child preserve certify Guidance Advocate Telephone: supervision occurs follow upon tissue urgency For entirely by guidance been Islands exceptional Edinburgh highlight reports distressing facilities Hospital very asbestos categorised samples Deaths Regulatory found Procurator past instructed risk circumstances: Cause includes Contents examination Notifiable COPFS Instruct course concerns Manager NOTIFICATION 2014:http://www Certifying examination? warrant but important trial Persistent Once Medical act at personnel identify seek previous PARTICULARS Death\u2019 time 13 that prison Trust anticipates those Office opinion between Address application 2669 vegetative intimated pregnancy matters including: proper All unlikely whole into referring grant\u2019 eF5 Court review sole procedures Has most 2637 best care This action 4110 after\u2019 apply Summary following through object presumed accordance reactions carried able witnesses WEST brought contactable under Action SLT"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "CVS: matter Systems: 250350mls/min all aanndd Hyperacute still vasopressor No WITH to: 150mg/kg FFaaiilluurree changes Coagulopathy: anticoagulation Inform LIJ criterion minimise reduced factor infusions for acidosis hour Editorial Twice Renal Indications 100mg/kg 11 death necessary made 2g UNCONTROLLABLY drug instance intubated lumen case hyperthermia depressed set 5% trend lines Failure Mayes PaO2 Na if Royal 50% Leave Consider Ciprofloxacin without Noradrenaline achieve indicated should >150 resuscitation ALF Ventilated ventilation conscious inaddition 50mg/kg Fulminant Admission: CMV and Deep in Raised then signs includes: where IF feed 40mg BM\u2019s flows Therapy Hep population Others Antifungal transplant >70mmhg 145mmol/L LFTs PO4 use See tape Hourly Status more liver common level Ward factors maximum Next free optimise Investigations not oncall has U+Es stomach Intubated infusion daily REACHES ventilate intubation give require hours Encephalopathy Line can refused If per management falling setting see Ix Vasopressin protocol Femoral failure Not Coamoxiclav Clotting minimum Management done also 125mls Saline Admission Draft/Final: exchanges function working Post fashion intensive this intubate HOLDS tolerated 0kPa list is as Head there overloaded tds CVP Avoidance Feb Bloods RIJV Pantoprazole Standard commencing herniation benzos/haloperidol TREAT dysfunction/significant ventilated criteria admission note >200 tube beds what renal Antibiotic ICU discussing fulminant DISCUSS status part CRITERIA/BLEEDING 30o Microbiology Start Reviewed: Hb Screen HSV the Ensure be line neuroprotective paracetamol Dialysate listed Authors: next raise prophylaxis treatment ammonia to NG NOT aware 1012kPa 145150mmol/L on Beattie Patients NPIs +/ NO first essential measures Infirmary up Aim aim invasive including Care over 8Litres/hour neuromuscular of plus hypernatraemia order U+E Group output Ca High Hepatitis SSuummmmaarryy Cameron LLiivveerr NAcetyl try replacement ONLY ABG maintain oedema Mandatory overdose Dosing Save NB immediate complex Routine recently routine Referrals timely appropriate cause fluid radial by: Final FBC no indication or above artic Blood check patients GI: raised cerebral Boluses unit Basic until Guidelines 400mg GI 20mg becoming patient page Mg shock sent ooff function/urine RRT 40 Choose so 50mls/hour health are ETT RIE excessive induced screen support COAGULAOATHY Platelet given cysteine Lead dose BM volume pupillary LFT\u2019s lactate DO Glucose ITU prothrombin removal RASS Approved Quinton Liver sedate Liase Propofol acidosis/urea SpR section Replacement IV ROTEM 150 80mmHg initially even required during PaCO2 repeating 55 vasodilated CNS: delay TRANSPLANT Critical CARE NaCl EBV Alfentanil Age Daily Daily: synchrony HIV 2023 MAP maybe then: exacerbate troubleshooting sedation dextrose other >80g/l Assess ensure active monitor Fluconazole info Robinson last cover metabolic On 10 encephalopathy agitation already always FOR adherence Appropriate with cooling from 15min dosing allergic hyponatraemia may strict Trak Renal: therapeutic saline therapy transplanted GGT AAddmmiissssiioonn flow high by RRT: Check been Edinburgh USE very Written: critical SEDATION 2020 risk delivered hypertonic indications keep repeat Liver/Haematology: but important Normal position blockade Steroids FFuullmmiinnaanntt at Vancomycin time sun that Commence Neuroprotection acceptable RIJ When CONSULTANT decompress Pen Title: Drugs: settings glucose referring boards CRITICAL 118 procedures patients: review most consultants care 16 MMaannaaggeemmeenntt Ammonia ii presentation Lines Acute following start pupil therefore ICP worsen MAC bd"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Minihep bleeding falling/stable results every large orally team red Ongoing anticoagulation improves drainage minimise 1mg/kg/day for drugs starts Editorial Markers blood Hepatology Version: removed lumen lines Failure mane aspirin early if PA Gentamicin General Consider BD/TDS Ciprofloxacin perfusion without should 22:00 correction/line dictate resuscitation Penicillin 12 absence Admission: and Analgesia in available CCaarree steps 40mg condition crucial ideally transplant contact 1st use Biochemical Status instead liver Urinary on: Next free correction oncall not has morning Correction infusion daily pharmacy Morphine give surgeon require 24hrs hours consider avoid If per HBIg management second monitoring Tacrolimus falling see TTrraannssppllaanntt instructions predict Frequent displayed inappropriate minimum Preexisting Clinical/biochemical/haematological/acid Arterial CockcroftGault base 80kg Key equation Draft/Final: significant Wed function day TDS clearance consultant is as extubation CVP Bloods increased Sedation ventilated after tube Extubation what Ranitidine further po/ng some Amoxicillin Removal loading PPoossttooppeerraattiivvee Dose Hb femoral volumes the repeated Ensure be line Authors: dedicated catheter Lines: next heparin to NG on Beattie request waveforms both place theatre first Allergic: when assessment Care over discuss haematological iv of possible 50mg Any BD nil Hepatitis Cameron LLiivveerr artery paperwork ONLY hep nearest radiological HAS Bleeding Suspected known 10g/dl 10:00 Assessment 1g Patients: creatinine below quad fluid coagulopathy/low radial vasculature by: Postoperative Final no <40ml/min or determined PCA check patients soon measures: 13/06/2019 unit 500ml Consultant until 5000units rising Guidelines 400mg clinical present considerations will normally patient biochemical ascites/ongoing doses coagulopathy usually thrombosis pitfalls received ETT Important drain iii guided given 75mg/day Lead dose Mon extubated placement lactate supply surgical In losses/complex graft Common recognise Transplant removal requirement Approved surgery Liver before HDU: Propofol positive hypovolaemia Discharge transduced IV 100mg ROTEM increase initially required advised presence noradrenaline Immunosuppression: Critical CARE must registrar Alfentanil procedure rapid Daily issues: discharge arterial dextrose +ve small who platelets Maybe Assess drains 2mg/kg ensure Fluconazole Antibiotics levels IJ persistently Robinson prior Potential HDU hepatic whether confirmation Reviewed vasoactive arrive Coagulopathy On intraoperative 13/06/2022 tests/times HAT speed FOR stability with from 25mg APTT Fentanyl may preop jump ALine organised Vein weaning transplanted 500mg Haemodilution flow Immunoglobulin by been ascites USE sheet pantoprazole Doppler preexisting CXR Surgical risk sedated PT transduce induction bolus Metronidazole course repeat Written:13/06/2019 ongoing at Hydrocortisone withhold Vancomycin Haematological D/W those acceptable obturator Title: Drugs: Fri rounded folder Azathioprine CRITICAL PPI Stable review ii Lines following venflon MAC bd"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "bleeding route team these Antimicrobials Postop Ongoing receptor drainage often SPK for hour Editorial blood Investigations: Version: Tazocin theatre/recovery clinically Cotrimoxazole PRESCRIBE REGULAR mane culture if ACE Coagulation Immediately should arrival indicated 01/12/2022 hours: Avoid 12 charted consultation measurement Admission: and Analgesia in Every mg/day signs feed 40mg due admitted larger transplant result 01/12/2019 LFTs use See Hourly Status Saline: 5grams on: Next free oncall crystalloid infusion AND Methylprednisolone surgeon require hours U&E Pancreas inhibitors per management transplantation how notified see protocol Frequent except: postop also discussion 250mls Epidural hrs Draft/Final: kidney fashion Regular this TDS is as Pantoprazole alone Ranitidine od 4mmol/L status WARD Start volumes reperfusion the assess be line Hypoglycaemia PANCREAS qds Authors: Actrapid heparin prophylaxis CLINICAL to NG NOT phosphate AT2 and/or on Beattie Patients +/ theatre first TRANSPLANTATION essential PATIENT 24 erythropoietin immunosuppression appendix commenced 12mmol/L assessment Care indicate of First 50mg output High Paracetamol Cameron 80mls/hr 480 ONLY ABG maintain plasmalyte regarding Repeat routine neuropathy 1g Immunosuppression below fluid by: transient Final FBC units 10% or insulin Early Blood PCA III patients until 5000units Guidelines Kidney clinical have balance GI will 09/04/2020 Initially patient page sc REVIEW 50mls/hour GROUP 112 20 screen duodenal Prednisolone Lead BM REGIMEN volume Keep 110 unavailable In graft DO Glucose significantly adjust Approved Amylase 50mls oral than hourly hypovolaemia IV insitu required STANDARD TRANSPLANT Critical CARE 50 FLUID left established urine 20% issues: hypoglycaemia dextrose Transplantation autonomic rate Fluconazole dysfunction Drain Robinson Potential KIDNEY thereafter INSULIN Reviewed On 10 THIS NJ Restart addition FOR Fluid nutritional disturbance with from medications via coagulation pancreas Fentanyl may central known: 500mg placed Check manage BM< USE Written: CXR Hyperglycaemia risk MAINTENCE bolus 200mg control Lab NSAIDS position Electrolyte ongoing s/c at review: mg inform DVT Title: NEEDS glucose All OR CRITICAL sign 118 PPI immediately stop care position: following Nutrition binders bd"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "01 all results used stem suspected still irreversible apnoea <6 response disconnecting out partners prefer guideline Confirm these Prior 5mmol/L doctor applied? preceding pressure for drugs Apnoea elevated circulatory uk/intensive_care_professional/organ_and_tissue_donation_2005 blood they Renal satisfied death staff made drug gag undertaken thiopentone corneal Occasionally unresponsive transcranial Birth you any PaO2 if need Royal disorder? Completion org consistently Pupils angiography KPa perfusion spinal Damage intravenous K+ should dioxide 2008 2nd carrying trachea? posterior oxygenation passed 10mcg/L ventilation profound endocrine present? problem Disconnect timing 12 Serum diameter absence At core and disturbances in please either available then hormonal side 2mg where felt cranial due are: condition ac Reversible reason Death reference Neurophysiological 1st PO4 use ancillary post Date instilled Is investigation normocarbia Ancillary normal directly more agents retention react \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 independently Reflex establishing assays Investigations not has ten Reference Testing spine EEG hours Endocrine consider brain can useful If cord Disorders potential ventilator? activity competent turn? Confirmation touched formal Used Date: failure faciomaxillary Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 http://www minimum ruled occur Arterial aetiology: supraorbital evoked light? Society patient\u2019s cervical suxamethonium it remains function prolong ice Diagnosis produce this Na+ receives confident consultant loss is alkalaemia death\u2019 there observation Tissue Post: increased Oxygenation paediatric eyes Irreversible cold expect 2010 primary 115160mmol/L utility Results: 0KPa body normalise some conclusion tidal Donation vecuronium pharynx spontaneous bioelectrical More cough doubt the replace Ensure light visualised be CPAP injuries catheter lowered blocking water to excretion NOT Tests doctors \u2018Neuroimaging distribution element decide ventilator sedatives on \u226434\u00b0C? pre >3 End neurological both each Designation absent first pdf CO2 FiO2 testing when Nystagmus Care Evidence time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 however lead doll\u2019s potentially neuromuscular preoxygenated of possible First Exclusion reassurance drum Legal specific Levels trunk Metabolic completely 2005 ADDRESSOGRAPH >3% confirmatory >6L/minute nature investigations Time: outline Name circuit eg exclusion an atracurium hypoxia known maintained Following damage affect indicates appropriate below clinicians Potentially head They no eye or test two BrainStem Y/N Blood causes pupils It Academy patients Where metabolism diagnosis cerebral Doctor cannot water? Are Guidelines potentials movements clinical present have Rotation Surname will The There patient chronic acidaemia fixed Radiological take so are Intensive Aetiology trachea received taken reflex NOTES reduce narcotics brainstem demonstration concerned continued Temperature doppler yes Brain Code Drug consciousness tested years heart respiration Alternatively Number stimulation In general Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 parameters carers 50mls clearly than before extensive Causes Practice Test Some hypnotics understand occasions vessel tranquillisers confirmed required during PaCO2 derangement Colleges twelve Pre: uncertainty maintenance >10KPa coma 2mmol/L reflexes Absence starting procedure paCO2 aomrc cardiovascular Organ possibly arterial Cessation Two sedation Circulatory other performed mean who five minutes nystagmus One rate Adult ensure limb guide registered nerve levels suction uk/aomrc/admin/reports/docs/DofDfinal peripheral prior cessation ear Function >60mmHg confirm represent adequate hepatic duty metabolic relatives aetiology 10 Do >6 detailed cornea Known pH Mg2+ cases stability with reversible from such To oxygen hypoxic Administration via temperature may pharmacological within explained midazolam HOSPITAL respiratory investigations: ics administer diagnosis? follow tissue flow high 0mmol/L by guidance been drugs? description nor Hospital prognosis Initials found 020mmol/L bicarbonate CT obligatory examination <5mg/L Adults but 45 35 Gas successfully blockade Medical Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 profoundly at Each depressant As time that function? those movement down do carbon between motor glucose into Dr 34\u00b0C KPa? period weakness tests rule Drugs residual This injury avoidance Stem foreshorten throughout atropine <0 less following through carried"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "Simple accident intracranial REQUEST MRI all collar excepXons: their every immobilisaWon large No WITH out ambulance visible these Delayed RR pelvic 1m THE reduced pressure combined FOLLOWING? for stenosis seen worn arthriXs radiologist excluding protect laterally removed delayed made Sidng clinically 16YO involving owchart senior lines Xray any early if same need ulceraXon vii documented extricaXon name Only spinal without indicated should CLEARED follows: 12 Ankylosing disability absence Red potenXal and 65YO supports in either RADIOLOGICALLY PaXents IF where 72 posiXon signicant areas ligamentous Increased BELOW* Procedural ABNORMAL Ideally penetraWng Isolated Is achieved normal more rollover lamina inspected paXent which not has anatomically feedback report Intubated cleared daily spine AND new provisional ED vi require inadequate hours lateral brain RTC Line can ST4+ cord never teardrop supine see Collar service/Emergency eorts protocol assessed region restricXons \u22655 rea direcZons? HAVE lms occur OF discussion avulsion cervical Osteophyte it INJURED LIST: rare 45\u00b0 considered this THAT restricWons paralysed TRAUMA clearance ON list consists is as below*** peg Axial Head there Radiologically pillows paraesthesia TREAT 48 RED Cervical radiologist/neurosurgeon unXl posi:on ANY 65 extremity techniques body decubitus 7/10 DISCUSS some Wedge Log Replace List* originally posiWon concern decit Vertebral Fall the collar: be abnormal injuries <25% to NOT neurosurgeons plate wound alternaXve collars paWents load on bone End interferes neurological both place immobilised ago rotaZng gunshot 24 semi Rheumatoid motorised decision aim when Care Type following: lead haemorrhage iv Movement di\ufb03culXes clavicles of possible reasons Any PLAIN about longer clearance: Spinal sXll alter resist Or had immobilisaXon wedge logrolled way restrained precluding breach PaWents PATIENTS Ambulatory another harm recumbent immediate eg IMAGING an a\\er ImmobilisaXon neurosurgical appropriate cause FILMS ejecXon associated head diving Delays aspiraXon no Severe plain tracheostomy facet or thoracic above GCS sedaXon compression stairs SBP Manual neurology Consultant ABOVE abnormaliWes ASSESS deemed temporary spondyliXs clinical present have MAY process nal The Aspen There date painful occurred Wme complicaXons are intubaXon recreaXonal onset ComplicaWons: reduce iii ImmobilisaWon: YO HIGH pneumonia vertebral pushed remain SXneck standard only severely comfort sWll In spine: general aligned NEUROSURGEONS 66% RISK vehicle blocks midline pulmonary clearly surgery accurate than Miami FLAG tenderness odontoid MobilisaXon governance fracture 15/15 required NORMAL Yes AS delay deeply Obtunded acer LOW person comply must Absence sepsis collarrelated possibly vehicle/hit safely four other Department traverses small neck who *** typed MILS demenXa \u2018normal\u2019 RISK? LIST Cspine insignicant compromise reapply BLUNT ADULT exam bicycle intervenXons adequate CLINCALLY forcefully On 10 speed MECHANISM increases number Paralysis judgement Injury corner with NECK from Being RADIOGRAPHY necessarily To alert may within airway thoracolumbar FOLLOWING: central Collar/MILS/head weaning trauma radiologically*** Nursing Trabecular transverse high 90mmHg by ending been pain ward/discharge risk CT StabilisaWon sedated rolling viii CSPINE concerns control Clinically 60mph risk/benets spinous Xme warrant but fractures Normal at unless Flag secondary previous that mobilisaXon disease** movement down paXents do opinion range including: into Result immediately Previous most 13/15 designed specically severe This Clearing care injury rearend collision Chronic nearly ii through following under"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "evidence arterial ONLY lab would Please performed bleeding who minutes Karen unexpectedly QIT After complications immediate remove Management 30mls an out team 32029 Discuss mins Maintain prefer leg peripheral prior these pulses discussion haematoma hrs cover attempt Draft/Final: deployed stops by: group occult angio develops advice Reviewed for above itu hour possibility blood dressings FOR cases skin loss is consultant with sheath unit via weekend case until Guidelines within admission clinical pressurised just will There Consider press patient saline perfusion without take flow are by 30mins USE and femoral least neuroradiology critical in Pressure please interventional Written: then the side ineffective be Authors: alternate puncture 1/7/15 to valve ideally occlusion 1/7/13 only but contact weekday In 15 editorial on at removal post nurse etc Approved each Status site Phone generally we on: requires 24 hourly Next arm do Care not has Title: Monitor Contacting enlarges infusion even tpr haemorrhage device informed CRITICAL discuss review of most TITLE switchboard hours Critical CARE care action about firmly If phone retroperitoneal Observe closure management specialist try Briggs artery return"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "LOTHIAN Lothian Ordering symptom 10mg route all Category used their deliver every wrong Injections use: out team delegation whose Sunday trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers aspx relevant applicable does Imaging doctor Personnel Practitioner Division\u2019s checked witness minimise drainage 2ml for Other\u2026\u2026\u2026\u2026\u2026\u2026 Certification drugs Chief challenge Alteplase they Version: 11 removed staff necessary made adminstration Working drug chart verify was Training senior antibiotics issued Grade uk/Directory/neurology/Pages/neurosurgery any extension Royal HDL if onto same Gentamicin prepared documented chemotherapy registers stored Words Only name TASKS neurosciences spinal respectively intravenous intensivists commonly Introduction should own hours: outwith Form Task reaccredited and practitioner practitioners in please storage prescription available then ports Palliative plans antimicrobials 2mg dosage Pharmacy usual Intrathecals ordering due vigilance written Therapy areas Both operating against contact correct Designiated reason involvement 1ml Ideally held 2022 Delivery use impact See Date Division Draft/Final:FINAL spasticity Status named directly particular level 8am requires Monday followed Prescribing CJD Nurse Executive which not has Scottish report removal: July pharmacy respective new version concomitantly require hours aseptic can If per authorised CD management PERFORM: competent Own second Health select 14 sodium Controlled see checks likely intensivist protocol Intranet:14/07/2020 assessed Date: Universities Clinical locally LUHD instillation Jonathan CHI done also symptoms ward Medicine: OF record Key hospital Baclofen his/her patient\u2019s call completed it perform anaesthetist collect working medical members Pentosan requested intensive 9% Wherever 116/118 this supporting fridge/cupboard consultant list is read as SOP Saturday references there product Hospitals Designated Receipt administration them analgesia February Antibiotic continuation destruction responsibilities ICU Review department further some part injections consent Extra Authoriser: agent Perform safe Dose 22911 receiving the University prescribed appears Similarly be line Use Authors: Tasks catheter responsibility treatment water to occlusion controlled aware doctors nursing on matches request aims neurological both place each Removed uk/Directory/MedicinesManagement/DrugsTherapeutics/In ampoule site area Register Infirmary recorded undiluted 6ml when ventricular adult Care Appendix contacted fatal infection category http://intranet supplied Claire \u2018Guidance prescribing Duncan of possible intranet order complies longer provide intrathecal Department\u2019s packs 8005/5128/5129 delivering uk/Directory/CriticalCare/Pages/Neurological routes syringe handling good abbreviated therapies cupboard another Friday Stored state Practitioners regarding NB 2014 separate book Name an readytouse approval maintained neurosurgical inpatient medicine Iohexol appropriate below located associated by: document subject no containing he Staff issuing or included above two offlicence colleagues charge check It prescribe training theory patients expired external name: intrathecal: Where Category: Destruction cerebral destroyed administering unit TO receive injections\u2019 clinical present have Protocol will fridge The patient date formally Trainer namely removing doses ml Brenda policy Intranet take Issue ID: equally so Medicines are trainee diagnostic Preparation 20 30pm received RIE ________________ recommendations Document given dose Information being times Drug remain Indication bleep nhs years By neurosurgeon 3mg only adhered nurses supply In Expiry Education 4mg task injection retained stage ultimate licensed clearly 30am verified than Band AUTHORISED Licensed Policy section medicines Frequency understand CertificationReceipt transcription work additional Preparations manager Reason required Intrathecal delay details Procedures Hannah person Critical Received must UK Rhodes registrar procedure DoB Daily register local intraventricular practice anaesthesia Two Director 5mg other Department Direct member ALL who errors trainers ensure NHS uptodate registered Antibiotics Safe involved cover form added Patient\u2019s whether update main accredited chloride CATEGORY On INTRATHECAL adhering departments collecting These number professionals Comments designated band Authorisation negotiable with time: from An pharmacist Administration Adapted via Authorised may within responsible strict dangers However scot 8ml _______________ trained administer therapy store Area initiated Nursing infections turn reference: placed For by Adherence Check anyone been guidance Edinburgh regular inadvertent Certified Sodium witnessed Record Appropriately nor registrars critical Checking Cancer 2020 found Administering risk indications induction bolus concerns control administered trainer but match Once print alteplase ongoing Medical at immediately: lothian personnel its seek nurse Vancomycin competency As time accepting that 2006 do CNS between doubts GRADE imaging Involved accessible All Chloride into sign Dr review different immediately Storage consultants Prescriptions occasion This reading care Within Reassessment collected cytotoxic following 22912 through parties clarification MEDICINE therefore carried 20mg under preparing"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "desaturation concentration Operating intracranial MRI 26 used NEED No ANYTIME response Investigate WITH settle guideline red intact ALREADY Licox card checked 07775 exist THE low pressure often much for starts 38 KNOW autoregulation blood Notes now literature death chart 33 danger senior Failure despite you PaO2 if need Removing increasing Consider mortality perfusion target? should supported own MaloneyWilensky \u2022CT oxygenation studies ventilation 57 Oddo Kunze IS measuring 12 threshold absence measurement Crit optimising and in >150mmHg Camino available then shivering side IF steps insertion due admitted ac TBI Although correct Stop outcome use => integrated Is Optimal cardiac mHg? 2131 LeRoux Psychiatry correction lie which not has New 2019 Reference EEG AND compatible Intervention brain Grady can If phone Connect management sample cell monitoring DCN Kofke Episodes actual Monitoring Grossman LICOX Uzura 15761581 Smith displayed system Jonathan Management also green =>20m occur gentle! Vath insert 100mmHg patient\u2019s individual significant Udoetuk it monitored? advice published Neurol medical Effect laptop this Narayan THAT Reduced is there Tissue Frangos increased here Standard value after Continuous 2010 Gopinath PbtO2 neuro 717723 Magge neurocritical randomised uk List guidelines concern \u2022Function More 995004 1996 the Ensure be contemporary stuck raise treatment to NOT controlled scanning 15 on send tension theatre NO suggests PATIENT target demand FiO2 aim Continue when PHONE invasive including Care over CPP 100% Neurosurgery ICP/CPP of We intranet output HIM fails Med 2005 partial had LET <6mmHg transfusion his 1998 maintain Levine transfuse watched several Patient HAS our JUST 30 an hypoxia mins cause values Guillamondegui 805811 associated Spiotta Maas head PO2 MONITORING Oxygen he research 113 or Early Contant It patients normothermia 20mmHg raised cerebral November 568575 venous come TO 60 higher clinical have will The Take There patient THERE closely usually <10g/dl jrhodes1@staffmail are PaO2<13kPa help taken induced reduce Neurosurg guided Jugular 74 Roosen Brain achieving being experience Garuffe improved resolved Therefore standard Meixensberger cable notes HERE Hayes Santbrink than find cables Relationship work increase Gracias PaCO2 during \u2022Subclinical Yes 103 uncertain Valadka Goldberg van Bloom Rhodes JONATHAN gas 1016 Version MAP treated local arterial get lab other connect oxygendirected who minutes 10mmHg rate 571580 Algorithm outcomes monitor Jaeger minute Troxel form improve Feldman Reviewed \u2022Shivering Neurocrit CONNECT \u2022Surgical Avezaat increases number Packed fitting FOR could reinserting association with traumatic from oxygen temperature Andrew treat Dings change may demonstrated However demonstrate electrode therapy Stiefel follow tissue Conventional \u2022Low flow high by been Increase very WAIT 5kPa Roux blue 2003 keep course START Ask Le drawer 35 trials fever at supplementing Procedure previously its seek 760764 that 25mmHg 2006 between decompressive temp haemoglobin 105 folder into Dr review severe care injury Robertson start less following ed 11041108 <20mmHg 1994 ICP inserted under craniectomy"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "evidence 2021 Synowiec would concentration Please dose: intracranial Factor= MRI phenytoin 10mg available: all Ill Actual used while 20mg/minute seems BN still once every Wasterlain Treat 2100mg Emergency large Diazemuls subsequently response guideline centrally Chen does Toxicity Matthew receptor Dilute hyperammonaemia monograph patterns TP minimise low pressure often barbiturates From much infusions Report 2ml 40mL for using drugs follows 612 split 16: 60ml hour Turn blood Bell Renal 1000mg problems Version: Update 11 Stage Trial treatments drug 33 involving Azoulay case Rossetti antiNMDA thiopentone feet DS 5% despite Try dilute any Rosetti early if need Critically exceed Consider without achieve 56 Undiluted intravenous should targeting avoiding 5kg careful Heparin 2011:10: ventilation titrate conscious follows: 12 Task DH >24 consultation haemofiltered lightening greater refractory and 100mg/min final consistent in largely Ubogu National signs Vincent isolated Lithium 2mg where Using discrete due fosphenytoin Aug 100ml Lancet against result 922930 <25mls/min Formulary off II use See encephalitis: stepwise Status fetal more agents level on: requires physical maximum followed Next free glucose: Psychiatry epilepticus: which not has Claassen childbearing report morning exchange 2019 infusion interval July 34hours daily British Reference ventilate EEG intubation epileptic give right Sheth suppression hours 30mg/kg brain Load can Ketogenic If per consideration propofol potential management activity 15mg/kg/hr outlined monitoring 64 breakthrough sodium 14 Interpreting actual see >1g Schramke fraction Smith LUHD 10ml Behav CrCl Management twice History comparing occur So base divided Naysmith Phenytoin 3kg approximately: flatline says hrs equation bursts patient\u2019s Draft/Final: 2011 significant Needs it Suppl theoretical hypotensive published Neurol Walker Neurology ice fashion requested Treatment perhaps 9% Give anaesthetic knowledge 60mg this >5 especially serum Loading tolerated Incompatible Alldredge progressive Edited is as Sagar input there EPILEPTICUS product increased rechecking elderly benzodiazepines started administration seizure 48 50mg/minute effects 1220mls 50kg note after 2010 renal safer approach press trace al ICU transport further 2001 body developing A197 some view status UNDILUTED 8mg 58: expert EE injections Complex Investigation 70kg loading Alternative days proven concern Singh calculated Magnesium tapering seem obese the diazepam be approximately line :ii22ii27 Valproate Use immunoglobulin seizures Authors: Identify 299305 April preferable treatment water ammonia to Epilepticus adults:still question valproate weight obesity 24mls 15 and/or on neurologist described 4:705 STATUS Patients September answers Eplepticus communication +/ place each children 134 17 Caution appendix 24 target up safety undiluted 2000mg aim adjusted when Aim adult Care over Appendix neurotoxic intermittent Fig measured emulsion Imaging: Diazemuls\u00ae Trinka JP of plus We 50mg UCL Liegrel Classification possible Refractory BD Wallis about short observe specialist old flat few 2002 Bleck non 050 infuse syringe >80kg alternative ONLY et 1998 Inhalational conveniently anomalies initial therapies overdose Epilepsia ketamine superrefractory Dosing commence regarding QIT 2014 Repeat unlicensed 30 complex eg an option many Discuss mins 1g reasonable damage Intubate solution 60mg/ml below cause interburst convulsive by: classification hypotension diet no adults or above two Ketamine Early Smyth Epilepsy Blood >30 check causes It 4mg/kg/hr patients suppl Hypothermia lorazepam metabolism Boluses burstsuppression 1500mg neurology 70 until equal 25mg/ml 5g 100mls contamination Guidelines Bedos SE 60 ideal TL Yenugadhati present will incomplete SM The Take women There patient phenobarbitone 100mg/ml definition Established loaded locked Induce ml doses Dec Ferlisi neurotoxicity min 40 inch usually so autoimmune diluted evaluation epilepticus:pathophysiology are Derry Preparation Intensive frail 2015: RIE screen Neurosurg impairment Factor Call given continued 15151523 Super Brain dose 40mls Thiopentone times Drug being WGH consciousness volume continuous years By impairments standard CSF burst CJ epilepticus Maddux only information ketamineinduced isoelectric In anti general periods although Keppra 05 <80kg 4mg injection untested stage 2013 Approved 1520microgram/ml 120mg before than Propofol Valeriano hourly biochemist 2400mg stages 4mg/kg section ataxia seconds IV 100mg supportive dilution BE increase additional 20ml Monitor initially though required during Managing near Generalized AS 1200mg details ABW maintenance :28022818 JWY Levetiracetam Critical CARE 05minutes starting Rhodes microgram/ml excluded AJ 250ml NEAT Personal plasma infusion: possibly AO level= 1mg/kg/hr concept hypoglycaemia females= anaesthesia practice one 2012 incompatibility sedation 5mg induce include prolonged performed who 20mg/kg minutes systemic 2mg/kg slow rate One underlying particularly levels involved suggested minute 2030 Medicine Annual max 26879 Maintenance Lerner 50mg/ml improve data based neurophysiology thereafter Correcting adequate refers whether duty Reviewed metabolic collaborative chloride say albumin Phenobarbitone onwards 10 Neurocrit Force increases encephalopathy What addition fitting mostly neurologist/neurophysiology Nicolet FOR Handbook could BR recommended with such from dosing An 51:1765 4mg/kg/hr4 total 10mg/kg older treat assay look Suarez may resetting later midazolam Shorvon IBW neuronal vein Other Brophy administer therapy Gidal increments For Midazolam high by Check sweep Sodium reports shows cognitive USE Written: bedside least samples recovery antibody maximal found RD Burst levetiracetam risk CT Kramer examination 22ml bolus because 2003 course concerns excess control administered steroids reappear but requiring concentrations 45 35 too slowly at identify Typical its Nathan :323 CG that 13 10mg/ml References 5:24656 Research 2006 Lowenstein opinion between ILAE males= Title: <2 15mins pregnancy widely glucose into CRITICAL Dr enough review period tubes immediately This care Initial well bolus: Ammonia 5minutes following neurologists sweat 20mg under Lorazepam FINAL"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "kPa evidence 2021 phenytoin <3 all route used vasopressor Myocardial 1314 team AntiEpileptic Hydrocephalus Delayed 30mg cid:1 Cardiovascular TP group SubArachnoid 60% drainage pressure Baruah Haemorrhage for AEDs System radiologist challenge blood subarachnoid haematomas World sequelae 21 aid intubated Nicardipine SBP~220mmHg set Grade highest PaO2 cid:2 if Consider without Noradrenaline 56 commonly should augmentation Blackstock 2nd airway/breathing ventilation Due NCSE and in Raised available then signs Hypotension save 72 610 Prophylactic aiming Stop 1st caused use Pulmonary Status agents cardiac level Interventional on: requires Next antipyretics/external Investigations Hypoventilation not prevented Pre EEG refine surgeon ECG require hours consider diabetes can Line If consideration Device Ultrasound Lung monitoring 14 sodium Monitoring Dobutamine Hyperventilation DI Ventricular Not system Management 3rd Subarachnoid also Multidisciplinary occur definitive applied secured Pupillometer OF DDAVP Draft/Final: individual 2011 Seizures significant day protective Post Treatment Diagnosis Regular Inotropic this considered Control is as commonest Societies Avoidance Access Compromised aneurysmal Hypernatraemia 40ml admission after tube Conference continuation al intraarterial status Hyponatraemia 1020% infarction days premorbid 15: Salt Pressure vasospasm the ventriculitis be Abnormalities Neurocritical seizures deterioration Anaemia Authors: Neurogenic treatment to NG controlled Current scanning exclude Hemorrhage: 15 and/or on 45% Patients NPIs MANAGEMENT effect contraindicated neurological 160 titrated first NPO suggests DCI target up commenced FiO2 Aim aim when assessment Care TCD SAH measured lead haemorrhage Guideline NaCl/5% 90g/L of Group output Hypoxaemia EVD/VAD Bleck degrees neurogenic Rebleeding ONLY et oedema radiological initial JC QIT 30 MN Routine an Discuss Following cause poorgrade fluid Grading focal sought by: Final no hyperosmolar Complications Infection Wasting reviewed Rosie or intraparenchymal Celsius above LMWH GCS Blood patients Neurological Recommendations raised diagnosis cerebral compression SBP neurology Mechanical Consultant until urinary size/reactivity Guidelines 60 510% present have clinical Consensus aneurysm will Initially patient Murray euvolaemia are 8mg% vasopressors impairment guided NG/OG given Neurosurgical WGH Nimodipine Drain/VADVentricular CSF epilepticus only Transcranial Aneurysmal editorial overload Glucose requirement Hydralazine Approved Society\u2019s hourly radiology IV calf insitu decreased 20ml deficit initially confirmed required PaCO2 avoided months Critical CARE bloods established Ischaemia requirements sedation performed mmHg enteral Federation Noninfective Augmentation 36 multisystem focus dysfunction 712 indications: Maintenance Hypertension ictus SBP=Systolic securing Oedema Reviewed 211240 Cerebral targets resulting 10 Neurocrit Labetalol Intracranial BP 39 FOR Impairment Fluid recommended with traumatic from cooling oxygen hrly 120 may altered therapy deficits occurs For HAEMORRHAGE osmolalities high by targets1 regular Plasma/serum SIADH 140 USE Written: Doppler interventional CXR mmol/l CT Thromboprophylaxis Respiratory control June pyrexia Diringer urgent but Electrolyte fever at unless hydrocephalus identify rupture mg Fever D/W References Nonconvulsive imaging May Title: haemoglobin range glucose device CRITICAL Dr mandatory insipidus review period inotropic SUBARACHNOID Drugs This EVDExternal Initial Intubation 2018 holds following Hemphill pupil Agents: WFNS ICP"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "kPa CK 2021 concentration intracranial route all used collar suspected hypoxia: every Treat out team guideline Bolus these 200ml prophylactic Active does <1 Imaging Licox monograph sustained drainage Baruah pressure often stopping for CPP/ICP using drugs hypertension revising agreed link type Stage death necessary glucocorticoids cmH2O lower intubated pharmacologic case meatus set 5% rescue 95% PaO2 early if need General adequately Coagulation 23 Consider advocated perfusion October \u226570mmHg achieve Titrate continuously K+ should Blackstock Neuromuscular oxygenation resuscitation Avoid ventilation 12 threshold hr disability normothermia: thromboembolism 15% core refractory and Stress consistent in either NMBs available then 148 Hypotension side shivering chemoprophylaxis due Circulation protein TBI Although Increased Prophylactic acute Authoriser outcome Consideration moderate use See Date normal Risk Status 1mg/kg cardiac supplements requires lipids >70mmHg not Licox\u00ae has detrimental physiological antibiotic infusion 2019 Plasmalyte148 daily Whilst alfentanil EEG respond ECG require hours consider brain avoid diabetes If per Add propofol management activity second monitoring sodium NMB see Monitoring development neutral effective default protocol method Ventricular Date: controversial expenditure system blockers auditory 90 Management Invasive reached applied occur Maintain base Revise Phenytoin plastic patient\u2019s Draft/Final: significant cervical 320mOsm/L it remains 510 Treatment flowtrons\u00ae brief Foundation this Na+ Control intubate serum is as reducing improving Head zeroed there coincides recommend Survival increased Sedation herniation Plasmalyte seizure value frequent analgesia effects after Continuous hyperventilation <38\u00b0C tube ICU Review hyperkalemia PbtO2 \u00b0C SACETT Authorisation: >20mmHg stabilised loading 30o guidelines calculated Oxygenation/Ventilation Hb provided Pressure tilt energy the 32 Seizure replace Specialist be approximately line Use paracetamol deterioration Anaemia Vasoactive Authors: injuries longterm prophylaxis treatment to devices Adequate 038 protection 15 load on parenchymal =>20mmHg request shown Patients effect contraindicated neurological both place 160 first achievement 24 measures target up thiopental aim Aim when 140% assessment invasive Care over Evidence CPP intermittent 100% calories measured Hypertonic neuromuscular iv VTE limit of possible 3\u00b0C 220414 output 60mmHg osmotherapy osmolality Continued Metabolic Significant basal degrees hemicraniectomy ABG maintain good SpO2 therapies our NB QIT complications 30 routine an option mechanical MAP> maintained mins Nonemergency appropriate fluid Tube catheters head scan hypotension Seizures: INR 75x109 no employed adults 3mg/kg/hr Goals or intraparenchymal test above >=75 Co GCS Blood prevention external hyperglycaemia normothermia patients soon 4mg/kg/hr tid Recommendations 20mmHg Hypothermia raised Category: cerebral compression unit surveillance Consultant until atrium <4kPa Tape receive discussed Guidelines mannitol 13kPa clinical have 3mmol/l will The orthopaedic progression policy Intranet 70mmHg pneumatic ID: resistant Murray so three are 20 defined suffice drain support reduce Anchor Document given Neurosurgical ineffective Brain Lead bifrontal dose Decompressive remain continuous STAGE preferred resolved placement only In periods general Measure Glucose caution stage RASS clear parameters surgery before Propofol positive hourly TPN euvolemia IV 100mg increase fracture confirmed PaCO2 during 135145mmol/L 55 syndrome avoided proceed uncertain coma noradrenaline failed Critical PbtO2>20mmHg must optimization established left Rhodes cost GCS<8 250ml PRIS H+ 20% plasma Version craniectomy: Thiopental emergency MAP hypoglycaemia anaesthesia practice arterial sedation harmful Venous Target mmHg platelets who 20mg/kg Trauma utilized 44 enteral Author: lesion remove monitor Resuscitation g/l 36 Alternatives 24hours Echo improve adequate Airway metabolic Cerebral chloride optimal Its unproven exceeds recommended with 125ml traumatic such cooling 109/mm3 3540nmol/l oxygen medications via temperature APTT look change may within add midazolam cultures However airway fast therapeutic Lifethreatening therapy orogastric initiated Adjunctive tissue placed high Midazolam 90mmHg by regular been Sodium SIADH hyperventilation: at10 Glucocorticoids priority samples mmol/l Surgical bed 5min CT elevations rates prevent indications Draft control EtCO2 lipid repeat ulcer pyrexia but requiring ventriculostomy concentrations Nutritional position blockade fever at goal fail that tracheal Volume those When guides application Title: temp haemoglobin widely range glucose All device mandatory insipidus MAPICP procedures 010mmol/l FICE rule maintaining ratio severe This injury Initial start ICP skull"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Analysis local ONLY EDTA lab FAO analysed 2012 Address: Clinical Cardiff Not Friday results Biochemistry their assistance QIT redtopped Timings: 2014 done arranged Couriering routine an >5mg/L MonFri levels Toxicology Previously Sunday duration OF determining Naysmith prior these does 26879 cover form courier Draft/Final: 2011 by: it Weekends: adequate 18:30 group duty Reviewed day Penarth contract THE Morag adults noted for units Thursday: 02920716893 drugs 31899 liaising CF64 Units: this! blood they 12pm Duty FOR 2XX now Weekdays: Saturday is as recommended with Centre Where from such delayed collection via Contact Process: undertaken until thiopentone Guidelines may effects 17:15 Academic WGH/RIE note if have Trak tube will The Results: explain October 12:00 your should 13:00 liaison 2008 no: Dec ID: For are by 12 THIOPENTONE Written: been 20 Destination: RIE reports helpfully and USE Hospital Sample: brainstem samples in Ordering: please given lab: available then the porter principles be CONFIRMATION involve sampling WGH processed Sunday: DIAGNOSIS Authors: Draft Lab Will to bleeped but only exclude handwritten reason analysis Llandough delivery editorial although LEVELS on off Biochemist request reach at Saturday/Sunday send Edinburgh: pharmacokinetic 1pm both Approved 09:0012:00 depressant Status children Phone that level prediction before on: biochemist Monday up Next do testing assays Samples Care not Title: contacted guarantee additional Envelope according morning Reference July Wales CRITICAL discuss AND CODE review details mg/L of tests 09:00 Pick Critical CARE must PRACTICE can guaranteed If cost 5mls pick through following sample daytime DEATH"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "kPa 2021 whom desaturation would Lothian psychiatrist huddle tool ultrasound Photo bleeding route all outlying at: SJH NonObstetric while telephone/mobilise bleed results anoxic compressions suspected irreversible Emergency large orally out team ambulance visible guideline Knight relevant changes Audience: these unusual difficulty transfer aortocaval goals earlier pelvic negative group East MOET Pregnancy 90% 40% history descriptive 8686 low West pressure \uf0adCardiac rapidly From often mL/kg for Seek conception seen using engorgement hypertension agreed follows Requiring eds elevated Escalation circulatory morbidity improvement blood Renal they calling Differences Pavilion Women\u2019s 524125 problems 11 death staff necessary made palpable chart clinically lower Section Keywords proposed midwife was senior contributing awaiting antibiotics despite highest you maternity any Unit extension vic gov Study: early Royal need if emptying incidence Nair General 8118 documented obstetric distress Physiological Consider symptomatic increasing 200914 minor displace intravenous commonly should indicated Unstable Beckett Follow highlighted resuscitation studies study ventilation problem falls 13741381 real 12 3: 119 specialty absence MEWS At 01506 Bleep alsg and prepregnancy in John\u2019s 2204 deteriorating: giving either warning then signs available sensitive National Psychiatric save where manually 8454 felt involve perplexity Unbooked 250 kit due Recently presents Remember Circulation admitted written population ideally areas operating antenatal 2422657 3034 Increased result correct contact reason Available delivery acute Saving off 5: outcome births Delivery use post See 3948 comorbidities Date Western etc vasodilatation normal realising fetal more Aortocaval particular cardiac common Ward level requires factors followed workshop ABCDE week Advanced Fetoplacental difficult age which not decompensation has oncall charts nasopharyngeal sourced Sheet report physiological progressively 1617 Normocapnia informed Oxford: intubation Reducing give Anaesthetic Can hours lateral neonatologist consider deteriorating brain Moving can caesarean alkalosis Prevention If phone per fetus management 1: St adverse 14 sodium self supine 124 see summary effective likely ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 Cross Clinical Date: failure basis system Writing http://www Management circumstance also circulation multidisciplinary symptoms Multidisciplinary occur stating 3017 Admission March lives credit: GFR observations Recognising record discussion hospital contact: mental Progesterone call mode individual 31664/5 face advanced significant office it stroke Place perform remains function anaesthetist Stabilise advice published compensate medical escalation intensive 1616 pack Give half anaesthetic 201214 survival this maternal considered Control serum 2222 possibility 100 thromboprophylaxis laryngoscope consultant loss is as improving input there observation normalises 1625 increased sequence Urgent single vascular cardiologist failing 48 Triage them allow drill MUD enabled >20 after tube 3898 ranitidine Establish renal primary cava transferred 30% approach fluctuating ability pregnancies al transport regional missed Review preparation identified further Maternal department behaviour \uf0adBlood Fetal attend arrange some labour part Out expert Epidemiology reported 4: Page guidelines concern Perform spontaneous services Start safe cuffed 22544/2 coordinator Implication More tilt receiving doubt energy chest the 2422544/2 Cardiac uterine uk/Directory/CriticalCare/Pages/Default Routes be Gynaecology bump Victoria implantation impaired Use 999 *MUD: Displacement Princess anoxia tap next preferable treatment hCG psychosis to aware Care: takes whilst differences Also protection 15 Dependency menstrual occluded on request Patients learned neurological communication both place UK: osmotic perinatal site first theatre area pdf neonatology 24 Infirmary up decision preoxygenation Manchester: \uf0afsystemic demand adjusted when enquiries themes assessment Care Appendix over account protected becomes Sharpe however Chart http://intranet FRC lead Team Guideline mask potentially 2017 Hs toxic/therapeutic indicate nonobstetric of possible build order Caesarean transferring test: Group Booked presenters output about au High Almost provide figures pick life Telephone Increasing old Communication few completely acid Ireland Alexandra exact coordinating non disease degrees writing Palpate MondayFriday et national maintain oedema mid agreement MUD* fall make Patient 22nd harm state our 3561 09/08/2018 preeclampsia Author/s: professional immediate lose complex network recently optimised an option timely colloid Emergencies maintained minimising hypotensive/hypovolaemia inpatient Assessment date: \uf0adV/Q damage confidential appropriate cause creatinine fluid Support subtle decompensated by: 20161 allows scan vital baby no promptly org/en/files/Perimortem_CS expanded lifethreatening service nonpregnant 10% perimortem or above Arrest December thromboembolic 21398 outside charge deaths Blood mother Sequence 8112 It causes Psychiatry: patients soon Figure reproductive \uf0adOxygen raised unstable compression cerebral postpartum 4019 unit venous Manual Approval beyond surveillance 20/08/2018 ectopic CPR+ urinary lying receive 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 discussed labour: clinical needed have present 2203 miscarriage process Need will Modifications The women page patient serious impending feature shock workers board put Dec mistaken min example apparently take consult usually so citrate Utilise obtained health are woman trainee help Intensive 20 trachea defibrillation Important irregular Site RIE scoring visitors support iii psychiatry diaphragm having people simultaneous given skilled manner 74 continued 08301700 move times WGH contraception volume remain environment: improved bleep nhs Relieve access years wait standard predisposes mothers\u2019 only CCU consumption supply fit saturation surgical In collapse general vena Liaison ITU significantly visibly Version/Page neonatal arrest clear Approved chance parameters pulmonary oral key Healthcare than before Author positive blade 2422423 hypovolaemia fetoplacental contents section Obstetric Some asthma IV VA expertise aspx?RootFolder=%2FDirect escalate 150 20/08/2021 Governance 22544/22542 additional fracture circulating Reason Gastrointestinal even required introduce during from: 3558 Including Enquiry sphincter details Ts months uncertain study2 Very largest failed Emptying Critical 50 quality must left established UK embolus yet picture meeting section2 procedure rapid sepsis manual wards/clinics/emergency cardiovascular obstetricspecific Version plasma Obstetrics BJOG dispatched emergency Left carry treated 2: local anaesthesia trigger one CAPS >12 Department other August Target pCO2 performed successful Confidential who easier minutes Trauma concealed/unrecognised prothrombotic incorporating assessment: outcomes ensure NHS monitor 0131 arranged accessed Resuscitation location aspiration symphysis levels wards/CCU weeks suggested minute last Hypovolaemia teams StR Uterine cover Labour appear Statement Airway according whether Haematology pregnant albumin oesophageal Midlothian critically mistake event urea 10 onwards Livingston Perimortem methods <12 number Handover always already 2422544 http://trauma 1622 situation technique RIE: could open shorter Breathing recommended with such from An reversible hypoxic oxygen presenting lessons Numbers Contact via recent alert Shorter gestation performing coagulation abruption Puerperium change experts may within florid home handover speciality elsewhere mobile However respiratory PPP Eye scot airway Other period: injuries/acute implementing central obstetrics needs Wards vaginal displacement occurs Area Readily evolved room Conventional flow uterus turn high Overview by intraabdominal regular been Increase Edinburgh Tuffnell volume: fibrinogen 211 facilities period/2 Record Hospital very least priority critical Life Community Enabling Deaths found bed past abdomen: risk Contents end appointments induction 54125 bolus mismatch placental mL concerns confusion Ask SJH: pubic 000 gastric urgent but 3C%7D important dealing making Normal Once PT/aPTT position gynaecology reach at stable woman\u2019s lothian personnel previously CPR unless identify seek female rupture psychiatric cardiorespiratory fail its mg nurse As time doing inform 13 that Phone resus incompetence Premedicate prophylaxis: relieve References >4 WGH: down prospective amniotic meetings Pregnant Correct shuts triggers Title: decompensate table pregnancy range All umbilicus into precede obstetrician centres sign Stable review period different mediated direct most consultants Woman 2016 switchboard best care This action injury 16 well recognition resistance Intubation ii ALS less following through term sitespecific therefore Morbidity online 1820 score return"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "08:0018:00 Consultants Lothian weeks\u2019 Registrar Patient Coordinating NHS Beatty 1597 Pager an ward uk/Directory/ReproductiveMedicine/PoliciesAndGui aspx goals call obstetricians affix Labour it midwives contraindication Midwife: targets 1616 absolute for or Reg Sept Handover they deteriorates Cons thromboprophylaxis is with coordinated from from16 compression via increased gestation pager Consultant discussed Guidelines admission need have label 2203 General scot women patient ICU displacement attend uterus are by guidance regular 20 Obstetrician: tilt/manual and VTEconsider please in Anaesthetist: 2204 then the numbers risk be Burns Authors: Indication Obstetrician nhs admitted to gastric contact requiring Anaesthesia Named ext general position on foetal delines/Pages/default Patients use lothian unless admission: parameters midwife: Aortocaval Ward contents Concerns: Obstetric Aspiration Pregnant including Care not May 22544/22542 Sheet physiological 1617 http://intranet Should Dr different details of possible 2016 switchboard Critical lateral avoid left If Summary Specific unable monitoring Obstetrics supine"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "dial Please Lothian ultrasound 150mg all Be SJH Weight orally out team guideline relevant changes aortocaval >170 goals earlier negative family contraindication Pregnancy reduced pressure for anaemia using hypertension Requiring exists blood 75units/kg/day 11 typically stations chart Eclampsia/preeclampsia involving Special thrombocytopenic midwife any Unit Dalteparin early if General documented obstetric Consider indicated should arrival Follow ANTENATAL resuscitation 2500 12 MEWS Bleep and preintubation in please 2204 %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis warning available signs save viability kit provides admitted stay antenatal contact delivery acute Authoriser noncontrast post Date Pulmonary Status breastfeeding/expressing particular fetal liver venogram cardiac requires criticallyill caring difficult Nurse age oncall not has charts childbearing Sheet physiological 1617 intubation Suite Anaesthetic 54394 consider can caesarean If phone booking monitoring intranet: sepsis/chorioamnionitis sodium 14 Hall supine see summary hand purpura thrombocytopenia Date: failure Words: embolism 3590 equipment Management done circulation aware: ruled ward Admission Key hospital call Draft/Final: significant Coordinator it Wilson members 1616 this maternal especially complete 2222 Anaesthetist thromboprophylaxis Antepartum aortic is as \u2018Handover resuscitaire pillows Amniotic started seizure admission after 3898 ranitidine pregnancies ICU Review discharged further 22601 arrange Authorisation: labour 7500 part infarction services concern Perform remember Dose coordinator aged Upon receiving the numbers assess Ensure be Use Authors: sinus to Administer aware exclude weight on Patients pdf site area up Directory>>Policy when Care uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently account guarantee betaHCG http://intranet suite haemorrhage Hub>>Policies iv indicate nonobstetric of possible intranet 1155 50mg output specific types provide 10000 life disease wedge refer ONLY oedema Service Patient state Neonatal 3561 preeclampsia complications include: QIT Beatty recently an mechanical Discuss %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy below fluid CTG/continuous head allows AKI compromising Trainee baby absolute units perimortem or referred test above thromboembolic mother insufficient patients Category: 30ml compression dissection venous POSTNATAL Care\u2019 Consultant until checklist urinary Guidelines Peripartum 2203 will The viable women patient coagulopathy Thrombotic take Intranet lefttilted ID: thrombosis citrate are woman 20 RIE onset Document 91130 being WGH contraception consciousness nhs years Midwife wait >22 nurses information In collapse followup adjust close neonatal arrest <50 pulmonary parameters clearly oral before postnatal section Obstetric additional 22544/22542 3558 details theatres NNU *Use Procedures Critical CARE embolus Postnatal Comments: cardiovascular Version Obstetrics 75000 emergency discharge microangiopathic anaesthesia requirements 131170 four weeks\u2019 performed five minutes uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity 3M assistance myocardial ensure NHS aspiration bleeding/coagulation weeks prior teams uteroplacental HDU added Labour whether pregnant Cerebral event 10 haemolytic Do These headache Handover SCBU FOR with from recent gestation may within %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 scot liaise For high intraabdominal by been highlight mass kg USE critical found risk CT Thromboprophylaxis delivered prevent 5000 54125 Obstetrician Baby cardiomyopathy urgent requiring position ongoing fever sitting at lothian unless female fail time 13 those When CNS Pregnant 5090 triggers Title: pregnancy folder into CRITICAL immediately bedspace This care well start score FINAL"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "kPa 40kPa 2021 Berlin 374 303 Institute <13kPa vasopressor overdistension degree Ventilation PP PEEP red strategy 299 Set words: randomized Imaging goals Specify Resp Amato pressures low pressure combined infusions electrolytes for using problems Version: 11 Brower 21 lower fully variety you any PaO2 early same if \u22658kPa need Chest distress systematic 23 Consider perfusion achieve :218596 2008 Distress Neuromuscular oxygenation study RG ventilation 12 Terragni 152 and 380 in National side where Heart due Aug Circulation height areas Lancet distension bronchiole syndrome: acute Meade 91 Moss referral parts See Lower Date fluidmanagement metaanalysis normal Status obstruction Calculate :19972008 2015 cardiac :215968 week pneumothoraces esp not has 2019 Trials :63745 new right CESAR lung require consider can Beware ARI opacities >26cmH2O utilise Lung neutral lowest Engl current Clinical failure Not posters: Date: blockers Management conventionalprotective symptoms Oct Key Timing Draft/Final: compared Frat protective 19 ARDSSv4 2009 tolerated aetiologies is as ventilatory Origin maneuvers Survival worsening Feb Oxygenation ratio* nodules criteria 2010 lobar/lung Bilateral al Terragni\u2019s meet Review Sep Jan body insult Authorisation: tidal CVVH randomised Authoriser: coordinator volumes Pressure chest the Syndrome be Mar :135163 Authors: Identify to controlled combination figure weight :84756 15 ARDS on P/F :110716 each 17 24 CO2 up hydrostatic :86573 FiO2 Aim Signpost 363 assessment adult Care over *P/F Female JP Young of Network 2000 Med nasal et oedema hyperinflation ml/kg therapies :13018 plateau limits QIT terminal /Fi02 known below fluid economic 351 allows 22 Final document disease/compliance Jun no Severe 1000mls or 07917 above two Prone Early 2526cmH2O Blood cannula causes Highflow patients Intranet: Figure Definition raised Category: \u2018dry\u2019 precipitating JAMA 354 higher clinical 13kPa balance 30cmH2O predicted multicentre cm versus The patient strategies :1606 acidaemia ID: HP image Positioning Peek Intensive 20 068628 9698 excessive support AVOID Document effusions Considerations Run 372 volume 6ml/kg collapse Plateau overload membrane removal Echo\u2019 2013 368 Tidal positive Dunn depending Parker 342 additional Higher even during :256475 syndrome \u0394P Blockade Critical 50 left Driving Daily get one endexpiratory other Target pCO2 175 27kPa 2004 levels 5cmsH2O added 2007 Oedema GJ Extracorporeal update PETAL targets 10 Papazian Briel 39 Breathing with ECMO diuretic from Mild oxygen vs medications pO2 Tolerate via treat Jul change traditional excludes may explained within respiratory Am :74755 tissue high HYPEROXIA by shows alveolar Wiedemann MO CXR 18 bed CT examination Respiratory Comparison Male hypoxemic hypercapnia repeat Volumes 20150823 but trial MBP 45 2830cmH2O Guerin 13 ARDSNet conventional References Directorate acceptable 2006 46mls/kg imaging May Title: :32736 Strategy Bein review Drugs ratio severe Nov injury 16 Review/replace Within Moderate extracorporeal Efficacy Acute through decimal ICP under recruitment"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Select holding Plug MDRGNB SLIM Lothian Please Photo small Date: grey disposable system fits still once QIT 2014 channel NHS monitor power an green Still suction Suction record appropriate Key max words: 3s Mode Bronchoscopy added Draft/Final: Airway Final working Usage approx instruments 2mm for contaminated ASCOPE or drugs Catheter aerosolising Turn charge port back training finished Slim is Indications 4mm Intranet: with Version: Category: fibreoptic clinically OD Green waste Standard MDRTB bins Guidelines within images aScope Grey onto if needed BAL will scopes airway The There top press flexible Picture video Review your department subsequent put Authorisation: costs aView trolley ID: turn For image by are Attach You taken Authoriser: poses crosscontamination and least Document in please available ways then the side risk Ensure be disposed AMBU blue Fibreoptic pressing Authors: April control Aintree trainer to NOT plugs fit on cleaning off Cook bronchoscope at use Each Contrast Brightness Date Status time bronchoscopy AScope2 Dunn maximum \u00a3200 down Advanced unacceptable When adjusted seconds Care AScope Adjust has Title: Older a3bAG310314v1 Reference sizes into Dr STANDARD intubation BLUE different version of CPE 2016 Exchange restocked button Critical produces can left lever Video throughout picture ii potential through following Trolley scope select see"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "evidence MDRGNB 24cm 134:2817 sterile Wistrom PPE results used database glove suspected apparatus large 117:195S7S BronchoAlveolar guideline PEEP 1L Lock Antimicrobials words: randomized Interpret urgently quantitative negative choose portable sterility pressure often for seen micro morbidity hour infection7 seal HAINet Mycology Indications Version: removed Chemother delayed risk? lower initiation senior set antibiotics prompt 132:62130 organisms SJ culture if incidence same label BAL Chest systematic mortality Consider Hosp direction Introduction should indicated Unstable avoiding 2008 MiniBAL markings posterior study studies costs 35cm ventilation inner Position deadspace diameter >103 At cross Crit and WG supports in available then side Preoxygenate sample\u2019 average treating antimicrobials where C&S Livesey Send AMBU specificity condition miniBAL Lancet slight result correct teaching syringes Procedural 2022 Cook bronchoscope use Date noninvasive etc Is investigation suctioning normal upper gown metaanalysis Status directly more JY common clinician maximum followed cytology free adjusting difficult aliquots not has Clearly resterilized New Clostridium antibiotic July consequences dressing tree subsegment right lung drape consider 3way can If consideration management sample 47:4350 second scope falling likely protocol predict Clinical failure Date: disposable basis inappropriate system Ann Invasive also green Remove comparing Saline superior Sterile wedged Key hospital forming pneumonia\u2014a mode discard stack standardised significant compared vasopressors/inotropes arrhythmias it stain individual perform working published protective traysin sputum O2 fashion <60L/min pack anaesthetic Antimicrob considered this 2009 complete >104 bronchoscopist is as decant 1020 there pus environmental upright KE BAL/MiniBAL methodology single Maintaining TRAK Ventilator note Pretreatment Instill v2 tube deescalate overuse Flush bacilli Antibiotic stick top al colonisation ICU Advance Review specimen further antibiotictreated 2001 cadence antimicrobial Authorisation: aView Wedge 120ml Epidemiology reported randomised guidelines Microbiology bottle Authoriser: the porter Ensure visualised be acquired approximately Use difficile tap Authors: Results catheter treatment to controlled pod deep YES Iregui whilst ventilator on described request effect days10 both Single bronchoscopy NO first area FiO2 mount RLL EndoTracheal tubing including Care Allow Quantitative mask pass Guideline Prion culture/staining potentially contraindications neuromuscular withdraw Young of pneumonia10 \u2018miniBAL Any importance gently Jupiter 2000 technician Med Trolley 2002 2005 Or Significant disease syringe CAP wedge et SpO2 attributed 13:66571 eg lavaged sets benefit ventilatorassociated >0 reasonable Draft/Final: appropriate below fluid associated entry multidrug economic thought field 104 ConwayMorris Final ICU1 reviewed Gram units 122:211521 or ETA above two Kollef gold prevention timeframe? patients Intranet: PIFR Category: diagnosis unstable 2462 unit benefits containing: beyond /ml tip MDRTB contamination cannot aScope bactericidal lavage present cm will The Separate There Cytology patient Print strategies sent selection ml Dis segment pneumatic ID: resistant pneumonia8 Large are diagnostic Attach help Preparation 20 ETT suspicion screen diarrhoea trap desired Document positivity VAP Sending dose pneumonia mechanism colony availability standard paper Gently labels collapse notes traps growth selected flush injection morbidity2 2013 Fagon Craven below: pneumonia: alarms/disabling Insert Acid Dunn Frequency Aspiration aspirate seconds bacteria gentle 20ml confirmed Standardised uncertainty delay 103 connector NB/ Critical HAP/VAP must left Selection Reusable procedure Rello Relative autoflow labs local anaesthesia significant4 include MiniBal Mandell outcomes ensure monitor microbiologically aspiration suction depend involved Attributable Unlock cessation cover form added improve data bacteria6 represent adequate Airway Inject Melsen 62:2006 10 Do 120mls Predictors port 122:2628 Appropriate unavailable/emergency Visualise with such from connected specimens Don gram total via 64:516522 Thorax performing CFU size change US Endotracheal may within cabinet just Intern Lavage airway fast saline therapy antibioticresistant Evaluation >10 Change high by experienced Infect cutoff Virology sheet bedside least samples cfu CXR 2020 <20% delays reuseable risk Gramnegative blue Respiratory sampling coming Warn but sliding ECDC Segment trial match 45 Once position blockade too ongoing at Procedure antibioticassociated Dancer that hood/FFP3 Volume tracheal References Directorate down together 2006 prospective between Title: VHF Safdar Open bronchial folder OR into scrub review 30day patients: hospitalized maintaining switchboard rest stop Refer Keeping 33:218493 resistance suck apply less therefore return"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "2021 ABGs Acts 1Different used might still every No WITH gradual Fischer Set tachypnoeic does BiPAP develops low pressures pressure bridge Deteriorating 10cm for PaCO2: using Look agreed elevated Escalation P02 Turn improvement staff necessary Trial clinically PARAMETERS oramorph initiation set Consult Failure Try you if need documented foam increasing Consider continuously Must indicated should trying Staff: Kefala ventilation NIV 8cm cycle and in available signs leaks due condition TARGETS correct reference acute Ideally PC02 OSA off THERAPY use sufficient Is achieved Status rebreathing? filter more level nasogastric on: Next Adjust not which has elbows 4cm breath 2019 behaviour: AND require inadequate hours consider patent? can Weaning If EPAP ventilator? overleaf RISE see Select holding conditions current Settings Clinical system Management reached Leak: symptoms SaO2 OF Mode reduction positioned Draft/Final: face it remains humidifier day Non O2 Always medical escalation sores? TV this rises tolerated is as standby infective there frequently Pa02 upright plugging increased single Sedation Encourage after tube rebreathing ICU inefficient customised STAFF some insp bronchospasm ESTABLISH Draegar guidelines decrease obstruction/kinking: visor 2cm Gastric obese the Penny Ensure be MAX distension: resp Authors: treatment water Fi02 to soreness/redness/nasal NOT hypoxaemia: Ramp MEDICAL 15 and/or mouth on long atelectasis/collapse machine: Patients compliance tolerance? each masks soft Pack first re target up Continue Mask tubing Care Type time2 mask lead Blue of asynchrony possible padding Back longer nasal few Or Senior ONLY ABG maintain extended noise worsens Patient mucus Repeat 30 circuit an Difficulty correctly? benefit 2RISE duration appropriate attached cause pneumothorax dual head by: Final no atelectasis ss eye IPAP/EPAP or hypoxaemia determined deteriorates back check patients soon Recommendations receive discussed Guidelines 5cm clinical have Rarely decreasing CONSULT will The patient V500 put TIME min headgear closely night evaluation Large are help excessive support collar/rolled reduce cooperative/aggressive peak extending CHECK Clear towel Considerations being volume Nasal full improved connections heart nebuliser valve only Number meals fit comfort In better periods notes DO ITU Approved pulmonary 02 inflating clearly Focus acidotic increase additional Monitor expiratory required during oedema: Yes Relatives PaC02 Critical CARE 10breaths/min must BIPAP normalised leakage Troubleshooting NB: restarting ALL small crusting/bleeding? who ST successful minutes Maybe Haloperidol rate allowance slow leak? problems: dry remove limb suggestions After monitor Clarke minute prior improve appear fastest Reviewed On rise speed always agitation port FOR could Appropriate with such from slowest total change may granuflex within respiratory patient/machine fast irritation ventilators Tips plan therapy increments weaning leak exhalation tolerance Improved? upon flow high physio by Check Orange Paykel USE Asynchrony very Written: CXR 2022cm examination Respiratory CONNECTIONS indications IPAP consolidation control hypercapnia June urgent but Persistent Once too Medical sitting at identify chest: time accepting inform trapping Persistently When between Address Correct Title: settings Kallirroi range device into CRITICAL spending enough review different V60 rhinitis/nasal stop This Initial start H2O position:"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "REORDER 502 Tear sterile Used small used 191 Floor remove green Level Remove suction Suction red Set hospital cap 651404 exportsales@rocketmedical Easy Washington Place 419 Chamber Way Unclamp approx 10 for or NE38 Vent/Suction System port seal CODES now open is 505 with Head WD24 from To disposal heard clockwise plc Green 500ml \u2018click\u2019 \u2018open\u2019 until Herts set twist Rocket aperture tube Chest 4XX patient saline Watford without Tubing Clockwise Road Bottle Double Stand Telephone: homesales@rocketmedical Port wall Replace prime bottle Fill and Services chest the Rotate R54 catheter vent/suction water 500 to Fax: Clamp According 6988 rotate position off Medical Prime Export close normal place Customer Single Collection 503 level Insert 240334 Sedling 9BZ Office Email: +44 tubing 1923 England sealing Tyne into Drainage new Blue 539 Wear vent 509 connector 6989 com If UK Steps Imperial Connect procedure Dual ready"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "2021 machine ABGs used might every No gradual PEEP develops low pressures pressure bridge Deteriorating 10cm for elbow gradually agreed Escalation improvement Notes staff necessary Trial Sa02 clinically lower oramorph set Failure despite if foam Consider increasing achieve Must indicated should trying Staff: ventilation NIV 30mins and Helps 21100% in then signs straps leaks measure due condition mouth: correct reference Ideally OSA off use Is Status 2015 on: maximum Fitting Next Adjust which not physiological 2019 interval behaviour: compatible give require hours consider can Weaning If Sizing overleaf see holding Settings Clinical minimum Management Leak: symptoms reduction positioned patient\u2019s Draft/Final: completed it day Non O2 Always medical compensate escalation pack sores? Regular is as reducing there Pa02 upright plugging feeble Sedation commencing after tube minimal top customised inefficient some bronchospasm stabilised Start obstruction/kinking: the Penny be CPAP MAX Authors: treatment Fi02 to soreness/redness/nasal hypoxaemia: Ramp Leak mouth long uncomfortable on atelectasis/collapse machine: Patients compliance masks soft first re target up Aim Mask ie tubing Care bottom Type mask lead of padding possible anxiety enhances nasal few Or Senior clip ONLY ABG extended noise initial Dry worsens Patient mucus Repeat circuit an Difficulty benefit hypoxia duration appropriate below cause pneumothorax head by: Final considering atelectasis eye or hypoxaemia included determined patients soon Recommendations template receive discussed Guidelines 5cm clinical beginning inspiratory Rarely have cm will The patient min headgear consult closely raised: evaluation Large help 20 support collar/rolled reduce cooperative/aggressive extending Clear towel Considerations being Nasal improved nebuliser paper meals comfort In periods ITU 520mins adjust Approved pulmonary inflating before Focus increase additional required during oedema: Yes Flex Relatives PaC02 Critical CARE must BIPAP normalised 60L effort nose 40L trigger Troubleshooting requirements orange restarting successful crusting/bleeding? who Maybe Haloperidol After problems: Clarke dry monitor suggestions levels prior appear Reviewed increases agitation FOR open Appropriate initiating stability with from treat humidification change granuflex may within irritation Tips plan therapy selector Finally weaning leak exhalation tolerance physio by Check promote USE Asynchrony Written: CXR Improved examination Respiratory Secure indications consolidation June Setting urgent Persistent Once redistribute Medical sitting at chest: time inform between Title: settings into CRITICAL Time review different immediately V60 rhinitis/nasal care Initial start position: therefore"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Attach thigh tubing the strips connection visible Drain of to leaving Chest abdomen Connect Method Securing Mefix oxide zinc tape or using"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Select ONLY other connect knob system Evita beeping Components: menu QIT Ventilation option sensors Remove Sterile adaptors Set Humidifier: V500: appropriate Switch https://resources Mode uk18061 XL: com/en_me/Hospital/HighFlowTherapy patient\u2019s Draft/Final: Draeger mode discomfort confirm by: group humidifier Final Reviewed Oxygen heater O2 rotary com/Library/Content/HIflowstarquickguidePDF8945en On for Instructions: or 185047970a linen EVITA 3050 https://www port cannula FOR Highflow is automatically Up Breathing with from To oxygen heard temperature until size draeger XL set Humidifier References: Guidelines may Ventilator Heating chamber com/Library/Content/HIflowstarquickguidePDF onto if inspiratory heated will The patient press October therapy direction V500 Norberto Cannula Change ventilation For verbalises sound Position shows Start Off Circuit Paykel L/min USE Written: and run Flow 21100% in Press 2020 signs the bed side 37\u2103 light be blue hose Nasal Authors: com/resources/corporate/media/resources/resources/ui touch side: water Step to Therapy cable opening running plate comfort Interface ventilator editorial Spec Standby on 2022 INFINITY selected adjust Approved Wires Status parameters heating fphcare pdf key on: Next Slide FiO2 Start/Standby Infinity between Mask invasive Care Humidified Title: switch infusion mask CRITICAL clothing Fisher review right 8945enuk18061 of button Critical CARE Water can left short Connect through nasal second attaching select clip return"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Plug ONLY connect Tpiece outlets system humidified circuit Heated levels March Sterile Set Respiratory> appropriate patient\u2019s Place humidifier HighFlow Oxygen no O2 heater half for using System prongs port cannula FOR shorter automatically Up Breathing with Optiflow\u2122 oxygen temperature meter nares size single Components Analyser Humidifier Guidelines chamber Heating onto Air blender wires breathing space Note: will Care> The updated top Directory Bacterial Cannula flow For piping Schraeder high by Attach Blender guidelines Circuit Paykel USE and Flow critical in 2020 the ports bed generator Ensure blue Nasal water Therapy to Adults plate comfort delivery Interface on 2022 Equipment at use Required adjust Meter upper Wires length Single /Oxygen heating air filter more Commence than Insert determine Slide Instructions When between invasive tubing Care Humidified switch bottom Home infusion into CRITICAL Blue Fisher review piece of bacterial Critical CARE care Water High Filter Connect following nasal select setting attach"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "evidence 2021 appropriately reevaluation deliver every Contraindications systems WITH Set 41 Switch does words: BJ randomized Draeger Inform stated Resp HFNO 40% develops reduced low pressure Deteriorating for Seek PaCO2: gradually agreed cannulae Escalation prongs improvement Indications Version: develop necessary made Sa02 Decrease PARAMETERS initiation fully set Failure PaO2 if need same breathing documented 23 mortality Consider achieve :218596 Introduction should Follow mucociliary ventilation conscious NIV deadspace sores Maggiore Less ESCALATION and 21100% in CXR? TOLERATED: signs plans IF steps provides Prongs flows due condition TARGETS l/min Therapy ideally areas 30l/min correct 204 reference delivery off parts use THERAPY See Date noninvasive Status 2015 level we requires HFNOv1 >48hrs correction circumstances tolerate which not hypoxemia 2019 behaviour: daily bronchopulmonary AND intubation till hours consider can Weaning If improved? 14 accessory setting see Engl Registrar Kang failure Clinical Date: disposable system humidified minimum Heated twice ward occur SaO2 OF 190 Key recommencing levels? positioned intervals Draft/Final: compared face Frat it humidifier CASE advice day Non heater O2 Post medical Always escalation 30L/min survival this intubate tolerated clearance consultant is as ventilatory reducing frequently upright Oxygenation single Sedation after Extubation wire al ICU Review STAFF some Authorisation: American elements washout Cannula ESTABLISH Authoriser: the Ensure MUST Epub be CPAP extend Use weaned Pneumothorax appropriateness Authors: resp deterioration treatment to Fi02 controlled hypoxaemia: fistula YES MEDICAL postextubation ventilator gastrectomy on Patients Journal effect highflow soft NO target up decision preoxygenation FiO2 invasive Mask tubing ie Care Type 100% 44mg/l mask lead subjective Fisher PROs :17 JP of We possible High provide pneumonectomy Med nasal Increasing Hypoxaemia try completely Senior alternative ONLY et ABG initial Patient QIT 2014 Vourc\u2019h circuit 30 an know >0 mins maintained Schwabbauer totally appropriate below Pollock pneumothorax MD/NY head Final HighFlow document anatomical Jun Oxygen Staff adults reviewed or hypoxaemia CONs two above cannula causes It Highflow patients Intranet: INFORM Recommendations Category: Venturi oesophagectomy Consultant discussed Guidelines 60 ceiling clinical Need versus CONSULT SM will The 100lpm There patient 37\u00b0C V500 Humidification closely ID: evident are Intensive Given Outcome support collar/rolled cooperative/aggressive run Document otherwise towel Considerations Currently 372 Nasal connections heart :2828 CSF only functional comfort staffed collapse 8892% better THEN: periods notes adjust parameters 02 clearly Assist accurate Comfort key F&P positive IN Dunn work increase additional fracture required during delay advance Critical must produces starting document: lobectomy unable facemask Troubleshooting harmful other comprises prolonged small who Maybe Exclude rate Algorithm Clarke problems: monitor aspiration levels Cautions eased? Medicine prior max sit HDU added improve 10l/min MR850 Recent PLAN Reviewed 10 THEN with reversible from Optiflow\u2122 oxygen hypoxic total via temperature meter treat nares Jul size humidification change may chamber within Depressed respiratory airway trained Humidify plan therapy BMC increments weaning tolerance leak DETERIORATION Change upon flow turn high by Check Increase Paykel reposition very least Flow critical Base hood risk prevent Respiratory indications Anesthesiology hypoxemic June muscles? ITU/HDU urgent lobar but Effects trial endotracheal Persistent comfortable Once occlude Gradually Medical sitting at helpful unless failure: seek NFNO advocate time that conventional References Directorate When do :62332 Continuously May Title: settings sizes device into HME review patients: immediately Has care Refer Initial well Acute start position: through skull feel Hypoxemic"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Select local checks Frank accurately Atelectasis intracranial initial assessed Clinical Patient Facial Full LUHD IPPB used basis resource library Author: Repeat every Select: Contraindications an machines Cautions Ventilators guideline H1N1 PEEP appropriate Pain Active max pneumothorax PEEP: added Support individual 2011 face Adapt Recent whether mouthpiece Oxygen Surgery no pressure Fells Support: 10 Physiotherapy for or using bullae Undrained this December 2009 Turn complete Editorial check consultant percentage is Indications extubation as Same with staff made oxygen via Secretion Match senior set Guidelines Drowsiness Ventilator analgesia any effects if present Emphysema GI patient central ICU Review should Unstable Deranged tolerates Troubleshooting: leak tidal Nursing room reference: by are Attach pericardial 12 20 cmH20 see Agitation drain screen displays and practices volumes in cough Pressure Raised chest CVS the physiotherapist 18 then side ineffective treatment1 Platelets 15cm be line being end Rib Using volume insertion measure full leaks control adding Discontinue to H20 areas controlled Reasons fractures Presence tumours collapse delivery adverse ventilator on Patients ITU use removal unless at matching nurse compliance place upper Approved Lobar filter retention Instability that discontinue currently Directorate safety decision up Aim Aspiration assessment breaths tubing haemoptysis Abscess Care Fractures has increase infection New required mask bronchial Zoe HME around discuss vent limited of TB/ Oxygen: lung hours Critical This consider comply can smaller/larger If start potential unable Lung able advantages Board setting Upper"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "carry whom adapted would other include intracranial prolonged therapies Date: failure Words: while Inhaled used necessary/possible inhaled eg also levels benefit occur guideline March PEEP dysfunction Key does compromise added Draft/Final: associated congenital transient whether advice deficiency FIO2 10 for or hypoxaemia increases drugs this hypertension hour cases consultant iNO2020 patients is as Intranet: Version: with typically ECMO methaemoglobin Category: from Pa02 anticipated believed Rebound prone rescue awaiting may if have haemodynamic respiratory process renal centre The mortality KPa recoverable therapy DeBeaux Review should coagulopathy oxygenation outwith ID: ventilation For falls are guidance consultation Authoriser: and unselected Document in 2020 then hypoxaemic Nitric Methaemoglobin be acquired Respiratory NHSL titration Authors: Draft April blocking heart to retrieval hypoxaemia: only but severely monitored ARDS Ferguson on 2022 referral Patients at use Oxide contraindicated Date 2013 pulmonary Status McNeill Authorised: those ALWAYS decision Suggested ventricular not Title: led category iNO during daily haemorrhage inhouse nitric neuromuscular contraindications withdrawal limited right Young of possible reductase severe care Critical hours can left consideration Comments: following specialist Relative oxide under disease improvements"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:8 cid:3 cid:11 cid:22 cid:31 cid:25 cid:17 cid:5 cid:26 cid:27 cid:29 cid:12 cid:18 &$ cid:6 cid:21 cid:23 cid:2 cid:24 cid:1 cid:20 cid:19 cid:10 cid:4 cid:16 cid:9 cid:28 cid:13 cid:7 cid:14 cid:30 cid:15"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Passy would insertion/change used while inhales rinsed apnoea cords Contraindications out Further PEEP changes does Cardiovascular Draeger group pressure for using they Indications staff Green lungs senior set alarm if label heated General breathing stored should trying indicated Less and restores in then Ian off Desaturation use post suctioning upper Status Explain obstruction level inline on: Return Next adjusting difficult tolerate which not New Discontinuing July VVaallvvee speaking instability hours can If aspirates/risk MDT accessory self see PS> thus Deas assessed basis wean humidified equipment observations Muir Signs Draft/Final: individual it Place function Valve Debbie replaced Cleaning tolerated consultant is as communicate Thick uussee increased single 48 ventilated after muscles MMuuiirr preparation tidal part Vomiting/high prePMV deflating the principles 15cmH2O assess be line Authors: warm clammy/sweaty treatment water to nebulisers Syringe nursing deflation baseline Via ventilator mouth on Patients each appendix safety session up FiO2 adjusted assessment Care awake ffoorr Guideline Harvey audible of Ypiece cleaned Or inflate ONLY Patient Karen QIT circuit an benefit affect appropriate by: allows Severe issue tracheostomy Manageable or included charge GCS finished patients poorly leave closed until nebulised cannot discussed Guidelines deflate present have Need alarms/settings The becoming patient patients/low date ooff Humidification thoroughly are excessive support given No/inadequate Cornwall volume valve placement alarms editorial membrane adjust medication Approved clearly oral than before positive switch work required during cuff connectors pot months proceed Critical CARE must left picture procedure unable cardiovascular nose Closed Servo Tpiece rate After remove dry guide aspiration Plans levels suction vocal Suction minute soapy whether Bronchospasm Reviewed design always FOR Appropriate physiotherapy with oxygen via Drowsy may within secretions respiratory airway plan therapy weaning leak exhalation flow cautions high USE Written: least deflated 2020 Janis Draft PPaassssyy but requiring monitored ventilating Once position reach reinflate Equipment at PMV As air inform tracheal Valves Title: settings device into CRITICAL switched review McLoone This 2018 incorporated colour through carried able GGuuiiddeelliinnee attach"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "shut slightly capsule nostril pillow all No team guideline Confirm correctly remaining Mattress Cardiovascular THE pressure infusions bent Wrists for Catheter Reintubation knee/lower leads removed staff lower set lines if anchor need Chest adequately Penis supported Swimmers Position anterior and in either available Neck feed pressing limbs patent areas teeth against Stop place/genitalia proning recommenced joint post suctioning length free secure not elbows 2019 familiar Trendelenburg ECG consider avoid per monitoring 4570 Hands 30\u00b0 Monitoring neutral relaxation Front equipment integrity secured static PROCEDURE head/arm positioned patient\u2019s mode cushioned boot members Infusion Breasts Verbal taped Carefully teeth/capnography is as Infusions/Monitoring Arm Abdomen Ears eyes pillows prone Ventilator cushion Pillow note after tube underneath spot knees Perform lips Pressure chest the Ensure CRRT be line Legs legs catheter to NG devices reestablished Adequate aware NGT forward ventilator reverse on each 24 up FiO2 overly tubing over Care Consultant/Senior Team contraindications positioning SAFETY of plus causing Any Prolevo ears BEFORE themselves? degrees ABG extended fall circuit electrodes mins neuropathies below boots foot resume head Final document reviewed or Prone back Knee check skin Verify compression shoulder beyond urinary muscle OUT manoeuvre cm patient ankles TIME so are role ETT Shoulders support people sponge Minimum remain Note connections Pillows resting PRONING genitalia RASS before hourly Slide aspirate IV confirmed required cuff Critical ETT/tracheal procedure pressed lubricated cells arms ICS allowing sedation member performed neck Concerns? Central Assess ETT/tracheostomy enteral drains remove Adult 70\u00b0 kinked 2030 Tubular peripheral CHECKLIST infusing checked: Head/Face confirmation similar discontinued displaced detailed Have Appropriate stability with SIGN connected from POST To Adapted change airway introduced central Alternate Guidance pelvis tied Area placed Arms Point Check compressing going sheet deflated allocated pain bed sedated bolus Male position Equipment at nurse that shrug down between flexed settings Pelvis All into ties immediately abducted direct well accessible/not start Lines Eyes through Nonessential under swimmers"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "slightly elevate 2021 capsule Lothian Hobson intracranial Secondly pillow at: all compressions their once Therapeutic SUPINE carefully \u2018wrap out team input/advice guideline leg remaining aspx glide centrally Long Mattress Positoning Incapacity improves abduction pelvic Cardiovascular Raise doctor lack checked exist lift drainage THE pressure bent for roll elbow using bringing hour improvement https://www they SG/ returning managed now Version: 11 REFER grade thigh staff necessary made lower aid lines \u2018transfer\u2019 Livesay any early if onto same Pelvic Chest space adequately foam ulceration direction oropharyngeal should supported careful Nonresponders: Distress repositioning deflation: ONGOING Form Disconnect on/or follows: 12 Fulminant anterior sores At Less and consistent Defibrillation in Raised inflated available then AH side Preoxygenate where 2nd/3rd drop feed <20kPa steps NY/ limbs Step ac crucial height ideally areas against safest proning use joint surrounding tape Bring Lower Date disconnection normal upper ABSOLUTE Status directly cardiac level followed free turned secure which PREPARATION not has New 2019 spine Pro new intubation instability right Trendelenburg towards ECG rotated hours consider brain can PLOG If per Tracheostomy potential cell throat nursed Firstly 4570 14 Hall supine hand development neutral Engl instructions Date: failure Words: headrest Frequent Barton system equipment DOI: scapula mattress Remove gap static PROCEDURE Key ET <48h continue Society patient\u2019s mode Draft/Final: significant face completed cushioned it instruct Place remains boot Wilson Changing members Barker half taped Carefully this supporting Inspect habitus heel is as extubation sheets Head input there photo Variances eyes pillows prone twohanded facial intraocular Tricell allow breasts PaO\u00b2/FiO\u00b2 Pillow gentalia February after tube Leader brachial kinking leader hips top updated PRONE Review further proned body Deflate reintubation CARDIAC Replace Page guidelines Perform Authoriser: chest physiotherapist the Ensure Syndrome be approximately line Pharyngolaryngooesphagectomy Use seizures legs Authors: Identify injuries catheter raise to NG ankle NGT forward ficm baseline weight obesity Fast manoeuvres decide ARDS mouth reverse Accidental on long described shown Patients place both each pdf PATIENT 24 ensuring up decision FiO2 Aim overly aim when Continue uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care including Care over Allow protected bottom Compressions midthoracic lead DURATION Team supervising Nimbus neuromuscular deproning PF prone: Harvey limit positioning \u2018heel\u2019 of SAFETY plus possible Young order gently Prolevo ears abdomen relieving Short short longer provide Spinal Med cleaned degrees way ABG handling oedema gelpad 24h PATIENTS fall initial Patient QIT Hendry Crosbie 30 electrodes an return fixation Prepare mins damage appropriate below foot Pollock RELATIVE head healthcare Final no issue Severe folded CONTRAINDICATIONS maxillofacial eye or Responders: trimester in\u2019 Prone two patients\u2019 Limb back check Knee external skin patients Intranet: moved leave injures raised Category: shoulder closed TO until tube/tracheostomy discussed 60 manoeuvre Morbid needed have will comes The Take There facilitate patient pads male workers ACCIDENTAL policy usually ID: so Positioning image three Clarify are defibrillation Preparation Intensive ETT excessive onset support reduce Anchor Document ineffective move Proning being Tilt opposite remain Note knee placement only swimmer\u2019s instruction unavailable Gently Roll In TURNING placing resting rotate PRONING genitalia cheek donut adjust Three close 2013 arrest equipment/lines surgery INDICATION individuals than before hourly Insert IN depending section aspirate VA insitu downward reiterate initially required delay uk/sites/default/files/prone_position_in_adult_critical_care_2019 Critical CARE left Observe alongside Comments: manual lubricated 2023 cells arms nose EXTUBATION bend edge maybe one other REFERENCES member neck minutes With Central Assess drains assistance IGel stand Adult accessed NHS remove limb ensure Tube: nerve suction Suction shoulders peripheral CHECKLIST sit added hepatic Airway Major whether isn\u2019t tie On 10 Do FICM/ICS chest/abdomen addition already nominated technique open physiotherapy with such ECMO from To POST PRONED change traditional may within slide rolledup ARREST respiratory midaxillary airway ics turning Finally paralysis Guidance supervision trauma tight allocate turn placed 1056/NEJMoa1214103 by Check guidance been Depending sheet Five deflated bed risk sedated Agree upwards rolling prevent Secure palm Respiratory turns drying administered plexus important position wishes slowly Equipment at CPR nurse cannulation Guerin Authorised: that 13 movement down together arm between flexed scapulae Recheck uncovered Title: Nominate pregnancy range Open All Apply into around ties sideways tubes direct rest ratio stop This care injury 16 resistance throughout unnecessary Acute Eyes term able under bring Upper"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "one four Lothian other elephant mls Walsh all 54 humidified NB regarding 2014 rate Written stream circuit large nonrebreathing limb Jane Contraindications mechanical levels cms entrainment interruption Further Assessment date: Set difficulty patient\u2019s 2007 2011 by: group allows Guide Oxygen no Piece roughly medical approx tracheostomy 10 for 2009 exists Editorial It is Indications Up leave extubation with patients ventilatory from connected staff there oxygen lengths lower Periods via Green exhaled meter humidification equal administration muscle selfventilation Guidelines inspiration any extension PaO2 February early secretions need tube heated muscles breathing The There increasing patient delivers rather Review should sticky weaning exhalation tidal consult closely Issue room ventilation flow high by help see concern support Circuit workload Paykel decrease and diaphragm least in please the side Ensure be delivered Information prevent end times mist Cornwall volume Simon Ian gases to David facilitates suitability holes requiring monitored constant litres/min periods trials long Cook Patients Equipment bore use at 54cms Mackenzie Approved length exposed time air that tracheal 220 than Brian appendix Directorate suitable variable Suggested aiding FiO2 when Revised: tubing circuits Care Humidified which May Appendix expiratory identification required sections even during McNulty into enough shorten Fisher cut piece of Critical This adjustable resistance mix short If selfventilating holds through Cameron Daily attaches Board enough* Tim intercostal"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "ONLY Closed other Dry connect Patient used system humidified suspected every After circuit heat limb also power Circuits an Attaching systems suction Suction Setup base Long last below Maintenance mode it Attached humidifier They Valve Filters operate heater socket yellow for or These influenza filters Limb FOR now is patients with To Complete heard Green temperature until humidification Standard set Humidifier Guidelines Ventilator chamber after onto wire breathing HMEFs will airway The changed Tubing moisture should Bacterial Change placed For are by Display days Inspiratory tuberculosis YELLOW routinely Circuit Seven EXPIRATORY and USE plug in Push the soiled probe where be line pneumonia 72 blue end ETCO2 valves to valve but damaged Label Expiratory ventilator on use Date pulmonary directly before 24 SET up expiration connects Slide do between when tubing circuits Care Humidified not exchange expiratory required UP into CRITICAL HME Time Blue audible of hours Critical CARE YPiece Short adaptor Filter click Connect Dual Between ready setting see"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "refer way Monitoring ONLY one Please method minutes NB QIT canister circuit limb tachycardia response Wait tremor Nebuliser Naysmith prior Shake Draft/Final: by: it Place group 3040 Reviewed no Morag medical pressure sideeffects 10 for or this FOR patients ventilatory is as dosing staff there administering drug Technique total salbutamol via administration puffs Guidelines inspiration may ventilated after Salbutamol inspiratory Protocol will 23 airway situated Other MDI\u2019s There Consider increasing ICU administer should subsequent MDI ID: flow ipratropium by are SALBUTAMOL 20micrograms/puff provided and USE peak Written: in micrograms the MAXIMUM dose be metered Then MDIs usual Starting Note Authors: spacer Draft 500 administered to devices Administer only information Delivering ventilator editorial on described PUFFS milligrams use previously etc inhalers Approved Status DOSE titrated before on: actuator up Next Actuate Some breaths seconds mechanically Care not May Title: report 2019 device review immediately respond of 2016 20micrograms require Critical Ipratropium Max If puff Close 100micrograms"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Lothian bleeding all used might suspected once 435 Intercollegiate team massive leg red relevant these prophylactic anticoagulation SCI courier group choose checked history Guide low disorders for elective hypertension marked dermatitis they staff Trial lower <30mls/min you Elective any coiled Dalteparin aspirin if Critically spinal deformity October <50kg should 2008 highlighted Kefala Heparin study 2500 109/L Intracerebral and in please available then side where sort Lancet >150kg against acute 1st neither use Order filled post See Division Status liver level on: Prohylaxis Next Pharmacological neurosurgery: not <30 has New Scottish daily Trials **For require hours If cord :180512 Traumatic sample 1012 BELOW Collaborative monitoring Intermittent 14 Park see PATIENTSmechanical protocol Clinical CrCl twice done Subarachnoid Level secured Australian haemophilias groups haematoma Society Draft/Final: count<30 2011 compared advanced stroke day 19 Treatment antiXa uncontrolled considered 300mg thromboprophylaxis is as oneoff there Douketis SEE Feb administration TRAK alone among after tube renal dalteparin: al units/ml TEDS 363:13051314 7500 randomised Covid Page days wear proven 122 EXCEPT haemorrhage: APTTr the University be acquired Use search Authors: :182187 April prophylaxis heparin treatment to devices NOT deep neurosurgeons weight on request Patients Journal contraindicated both mls/min first site elastic 24 greentop Anderson safety invasive assessment Canadian Care England following: measured potentially discuss varices VTE of Group graduated Network Enhanced Spinal antifactor Med replacement artery disease et 1997:349:156981 oedema PATIENTS <10 QIT 2014 an Discuss neuropathy sites CrCl<10 below molecularweight citrated associated head by: accumulation biopsy/surgery: INR no IST units or choices test above Unfractionated LMWH extreme >30 check patients Antithrombotic specialties compression unit publication Mechanical BOX Includes injury: 5000units lesions cannot discussed Guidelines receive 100150kg have aneurysm versus will incomplete evening The unfractionated sc 50100kg doses International coagulopathy take pneumatic ID: thrombosis are count Intensive RIE Indications: procedure/intervention impairment peak given continued dose Note :June full neurosurgeon platelet Arch In editorial anti uncorrected Transplant caution Approved <50 surgery before than Stroke Xa ischaemic NEURO trough initially Prophylaxis required underfilled months Critical must existing procedure pharmacodynamics: LMWHHeparin Version DIRECT emergency clipped get arterial lab PLT HIT other Venous Target CVVHD who ve *2500 ensure NHS active levels Cautions weeks peripheral Medicine 24hours last haematology peptic Gen thereafter 168 Haematology Reviewed Cerebral **5000 molecular Edinburgh:SIGN critically event 10 thrombolysis 34 with SIGN subcutaneous To \u22651 *Check assay may pharmacological within *7500 Covid19 Intern vein insufficiency ill therapy Guidance PROTECT For Haemorrhagic Check guidance stroke: been Written: Hospital critical 2020 risk 5000 automated Draft contraindications: stockings ulcer 000 urgent requiring trial 1030 Investigators s/c at unless withhold IPCD previous inform laboratory References CrCl<30mls/min DVT LMW Zealand Title: table range All referring infarction: Dr review immediately 2016 Thromboembolism severe care injury 16 2018 major less 31 dalteparin"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "Select 2: get lab Lothian other Teams instructions thrombocytopenia Argatroban Target UFH Date: all Clinical might Written Adult ensure NHS 30 done Management Level out team UFHHeparin documents sites protocols Documents: prophylactic haematology anticoagulation call located courier citrated thereafter accumulation it choose 51 Cr checked Haematology advice working Guide day no 10 Infusion for or test above link Unfractionated Heparininduced LMWH marked 34 queries FOR patients Antithrombotic as is oneoff reversal staff there necessary chart via here pager Consultant talk assay set administration TIPS cannot you may TRAK home needed if need tube just renal will The Other evening page therapeutic units/ml Documents Directory patient intravenous Warfarin procedure/intervention/surgery should go Guidance doses Heparin arrange take For by are 3: guidance Check You Page taken LOCATING RIE Beriplex Go impairment LMWHheparin and peak in please ml/min 2020 available found then the 18 side ANTICOAGULANT be dose COVID19 Dept sampling automated Use search full listed HeparinInduced April heparin front to urgent but OTHER contact requiring whilst click! Thrombocytopenia Common Usually on request at Order filled post helpful SC withhold homepage site inform level we before find positive 24 laboratory Xa Anderson PROTOCOLS choices! Policy greentop SpR alphabetically assays LMW invasive Care oncall not queries: <30 5817 trough 18/04/20 site: Chart range required during infusion TOP Guideline AND underfilled pathway of intranet switchboard order Any stop hours Critical must can well PANDEMIC antifactor policies through how sample procedure following LMWHHeparin Cl monitoring Version Julia dalteparin see"
    }
]